,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-37,"October 01, 2013 -  September 30, 2014",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Bing  He,"Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Jefferey  Hayes (University of Rochester medical Center)|Eran  Meshorer (Hebrew University)|Joseph  Orly (Hebrew University)",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Rafael Cristian Casellas; PhD (NIAMS) |David  Landsman; PhD (NLM),"1. Deng T, Zhu ZI, Zhang S, Leng F, Cherukuri S, Hansen L, Mariño-Ramírez L, Meshorer E, Landsman D, Bustin M (2013). HMGN1 modulates nucleosome occupancy and DNase I hypersensitivity at the CpG island promoters of embryonic stem cells. Mol Cell Biol  33, 3377-89.   https://doi.org/10.1128/MCB.00435-13|2. Postnikov YV, Furusawa T, Haines DC, Factor VM, Bustin M (2014). Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Mol Cancer Res  12, 82-90.   https://doi.org/10.1158/1541-7786.MCR-13-0392|3. Zhang S, Schones DE, Malicet C, Rochman M, Zhou M, Foisner R, Bustin M (2013). High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization. J Biol Chem  288, 18104-9.   https://doi.org/10.1074/jbc.C113.469544",https://intramural.nih.gov/search/searchview.taf?ipid=83459
1,BC004504-42,"October 01, 2013 -  September 30, 2014",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Christophe  Cataisson|Luowei  Li|Francesca  Mascia|Kameron Bryan Rodrigues|Vanesa Cecilia Sanchez; PhD,Adam  Glick; PhD (NCI)|Ken  Greis (University of Cincinnati Cancer Institute),Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Dolph Lee Hatfield; PhD (Mouse Cancer Genetics Program),Maria Irene Morasso; PhD (NIAMS) |Wendy  Weinberg (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83460
2,BC004517-38,"October 01, 2013 -  September 30, 2014",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|N G  Jaspers (Genetics, Erasmus Univ)|Show all 12","Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Genetic Epidemiology Branch)|Michael  Bustin; PhD (Protein Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)","Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD) |Suvimol  Hill; MD (CC)","1. Brooks BP, Thompson AH, Bishop RJ, Clayton JA, Chan CC, Tsilou ET, Zein WM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki S, Emmert S, Iliff NT, Bradford P, Digiovanna JJ, Kraemer KH (2013). Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage. Ophthalmology  120, 1324-36.   https://doi.org/10.1016/j.ophtha.2012.12.044|2. Emmert S, Kraemer KH (2013). Do not underestimate nucleotide excision repair: it predicts not only melanoma risk but also survival outcome. J Invest Dermatol  133, 1713-7.   https://doi.org/10.1038/jid.2013.72|3. Kraemer K, DiGiovanna J (2014) Xeroderma Pigmentosum (updated Feb 13 2014). GeneReviews (Internet), in press.|4. Kraemer KH, Tamura D, Khan SG, Digiovanna JJ (2013). Burning issues in the diagnosis of xeroderma pigmentosum. Br J Dermatol  169, 1176.   https://doi.org/10.1111/bjd.12707|5. Kuschal C, DiGiovanna JJ, Khan SG, Gatti RA, Kraemer KH (2013). Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc Natl Acad Sci U S A  110, 19483-8.   https://doi.org/10.1073/pnas.1312088110|6. Masaki T, Wang Y, DiGiovanna JJ, Khan SG, Raffeld M, Beltaifa S, Hornyak TJ, Darling TN, Lee CC, Kraemer KH (2014). High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. Pigment Cell Melanoma Res  27, 454-64.   https://doi.org/10.1111/pcmr.12226|7. Tamura D, DiGiovanna JJ, Khan SG, Kraemer KH (2014). Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed  30, 146-52.   https://doi.org/10.1111/phpp.12108|8. Tan X, Anzick SL, Khan SG, Ueda T, Stone G, Digiovanna JJ, Tamura D, Wattendorf D, Busch D, Brewer CC, Zalewski C, Butman JA, Griffith AJ, Meltzer PS, Kraemer KH (2013). Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency. Hum Mutat  34, 1250-9.   https://doi.org/10.1002/humu.22354|9. Totonchy MB, Tamura D, Pantell MS, Zalewski C, Bradford PT, Merchant SN, Nadol J, Khan SG, Schiffmann R, Pierson TM, Wiggs E, Griffith AJ, DiGiovanna JJ, Kraemer KH, Brewer CC (2013). Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration. Brain  136, 194-208.   https://doi.org/10.1093/brain/aws317|10. Viana LM, Seyyedi M, Brewer CC, Zalewski C, DiGiovanna JJ, Tamura D, Totonchy M, Kraemer KH, Nadol JB (2013). Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration. Otol Neurotol  34, 1230-6.   https://doi.org/10.1097/MAO.0b013e31829795e9",https://intramural.nih.gov/search/searchview.taf?ipid=83461
3,BC005093-36,"October 01, 2013 -  September 30, 2014",GrowthDifferentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Susan  Mackem; MD,Frank  Costantini; PhD (Columbia University)|Harold  Lovvorn (Vanderbilt University)|Thomas C Carroll|Emilio  Casanova (Ludwig Boltzmann Institute)|Ryuichi  Nishnakamura (Kumamoto University - Institute of Molecular Embryology and Genetics),Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Mark B Lewandoski (Genetics of Vertebrate Development Section)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|James  Lautenberger; PhD (Office of the Director)|George  Nelson (Office of the Director),Lothar  Hennighausen; PhD (NIDDK),"1. Hall M, Perantoni A (2013) Wilms TumorNephroblastoma:  a metanephric caricature, in Stem Cell Handbook., in press.|2. Das A, Tanigawa S, Karner CM, Xin M, Lum L, Chen C, Olson EN, Perantoni AO, Carroll TJ (2013). Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation. Nat Cell Biol  15, 1035-44.   https://doi.org/10.1038/ncb2828|3. Tokar EJ, Person RJ, Sun Y, Perantoni AO, Waalkes MP (2013). Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype. Chem Res Toxicol  26, 96-105.   https://doi.org/10.1021/tx3004054",https://intramural.nih.gov/search/searchview.taf?ipid=83462
4,BC005148-35,"October 01, 2013 -  September 30, 2014",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,NULL,"Basic Research Laboratory, NCI",Gilbert  Smith; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83463
5,BC005177-34,"October 01, 2013 -  September 30, 2014",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kathyayini Venkataseshasai Divi|Corbin D Ester,NULL,Qing  Lan (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83464
6,BC005258-35,"October 01, 2013 -  September 30, 2014",Molecular Studies of Eukaryotic Gene Regulation,Bruce  Paterson; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Yikang  Rong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83465
7,BC005268-27,"October 01, 2013 -  September 30, 2014",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,Alastair  Goldman (University of Sheffield)|Alain  Nicolas,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83467
8,BC005270-33,"October 01, 2013 -  September 30, 2014",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Adelle  Abramovitz|Agnes  Czikora|Timothy E Esch|Tamas  Geczy|Noemi  Kedei|Jessica S Kelsey|Show all 11,"James  Stone (Dept. of Cardiology, University of Alberta)|Gary  Keck (Dept. of Chemistry, University of Utah)|Raz  Jelinek|Daniel J Lundberg|Julieta  Comin (University of Buenos Aires)|Jeewoo  Lee (Seoul National Univeristy)|Show all 10",Victor  Marquez; PhD (Chemical Biology Laboratory)|Megan L Peach (Chemical Biology Laboratory)|Susan H Garfield (Laboratory of Experimental Carcinogenesis),NULL,"1. Chen JQ, Heldman MR, Herrmann MA, Kedei N, Woo W, Blumberg PM, Goldsmith PK (2013). Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. Anal Biochem  442, 97-103.   https://doi.org/10.1016/j.ab.2013.07.022|2. Ha TH, Ryu H, Kim SE, Kim HS, Ann J, Tran PT, Hoang VH, Son K, Cui M, Choi S, Blumberg PM, Frank R, Bahrenberg G, Schiene K, Christoph T, Frormann S, Lee J (2013). TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides. Bioorg Med Chem  21, 6657-64.   https://doi.org/10.1016/j.bmc.2013.08.015|3. Kedei N, Lewin NE, Géczy T, Selezneva J, Braun DC, Chen J, Herrmann MA, Heldman MR, Lim L, Mannan P, Garfield SH, Poudel YB, Cummins TJ, Rudra A, Blumberg PM, Keck GE (2013). Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1. ACS Chem Biol  8, 767-77.   https://doi.org/10.1021/cb300671s|4. Lim KS, Lee H, Kim SE, Ha TH, Ann J, Son K, Choi S, Sun W, Pearce LV, DeAndrea-Lazarus IA, Blumberg PM, Lee J (2013). The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands. Eur J Med Chem  68, 233-43.   https://doi.org/10.1016/j.ejmech.2013.07.042|5. Song X, Lopez-Campistrous A, Sun L, Dower NA, Kedei N, Yang J, Kelsey JS, Lewin NE, Esch TE, Blumberg PM, Stone JC (2013) RasGRPs are targets of the anti-cancer agent ingenol-3-angelate. PLoS One 8:e72331|6. Thorat SA, Kang DW, Ryu H, Kim MS, Kim HS, Ann J, Ha T, Kim SE, Son K, Choi S, Blumberg PM, Frank R, Bahrenberg G, Schiene K, Christoph T, Lee J (2013). 2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists: structure activity relationships of the 2-oxy pyridine C-region. Eur J Med Chem  64, 589-602.   https://doi.org/10.1016/j.ejmech.2013.04.003|7. van Veghel D, Cleynhens J, Pearce LV, Blumberg PM, Van Laere K, Verbruggen A, Bormans G (2013). Synthesis and biological evaluation of [¹¹C]SB366791: a new PET-radioligand for in vivo imaging of the TRPV1 receptor. Nucl Med Biol  40, 141-7.   https://doi.org/10.1016/j.nucmedbio.2012.08.011|8. van Veghel D, Cleynhens J, Pearce LV, DeAndrea-Lazarus IA, Blumberg PM, Van Laere K, Verbruggen A, Bormans G (2013). New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation. ACS Chem Neurosci  4, 624-34.   https://doi.org/10.1021/cn300233v",https://intramural.nih.gov/search/searchview.taf?ipid=83468
9,BC005271-23,"October 01, 2013 -  September 30, 2014",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Ximiao  He|Sanjit  Mukherjee,NULL,Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Michael  Bustin; PhD (Protein Section)|Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,"1. Arteaga-Solis E, Zee T, Emala CW, Vinson C, Wess J, Karsenty G (2013). Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma. Cell Metab  17, 35-48.   https://doi.org/10.1016/j.cmet.2012.12.004|2. Caravaca JM, Donahue G, Becker JS, He X, Vinson C, Zaret KS (2013). Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev  27, 251-60.   https://doi.org/10.1101/gad.206458.112|3. Gao R, Das BB, Chatterjee R, Abaan OD, Agama K, Matuo R, Vinson C, Meltzer PS, Pommier Y (2014). Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel. DNA Repair (Amst)  13, 1-9.   https://doi.org/10.1016/j.dnarep.2013.09.001|4. Grøntved L, John S, Baek S, Liu Y, Buckley JR, Vinson C, Aguilera G, Hager GL (2013). C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J  32, 1568-83.   https://doi.org/10.1038/emboj.2013.106|5. He X, Chatterjee R, John S, Bravo H, Sathyanarayana BK, Biddie SC, FitzGerald PC, Stamatoyannopoulos JA, Hager GL, Vinson C (2013). Contribution of nucleosome binding preferences and co-occurring DNA sequences to transcription factor binding. BMC Genomics  14, 428.   https://doi.org/10.1186/1471-2164-14-428|6. Mann IK, Chatterjee R, Zhao J, He X, Weirauch MT, Hughes TR, Vinson C (2013). CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res  23, 988-97.   https://doi.org/10.1101/gr.146654.112|7. Rozenberg JM, Bhattacharya P, Chatterjee R, Glass K, Vinson C (2013). Combinatorial recruitment of CREB, C/EBPβ and c-Jun determines activation of promoters upon keratinocyte differentiation. PLoS One  8, e78179.   https://doi.org/10.1371/journal.pone.0078179",https://intramural.nih.gov/search/searchview.taf?ipid=83469
10,BC005317-31,"October 01, 2013 -  September 30, 2014",Role of Selenium in Development and Health,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Daniel Milgram Beaglehole|Bradley A Carlson|Ryuta  Tobe|Petra Akiko Tsuji,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Marcus  Conrad (Institute of Clinical Molecular Biology and Tumor Genetics)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Cindy D Davis (OD),"1. Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN (2014). Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci  39, 112-20.   https://doi.org/10.1016/j.tibs.2013.12.007|2. Kasaikina MV, Turanov AA, Avanesov A, Schweizer U, Seeher S, Bronson RT, Novoselov SN, Carlson BA, Hatfield DL, Gladyshev VN (2013). Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis. Carcinogenesis  34, 1089-95.   https://doi.org/10.1093/carcin/bgt011|3. Moustafa ME, Carlson BA, Anver MR, Bobe G, Zhong N, Ward JM, Perella CM, Hoffmann VJ, Rogers K, Combs GF, Schweizer U, Merlino G, Gladyshev VN, Hatfield DL (2013). Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFα. PLoS One  8, e57389.   https://doi.org/10.1371/journal.pone.0057389|4. Naranjo-Suarez S, Carlson BA, Tobe R, Yoo MH, Tsuji PA, Gladyshev VN, Hatfield DL (2013). Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. Mol Cells  36, 151-7.   https://doi.org/10.1007/s10059-013-0121-y|5. Patterson AD, Carlson BA, Li F, Bonzo JA, Yoo MH, Krausz KW, Conrad M, Chen C, Gonzalez FJ, Hatfield DL (2013). Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity. Chem Res Toxicol  26, 1088-96.   https://doi.org/10.1021/tx4001013|6. Seeher S, Carlson BA, Miniard AC, Wirth EK, Mahdi Y, Hatfield DL, Driscoll DM, Schweizer U (2014). Impaired selenoprotein expression in brain triggers striatal neuronal loss leading to co-ordination defects in mice. Biochem J  462, 67-75.   https://doi.org/10.1042/BJ20140423|7. Sengupta A, Lichti UF, Carlson BA, Cataisson C, Ryscavage AO, Mikulec C, Conrad M, Fischer SM, Hatfield DL, Yuspa SH (2013). Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J Invest Dermatol  133, 1731-41.   https://doi.org/10.1038/jid.2013.52|8. Turanov AA, Shchedrina VA, Everley RA, Lobanov AV, Yim SH, Marino SM, Gygi SP, Hatfield DL, Gladyshev VN (2014). Selenoprotein S is involved in maintenance and transport of multiprotein complexes. Biochem J  462, 555-65.   https://doi.org/10.1042/BJ20140076|9. Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL (2013). Abrogated thioredoxin system causes increased sensitivity to TNF-α-induced apoptosis via enrichment of p-ERK 1/2 in the nucleus. PLoS One  8, e71427.   https://doi.org/10.1371/journal.pone.0071427",https://intramural.nih.gov/search/searchview.taf?ipid=83470
11,BC005445-30,"October 01, 2013 -  September 30, 2014",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joanna  Anders|Christophe  Cataisson|Chang Hee  Han|Luowei  Li|Francesca  Mascia|Vanesa Cecilia Sanchez; PhD,Addie  Alkhas; MD|Philip  Dennis (Johns Hopkins Cancer Center)|Michael  Miles,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",John J O'Shea; MD (NIAMS) |Thomas B Friedman; PhD (NIDCD),"1. Wojciak-Stothard B, Abdul-Salam VB, Lao KH, Tsang H, Irwin DC, Lisk C, Loomis Z, Stenmark KR, Edwards JC, Yuspa SH, Howard LS, Edwards RJ, Rhodes CJ, Gibbs JS, Wharton J, Zhao L, Wilkins MR (2014) Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation 129:1770-80",https://intramural.nih.gov/search/searchview.taf?ipid=83471
12,BC005450-31,"October 01, 2013 -  September 30, 2014",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Songjoon  Baek|Ido  Goldstein; PhD|Michael Joseph Guertin|Thomas A Johnson|Sohyoung  Kim|Qizong  Lao; PhD|Show all 14,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Fahri  Saatcioglu (Department of Biology, University of Oslo)|John  Stamatoyanopolus (Genome Sciences, University of Washington)|Michael  Stallcup (Univ of Southern California)|Susanne  Mandrup (University of Southern Denmark)|Michael J Garabedian; PhD (Microbiology and Kaplan Cancer Center, New York University Medical Center)|Show all 11","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Charles  Vinson; PhD (Laboratory of Metabolism)|David  Levens; PhD (Laboratory of Pathology)|John Carl Oberholtzer (Laboratory of Pathology)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Michael  Dean; PhD (Laboratory of Experimental Immunology)","Greti  Aguilera Harwood; MD (NICHD) |Rafael Cristian Casellas; PhD (NIAMS) |Jay H Chung; MD, PhD (NHLBI) |Iain  Fraser (NIAID) |John J O'Shea; MD (NIAMS)","1. Grøntved L, John S, Baek S, Liu Y, Buckley JR, Vinson C, Aguilera G, Hager GL (2013). C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J  32, 1568-83.   https://doi.org/10.1038/emboj.2013.106|2. He X, Chatterjee R, John S, Bravo H, Sathyanarayana BK, Biddie SC, FitzGerald PC, Stamatoyannopoulos JA, Hager GL, Vinson C (2013). Contribution of nucleosome binding preferences and co-occurring DNA sequences to transcription factor binding. BMC Genomics  14, 428.   https://doi.org/10.1186/1471-2164-14-428|3. Lalmansingh AS, Arora K, Demarco RA, Hager GL, Nagaich AK (2013). High-throughput RNA FISH analysis by imaging flow cytometry reveals that pioneer factor Foxa1 reduces transcriptional stochasticity. PLoS One  8, e76043.   https://doi.org/10.1371/journal.pone.0076043|4. Miranda TB, Morris SA, Hager GL (2013). Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor. Mol Cell Endocrinol  380, 16-24.   https://doi.org/10.1016/j.mce.2013.03.002|5. Miranda TB, Voss TC, Sung MH, Baek S, John S, Hawkins M, Grøntved L, Schiltz RL, Hager GL (2013). Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Res  73, 5130-9.   https://doi.org/10.1158/0008-5472.CAN-13-0742|6. Mousavi K, Zare H, Dell'orso S, Grontved L, Gutierrez-Cruz G, Derfoul A, Hager GL, Sartorelli V (2013). eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell  51, 606-17.   https://doi.org/10.1016/j.molcel.2013.07.022",https://intramural.nih.gov/search/searchview.taf?ipid=83472
13,BC005522-27,"October 01, 2013 -  September 30, 2014",Thyroid StemProgenitor Cells,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Manabu  Iwadate|Shigetoshi  Yokoyama,NULL,NULL,"Jerrold M Ward; DVM, PhD (NIAID)","1. Kimura S (2014) Thyroid regeneration: how stem cells play a role? Front Endocrinology 5:55|2. Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S (2013). Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration. PLoS One  8, e80801.   https://doi.org/10.1371/journal.pone.0080801|3. Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, Crowley D, Whittaker CA, Meyerson M, Kimura S, Jacks T (2013). Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol Cell  50, 185-99.   https://doi.org/10.1016/j.molcel.2013.02.018",https://intramural.nih.gov/search/searchview.taf?ipid=83473
14,BC005562-27,"October 01, 2013 -  September 30, 2014",Xenobiotic-Metabolizing Enzymes,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",NULL,"Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Xiaochao  Ma (NCI)|Andrew  Patterson (Pennsylvania State University)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Fan X, Jiang Y, Wang Y, Tan H, Zeng H, Wang Y, Chen P, Qu A, Gonzalez FJ, Huang M, Bi H (2014). Wuzhi tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways. Drug Metab Dispos  42, 1982-90.   https://doi.org/10.1124/dmd.114.059535|2. Fang ZZ, Gonzalez FJ (2014). LC-MS-based metabolomics: an update. Arch Toxicol  88, 1491-502.   https://doi.org/10.1007/s00204-014-1234-6|3. Ma HY, Sun DX, Cao YF, Ai CZ, Qu YQ, Hu CM, Jiang C, Dong PP, Sun XY, Hong M, Tanaka N, Gonzalez FJ, Ma XC, Fang ZZ (2014). Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7. Toxicol Appl Pharmacol  277, 86-94.   https://doi.org/10.1016/j.taap.2014.02.021|4. Manna SK, Tanaka N, Krausz KW, Haznadar M, Xue X, Matsubara T, Bowman ED, Fearon ER, Harris CC, Shah YM, Gonzalez FJ (2014). Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology  146, 1313-24.   https://doi.org/10.1053/j.gastro.2014.01.017",https://intramural.nih.gov/search/searchview.taf?ipid=83474
15,BC005597-25,"October 01, 2013 -  September 30, 2014",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Ramatoulaye Kane Deme|Serhiy Volodymirovych Surkov; PhD|Yang  Zhang,"Carolyn  Suzuki (Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey)|Sung Gyun Kang; PhD|Joaquin  Ortega (McMaster University Health Sciences Centre)|Anuradha  Janakiraman (The City College of CUNY)|Alfred  Goldberg (Department Cell Biology, Harvard University Medical School)|George  Stan (University of Cincinnati)","Di S Xia; PhD, MS, BS (Crystallography Section)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)",Grzegorz  Piszczek; PhD (NHLBI) |Thomas B Friedman; PhD (NIDCD),"1. Humbard MA, Surkov S, De Donatis GM, Jenkins LM, Maurizi MR (2013). The N-degradome of Escherichia coli: limited proteolysis in vivo generates a large pool of proteins bearing N-degrons. J Biol Chem  288, 28913-24.   https://doi.org/10.1074/jbc.M113.492108|2. Maurizi MR, Stan G (2013). ClpX shifts into high gear to unfold stable proteins. Cell  155, 502-4.   https://doi.org/10.1016/j.cell.2013.10.007",https://intramural.nih.gov/search/searchview.taf?ipid=83475
16,BC005598-25,"October 01, 2013 -  September 30, 2014",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Carol O Cardarelli|King Leung Fung|Matthew David Hall|James Patrick Madigan|Kristen M Pluchino|Marina  Stukova|Show all 9,"Gergely  Szakcs (Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences)|JeanPierre  Gillet (University of Namur)","Di S Xia; PhD, MS, BS (Crystallography Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Susan  Bates; MD (Developmental Therapeutics Branch)","Chava  Kimchi-Sarfaty (OD) |Christopher P Austin; AB, MD (NCATS) |Robert  Innis; MD (NIMH) |Kevin G Chen; MD (NINDS)","1. Bakhsheshian J, Hall MD, Robey RW, Herrmann MA, Chen JQ, Bates SE, Gottesman MM (2013). Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos  41, 1805-12.   https://doi.org/10.1124/dmd.113.053140|2. Galski H, Oved-Gelber T, Simanovsky M, Lazarovici P, Gottesman MM, Nagler A (2013). P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway. Biochem Pharmacol  86, 584-96.   https://doi.org/10.1016/j.bcp.2013.06.004|3. Kannan P, Pike VW, Halldin C, Langer O, Gottesman MM, Innis RB, Hall MD (2013). Factors that limit positron emission tomography imaging of p-glycoprotein density at the blood-brain barrier. Mol Pharm  10, 2222-9.   https://doi.org/10.1021/mp400011g|4. Salari R, Kimchi-Sarfaty C, Gottesman MM, Przytycka TM (2013). Sensitive measurement of single-nucleotide polymorphism-induced changes of RNA conformation: application to disease studies. Nucleic Acids Res  41, 44-53.   https://doi.org/10.1093/nar/gks1009",https://intramural.nih.gov/search/searchview.taf?ipid=83476
17,BC005599-24,"October 01, 2013 -  September 30, 2014","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Yantenew  Gete|Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD,Yang  Xu (University of California)|Tatiana  Kutateladze (University of Colorado Denver School of Medicine),Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Horikawa I, Fujita K, Miller Jenkins L, Hiyoshi Y, Mondal A, Vojtesek B, Lane D, Appella E, Harris C (2014) Autophagic degradation of the inhibitory p53 isoform delta133p53alpha as a regulatory mechanism for p53-mediated senescence. Nat Commun, in press.|2. Lu X, Mazur SJ, Lin T, Appella E, Xu Y (2014). The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene  33, 2655-64.   https://doi.org/10.1038/onc.2013.209",https://intramural.nih.gov/search/searchview.taf?ipid=83477
18,BC005645-25,"October 01, 2013 -  September 30, 2014",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Maria Fernanda  Amarante|Veronica  Galli|Corrado  Gurgo|Robyn M Washington Parks,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)",NULL,Steven J Jacobson; PhD (NINDS) |Klaus  Strebel; PhD (NIAID),"1. Edwards D, Fukumoto R, de Castro-Amarante MF, Alcantara LC, Galvão-Castro B, Washington Parks R, Pise-Masison C, Franchini G (2014). Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission. J Virol  88, 2319-22.   https://doi.org/10.1128/JVI.03444-13|2. Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, Chevalier SA, Edwards D, Ruscetti F, Pise-Masison CA, Franchini G (2014) Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells. J Virol 88:393-402|3. PiseMasison C, Amarante M, EnoseAkahata Y, Buchmann R, Fenizia C, Washington Parks R, Edwards D, Fiocchi M, Alcantara L, Bialuk I, Graham J, Walser J, McKinnon K, GalvaoCastro B, Gessain A, Venzon D, Jacobson S, Franchini G (2014) Co-dependence of HTLV-1 p12 and p8 Functions in Virus Persistence. PLOS Pathogens, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83478
19,BC005673-24,"October 01, 2013 -  September 30, 2014",Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",NULL,"Melina  Kibbe (Division of Vascular Surgery, Northwestern University)|Jeffrey  Deschamps (Naval Research Laboratory)|Sonia  Donzelli|Paul  Shami (Medical Oncology, U of Utah)|Astrid  Weyerbrock (UNIVERSITTSKLINIKUM FREIBURG)","Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|David Anderson Wink (Radiation Biology Branch)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology)",NULL,"1. Holland RJ, Paulisch R, Cao Z, Keefer LK, Saavedra JE, Donzelli S (2013). Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase. Nitric Oxide  35, 131-6.   https://doi.org/10.1016/j.niox.2013.10.003|2. Wang YN, Collins J, Holland RJ, Keefer LK, Ivanic J (2013). Decoding nitric oxide release rates of amine-based diazeniumdiolates. J Phys Chem A  117, 6671-7.   https://doi.org/10.1021/jp404589p",https://intramural.nih.gov/search/searchview.taf?ipid=83480
20,BC005708-23,"October 01, 2013 -  September 30, 2014",Xenobiotic Receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",NULL,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Kalipada  Pahan; PhD (Department of Neurological Sciences, Rush University Medical Center)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah",NULL,Oksana  Gavrilova; PhD (NIDDK),"1. Cheng J, Fang ZZ, Kim JH, Krausz KW, Tanaka N, Chiang JY, Gonzalez FJ (2014). Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice. J Lipid Res  55, 455-65.   https://doi.org/10.1194/jlr.M044420|2. Feuermann Y, Kang K, Gavrilova O, Haetscher N, Jang SJ, Yoo KH, Jiang C, Gonzalez FJ, Robinson GW, Hennighausen L (2013). MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse. RNA Biol  10, 1807-14.   https://doi.org/10.4161/rna.27239|3. Holmstock N, Gonzalez FJ, Baes M, Annaert P, Augustijns P (2013). PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein. Mol Pharm  10, 1056-62.   https://doi.org/10.1021/mp300512r|4. Ito S, Satoh J, Matsubara T, Shah YM, Ahn SH, Anderson CR, Shan W, Peters JM, Gonzalez FJ (2013). Cholestasis induces reversible accumulation of periplakin in mouse liver. BMC Gastroenterol  13, 116.   https://doi.org/10.1186/1471-230X-13-116|5. Jiang C, Kim JH, Li F, Qu A, Gavrilova O, Shah YM, Gonzalez FJ (2013). Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes. J Biol Chem  288, 3844-57.   https://doi.org/10.1074/jbc.M112.426338|6. Johnson CH, Bonzo JA, Cheng J, Krausz KW, Kang DW, Luecke H, Idle JR, Gonzalez FJ (2013). Cytochrome P450 regulation by α-tocopherol in Pxr-null and PXR-humanized mice. Drug Metab Dispos  41, 406-13.   https://doi.org/10.1124/dmd.112.048009|7. Kim JH, Qu A, Reddy JK, Gao B, Gonzalez FJ (2014). Hepatic oxidative stress activates the Gadd45b gene by way of degradation of the transcriptional repressor STAT3. Hepatology  59, 695-704.   https://doi.org/10.1002/hep.26683|8. Lau SM, Cha KM, Karunatillake A, Stokes RA, Cheng K, McLean M, Cheung NW, Gonzalez FJ, Gunton JE (2013). Beta-cell ARNT is required for normal glucose tolerance in murine pregnancy. PLoS One  8, e77419.   https://doi.org/10.1371/journal.pone.0077419|9. Li F, Lu J, Cheng J, Wang L, Matsubara T, Csanaky IL, Klaassen CD, Gonzalez FJ, Ma X (2013). Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med  19, 418-20.   https://doi.org/10.1038/nm.3104|10. Liu HX, Fang Y, Hu Y, Gonzalez FJ, Fang J, Wan YJ (2013). PPARβ Regulates Liver Regeneration by Modulating Akt and E2f Signaling. PLoS One  8, e65644.   https://doi.org/10.1371/journal.pone.0065644|11. Mejia-Garcia A, Sanchez-Ocampo EM, Galindo-Gomez S, Shibayama M, Reyes-Hernandez O, Guzman-Leon S, Gonzalez FJ, Elizondo G (2013). 2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances CCl4-induced hepatotoxicity in an aryl hydrocarbon receptor-dependent manner. Xenobiotica  43, 161-8.   https://doi.org/10.3109/00498254.2012.707790|12. Montanez JE, Peters JM, Correll JB, Gonzalez FJ, Patterson AD (2013). Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha. Toxicol Pathol  41, 410-8.   https://doi.org/10.1177/0192623312466960|13. Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ (2014). Role of Myc in hepatocellular proliferation and hepatocarcinogenesis. J Hepatol  60, 331-8.   https://doi.org/10.1016/j.jhep.2013.09.024|14. Sato S, Shirakawa H, Tomita S, Tohkin M, Gonzalez FJ, Komai M (2013). The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicol Appl Pharmacol  273, 90-9.   https://doi.org/10.1016/j.taap.2013.08.017|15. Singh A, Happel C, Manna SK, Acquaah-Mensah G, Carrerero J, Kumar S, Nasipuri P, Krausz KW, Wakabayashi N, Dewi R, Boros LG, Gonzalez FJ, Gabrielson E, Wong KK, Girnun G, Biswal S (2013). Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest  123, 2921-34.   https://doi.org/10.1172/JCI66353|16. Viswakarma N, Jia Y, Bai L, Gao Q, Lin B, Zhang X, Misra P, Rana A, Jain S, Gonzalez FJ, Zhu YJ, Thimmapaya B, Reddy JK (2013) The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase. J Biol Chem 288:27898-911|17. Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E, Becker K, Biragyn A (2013). Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α. J Immunol  190, 2575-84.   https://doi.org/10.4049/jimmunol.1201920|18. Yao PL, Gonzalez FJ, Peters JM (2014). Targeting estrogen receptor-β for the prevention of nonmelanoma skin cancer. Cancer Prev Res (Phila)  7, 182-5.   https://doi.org/10.1158/1940-6207.CAPR-13-0409|19. Zhu B, Ferry CH, Blazanin N, Bility MT, Khozoie C, Kang BH, Glick AB, Gonzalez FJ, Peters JM (2014). PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling. Oncogene  33, 5348-59.   https://doi.org/10.1038/onc.2013.477",https://intramural.nih.gov/search/searchview.taf?ipid=83481
21,BC005740-22,"October 01, 2013 -  September 30, 2014",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Aleksandra M Michalowska|Kent W Hunter; PhD|Lalage  Wakefield; PhD,Alfonso  Calvo (University of Pamplona)|Tamaro  Hudson (Howard University),"Dolph Lee Hatfield; PhD (Mouse Cancer Genetics Program)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Young S Kim (Nutritional Science Research Group)|Elise C Kohn; MD (Clinical Investigations Branch)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|David Anderson Wink (Radiation Biology Branch)",Chuxia  Deng; PhD (NIDDK),"1. Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM, Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, Lee HD, Green JE (2013). LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Res Treat  141, 89-99.   https://doi.org/10.1007/s10549-013-2662-3|2. Chu IM, Lai WC, Aprelikova O, El Touny LH, Kouros-Mehr H, Green JE (2013). Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß. PLoS One  8, e61125.   https://doi.org/10.1371/journal.pone.0061125|3. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM, Hunter KW (2013). Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One  8, e72287.   https://doi.org/10.1371/journal.pone.0072287",https://intramural.nih.gov/search/searchview.taf?ipid=83482
22,BC005785-20,"October 01, 2013 -  September 30, 2014",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jeffrey E Green; MD,NULL,Miriam R Anver (Office Of The Director)|Dominic  Esposito; PhD (Office Of The Director)|Jinqiu  Chen (Pigment Cell Biology Section)|Ashish Kumar Lal (Cancer Genetics Branch)|Ana  Robles (Laboratory of Human Carcinogenesis)|Maxwell P Lee; PhD (Basic Research Laboratory),Rea  Ravin; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83483
23,BC005793-20,"October 01, 2013 -  September 30, 2014",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83484
24,BC006140-38,"October 01, 2013 -  September 30, 2014",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,William M Bonner; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Allison  Burrell|Daisuke  Maeda|Christophe  Redon|Urbain Sossou  Weyemi|Susan  Bates; MD|Mirit I Aladjem; PhD|Show all 7,"David  Brenner (Columbia University)|Igor  Koturbash (Department of Biological Sciences, University of Lethbridge)|Alexandros  Georgakilas (East Carolina University)|Alexey  Kondratiev (Georgetown University)|Valeria  Audoshina (Georgetown University)|Ashutosh  Rao|Show all 16","Jiuping  Ji (Office of the Director)|Shivaani  Kummar; PhD (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",Daman  Kumari; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83485
25,BC006150-33,"October 01, 2013 -  September 30, 2014","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Monica M Abdelmalak|Keli  Agama|Muthana  Al Abo|Katherine W Fesen|Rui  Gao|Shar-Yin Naomi Huang|Show all 18,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yuk  Sham (University of Minnesota)|Show all 7","Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Robert J Fisher (Office Of The Director)|Joseph E Tomaszewski (Office of the Director)|David S Waugh; PhD (Protein Engineering Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)","Christopher P Austin; AB, MD (NCATS) |Weidong  Wang; PhD (NIA)","1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Fatoba ST, Tognetti S, Berto M, Leo E, Mulvey CM, Godovac-Zimmermann J, Pommier Y, Okorokov AL (2013). Human SIRT1 regulates DNA binding and stability of the Mcm10 DNA replication factor via deacetylation. Nucleic Acids Res  41, 4065-79.   https://doi.org/10.1093/nar/gkt131|3. Gao R, Das BB, Chatterjee R, Abaan OD, Agama K, Matuo R, Vinson C, Meltzer PS, Pommier Y (2014). Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel. DNA Repair (Amst)  13, 1-9.   https://doi.org/10.1016/j.dnarep.2013.09.001|4. Grohar PJ, Segars LE, Yeung C, Pommier Y, D'Incalci M, Mendoza A, Helman LJ (2014). Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. Clin Cancer Res  20, 1190-203.   https://doi.org/10.1158/1078-0432.CCR-13-0901|5. Huang SY, Murai J, Dalla Rosa I, Dexheimer TS, Naumova A, Gmeiner WH, Pommier Y (2013). TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res  41, 7793-803.   https://doi.org/10.1093/nar/gkt483|6. Huang SY, Pommier Y (2013). Cross-over of RNA 3'-phosphate ligase into the DNA world. Proc Natl Acad Sci U S A  110, 20354-5.   https://doi.org/10.1073/pnas.1320033110|7. Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, Zhang H, Pommier Y (2014). Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res  20, 4873-81.   https://doi.org/10.1158/1078-0432.CCR-13-3373|8. Maede Y, Shimizu H, Fukushima T, Kogame T, Nakamura T, Miki T, Takeda S, Pommier Y, Murai J (2014). Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel. Mol Cancer Ther  13, 214-20.   https://doi.org/10.1158/1535-7163.MCT-13-0551|9. Murai J, Huang SY, Renaud A, Zhang Y, Ji J, Takeda S, Morris J, Teicher B, Doroshow JH, Pommier Y (2014). Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. Mol Cancer Ther  13, 433-43.   https://doi.org/10.1158/1535-7163.MCT-13-0803|10. Murai J, Marchand C, Shahane SA, Sun H, Huang R, Zhang Y, Chergui A, Ji J, Doroshow JH, Jadhav A, Takeda S, Xia M, Pommier Y (2014). Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform. DNA Repair (Amst)  21, 177-82.   https://doi.org/10.1016/j.dnarep.2014.03.006|11. Pommier Y (2013). Drugging topoisomerases: lessons and challenges. ACS Chem Biol  8, 82-95.   https://doi.org/10.1021/cb300648v|12. Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C (2014). Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair (Amst)  19, 114-29.   https://doi.org/10.1016/j.dnarep.2014.03.020|13. Singhal G, Leo E, Setty SK, Pommier Y, Thimmapaya B (2013). Adenovirus E1A oncogene induces rereplication of cellular DNA and alters DNA replication dynamics. J Virol  87, 8767-78.   https://doi.org/10.1128/JVI.00879-13",https://intramural.nih.gov/search/searchview.taf?ipid=83486
26,BC006161-31,"October 01, 2013 -  September 30, 2014",DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Andrea Simone Baechler|Shar-Yin Naomi Huang|Salim  Khiati|Hongliang  Zhang|James Halpern Doroshow|Kurt  Kohn; PhD,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch)|Joseph E Tomaszewski (Office of the Director)|Chand  Khanna; MD (Pediatric Oncology Branch),NULL,"1. Coletta A, Castelli S, Chillemi G, Sanna N, Cushman M, Pommier Y, Desideri A (2013). Solvent dependency of the UV-Vis spectrum of indenoisoquinolines: role of keto-oxygens as polarity interaction probes. PLoS One  8, e73881.   https://doi.org/10.1371/journal.pone.0073881|2. Conda-Sheridan M, Reddy PV, Morrell A, Cobb BT, Marchand C, Agama K, Chergui A, Renaud A, Stephen AG, Bindu LK, Pommier Y, Cushman M (2013). Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1). J Med Chem  56, 182-200.   https://doi.org/10.1021/jm3014458|3. Huang SY, Murai J, Dalla Rosa I, Dexheimer TS, Naumova A, Gmeiner WH, Pommier Y (2013). TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs. Nucleic Acids Res  41, 7793-803.   https://doi.org/10.1093/nar/gkt483|4. Huang SY, Pommier Y (2013). Cross-over of RNA 3'-phosphate ligase into the DNA world. Proc Natl Acad Sci U S A  110, 20354-5.   https://doi.org/10.1073/pnas.1320033110|5. Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, Zhang H, Pommier Y (2014). Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res  20, 4873-81.   https://doi.org/10.1158/1078-0432.CCR-13-3373|6. Maede Y, Shimizu H, Fukushima T, Kogame T, Nakamura T, Miki T, Takeda S, Pommier Y, Murai J (2014). Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel. Mol Cancer Ther  13, 214-20.   https://doi.org/10.1158/1535-7163.MCT-13-0551|7. Pommier Y (2013). Drugging topoisomerases: lessons and challenges. ACS Chem Biol  8, 82-95.   https://doi.org/10.1021/cb300648v|8. Siu FM, Pommier Y (2013). Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study. Nucleic Acids Res  41, 10010-9.   https://doi.org/10.1093/nar/gkt791|9. Sobek S, Dalla Rosa I, Pommier Y, Bornholz B, Kalfalah F, Zhang H, Wiesner RJ, von Kleist-Retzow JC, Hillebrand F, Schaal H, Mielke C, Christensen MO, Boege F (2013). Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I. Nucleic Acids Res  41, 9848-57.   https://doi.org/10.1093/nar/gkt768|10. Taliani S, Pugliesi I, Barresi E, Salerno S, Marchand C, Agama K, Simorini F, La Motta C, Marini AM, Di Leva FS, Marinelli L, Cosconati S, Novellino E, Pommier Y, Di Santo R, Da Settimo F (2013). Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors. J Med Chem  56, 7458-62.   https://doi.org/10.1021/jm400932c",https://intramural.nih.gov/search/searchview.taf?ipid=83487
27,BC006192-26,"October 01, 2013 -  September 30, 2014",Investigating Regulatory Networks that Control Cell Proliferation and Apoptosis,Kurt  Kohn; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Mirit I Aladjem; PhD|Yves  Pommier; PhD|Barry R Zeeberg; PhD,NULL,NULL,NULL,"1. Kohn KW, Zeeberg BM, Reinhold WC, Pommier Y (2014). Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype. PLoS One  9, e99269.   https://doi.org/10.1371/journal.pone.0099269",https://intramural.nih.gov/search/searchview.taf?ipid=83488
28,BC006198-25,"October 01, 2013 -  September 30, 2014",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",James A Kelley; PhD,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Michael  Yaffe (Massachusetts Institute of Technology)|David  Knipe; PhD (Microbiology, Harvard Medical School)|Manchao  Zhang; PhD",David S Waugh; PhD (Protein Engineering Section)|Kyung  Lee; PhD (Chemistry Section)|Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,"1. Hogan M, Bahta M, Cherry S, Lountos GT, Tropea JE, Zhao BM, Burke TR, Waugh DS, Ulrich RG (2013). Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase. Chem Biol Drug Des  81, 323-33.   https://doi.org/10.1111/cbdd.12097|2. Qian WJ, Burke TR (2013). Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form. Amino Acids  45, 1143-8.   https://doi.org/10.1007/s00726-013-1567-0|3. Qian WJ, Park JE, Lim D, Lai CC, Kelley JA, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR (2014). Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells. Biopolymers  102, 444-55.   https://doi.org/10.1002/bip.22569|4. Qian WJ, Park JE, Lim D, Park SY, Lee KW, Yaffe MB, Lee KS, Burke TR (2013). Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs. Chem Biol  20, 1255-64.   https://doi.org/10.1016/j.chembiol.2013.09.005",https://intramural.nih.gov/search/searchview.taf?ipid=83489
29,BC007333-23,"October 01, 2013 -  September 30, 2014",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Monica M Abdelmalak|Keli  Agama|Katherine W Fesen|Christophe R Marchand,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory),NULL,"1. Johnson BC, Métifiot M, Ferris A, Pommier Y, Hughes SH (2013). A homology model of HIV-1 integrase and analysis of mutations designed to test the model. J Mol Biol  425, 2133-46.   https://doi.org/10.1016/j.jmb.2013.03.027",https://intramural.nih.gov/search/searchview.taf?ipid=83490
30,BC007363-20,"October 01, 2013 -  September 30, 2014",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,Peter  Cherepanov (Imperial College London)|Duane  Grandgnett (The St. Louis University School of Medicine),Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83491
31,BC007365-20,"October 01, 2013 -  September 30, 2014",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,"Richard  Kahn (Emory University)|Elizabeth  Sztul (University of Alabama)|Tom  Abrams (University of Maryland)|Marilyn G Farquhar; PhD (Cellular & Molecular Medicine, UCSD)|Robert  Kalb|James  Keen (Jefferson University)|Show all 7","Lino  Tessarollo (Mouse Cancer Genetics Program)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)","J Silvio  Gutkind; PhD (NIDCR) |James  Gruschus; PhD (NHLBI) |Kenneth Manao Yamada; MD, PhD (NIDCR) |Julie G Donaldson; PhD (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Peter W Schuck; PhD (NIBIB)","1. Chen PW, Jian X, Yoon HY, Randazzo PA (2013). ARAP2 signals through Arf6 and Rac1 to control focal adhesion morphology. J Biol Chem  288, 5849-60.   https://doi.org/10.1074/jbc.M112.415778|2. Hosokawa H, Dip PV, Merkulova M, Bakulina A, Zhuang Z, Khatri A, Jian X, Keating SM, Bueler SA, Rubinstein JL, Randazzo PA, Ausiello DA, Grüber G, Marshansky V (2013). The N termini of a-subunit isoforms are involved in signaling between vacuolar H+-ATPase (V-ATPase) and cytohesin-2. J Biol Chem  288, 5896-913.   https://doi.org/10.1074/jbc.M112.409169|3. Shiba Y, Kametaka S, Waguri S, Presley JF, Randazzo PA (2013). ArfGAP3 regulates the transport of cation-independent mannose 6-phosphate receptor in the post-Golgi compartment. Curr Biol  23, 1945-51.   https://doi.org/10.1016/j.cub.2013.07.087",https://intramural.nih.gov/search/searchview.taf?ipid=83492
32,BC008303-42,"October 01, 2013 -  September 30, 2014",Mechanisms of Viral Fusion and Inactivation,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Yechiel  Shai (Biological Chemistry, Weizmann  Institute, Israel)|Jeeseong  Hwang (NIST)",Stephen J Lockett; PhD (Office Of The Director)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program),"Bernard  Moss; MD, PhD (NIAID)","1. Klug YA, Ashkenazi A, Viard M, Porat Z, Blumenthal R, Shai Y (2014). Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site. Biochem J  461, 213-22.   https://doi.org/10.1042/BJ20140189",https://intramural.nih.gov/search/searchview.taf?ipid=83493
33,BC008382-31,"October 01, 2013 -  September 30, 2014",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Eckart  Bindewald|Kazimierz Wojcieck Kasprzak|Hugo Murua Martinez; PhD,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|R  Padmanabhan (Department of Microbiology and Immunology, Geogetown University School of Medicine)|Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luiz  Penalva (Cellular and Structural Biology, Research Institute, University of Texas Health Science Center at San Antonio)|Gregory  Chirikjian (Mechanical Engineering, Johns Hopkins University)|Show all 11",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Bindewald E, Shapiro BA (2013). Computational detection of abundant long-range nucleotide covariation in Drosophila genomes. RNA  19, 1171-82.   https://doi.org/10.1261/rna.037630.112|2. Gao F, Gulay SP, Kasprzak W, Dinman JD, Shapiro BA, Simon AE (2013). The kissing-loop T-shaped structure translational enhancer of Pea enation mosaic virus can bind simultaneously to ribosomes and a 5' proximal hairpin. J Virol  87, 11987-2002.   https://doi.org/10.1128/JVI.02005-13|3. Kim T, Shapiro BA (2013). The role of salt concentration and magnesium binding in HIV-1 subtype-A and subtype-B kissing loop monomer structures. J Biomol Struct Dyn  31, 495-510.   https://doi.org/10.1080/07391102.2012.706072|4. Sztuba-Solinska J, Teramoto T, Rausch JW, Shapiro BA, Padmanabhan R, Le Grice SF (2013). Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome. Nucleic Acids Res  41, 5075-89.   https://doi.org/10.1093/nar/gkt203|5. Zhong L, Wang JT, Wen D, Aris V, Soteropoulos P, Shapiro BA (2013). Effective classification of microRNA precursors using feature mining and AdaBoost algorithms. OMICS  17, 486-93.   https://doi.org/10.1089/omi.2013.0011",https://intramural.nih.gov/search/searchview.taf?ipid=83494
34,BC008710-37,"October 01, 2013 -  September 30, 2014",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Shannon M Doyle|Joel R Hoskins|Andrea Nicole Kravats|Monica  Markovski|Shankar  Shastry,George  Stan (University of Cincinnati)|David  Agard (UCSF),Leonard  Neckers; PhD (Urologic Oncology Branch)|Susan  Gottesman; PhD (Biochemical Genetics Section)|Jane Beth Trepel (Developmental Therapeutics Branch),Daniel C Masison; PhD (NIDDK),"1. Doyle SM, Genest O, Wickner S (2013). Protein rescue from aggregates by powerful molecular chaperone machines. Nat Rev Mol Cell Biol  14, 617-29.   https://doi.org/10.1038/nrm3660|2. Markovski M, Wickner S (2013). Preventing bacterial suicide: a novel toxin-antitoxin strategy. Mol Cell  52, 611-2.   https://doi.org/10.1016/j.molcel.2013.11.018",https://intramural.nih.gov/search/searchview.taf?ipid=83455
35,BC008714-37,"October 01, 2013 -  September 30, 2014",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Jiandong  Chen|Natalie  Gilbert|Hyun-Jung  Lee|Nadim  Majdalani|Ashley S Parker|Daniel Joseph Schu|Show all 8,"Linda  Kenney (Microbiology, U. of Illinois School of Medicine)|Maude  Guillier|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)|Ben  Luisi (University of Cambridge)",NULL,"Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC)","1. De Lay N, Schu DJ, Gottesman S (2013). Bacterial small RNA-based negative regulation: Hfq and its accomplices. J Biol Chem  288, 7996-8003.   https://doi.org/10.1074/jbc.R112.441386|2. Moon K, Six DA, Lee HJ, Raetz CR, Gottesman S (2013). Complex transcriptional and post-transcriptional regulation of an enzyme for lipopolysaccharide modification. Mol Microbiol  89, 52-64.   https://doi.org/10.1111/mmi.12257|3. Zhang A, Schu DJ, Tjaden BC, Storz G, Gottesman S (2013). Mutations in interaction surfaces differentially impact E. coli Hfq association with small RNAs and their mRNA targets. J Mol Biol  425, 3678-97.   https://doi.org/10.1016/j.jmb.2013.01.006",https://intramural.nih.gov/search/searchview.taf?ipid=83495
36,BC008751-34,"October 01, 2013 -  September 30, 2014",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Amlanjyoti  Dhar|Phuoc  Le|Dale  Lewis; PhD|Francisco Jesus Malagon Bautista|Zhong  Qian|Andrei  Trostel,Laura  Finzi (University of Milan)|Szabolcs  Semsey|Michal  Hammel (Lawrence Berkeley National Laboratory),Victor  Zhurkin; PhD (Laboratory of Cell Biology)|Peter C Fitzgerald (Office of the Director),NULL,"1. Barupal DK, Lee SJ, Karoly ED, Adhya S (2013). Inactivation of metabolic genes causes short- and long-range dys-regulation in Escherichia coli metabolic network. PLoS One  8, e78360.   https://doi.org/10.1371/journal.pone.0078360|2. Lee SJ, Trostel A, Adhya S (2014). Metabolite changes signal genetic regulatory mechanisms for robust cell behavior. MBio  5, e00972-13.   https://doi.org/10.1128/mBio.00972-13",https://intramural.nih.gov/search/searchview.taf?ipid=83496
37,BC008752-34,"October 01, 2013 -  September 30, 2014",Thyroid Hormone Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Cho Rong  Han|Jeong-Won  Park|Sunmi  Park|Mark Cauthen Willingham|Li  Zhao,"Anneke  Alkemade (University of Amsterdam Medical Center)|Anthony  Hollenberg (Harvard University)|James  Lechleiter (University of Texas Health Science Center at San Antonio)|G.R.  Williams (Imperial College London, Imperial College London)","Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Douglas  Forrest; PhD (NIDDK),"1. Fozzatti L, Kim DW, Park JW, Willingham MC, Hollenberg AN, Cheng SY (2013). Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α. Proc Natl Acad Sci U S A  110, 7850-5.   https://doi.org/10.1073/pnas.1222334110|2. Fozzatti L, Park JW, Zhao L, Willingham MC, Cheng SY (2013). Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer. PLoS One  8, e67954.   https://doi.org/10.1371/journal.pone.0067954|3. Kim DW, Walker RL, Meltzer PS, Cheng SY (2013). Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. Carcinogenesis  34, 2389-400.   https://doi.org/10.1093/carcin/bgt175|4. Kim WG, Park JW, Willingham MC, Cheng SY (2013). Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology  154, 2936-47.   https://doi.org/10.1210/en.2013-1128|5. Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng SY (2013). Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression. Endocrinology  154, 25-35.   https://doi.org/10.1210/en.2012-1728|6. Park JW, Zhao L, Cheng SY (2013). Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models. Am J Cancer Res  3, 302-11.|7. Wark L, Danescu A, Natarajan S, Zhu X, Cheng SY, Hombach-Klonisch S, Mai S, Klonisch T (2014). Three-dimensional telomere dynamics in follicular thyroid cancer. Thyroid  24, 296-304.   https://doi.org/10.1089/thy.2013.0118",https://intramural.nih.gov/search/searchview.taf?ipid=83497
38,BC008753-32,"October 01, 2013 -  September 30, 2014",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Fatima Ghazanfar Ali-Rahmani|Prince K Awuah|Richard A Beers|Tapan K Bera|Youjin  Jang|Jasmin  Leshem|Show all 14,"Itai  Benhar (Tel Aviv University)|DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Ulrich  Brinkmann (NCI)|Iekuni  Ichikawa (Vanderbilt University School of Medicine)|Namiko  Kobayashi (University of Tsukaba)|ChienTsun  Kuan (Duke University)|Show all 13","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Oleg Y Chertov (Office Of The Director)|David J Fitzgerald; PhD (Biotherapy Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Byungkook  Lee; PhD (Molecular Modeling Section)",Chang Hum  Paik; PhD (CC),"1. Chandramohan V, Bao X, Kato Kaneko M, Kato Y, Keir ST, Szafranski SE, Kuan CT, Pastan IH, Bigner DD (2013). Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors. Int J Cancer  132, 2339-48.   https://doi.org/10.1002/ijc.27919|2. Chandramohan V, Bao X, Keir ST, Pegram CN, Szafranski SE, Piao H, Wikstrand CJ, McLendon RE, Kuan CT, Pastan IH, Bigner DD (2013) Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy. Clin Cancer Res 19:4717-27|3. Choi BD, Kuan CT, Cai M, Archer GE, Mitchell DA, Gedeon PC, Sanchez-Perez L, Pastan I, Bigner DD, Sampson JH (2013). Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc Natl Acad Sci U S A  110, 270-5.   https://doi.org/10.1073/pnas.1219817110|4. Choi BD, Pastan I, Bigner DD, Sampson JH (2013). A novel bispecific antibody recruits T cells to eradicate tumors in the ""immunologically privileged"" central nervous system. Oncoimmunology  2, e23639.   https://doi.org/10.4161/onci.23639|5. Denton PW, Long JM, Wietgrefe SW, Sykes C, Spagnuolo RA, Snyder OD, Perkey K, Archin NM, Choudhary SK, Yang K, Hudgens MG, Pastan I, Haase AT, Kashuba AD, Berger EA, Margolis DM, Garcia JV (2014). Targeted cytotoxic therapy kills persisting HIV infected cells during ART. PLoS Pathog  10, e1003872.   https://doi.org/10.1371/journal.ppat.1003872|6. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|7. Hu X, Wei H, Xiang L, Chertov O, Wayne AS, Bera TK, Pastan I (2013). Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8. Leuk Res  37, 1551-6.   https://doi.org/10.1016/j.leukres.2013.08.005|8. Huang YH, Terabe M, Pendleton CD, Stewart Khursigara D, Bera TK, Pastan I, Berzofsky JA (2013). Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE. PLoS One  8, e64365.   https://doi.org/10.1371/journal.pone.0064365|9. Liu XF, FitzGerald DJ, Pastan I (2013). The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas toxin. Cancer Res  73, 2281-8.   https://doi.org/10.1158/0008-5472.CAN-12-3436|10. Liu XF, Xiang L, FitzGerald DJ, Pastan I (2014). Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitors. Mol Cancer Ther  13, 82-9.   https://doi.org/10.1158/1535-7163.MCT-13-0726|11. Mattoo AR, Pastan I, Fitzgerald D (2013). Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P. PLoS One  8, e75576.   https://doi.org/10.1371/journal.pone.0075576|12. Miyazaki Y, Shimizu A, Pastan I, Taguchi K, Naganuma E, Suzuki T, Hosoya T, Yokoo T, Saito A, Miyata T, Yamamoto M, Matsusaka T (2014). Keap1 inhibition attenuates glomerulosclerosis. Nephrol Dial Transplant  29, 783-91.   https://doi.org/10.1093/ndt/gfu002|13. Molavi O, Xiong XB, Douglas D, Kneteman N, Nagata S, Pastan I, Chu Q, Lavasanifar A, Lai R (2013). Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma. Biomaterials  34, 8718-8725.   https://doi.org/10.1016/j.biomaterials.2013.07.068|14. Piao H, Kuan CT, Chandramohan V, Keir ST, Pegram CN, Bao X, Månsson JE, Pastan IH, Bigner DD (2013). Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas. MAbs  5, 748-62.   https://doi.org/10.4161/mabs.25860|15. Sakamoto K, Ueno T, Kobayashi N, Hara S, Takashima Y, Pastan I, Matsusaka T, Nagata M (2014). The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis. Am J Physiol Renal Physiol  306, F98-F104.   https://doi.org/10.1152/ajprenal.00228.2013|16. Terrier B, Nagata S, Ise T, Rosenzwajg M, Pastan I, Klatzmann D, Saadoun D, Cacoub P (2014). CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis. Arthritis Rheumatol  66, 433-43.   https://doi.org/10.1002/art.38222|17. Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I (2013). A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene. J Biol Chem  288, 12305-12.   https://doi.org/10.1074/jbc.M113.461343|18. Yamada S, Nakamura J, Asada M, Takase M, Matsusaka T, Iguchi T, Yamada R, Tanaka M, Higashi AY, Okuda T, Asada N, Fukatsu A, Kawachi H, Graf D, Muso E, Kita T, Kimura T, Pastan I, Economides AN, Yanagita M (2014). Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury. PLoS One  9, e89135.   https://doi.org/10.1371/journal.pone.0089135|19. Yamaguchi T, Danjo T, Pastan I, Hikida T, Nakanishi S (2013). Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear. Neuron  78, 537-44.   https://doi.org/10.1016/j.neuron.2013.02.035",https://intramural.nih.gov/search/searchview.taf?ipid=83498
39,BC008756-27,"October 01, 2013 -  September 30, 2014",Genetically Engineered Mouse Models to Study RTK Function in Melanoma,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Heather Marie Farthing|Liping  Huang|Kerrie Leanne Marie|Prasun J Mishra|Jennifer D Rieker|Yanlin  Yu|Show all 7,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Scott  Lowe (Cold Spring Harbor Laboratory)|Norman  Sharpless (University of North Carolina)|Show all 14","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Miriam R Anver (Office Of The Director)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Margaret Anne Tucker (Human Genetics Program)|Howard A Young; PhD (Laboratory of Experimental Immunology)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)",Heinz  Arnheiter; MD (NINDS) |J Silvio  Gutkind; PhD (NIDCR) |William James Pavan; PhD (NHGRI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83499
40,BC008757-27,"October 01, 2013 -  September 30, 2014",Bio-Therapies for the Treatment of Cancer and Infectious Disease,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Evan  Angelus|Antonella  Antignani; BS, PhD|Robert J Sarnovsky|Nathan C Simon|Emily C Weiss",NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter C Fitzgerald (Office of the Director),Scott E Martin (NCATS) |Craig Joseph Thomas (NCATS),"1. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|2. Liu XF, FitzGerald DJ, Pastan I (2013). The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas toxin. Cancer Res  73, 2281-8.   https://doi.org/10.1158/0008-5472.CAN-12-3436|3. Liu XF, Xiang L, FitzGerald DJ, Pastan I (2014). Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitors. Mol Cancer Ther  13, 82-9.   https://doi.org/10.1158/1535-7163.MCT-13-0726",https://intramural.nih.gov/search/searchview.taf?ipid=83500
41,BC008905-33,"October 01, 2013 -  September 30, 2014",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",NULL,Igor  Barsukov (University of Liverpool)|Steven J Carr|Pierre  Lavigne (University of Liverpool),Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83501
42,BC009003-32,"October 01, 2013 -  September 30, 2014",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,"Gabriella  Minchiotti (CNR, Institute of Genetics)|Masaharu  Seno (Biotechnology, Okayama University)",NULL,NULL,"1. Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D (2014) The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition. Semin Cancer Biol 29:51-8",https://intramural.nih.gov/search/searchview.taf?ipid=83502
43,BC009052-25,"October 01, 2013 -  September 30, 2014",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Carla Vanessa Correia Cerqueira|Nicolas  Cuburu; PhD|Patricia  Day; PhD|Alessandra  Handisurya|Yuk Ying S Pang|Hanna  Seitz|Show all 8,Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Reinhard  Glueck (Etna Biotech)|Maria Jose  Alsonso (University of Santiago de Compostela)|Elisabet  de los Pinos (Aura Biosciences Inc.)|Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Show all 7,Ligia  Pinto (Infection & Immunoepidemiology Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch),"Barney S Graham; MD, PhD (NIAID) |Jeffrey  Cohen; MD (NIAID) |Alan T Remaley; MD, PhD (CC)","1. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012, et al. [5 more authors] (2013). Comprehensive control of human papillomavirus infections and related diseases. Vaccine  31 Suppl 8, I1-31.   https://doi.org/10.1016/j.vaccine.2013.07.026|2. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT (2013). Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol  87, 3862-70.   https://doi.org/10.1128/JVI.03222-12|3. Handisurya A, Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT (2013). Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization. J Virol  87, 13214-25.   https://doi.org/10.1128/JVI.02162-13|4. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR, CVT Vaccine Group (2013). Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One  8, e68329.   https://doi.org/10.1371/journal.pone.0068329|5. Jagu S, Kwak K, Schiller JT, Lowy DR, Kleanthous H, Kalnin K, Wang C, Wang HK, Chow LT, Huh WK, Jaganathan KS, Chivukula SV, Roden RB (2013). Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine. J Virol  87, 6127-36.   https://doi.org/10.1128/JVI.03218-12|6. Lang Kuhs KA, Gonzalez P, Struijk L, Castro F, Hildesheim A, van Doorn LJ, Rodriguez AC, Schiffman M, Quint W, Lowy DR, Porras C, Delvecchio C, Katki HA, Jimenez S, Safaeian M, Schiller J, Solomon D, Wacholder S, Herrero R, Kreimer AR, Costa Rica Vaccine Trial Group (2013). Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis  208, 1643-52.   https://doi.org/10.1093/infdis/jit369|7. Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Pinto LA (2013). Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial. Hum Vaccin Immunother  9, 1399-406.   https://doi.org/10.4161/hv.24340|8. Schiller J, Lowy D (2013) Virus Infection and Cancer: an Overview. Recent Results in Cancer Research 193:1-10",https://intramural.nih.gov/search/searchview.taf?ipid=83503
44,BC009262-32,"October 01, 2013 -  September 30, 2014",Immunophysiological Mechanisms in the Biological Therapy of Cancer,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Qun  Jiang|Anthony J Scarzello|Jonathan  Weiss|John R Ortaldo; PhD|Howard A Young; PhD|Show all 8,"Bill  Murphy (Clinical Research, University of Nevada at Reno)|Sylvie  Guichard (AstraZeneca)",Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|William Marston Linehan; MD (Urologic Oncology Branch)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)|David Anderson Wink (Radiation Biology Branch)|Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,"1. Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ (2013). Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med  210, 2223-37.   https://doi.org/10.1084/jem.20131219",https://intramural.nih.gov/search/searchview.taf?ipid=83504
45,BC009265-32,"October 01, 2013 -  September 30, 2014",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Steven Edward Bowen|Hyein  Jeon|Masashi  Watanabe|Joy A Williams|Chiharu  Fujihara,"Ferenc  Livak (School of Medicine, University of Maryland)|Gail  Bishop (University of Iowa)|Yousuke  Takahama (Tokushima)",Lionel  Feigenbaum (Office of the Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),Ranjan  Sen; PhD (NIA),"1. Bowen S, Sun P, Livak F, Sharrow S, Hodes RJ (2014). A novel T cell subset with trans-rearranged Vγ-Cβ TCRs shows Vβ expression is dispensable for lineage choice and MHC restriction. J Immunol  192, 169-77.   https://doi.org/10.4049/jimmunol.1302398|2. Bowen S, Wangsa D, Ried T, Livak F, Hodes RJ (2013). Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans-rearrangements in ATM-deficient thymocytes. Nucleic Acids Res  41, 4535-48.   https://doi.org/10.1093/nar/gkt154|3. Hathcock KS, Bowen S, Livak F, Hodes RJ (2013). ATM influences the efficiency of TCRβ rearrangement, subsequent TCRβ-dependent T cell development, and generation of the pre-selection TCRβ CDR3 repertoire. PLoS One  8, e62188.   https://doi.org/10.1371/journal.pone.0062188|4. Lucas CR, Cordero-Nieves HM, Erbe RS, McAlees JW, Bhatia S, Hodes RJ, Campbell KS, Sanders VM (2013). Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes. J Immunol  190, 723-36.   https://doi.org/10.4049/jimmunol.1201646",https://intramural.nih.gov/search/searchview.taf?ipid=83506
46,BC009273-27,"October 01, 2013 -  September 30, 2014",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)|Ed  Palmer (University of Basel)|Show all 7","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office of the Director)|Dinah  Singer; PhD (Molecular Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Carl  Wu; PhD (Laboratory Of Biochemistry & Molecular Biology)","Paul E Love; MD, PhD (NICHD)","1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83507
47,BC009279-29,"October 01, 2013 -  September 30, 2014",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Helit  Cohen|Jocelyn D Weissman,NULL,Susan  Sharrow (Experimental Immunology Branch)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression)|Brian  Lewis (Lymphoid Malignancies Branch),NULL,"1. Barbash ZS, Weissman JD, Campbell JA, Mu J, Singer DS (2013). Major histocompatibility complex class I core promoter elements are not essential for transcription in vivo. Mol Cell Biol  33, 4395-407.   https://doi.org/10.1128/MCB.00553-13",https://intramural.nih.gov/search/searchview.taf?ipid=83508
48,BC009281-28,"October 01, 2013 -  September 30, 2014",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Yungping  Chiang|Masashi  Watanabe,NULL,Lionel  Feigenbaum (Office of the Director),Ranjan  Sen; PhD (NIA),"1. Williams JA, Zhang J, Jeon H, Nitta T, Ohigashi I, Klug D, Kruhlak MJ, Choudhury B, Sharrow SO, Granger L, Adams A, Eckhaus MA, Jenkinson SR, Richie ER, Gress RE, Takahama Y, Hodes RJ (2014). Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways. J Immunol  192, 630-40.   https://doi.org/10.4049/jimmunol.1302550",https://intramural.nih.gov/search/searchview.taf?ipid=83509
49,BC009283-30,"October 01, 2013 -  September 30, 2014",Consequences of chronic Interferon-gamma expression on the host,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Alec Thomas Barlow|Fan Ching  Lin|Della A Reynolds|Michael E Sanford|Sarah Elizabeth Turner|Julio C Valencia; MD|Show all 9,Ram  Savan|Andrew  Welcher (Amgen)|Monika  Wolkers (Sanquin),Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program)|David Anderson Wink (Radiation Biology Branch),Arya  Biragyn; PhD (NIA) |Daniel Leo Barber (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83510
50,BC009285-28,"October 01, 2013 -  September 30, 2014",Responses of MHC Class I Genes to Exogeneous Stimuli,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",NULL,NULL,NULL,NULL,"1. Devaiah BN, Singer DS (2013). CIITA and Its Dual Roles in MHC Gene Transcription. Front Immunol  4, 476.   https://doi.org/10.3389/fimmu.2013.00476|2. Soe KC, Devaiah BN, Singer DS (2013). Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity. Biochim Biophys Acta  1829, 1184-90.   https://doi.org/10.1016/j.bbagrm.2013.09.001",https://intramural.nih.gov/search/searchview.taf?ipid=83511
51,BC009287-30,"October 01, 2013 -  September 30, 2014",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",Arthur A Hurwitz,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Aiello FB, Graciotti L, Procopio AD, Keller JR, Durum SK (2013). Stemness of T cells and the hematopoietic stem cells: fate, memory, niche, cytokines. Cytokine Growth Factor Rev  24, 485-501.   https://doi.org/10.1016/j.cytogfr.2013.10.002",https://intramural.nih.gov/search/searchview.taf?ipid=83512
52,BC009369-24,"October 01, 2013 -  September 30, 2014",Studies of Receptor Interactions and Effects of Alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"Michael  Bustin; PhD (Protein Section)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Wei F, Yang D, Tewary P, Li Y, Li S, Chen X, Howard OM, Bustin M, Oppenheim JJ (2014). The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Cancer Res  74, 5989-98.   https://doi.org/10.1158/0008-5472.CAN-13-2042",https://intramural.nih.gov/search/searchview.taf?ipid=83516
53,BC009392-22,"October 01, 2013 -  September 30, 2014",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",NULL,Michael  Glickman (Technion)|Joseph  Roitelman,Robert Andrew Byrd (Structural Biophysics Laboratory)|Chand  Khanna; MD (Pediatric Oncology Branch)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Metzger MB, Pruneda JN, Klevit RE, Weissman AM (2014). RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim Biophys Acta  1843, 47-60.   https://doi.org/10.1016/j.bbamcr.2013.05.026|2. Shao J, Choe V, Cheng H, Tsai YC, Weissman AM, Luo S, Rao H (2014). Ubiquitin ligase gp78 targets unglycosylated prion protein PrP for ubiquitylation and degradation. PLoS One  9, e92290.   https://doi.org/10.1371/journal.pone.0092290",https://intramural.nih.gov/search/searchview.taf?ipid=83449
54,BC009404-20,"October 01, 2013 -  September 30, 2014",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)",Lionel  Feigenbaum (Office of the Director),NULL,"1. Bosch B, Berger AC, Khandelwal S, Heipertz EL, Scharf B, Santambrogio L, Roche PA (2013). Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells. J Biol Chem  288, 24286-92.   https://doi.org/10.1074/jbc.M113.461996|2. Bosch B, Heipertz EL, Drake JR, Roche PA (2013). Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters. J Biol Chem  288, 13236-42.   https://doi.org/10.1074/jbc.M112.442640|3. Cho KJ, Roche PA (2013). Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination. Front Immunol  4, 369.   https://doi.org/10.3389/fimmu.2013.00369|4. Furuta K, Walseng E, Roche PA (2013). Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation. Proc Natl Acad Sci U S A  110, 20188-93.   https://doi.org/10.1073/pnas.1312994110",https://intramural.nih.gov/search/searchview.taf?ipid=83517
55,BC009405-20,"October 01, 2013 -  September 30, 2014",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Immune Regulation Section, NCI",Karen  Hathcock|Yungping  Chiang,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch)|Lionel  Feigenbaum (Office of the Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),Herbert Carpenter Morse; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83518
56,BC010001-19,"October 01, 2013 -  September 30, 2014",MolecularCellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Wonil  Kim|Kimberly D Klarmann|Satyendra Kumar Singh|Lei  Sun|Pengnian Charles Lin; PhD|Peter F Johnson; PhD|Show all 7,NULL,Laura  Schmidt (Urologic Oncology Branch)|Serguei V Kozlov (Office of the Director)|Masaya  Baba (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83519
57,BC010006-19,"October 01, 2013 -  September 30, 2014",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Hee Jun  Cho; PhD|Yoo-Seok  Hwang|Kathleen T Soria|Jaeho  Yoon; PhD|Deborah K Morrison,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83520
58,BC010008-19,"October 01, 2013 -  September 30, 2014",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Adrian  Eiden|Joy Michelle Gary|John K Simmons|Ke  Zhang|Shuling  Zhang; MD, PhD|Robert Mark Simpson; DVM, PhD",NULL,NULL,"Rafael Cristian Casellas; PhD (NIAMS) |Toren  Finkel; MD, PhD (NHLBI)","1. Smrž D, Bandara G, Zhang S, Mock BA, Beaven MA, Metcalfe DD, Gilfillan AM (2013). A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses. J Immunol Methods  390, 52-62.   https://doi.org/10.1016/j.jim.2013.01.008|2. Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, DuBois W, Ward T, deCabo R, Gavrilova O, Mock B, Finkel T (2013). Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep  4, 913-20.   https://doi.org/10.1016/j.celrep.2013.07.030|3. Zhang S, Pruitt M, Tran D, Du Bois W, Zhang K, Patel R, Hoover S, Simpson RM, Simmons J, Gary J, Snapper CM, Casellas R, Mock BA (2013). B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol  191, 1692-703.   https://doi.org/10.4049/jimmunol.1201767",https://intramural.nih.gov/search/searchview.taf?ipid=83521
59,BC010012-19,"October 01, 2013 -  September 30, 2014",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Poonam  Tewary|Robert  Wiltrout; PhD,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Neil  Cross (Sheffield Hallam University)",Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|David Anderson Wink (Radiation Biology Branch),NULL,"1. Sayers T, Brooks A, Sayers T, Chertov O (2014) Increased Secretory Leukocyte Protease Inhibitor (SLPI) Production by Highly Metastatic Mouse Breast Cancer Cells. PLOS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83522
60,BC010013-19,"October 01, 2013 -  September 30, 2014",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Laboratory of Experimental Immunology, NCI","Theodore Tzvetanov Drashansky|Hong-Chuan  Li|Matthew Vincent McCullen|Paul  Wright|Giorgio  Trinchieri|Mary  Carrington; MS, PhD|Show all 8","Jeffrey  Miller (University of Minnesota Cancer Center)|Andrew  Makrigiannis (ICRM)|Colin  Brooks (School of Biosciences, University of Newcastle)|Kerry  Campbell (Immunobiology, Fox Chase Cancer Institute)|William  Murphy (UC Davis)|Yenan  Bryceson (Karolinska Institute)|Show all 7",NULL,NULL,"1. Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy WJ (2013). Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol  191, 688-98.   https://doi.org/10.4049/jimmunol.1300202|2. Barao I, Wright PW, Sungur CM, Anderson SK, Redelman D, Murphy WJ (2013). Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant  19, 1446-52.   https://doi.org/10.1016/j.bbmt.2013.07.021|3. Cichocki F, Miller JS, Anderson SK, Bryceson YT (2013). Epigenetic regulation of NK cell differentiation and effector functions. Front Immunol  4, 55.   https://doi.org/10.3389/fimmu.2013.00055|4. Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW (2013). LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells. PLoS Pathog  9, e1003357.   https://doi.org/10.1371/journal.ppat.1003357|5. Wright PW, Huehn A, Cichocki F, Li H, Sharma N, Dang H, Lenvik TR, Woll P, Kaufman D, Miller JS, Anderson SK (2013). Identification of a KIR antisense lncRNA expressed by progenitor cells. Genes Immun  14, 427-33.   https://doi.org/10.1038/gene.2013.36",https://intramural.nih.gov/search/searchview.taf?ipid=83523
61,BC010014-19,"October 01, 2013 -  September 30, 2014",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Robert M Leighty (Office Of The Director)|Carl E Mcintosh (Office of the Director),NULL,"1. Yu W, McIntosh C, Lister R, Zhu I, Han Y, Ren J, Landsman D, Lee E, Briones V, Terashima M, Leighty R, Ecker JR, Muegge K (2014). Genome-wide DNA methylation patterns in LSH mutant reveals de-repression of repeat elements and redundant epigenetic silencing pathways. Genome Res  24, 1613-23.   https://doi.org/10.1101/gr.172015.114",https://intramural.nih.gov/search/searchview.taf?ipid=83524
62,BC010015-19,"October 01, 2013 -  September 30, 2014",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,Philip M Murphy; MD (NIAID),"1. Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM (2013). Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest  123, 1694-704.   https://doi.org/10.1172/JCI65569|2. Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A, Chen K, Liu Y, Liu M, Oppenheim JJ, Wang JM (2013) Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One 8:e58791",https://intramural.nih.gov/search/searchview.taf?ipid=83525
63,BC010017-19,"October 01, 2013 -  September 30, 2014","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Phuoc  Le|Sangmi  Lee|Francisco Jesus Malagon Bautista|Andrei  Trostel,NULL,NULL,NULL,"1. Adhya S, Biswas B, Merril C (2013) Therapeutic and prophylactic applications of bacteriophage and its components in modern medicine, in Bacterial Pathogenesis. Maloy S, Cossart P, eds., pp. In Press.|2. Adhya S, Merril CR, Biswas B (2014). Therapeutic and prophylactic applications of bacteriophage components in modern medicine. Cold Spring Harb Perspect Med  4, a012518.   https://doi.org/10.1101/cshperspect.a012518",https://intramural.nih.gov/search/searchview.taf?ipid=83526
64,BC010020-19,"October 01, 2013 -  September 30, 2014",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Joan  Aaron|Barbara  Debrah|Sonya C Duke|Elizabeth J Maestri|Timonthy R McNickle|David  Waters,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|Ramy A Ibrahim|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Alan S Wayne; MD","Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Pastan I, Hassan R (2014). Discovery of mesothelin and exploiting it as a target for immunotherapy. Cancer Res  74, 2907-12.   https://doi.org/10.1158/0008-5472.CAN-14-0337",https://intramural.nih.gov/search/searchview.taf?ipid=83527
65,BC010021-19,"October 01, 2013 -  September 30, 2014",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Corinne A Boulanger-Espeut|Andrea Lynn George; PhD|Sonia Menin Rosenfield|Robert  Callahan; PhD,"Cathrin  Brisken (ISREC/EPFL)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)",NULL,NULL,"1. Boulanger CA, Bruno RD, Mack DL, Gonzales M, Castro NP, Salomon DS, Smith GH (2013). Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. PLoS One  8, e62019.   https://doi.org/10.1371/journal.pone.0062019|2. Bruno RD, Rosenfield SM, Smith GH (2013). Late developing mammary tumors and hyperplasia induced by a low-oncogenic variant of mouse mammary tumor virus (MMTV) express genes identical to those induced by canonical MMTV. Mol Cancer  12, 79.   https://doi.org/10.1186/1476-4598-12-79|3. Rosenfield SM, Smith GH (2013). Redirection of Human Cancer Cells upon the Interaction with the Regenerating Mouse Mammary Gland Microenvironment. Cells  2, 43-56.   https://doi.org/10.3390/cells2010043",https://intramural.nih.gov/search/searchview.taf?ipid=83528
66,BC010022-19,"October 01, 2013 -  September 30, 2014",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Elizabeth  Binns-Roemer|Victor A David|Sarwat Naz Kazmi|Sophie Mh Limou|Efe  Sezgin|Noah Gregory Totsline|Show all 7,Gregory D Kirk|Etienne  Pays (Universite Libre de Bruxelles)|Tara  Oleksyk (Uiversity of Puerto Rico)|Mohammed  Atta (Johns Hopkins University)|Rajendra  Bhimma (University of KwaZulu-Natal)|Mona  Doshi (Wayne State University)|Show all 11,William Marston Linehan; MD (Urologic Oncology Branch)|Mark  Purdue (Occupational and Environmental Epidemiology Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. Astermark J, Donfield SM, Gomperts ED, Schwarz J, Menius ED, Pavlova A, Oldenburg J, Kessing B, DiMichele DM, Shapiro AD, Winkler CA, Berntorp E, Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort (2013). The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Blood  121, 1446-54.   https://doi.org/10.1182/blood-2012-06-434803|2. Gasser DL, Winkler CA, Peng M, An P, McKenzie LM, Kirk GD, Shi Y, Xie LX, Marbois BN, Clarke CF, Kopp JB (2013). Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10. Am J Physiol Renal Physiol  305, F1228-38.   https://doi.org/10.1152/ajprenal.00143.2013|3. Ko WY, Rajan P, Gomez F, Scheinfeldt L, An P, Winkler CA, Froment A, Nyambo TB, Omar SA, Wambebe C, Ranciaro A, Hirbo JB, Tishkoff SA (2013). Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations. Am J Hum Genet  93, 54-66.   https://doi.org/10.1016/j.ajhg.2013.05.014|4. Kumar R, Nguyen EA, Roth LA, Oh SS, Gignoux CR, Huntsman S, Eng C, Moreno-Estrada A, Sandoval K, Peñaloza-Espinosa RI, López-López M, Avila PC, Farber HJ, Tcheurekdjian H, Rodriguez-Cintron W, Rodriguez-Santana JR, Serebrisky D, Thyne SM, Williams LK, Winkler C, Bustamante CD, Pérez-Stable EJ, Borrell LN, Burchard EG (2013). Factors associated with degree of atopy in Latino children in a nationwide pediatric sample: the Genes-environments and Admixture in Latino Asthmatics (GALA II) study. J Allergy Clin Immunol  132, 896-905.e1.   https://doi.org/10.1016/j.jaci.2013.02.046|5. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators (2013). APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med  369, 2183-96.   https://doi.org/10.1056/NEJMoa1310345|6. Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E, Hemophilia Inhibitor Genetics Study Combined Cohort (2013). F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Haemophilia  19, 113-8.   https://doi.org/10.1111/hae.12004|7. Thameem F, Igo RP, Freedman BI, Langefeld C, Hanson RL, Schelling JR, Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E, Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC, Nelson RG, Pahl MV, Parekh RS, Kao WH, Rasooly RS, Family Investigation of Nephropathy and Diabetes Research Group, et al. [4 more authors] (2013). A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND). PLoS One  8, e81888.   https://doi.org/10.1371/journal.pone.0081888",https://intramural.nih.gov/search/searchview.taf?ipid=83529
67,BC010027-20,"October 01, 2013 -  September 30, 2014",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Miroslav  Dundr|Thomas A Johnson|Iain Andrew Sawyer; PhD|Rodney Louis Schiltz; PhD|Diana  Stavreva|Myong-Hee  Sung|Show all 8,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),John J O'Shea; MD (NIAMS) |Rafael Cristian Casellas; PhD (NIAMS),"1. Aguilar-Arnal L, Hakim O, Patel VR, Baldi P, Hager GL, Sassone-Corsi P (2013). Cycles in spatial and temporal chromosomal organization driven by the circadian clock. Nat Struct Mol Biol  20, 1206-13.   https://doi.org/10.1038/nsmb.2667|2. Dull AB, George AA, Goncharova EI, Evans JR, Wamiru A, Cartner LK, Hager GL, McMahon JB (2014). Identification of compounds by high-content screening that induce cytoplasmic to nuclear localization of a fluorescent estrogen receptor α chimera and exhibit agonist or antagonist activity in vitro. J Biomol Screen  19, 242-52.   https://doi.org/10.1177/1087057113504136|3. Hakim O, Sung MH, Nakayamada S, Voss TC, Baek S, Hager GL (2013). Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation. Genome Res  23, 462-72.   https://doi.org/10.1101/gr.147652.112|4. Kieffer-Kwon KR, Tang Z, Mathe E, Qian J, Sung MH, Li G, Resch W, Baek S, Pruett N, Grøntved L, Vian L, Nelson S, Zare H, Hakim O, Reyon D, Yamane A, Nakahashi H, Kovalchuk AL, Zou J, Joung JK, Sartorelli V, Wei CL, Ruan X, Hager GL, Ruan Y, et al. [1 more author] (2013). Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell  155, 1507-20.   https://doi.org/10.1016/j.cell.2013.11.039",https://intramural.nih.gov/search/searchview.taf?ipid=83532
68,BC010030-19,"October 01, 2013 -  September 30, 2014",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Eduardo Emilio Chufan; PhD|John E Golin|Christian  Guerrero|Khyati  Kapoor; PhD|Zuben  Sauna; PhD|Suneet  Shukla|Show all 9,"Rajendra  Prasad (Jawaharlal Nehru University)|Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Liwu  Fu (Sun Yat-Sen University)","Di S Xia; PhD, MS, BS (Crystallography Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Stewart  Durell (Laboratory of Cell Biology)",Craig Joseph Thomas (NCATS),"1. Kapoor K, Bhatnagar J, Chufan EE, Ambudkar SV (2013). Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70. J Biol Chem  288, 32622-36.   https://doi.org/10.1074/jbc.M113.498980|2. Sim HM, Bhatnagar J, Chufan EE, Kapoor K, Ambudkar SV (2013). Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformations. Biochemistry  52, 7327-38.   https://doi.org/10.1021/bi4007786|3. Singh S, Prasad NR, Kapoor K, Chufan EE, Patel BA, Ambudkar SV, Talele TT (2014). Design, synthesis, and biological evaluation of (S)-valine thiazole-derived cyclic and noncyclic peptidomimetic oligomers as modulators of human P-glycoprotein (ABCB1). Chembiochem  15, 157-69.   https://doi.org/10.1002/cbic.201300565|4. Wu C, Ambudkar S (2014) The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy. Acta Pharmaceutica Sinica B 4:104-111",https://intramural.nih.gov/search/searchview.taf?ipid=83533
69,BC010251-19,"October 01, 2013 -  September 30, 2014",Wnt Signaling and Secreted Frizzled-Related Proteins,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Bolormaa  Baljinnyam|Charles Peter Xavier,Alain  Dabdoub (Sunnybrook Research Institute; University of Toronto)|Gunnar  Schulte (Karolinska Institute)|Aykut  Uren (Georgetown University Medical Center),Robert  Callahan; PhD (Basic Research Laboratory)|Mitchell  Ho (Laboratory of Molecular Biology)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Bradley D St Croix (Mouse Cancer Genetics Program),Gibbes  Johnson (OD),"1. Xavier CP, Melikova M, Chuman Y, Üren A, Baljinnyam B, Rubin JS (2014). Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling. Cell Signal  26, 94-101.   https://doi.org/10.1016/j.cellsig.2013.09.016",https://intramural.nih.gov/search/searchview.taf?ipid=83534
70,BC010277-17,"October 01, 2013 -  September 30, 2014",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Jyoti Krishna Jha|Revathy  Ramachandran; PhD|Yawen  Bai; PhD,Rajagopala  Venkatappa (J Craig Ventor Institute)|Malanie  Blokesch (Global Health Institute),Peter C Fitzgerald (Office of the Director)|Lisa Marie Jenkins (Pigment Cell Biology Section)|Alexander  Wlodawer; PhD (Protein Structure Section),Aravind L Iyer; PhD (NLM) |Rodolfo  Ghirlando; PhD (NIDDK),"1. Ramachandran R, Jha J, Chattoraj DK (2014) Chromosome Segregation in Vibrio cholerae. J Mol Microbiol Biotechnol 24:360-70",https://intramural.nih.gov/search/searchview.taf?ipid=83537
71,BC010278-17,"October 01, 2013 -  September 30, 2014",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Lesley Ann Earl; PhD|Giovanna  Grandinetti|Lisa M. Hartnell|Kedar  Narayan,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Chris  Szakal (NIST)|Thomas  Hope (Northwestern University Medical School)|Michael  Phaneuf (Fibics Inc.)",Eric O Freed; PhD (Retroviral Replication Laboratory)|Jeffrey D Lifson; MD (Office Of The Director)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology),Donald F Bliss (NLM) |Terry S Yoo; PhD (NLM) |Robert S Balaban; PhD (NHLBI),"1. Earl LA, Lifson JD, Subramaniam S (2013). Catching HIV 'in the act' with 3D electron microscopy. Trends Microbiol  21, 397-404.   https://doi.org/10.1016/j.tim.2013.06.004|2. Narayan K, Danielson CM, Lagarec K, Lowekamp BC, Coffman P, Laquerre A, Phaneuf MW, Hope TJ, Subramaniam S (2014). Multi-resolution correlative focused ion beam scanning electron microscopy: applications to cell biology. J Struct Biol  185, 278-84.   https://doi.org/10.1016/j.jsb.2013.11.008|3. Schauder DM, Kuybeda O, Zhang J, Klymko K, Bartesaghi A, Borgnia MJ, Mayer ML, Subramaniam S (2013). Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A  110, 5921-6.   https://doi.org/10.1073/pnas.1217549110|4. Wang T, Choi E, Monaco MC, Campanac E, Medynets M, Do T, Rao P, Johnson KR, Elkahloun AG, Von Geldern G, Johnson T, Subramaniam S, Hoffman DA, Hoffman D, Major E, Nath A (2013). Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation. PLoS One  8, e81720.   https://doi.org/10.1371/journal.pone.0081720|5. Wu X, Subramaniam S, Case DA, Wu KW, Brooks BR (2013). Targeted conformational search with map-restrained self-guided Langevin dynamics: application to flexible fitting into electron microscopic density maps. J Struct Biol  183, 429-440.   https://doi.org/10.1016/j.jsb.2013.07.006",https://intramural.nih.gov/search/searchview.taf?ipid=83538
72,BC010283-17,"October 01, 2013 -  September 30, 2014",DNA Repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83539
73,BC010292-17,"October 01, 2013 -  September 30, 2014",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",NULL,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Byrd RA, Weissman AM (2013). Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase. EMBO J  32, 2087-9.   https://doi.org/10.1038/emboj.2013.158|2. Das R, Liang YH, Mariano J, Li J, Huang T, King A, Tarasov SG, Weissman AM, Ji X, Byrd RA (2013). Allosteric regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J  32, 2504-16.   https://doi.org/10.1038/emboj.2013.174|3. Metzger MB, Liang YH, Das R, Mariano J, Li S, Li J, Kostova Z, Byrd RA, Ji X, Weissman AM (2013). A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms. Mol Cell  50, 516-27.   https://doi.org/10.1016/j.molcel.2013.04.004|4. Weissman AM (2013). Ubiquitin and drug discovery: challenges and opportunities. Cell Biochem Biophys  67, 1-2.   https://doi.org/10.1007/s12013-013-9620-x",https://intramural.nih.gov/search/searchview.taf?ipid=83450
74,BC010297-17,"October 01, 2013 -  September 30, 2014",Identification of Genetic Factors Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Victor A David|Sophie Mh Limou|Efe  Sezgin|Noah Gregory Totsline,Gregory D Kirk|William  Wester (Vanderbilt University School of Medicine)|Luis  Soto-Ramerez (Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran),James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83540
75,BC010298-17,"October 01, 2013 -  September 30, 2014",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera,NULL,Christine Campo Alewine (Medical Oncology Branch),NULL,"1. Zhang J, Bera T, Liu W, Du X, Alewine C, Hassan R, Pastan I (2014) Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice. PloS One, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83541
76,BC010300-17,"October 01, 2013 -  September 30, 2014",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Walter A Baseler; PhD|Kimberly Covington Boelte|Luke Cynlais Davies; BSC|Selinda Jane Orr|Laura Ann R Quigley|Jonathan  Shakesprere|Show all 7,"Weiguo  Zhang (NICHHD)|Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|Mary  Nakamura (Laboratoire d'Hematologie, UCSF)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Neil  Gow (Unversity of Aberdeen)|Show all 8",Oleg Y Chertov (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|William Marston Linehan; MD (Urologic Oncology Branch)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),"Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Igal  Gery; PhD (NEI) |Suk See De Ravin; MD, PhD (NIAID) |Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI)","1. Montalvo V, Quigley L, Vistica BP, Boelte KC, Nugent LF, Takai T, McVicar DW, Gery I (2013). Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes. Immunology  140, 475-82.   https://doi.org/10.1111/imm.12158|2. Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW (2013). LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells. PLoS Pathog  9, e1003357.   https://doi.org/10.1371/journal.ppat.1003357",https://intramural.nih.gov/search/searchview.taf?ipid=83542
77,BC010301-17,"October 01, 2013 -  September 30, 2014",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Evgeny  Arons|Sarah Isabel Davies|Barbara  Debrah|Sonya C Duke|Lesley Ann Mathews|Katherine  Still|Show all 7,Arthur  Frankel (Texas A&M)|Michael  Grever (Ohio State Universithy)|Ramy A Ibrahim|Farhad  Ravandi (MD Anderson)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Jan  Burger (MD Anderson)|Show all 14,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|David J Fitzgerald; PhD (Biotherapy Section)|Elad  Sharon (Investigational Drug Branch)",Sharon D Adams (CC) |Raul Cipriano Braylan; MD (CC) |Katherine Rainsford Calvo (CC) |Nicholas  Patronas; MD (CC),"1. Burotto M, Stetler-Stevenson M, Arons E, Zhou H, Wilson W, Kreitman RJ (2013). Bendamustine and rituximab in relapsed and refractory hairy cell leukemia. Clin Cancer Res  19, 6313-21.   https://doi.org/10.1158/1078-0432.CCR-13-1848|2. Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M (2013). Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clin Cancer Res  19, 6873-81.   https://doi.org/10.1158/1078-0432.CCR-13-1752|3. Shao H, Calvo KR, Grönborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM (2013). Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res  37, 401-409.   https://doi.org/10.1016/j.leukres.2012.11.021",https://intramural.nih.gov/search/searchview.taf?ipid=83543
78,BC010304-16,"October 01, 2013 -  September 30, 2014",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Lakshmi  Balagopalan|Nathan  Coussens|Ellen  Dinerman|Geoffrey  Guittard; PhD|Wenmei  Li; PhD|Hiba Omer Malik|Show all 10,"Carl  June (University of Pennsylvania)|Wolfgang  Losert (University of Maryland)|Jeroen  Roose (University of California, San Francisco)|Eugene  Santos (University of Salamanca)",Ettore  Appella; MD (Chemical Immunology Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling),"Peter W Schuck; PhD (NIBIB) |Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83544
79,BC010307-15,"October 01, 2013 -  September 30, 2014",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Deborah K Morrison,Carlos  Caldas (Cancer Research UK Cambridge Research Institute)|Snehalata Anil Pawar|Fiona  Yull (Vanderbilt University)|Goran  Landberg (Paterson Institute for Cancer Research),Jonathan  Keller; PhD (Mouse Cancer Genetics Program)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,"1. Balamurugan K, Sharan S, Klarmann KD, Zhang Y, Coppola V, Summers GH, Roger T, Morrison DK, Keller JR, Sterneck E (2013). FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4. Nat Commun  4, 1662.   https://doi.org/10.1038/ncomms2677|2. Balamurugan K, Sterneck E (2013). The many faces of C/EBPδ and their relevance for inflammation and cancer. Int J Biol Sci  9, 917-33.   https://doi.org/10.7150/ijbs.7224|3. Pawar SA, Shao L, Chang J, Wang W, Pathak R, Zhu X, Wang J, Hendrickson H, Boerma M, Sterneck E, Zhou D, Hauer-Jensen M (2014) C/EBP deficiency sensitizes mice to ionizing radiation-induced hematopoietic and intestinal injury. PLoS One 9:e94967|4. Veltmaat JM, Ramsdell AF, Sterneck E (2013). Positional variations in mammary gland development and cancer. J Mammary Gland Biol Neoplasia  18, 179-88.   https://doi.org/10.1007/s10911-013-9287-3",https://intramural.nih.gov/search/searchview.taf?ipid=83457
80,BC010308-16,"October 01, 2013 -  September 30, 2014",In vivo Imaging Analysis of SteroidNuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Tina Branscombe Miranda|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD|Diana  Stavreva|Lyuba  Varticovski,Luke  Iwanowicz (USGS-BRD)|Stafford  Lightman (University of Bristol)|Adali  Pecci (Ciudad Universitaria),James  McMahon; PhD (Molecular Targets Laboratory),NULL,"1. Stavreva D, Varticovski L, Hager G (2014) A quantitative high-throughput assay for detection of biologically active endocrine-disrupting chemicals in water, in Aquananotechnology: Global Prospects., in press.|2. Miranda TB, Voss TC, Hager GL (2013). High-throughput fluorescence-based screen to identify factors involved in nuclear receptor recruitment to response elements. Methods Mol Biol  1042, 3-12.   https://doi.org/10.1007/978-1-62703-526-2_1",https://intramural.nih.gov/search/searchview.taf?ipid=83547
81,BC010309-16,"October 01, 2013 -  September 30, 2014",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,Miroslav  Dundr|Angus  Lamond (Wellcome Trust)|Poulikos  Poulikakos (Mount Sinai Medical School)|Jason  Lieb (University North Carolina)|Stephan  Mathas (Charite University),Stephen J Lockett; PhD (Office Of The Director),"Christopher P Austin; AB, MD (NCATS) |James  Inglese (NCATS)","1. Cavalli G, Misteli T (2013). Functional implications of genome topology. Nat Struct Mol Biol  20, 290-9.   https://doi.org/10.1038/nsmb.2474|2. Misteli T (2013). The cell biology of genomes: bringing the double helix to life. Cell  152, 1209-12.   https://doi.org/10.1016/j.cell.2013.02.048|3. Roukos V, Burman B, Misteli T (2013). The cellular etiology of chromosome translocations. Curr Opin Cell Biol  25, 357-64.   https://doi.org/10.1016/j.ceb.2013.02.015|4. Roukos V, Voss TC, Schmidt CK, Lee S, Wangsa D, Misteli T (2013). Spatial dynamics of chromosome translocations in living cells. Science  341, 660-4.   https://doi.org/10.1126/science.1237150|5. Sciamanna I, Gualtieri A, Cossetti C, Osimo EF, Ferracin M, Macchia G, Aricò E, Prosseda G, Vitullo P, Misteli T, Spadafora C (2013). A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines. Oncotarget  4, 2271-87.   https://doi.org/10.18632/oncotarget.1403|6. Sharma V, Misteli T (2013). Non-coding RNAs in DNA damage and repair. FEBS Lett  587, 1832-9.   https://doi.org/10.1016/j.febslet.2013.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=83548
82,BC010313-16,"October 01, 2013 -  September 30, 2014",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Jittiporn  Chaisaingmongkol; PhD|Hien Thi-Thu Dang|Carlos Eduardo Echeverria|Marshonna J Forgues|Juling  Ji|Show all 7,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Masao  Omata (University of Tokyo)|Show all 12,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|James  McMahon; PhD (Molecular Targets Laboratory)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",NULL,"1. Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW (2013). Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology  144, 1066-1075.e1.   https://doi.org/10.1053/j.gastro.2013.01.054|2. Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M (2013). Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A  110, E1083-91.   https://doi.org/10.1073/pnas.1217868110|3. Hsiao TH, Chen HI, Roessler S, Wang XW, Chen Y (2013). Identification of genomic functional hotspots with copy number alteration in liver cancer. EURASIP J Bioinform Syst Biol  2013, 14.   https://doi.org/10.1186/1687-4153-2013-14|4. Ji J, Yu L, Yu Z, Forgues M, Uenishi T, Kubo S, Wakasa K, Zhou J, Fan J, Tang ZY, Fu S, Zhu H, Jin JG, Sun HC, Wang XW (2013). Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma. Int J Biol Sci  9, 303-12.   https://doi.org/10.7150/ijbs.6214|5. Ozdemir B, Abd-Almageed W, Roessler S, Wang XW (2013). iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models. PLoS One  8, e78624.   https://doi.org/10.1371/journal.pone.0078624|6. Parpart S, Wang XW (2013). microRNA Regulation and Its Consequences in Cancer. Curr Pathobiol Rep  1, 71-79.   https://doi.org/10.1007/s40139-012-0002-7|7. Roessler S, Budhu A, Wang X (2014) Deciphering cancer heterogeneity: the biological space. Front Cell Dev Biol 2:12|8. Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang X, Kaneko S (2014). Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology  60, 1674-85.   https://doi.org/10.1002/hep.27093|9. Zhu WW, Guo JJ, Guo L, Jia HL, Zhu M, Zhang JB, Loffredo CA, Forgues M, Huang H, Xing XJ, Ren N, Dong QZ, Zhou HJ, Ren ZG, Zhao NQ, Wang XW, Tang ZY, Qin LX, Ye QH (2013). Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma. Clin Cancer Res  19, 3944-54.   https://doi.org/10.1158/1078-0432.CCR-12-3363",https://intramural.nih.gov/search/searchview.taf?ipid=83550
83,BC010319-16,"October 01, 2013 -  September 30, 2014",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao|Lothar  Esser|Wai-Kwan  Tang|Tao  Wan|Fei  Zhou,"Chang-An  Yu (Biochemistry and Molecular Biology, Oklahoma State University)|Zhao Hai  Qin (China Agriculture University)",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section),NULL,"1. Yu C, Yu L, Xia D (2013) Ubiquinol-cytochrome c oxidoreductase (Complex III), in Encyclopedia of Biophysics., pp. 2679-2684.|2. Esser L, Yu CA, Xia D (2014). Structural basis of resistance to anti-cytochrome bc₁ complex inhibitors: implication for drug improvement. Curr Pharm Des  20, 704-24.   https://doi.org/10.2174/138161282005140214163327",https://intramural.nih.gov/search/searchview.taf?ipid=83552
84,BC010326-15,"October 01, 2013 -  September 30, 2014","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Lan  Jin|Xing  Jing|Smita  Kakar; PhD|Vandana  Kumari; PhD|Gary X Shaw|Genbin  Shi|Show all 7,Honggao  Yan|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University)|Jorge  Cruz-Reyes (Texas A&M University),Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Larry K Keefer; PhD (Chemical Biology Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,"1. Court DL, Gan J, Liang YH, Shaw GX, Tropea JE, Costantino N, Waugh DS, Ji X (2013). RNase III: Genetics and function; structure and mechanism. Annu Rev Genet  47, 405-31.   https://doi.org/10.1146/annurev-genet-110711-155618|2. Das R, Liang YH, Mariano J, Li J, Huang T, King A, Tarasov SG, Weissman AM, Ji X, Byrd RA (2013). Allosteric regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J  32, 2504-16.   https://doi.org/10.1038/emboj.2013.174|3. Metzger MB, Liang YH, Das R, Mariano J, Li S, Li J, Kostova Z, Byrd RA, Ji X, Weissman AM (2013). A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms. Mol Cell  50, 516-27.   https://doi.org/10.1016/j.molcel.2013.04.004",https://intramural.nih.gov/search/searchview.taf?ipid=83553
85,BC010328-15,"October 01, 2013 -  September 30, 2014",Role of CEBP transcription factors in regulating cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Sandip  Basu|Mesfin Ademe Gonit|Xiaoli  Lou|Nancy C Martin|Manasi Kiran Mayekar|Jacqueline  Salotti; PhD|Show all 8,Robert  Smart (North Carolina State University)|Hongwei  Gao (Harvard Medical School)|Warren  Tourtellotte (Northwestern University)|JoAnne  Richards (Baylor College of Medicine)|Huaxi  Xu (Sanford-Burnham Medical Research Institute),Alexander  Wlodawer; PhD (Protein Structure Section)|Maria  Miller (Protein Structure Section)|William Gregory Alvord (Office Of The Director)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Diana C Haines (Office Of The Director),NULL,"1. Huggins CJ, Malik R, Lee S, Salotti J, Thomas S, Martin N, Quiñones OA, Alvord WG, Olanich ME, Keller JR, Johnson PF (2013). C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ. Mol Cell Biol  33, 3242-58.   https://doi.org/10.1128/MCB.01674-12|2. Wang X, Zhao Y, Zhang X, Badie H, Zhou Y, Mu Y, Loo LS, Cai L, Thompson RC, Yang B, Chen Y, Johnson PF, Wu C, Bu G, Mobley WC, Zhang D, Gage FH, Ranscht B, Zhang YW, Lipton SA, Hong W, Xu H (2013). Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nat Med  19, 473-80.   https://doi.org/10.1038/nm.3117|3. Yan C, Johnson PF, Tang H, Ye Y, Wu M, Gao H (2013). CCAAT/enhancer-binding protein δ is a critical mediator of lipopolysaccharide-induced acute lung injury. Am J Pathol  182, 420-30.   https://doi.org/10.1016/j.ajpath.2012.10.013|4. Yan C, Tang H, Gao H, Johnson PF, Ye Y, Wu M (2013). Authors' reply. Am J Pathol  182, 1459-60.",https://intramural.nih.gov/search/searchview.taf?ipid=83554
86,BC010329-15,"October 01, 2013 -  September 30, 2014",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Alyson Kara Freeman|Robert L Kortum|Daniel A Ritt|Suzanne I Specht|Elizabeth Mclean Terrell,"Premkumar  Reddy (Mount Sinai School of Medicine)|Robert  Rottapel (University of Toronto)|John Fickes Brognard; MS|Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)",Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,"1. Freeman A, Morrison D (2013) Mechanisms and Potential Therapies for Acquired Resistance to Inhibitors Targeting the Raf or MEK Kinases in Cancer, in Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy. Bonavida B, ed., pp. 47-68.|2. Freeman AK, Ritt DA, Morrison DK (2013). Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. Mol Cell  49, 751-8.   https://doi.org/10.1016/j.molcel.2012.12.018|3. Freeman AK, Ritt DA, Morrison DK (2013). The importance of Raf dimerization in cell signaling. Small GTPases  4, 180-5.   https://doi.org/10.4161/sgtp.26117",https://intramural.nih.gov/search/searchview.taf?ipid=83555
87,BC010331-15,"October 01, 2013 -  September 30, 2014",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Parthibane  Velayoudame,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)|Patrick  Dolph (Dartmouth College)",NULL,NULL,"1. Kunduri G, Yuan C, Parthibane V, Nyswaner K, Kanwar R, Nagashima K, Britt S, Mehta N, Kotu V, Porterfield M, Tiemeyer M, Dolph P, Acharya J, Acharya J (2014) Phosphatidic Acid Phospholipase A1 Mediates ER-Golgi Transit of a Family of G-Protein Coupled Receptors. The Journal of Cell Biology, in press.|2. Rahman M, Nirala N, Singh A, Zhu L, Taguchi K, Bamba T, Fukusaki E, Shaw L, Lambright D, Acharya J, Acharya J (2014) Drosophila Sirt2  mammalian SIRT3 deacetylates ATP synthase #946;  and regulates Complex V activity. The Journal of Cell Biology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83556
88,BC010333-15,"October 01, 2013 -  September 30, 2014",The Segregation of Bacterial Chromosomes to Daughter Cells,Stuart J Austin|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Flemming  Hansen (BioCentrum, Technical University of Denmank)|Alba  Guarne; PhD|Suckjoon  Jun (Harvard University)",Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83557
89,BC010334-15,"October 01, 2013 -  September 30, 2014",Posttranscriptional control of gene expression,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Rachel Elizabeth Kelly Beach|Jenifer L Bear|Cristina  Bergamaschi|Guy Robert Pilkington|Bethany Anne Nagy|George N Pavlakis; MD, PhD","Mila  Ayash-Rashkovsky (Dana-Farber Cancer Institute)|Kate  Broderick (Inovio Pharmaceuticals, Inc.)|Siddappa  Byrareddy (Dana-Farber Cancer Institute)|Mick  Correll (Dana-Farber Cancer Institute)|Welkin  Johnson; PhD (Dept of Microbiology and Mol Genetics, Harvard Medical School)|Victor  Kramer (Dana-Farber Cancer Institute)|Show all 11",Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)|Miriam R Anver (Office Of The Director)|Oleg Y Chertov (Office Of The Director)|Elena  Chertova (Office Of The Director)|Raymond C Sowder (Office Of The Director),NULL,"1. Byrareddy SN, Ayash-Rashkovsky M, Kramer VG, Lee SJ, Correll M, Novembre FJ, Villinger F, Johnson WE, von Gegerfelt A, Felber BK, Ruprecht RM (2013) Live attenuated Rev-independent NefSIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. PLoS One 8:e75556|2. Chertova E, Bergamaschi C, Chertov O, Sowder R, Bear J, Roser JD, Beach RK, Lifson JD, Felber BK, Pavlakis GN (2013). Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer. J Biol Chem  288, 18093-103.   https://doi.org/10.1074/jbc.M113.461756|3. Jalah R, Rosati M, Ganneru B, Pilkington GR, Valentin A, Kulkarni V, Bergamaschi C, Chowdhury B, Zhang GM, Beach RK, Alicea C, Broderick KE, Sardesai NY, Pavlakis GN, Felber BK (2013). The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem  288, 6763-76.   https://doi.org/10.1074/jbc.M112.436675",https://intramural.nih.gov/search/searchview.taf?ipid=83558
90,BC010336-15,"October 01, 2013 -  September 30, 2014",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Molecular Control and Genetics Section, NCI",Mikhail G Bubunenko|Katherine Ann Cascino|Nina C Costantino|Jordan Daniel Jensen|Michelle  Miron|Adam Robert Parks; PhD|Show all 8,"David  Friedman (University of Michigan School of Medicine)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Kenon  Murphy (Molecular Genetics and Microbiology, University of Massachusetts Med. School)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|JeanHerve  Alix (CNRS at University of Paris)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Sankar  Adhya; PhD (Developmental Genetics Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Jeffrey N Strathern (Genome Recombination and Regulation Section),NULL,"1. Sawitzke J, Bubunenko M, Thomason L, Costantino N, Court D (2013) Recombineering: A modern approach to genetic engineering, in Brenner's Encyclopedia of Genetics. Maloy S, Hughes K, eds., pp. 109-112.|2. Arbel-Goren R, Tal A, Friedlander T, Meshner S, Costantino N, Court DL, Stavans J (2013). Effects of post-transcriptional regulation on phenotypic noise in Escherichia coli. Nucleic Acids Res  41, 4825-34.   https://doi.org/10.1093/nar/gkt184|3. Li XT, Thomason LC, Sawitzke JA, Costantino N, Court DL (2013). Positive and negative selection using the tetA-sacB cassette: recombineering and P1 transduction in Escherichia coli. Nucleic Acids Res  41, e204.   https://doi.org/10.1093/nar/gkt1075|4. Strader MB, Hervey WJ, Costantino N, Fujigaki S, Chen CY, Akal-Strader A, Ihunnah CA, Makusky AJ, Court DL, Markey SP, Kowalak JA (2013). A coordinated proteomic approach for identifying proteins that interact with the E. coli ribosomal protein S12. J Proteome Res  12, 1289-99.   https://doi.org/10.1021/pr3009435|5. Zhou YN, Lubkowska L, Hui M, Court C, Chen S, Court DL, Strathern J, Jin DJ, Kashlev M (2013). Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J Biol Chem  288, 2700-10.   https://doi.org/10.1074/jbc.M112.429464",https://intramural.nih.gov/search/searchview.taf?ipid=83559
91,BC010338-15,"October 01, 2013 -  September 30, 2014",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder|Irene Hwang Hung|Michelle Ying Sutanto,"Gregg  Duester (Department of OncoDevelopmental Biology, Burnham Institute)|Trevor  Williams (University of Colarado)|Thomas  Schimmang (University of Valladolid)|Gary C Schoenwolf",Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,"1. Anderson MJ, Naiche LA, Wilson CP, Elder C, Swing DA, Lewandoski M (2013). TCreERT2, a transgenic mouse line for temporal control of Cre-mediated recombination in lineages emerging from the primitive streak or tail bud. PLoS One  8, e62479.   https://doi.org/10.1371/journal.pone.0062479|2. Sauer S, Burkett SS, Lewandoski M, Klar AJ (2013). A CO-FISH assay to assess sister chromatid segregation patterns in mitosis of mouse embryonic stem cells. Chromosome Res  21, 311-28.   https://doi.org/10.1007/s10577-013-9358-8",https://intramural.nih.gov/search/searchview.taf?ipid=83560
92,BC010341-15,"October 01, 2013 -  September 30, 2014",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Sreejith  Raran Kurussi; PhD,NULL,NULL,NULL,"1. Raran-Kurussi S, Tözsér J, Cherry S, Tropea JE, Waugh DS (2013). Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases. Anal Biochem  436, 142-4.   https://doi.org/10.1016/j.ab.2013.01.031",https://intramural.nih.gov/search/searchview.taf?ipid=83561
93,BC010345-15,"October 01, 2013 -  September 30, 2014",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Ravindra Babu  Chalamalasetty|Robert John Garriock|Jessica Dolores Grisez|Mark William Lorne Kennedy; PhD|Nikita Ajit Salker|Sara E Parkin,NULL,Mark B Lewandoski (Genetics of Vertebrate Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83563
94,BC010348-15,"October 01, 2013 -  September 30, 2014",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Protein Structure Section, NCI",NULL,"Ben  Dunn (Biochem. & Mol. Biol., University of Florida)|Mariusz  Jaskolski (Adam Mickiewicz University)",Barry R O'Keefe (Molecular Targets Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section),NULL,"1. Wlodawer A, Gustchina A, James M (2013) Chapter 2 - Catalytic Pathways of Aspartic Peptidases, in Handbook of Proteolytic Enzymes (Third Edition). Rawlings N, Salvesen G, eds., pp. 19-26.|2. Wlodawer A, Kervinen J (2013) Chapter 23 - Phytepsin, in Handbook of Proteolytic Enzymes (Third Edition). Rawlings N, Salvesen G, eds., pp. 118-124.|3. Dunn BM, Wlodawer A (2013). The regulation of proteolysis around the world. Curr Opin Struct Biol  23, 795-6.   https://doi.org/10.1016/j.sbi.2013.10.004|4. Ferreira Rda S, Zhou D, Ferreira JG, Silva MC, Silva-Lucca RA, Mentele R, Paredes-Gamero EJ, Bertolin TC, Dos Santos Correia MT, Paiva PM, Gustchina A, Wlodawer A, Oliva ML (2013). Crystal Structure of Crataeva tapia Bark Protein (CrataBL) and Its Effect in Human Prostate Cancer Cell Lines. PLoS One  8, e64426.   https://doi.org/10.1371/journal.pone.0064426|5. Pletneva NV, Pletnev VZ, Souslova E, Chudakov DM, Lukyanov S, Martynov VI, Arhipova S, Artemyev I, Wlodawer A, Dauter Z, Pletnev S (2013). Yellow fluorescent protein phiYFPv (Phialidium): structure and structure-based mutagenesis. Acta Crystallogr D Biol Crystallogr  69, 1005-12.   https://doi.org/10.1107/S0907444913004034|6. Wlodawer A, Minor W, Dauter Z, Jaskolski M (2013). Protein crystallography for aspiring crystallographers or how to avoid pitfalls and traps in macromolecular structure determination. FEBS J  280, 5705-36.   https://doi.org/10.1111/febs.12495|7. Yao J, Wlodawer A, Guo H (2013). Understanding the autocatalytic process of pro-kumamolisin activation from molecular dynamics and quantum mechanical/molecular mechanical (QM/MM) free-energy simulations. Chemistry  19, 10849-52.   https://doi.org/10.1002/chem.201301310|8. Zhang F, Walcott B, Zhou D, Gustchina A, Lasanajak Y, Smith DF, Ferreira RS, Correia MT, Paiva PM, Bovin NV, Wlodawer A, Oliva ML, Linhardt RJ (2013). Structural studies of the interaction of Crataeva tapia bark protein with heparin and other glycosaminoglycans. Biochemistry  52, 2148-56.   https://doi.org/10.1021/bi400077b|9. Zhou D, Lobo YA, Batista IF, Marques-Porto R, Gustchina A, Oliva ML, Wlodawer A (2013). Crystal structures of a plant trypsin inhibitor from Enterolobium contortisiliquum (EcTI) and of its complex with bovine trypsin. PLoS One  8, e62252.   https://doi.org/10.1371/journal.pone.0062252",https://intramural.nih.gov/search/searchview.taf?ipid=83564
95,BC010350-15,"October 01, 2013 -  September 30, 2014",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Candido  Alicea; PhD|Jenifer L Bear|Cristina  Bergamaschi|Katherine Alina Goetz|Xintao  Hu|Rebecca Lynn Matthews|Show all 22,"Ruth  Ruprecht (Dana-Farber Cancer Institute)|David  Weiner (University of Pennsylvania)|Amitinder  Kaur (New England Primate Research Center)|Larry  Liao (Duke Human Vaccine Initiative)|Bart  Haynes (Duke Human Vaccine Institute)|James  Mullins; PhD (Microbiology, University of Washington)|Show all 40",Julian Wallace Bess (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Mairi Hall McLean (Laboratory of Molecular Immunoregulation)|Michael  Piatak (Office Of The Director)|James D Roser (Office Of The Director),Ira  Berkower (OD) |Vanessa  Hirsch (NIAID) |Max Flint Hockenbury (OD) |Adrian Bernard McDermott; PhD (NIAID) |Yisheng  Ni; PhD (OD) |Lois Jean Patterson (OD),"1. Byrareddy SN, Ayash-Rashkovsky M, Kramer VG, Lee SJ, Correll M, Novembre FJ, Villinger F, Johnson WE, von Gegerfelt A, Felber BK, Ruprecht RM (2013) Live attenuated Rev-independent NefSIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. PLoS One 8:e75556|2. Kulkarni V, Rosati M, Bear J, Pilkington GR, Jalah R, Bergamaschi C, Singh AK, Alicea C, Chowdhury B, Zhang GM, Kim EY, Wolinsky SM, Huang W, Guan Y, LaBranche C, Montefiori DC, Broderick KE, Sardesai NY, Valentin A, Felber BK, Pavlakis GN (2013). Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques. Hum Vaccin Immunother  9, 2081-94.   https://doi.org/10.4161/hv.25473|3. Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang GM, Le Gall S, Broderick KE, Sardesai NY, Heckerman D, Mothe B, Brander C, Weiner DB, Mullins JI, Pavlakis GN, Felber BK (2013). HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. PLoS One  8, e60245.   https://doi.org/10.1371/journal.pone.0060245|4. Kulkarni V, Rosati M, Valentin A, Jalah R, Alicea C, Yu L, Guan Y, Shen X, Tomaras GD, LaBranche C, Montefiori DC, Irene C, Prattipati R, Pinter A, Sullivan SM, Pavlakis GN, Felber BK (2013). Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia. Hum Vaccin Immunother  9, 2069-80.   https://doi.org/10.4161/hv.25442|5. Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, von Gegerfelt A, Huang W, Guan Y, Keele BF, Bess JW, Piatak M, Lifson JD, Williams WT, Shen X, Tomaras GD, Amara RR, Robinson HL, Johnson W, Broderick KE, Sardesai NY, Venzon DJ, Hirsch VM, Felber BK, Pavlakis GN (2013). DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A  110, 2975-80.   https://doi.org/10.1073/pnas.1215393110|6. Vaccari M, Halwani R, Patterson LJ, Boasso A, Beal J, Tryniszewska E, Hryniewicz A, Venzon D, Haddad EK, El-Far M, Rosati M, Pavlakis GN, Felber BK, Al-Muhsen S, Robert-Guroff M, Sekaly RP, Franchini G (2013). Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS. J Virol  87, 3526-37.   https://doi.org/10.1128/JVI.02686-12|7. Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, Pollara J, Hryniewicz A, Ferrari G, Guan Y, Forthal DN, Venzon D, Fenizia C, Morgan T, Montefiori D, Lifson JD, Miller CJ, Silvestri G, Rosati M, Felber BK, Pavlakis GN, Tartaglia J, Franchini G (2013). Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol  87, 3538-48.   https://doi.org/10.1128/JVI.02863-12|8. Virnik K, Hockenbury M, Ni Y, Beren J, Pavlakis GN, Felber BK, Berkower I (2013). Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques. Retrovirology  10, 99.   https://doi.org/10.1186/1742-4690-10-99",https://intramural.nih.gov/search/searchview.taf?ipid=83565
96,BC010378-15,"October 01, 2013 -  September 30, 2014",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Miroslawa  Dauter|Zhipu  Luo|Sergei V Pletnev|Milosz Jacek Ruszkowski; PhD,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Alexander  Wlodawer; PhD (Protein Structure Section),NULL,"1. Borek D, Dauter Z, Otwinowski Z (2013). Identification of patterns in diffraction intensities affected by radiation exposure. J Synchrotron Radiat  20, 37-48.   https://doi.org/10.1107/S0909049512048807|2. Dauter Z (2013). On optimal placement of molecules in the unit cell. Acta Crystallogr D Biol Crystallogr  69, 872-8.   https://doi.org/10.1107/S0907444913002722|3. Dauter Z (2013). Placement of molecules in (not out of) the cell. Acta Crystallogr D Biol Crystallogr  69, 2-4.   https://doi.org/10.1107/S0907444912044794|4. Dauter Z, Weiss MS, Einspahr H, Baker EN (2013). Expectation bias and information content. Acta Crystallogr Sect F Struct Biol Cryst Commun  69, 83.   https://doi.org/10.1107/S1744309113001486|5. Liebschner D, Dauter M, Brzuszkiewicz A, Dauter Z (2013). On the reproducibility of protein crystal structures: five atomic resolution structures of trypsin. Acta Crystallogr D Biol Crystallogr  69, 1447-62.   https://doi.org/10.1107/S0907444913009050|6. Luo Z, Rajashankar K, Dauter Z (2014). Weak data do not make a free lunch, only a cheap meal. Acta Crystallogr D Biol Crystallogr  70, 253-60.   https://doi.org/10.1107/S1399004713026680|7. Pletnev S, Subach FV, Verkhusha VV, Dauter Z (2014). The rotational order-disorder structure of the reversibly photoswitchable red fluorescent protein rsTagRFP. Acta Crystallogr D Biol Crystallogr  70, 31-9.   https://doi.org/10.1107/S1399004713024644|8. Pletnev VZ, Pletneva NV, Lukyanov KA, Souslova EA, Fradkov AF, Chudakov DM, Chepurnykh T, Yampolsky IV, Wlodawer A, Dauter Z, Pletnev S (2013) Structure of the red fluorescent protein from a lancelet (Branchiostoma lanceolatum): a novel GYG chromophore covalently bound to a nearby tyrosine. Acta Crystallogr D Biol Crystallogr 69:1850-60|9. Pletneva NV, Pletnev VZ, Souslova E, Chudakov DM, Lukyanov S, Martynov VI, Arhipova S, Artemyev I, Wlodawer A, Dauter Z, Pletnev S (2013). Yellow fluorescent protein phiYFPv (Phialidium): structure and structure-based mutagenesis. Acta Crystallogr D Biol Crystallogr  69, 1005-12.   https://doi.org/10.1107/S0907444913004034|10. Ruszkowski M, Brzezinski K, Jedrzejczak R, Dauter M, Dauter Z, Sikorski M, Jaskolski M (2013). Medicago truncatula histidine-containing phosphotransfer protein: structural and biochemical insights into the cytokinin transduction pathway in plants. FEBS J  280, 3709-20.   https://doi.org/10.1111/febs.12363|11. Sliwiak J, Jaskolski M, Dauter Z, McCoy AJ, Read RJ (2014). Likelihood-based molecular-replacement solution for a highly pathological crystal with tetartohedral twinning and sevenfold translational noncrystallographic symmetry. Acta Crystallogr D Biol Crystallogr  70, 471-80.   https://doi.org/10.1107/S1399004713030319|12. Wlodawer A, Minor W, Dauter Z, Jaskolski M (2013). Protein crystallography for aspiring crystallographers or how to avoid pitfalls and traps in macromolecular structure determination. FEBS J  280, 5705-36.   https://doi.org/10.1111/febs.12495",https://intramural.nih.gov/search/searchview.taf?ipid=83566
97,BC010379-15,"October 01, 2013 -  September 30, 2014",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),Adrian Riu Ferre-D'Amare (NHLBI),"1. Fang X, Wang J, O'Carroll IP, Mitchell M, Zuo X, Wang Y, Yu P, Liu Y, Rausch JW, Dyba MA, Kjems J, Schwieters CD, Seifert S, Winans RE, Watts NR, Stahl SJ, Wingfield PT, Byrd RA, Le Grice SF, Rein A, Wang YX (2013). An unusual topological structure of the HIV-1 Rev response element. Cell  155, 594-605.   https://doi.org/10.1016/j.cell.2013.10.008",https://intramural.nih.gov/search/searchview.taf?ipid=83567
98,BC010380-15,"October 01, 2013 -  September 30, 2014",Recombination and Regulation,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83568
99,BC010381-15,"October 01, 2013 -  September 30, 2014",Studies on Silencing,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83569
100,BC010385-15,"October 01, 2013 -  September 30, 2014",Studies on mat1 Imprinting,Amar J S Klar; PhD,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83570
101,BC010387-15,"October 01, 2013 -  September 30, 2014",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Suzanne A Hartford|Betty K Martin|Thirthagiri  Eswary,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),Chuxia  Deng; PhD (NIDDK),"1. Biswas K, Sharan S (2013) Manipulating the mouse genome using recombineering. Advancements in Genetic Engineering 4:1-5|2. Chang S, Sharan SK (2013). The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression. Transcription  4, 24-8.   https://doi.org/10.4161/trns.22600|3. Mukherjee M, Ge G, Zhang N, Edwards DG, Sumazin P, Sharan SK, Rao PH, Medina D, Pati D (2014). MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas. Oncogene  33, 5511-5522.   https://doi.org/10.1038/onc.2013.493",https://intramural.nih.gov/search/searchview.taf?ipid=83571
102,BC010390-15,"October 01, 2013 -  September 30, 2014",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Erkan  Kiris|Francesco  Tomassoni Ardori; PhD|Colleen A Barrick|Gianluca  Fulgenzi|Mary Ellen  Palko|Show all 7,"Susan  Dorsey (University of Maryland)|Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)",NULL,NULL,"1. Baydyuk M, Xie Y, Tessarollo L, Xu B (2013). Midbrain-derived neurotrophins support survival of immature striatal projection neurons. J Neurosci  33, 3363-9.   https://doi.org/10.1523/JNEUROSCI.3687-12.2013|2. Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS (2013). Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med  19, 695-703.   https://doi.org/10.1038/nm.3155",https://intramural.nih.gov/search/searchview.taf?ipid=83572
103,BC010391-15,"October 01, 2013 -  September 30, 2014",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Colleen A Barrick|Jodi L Becker|Gianluca  Fulgenzi|Erkan  Kiris|Mary Ellen  Palko|Francesco  Tomassoni Ardori; PhD,NULL,"Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"1. Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS (2013). Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. Nat Med  19, 695-703.   https://doi.org/10.1038/nm.3155",https://intramural.nih.gov/search/searchview.taf?ipid=83573
104,BC010411-15,"October 01, 2013 -  September 30, 2014",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Yves  Pommier; PhD|Vladimir L Larionov; PhD, DSc","Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Elsa  Bronze Da Rocha (University Do Porto)|lizhao  wu (Rutgers New Jersey Medical School Cancer Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)","Kyungjae  Myung; BS, MS, PhD (NHGRI) |Karen P Usdin; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83574
105,BC010412-15,"October 01, 2013 -  September 30, 2014",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Alan Anthony Merk|Sriram  Subramaniam; PhD,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Bartesaghi A, Merk A, Borgnia MJ, Milne JL, Subramaniam S (2013). Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol  20, 1352-7.   https://doi.org/10.1038/nsmb.2711|2. Harris AK, Bartesaghi A, Milne JL, Subramaniam S (2013). HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1. J Virol  87, 7191-6.   https://doi.org/10.1128/JVI.03284-12|3. Merk A, Subramaniam S (2013). HIV-1 envelope glycoprotein structure. Curr Opin Struct Biol  23, 268-76.   https://doi.org/10.1016/j.sbi.2013.03.007",https://intramural.nih.gov/search/searchview.taf?ipid=83575
106,BC010413-14,"October 01, 2013 -  September 30, 2014",Human Artificial Chromosomes for Cancer Research and Functional Genomics,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Mirit I Aladjem; PhD|Yves  Pommier; PhD,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)",NULL,Danny L Sackett; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83458
107,BC010418-15,"October 01, 2013 -  September 30, 2014",Signaling Events Regulating Chemotaxis,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Chenlu  Wang|Weiye  Wang|Wolfgang  Losert; PhD,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),Alan Robert Kimmel; PhD (NIDDK) |Tian  Jin; PhD (NIAID) |John Robert Hogg (NHLBI),"1. McCann C, Parent C (2013) Eukaryotic chemotaxis, in The Encyclopedia of Biological Chemistry. Lennarz W, Lane M, eds., pp. 236-240.|2. Brzostowski JA, Sawai S, Rozov O, Liao XH, Imoto D, Parent CA, Kimmel AR (2013). Phosphorylation of chemoattractant receptors regulates chemotaxis, actin reorganization and signal relay. J Cell Sci  126, 4614-26.   https://doi.org/10.1242/jcs.122952|3. Parent CA, Weiner OD (2013). The symphony of cell movement: how cells orchestrate diverse signals and forces to control migration. Curr Opin Cell Biol  25, 523-5.   https://doi.org/10.1016/j.ceb.2013.07.011",https://intramural.nih.gov/search/searchview.taf?ipid=83576
108,BC010419-15,"October 01, 2013 -  September 30, 2014",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Liuya  Tang|Yi  Tang|Veenu  Tripathi; PhD|Jennifer A Wang|Xuan  Xu,NULL,Ming  Zhou (Nucleic Acids Section)|Miriam R Anver (Office Of The Director)|Jing  Huang (Laboratory of Cancer Biology and Genetics)|Lisa Marie Jenkins (Pigment Cell Biology Section),"Sushil Gopal Rane; MS, PhD (NIDDK)","1. Zhang YE, Newfeld SJ (2013). Meeting report - TGF-β superfamily: signaling in development and disease. J Cell Sci  126, 4809-13.   https://doi.org/10.1242/jcs.142398",https://intramural.nih.gov/search/searchview.taf?ipid=83577
109,BC010425-15,"October 01, 2013 -  September 30, 2014",Strategies for Therapeutic Cancer Vaccine Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jessa Nicole Bame|Renee Nicole Donahue|Benedetto Paolo Farsaci; PhD|Italia  Grenga|Lauren Marissa Lepone|Kwong Yok Tsang|Show all 8,Philip  Kantoff (Dana-Farber Cancer Institute)|James  Breitmeyer (BN ImmunoTherapeutics),Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Jeffrey  Gildersleeve (Chemical Biology Laboratory)|William Laurence Dahut; MD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines (Chapter 20), in Cancer Immunotherapy: Immune Suppression and Tumor Growth, 2nd Edition. Prendergast G, Jaffee E, eds., pp. 309-332.|2. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC (2013). Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clin Cancer Res  19, 1290-9.   https://doi.org/10.1158/1078-0432.CCR-12-2478|3. Gulley J, Madan R, Tsang K, Jochems C, Marte J, Farsaci B, Tucker J, Hodge J, Liewehr D, Steinberg S, Heery C, Schlom J (2013) Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer. Cancer Immunol Res 2:133-141|4. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|5. Madan RA, Tsang KY, Bilusic M, Vergati M, Poole DJ, Jochems C, Tucker JA, Schlom J, Giaccone G, Gulley JL (2013). Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer. Oncologist  18, 821-2.   https://doi.org/10.1634/theoncologist.2013-0199|6. Schlom J (2013). Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid Rees. Expert Rev Vaccines  12, 1121-4.   https://doi.org/10.1586/14760584.2013.836913",https://intramural.nih.gov/search/searchview.taf?ipid=83578
110,BC010440-13,"October 01, 2013 -  September 30, 2014","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Mayukh  Chakrabarti|Rudy Charles Clausen|Hyunbum  Jang|Buyong  Ma|Ruxi  Qi|Chung  Tsai|Show all 7,"Carlos  Aleman (Engineering, Univ. Barcelona)|Turkan  Haliloglu|Ratnesh  Lal (Medical School, University of Chicago)|David  Zanuy (Institute Polytechnical)|Bruce  Kagan (UCLA)|Peter  Csermely (Semmelweis University)|Show all 20",Robert  Blumenthal; PhD (Basic Research Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Nadya I Tarasova; PhD (Cancer Inflammation Program),"Zhong  Chen; MD, PhD (NIDCD) |Carter  Van Waes; MD, PhD (NIDCD)","1. Cronin M, Coolbaugh MJ, Nellis D, Zhu J, Wood DW, Nussinov R, Ma B (2015). Dynamics differentiate between active and inactive inteins. Eur J Med Chem  91, 51-62.   https://doi.org/10.1016/j.ejmech.2014.07.094|2. Huang Q, Yu L, Levine AJ, Nussinov R, Ma B (2014). Dipeptide analysis of p53 mutations and evolution of p53 family proteins. Biochim Biophys Acta  1844, 198-206.   https://doi.org/10.1016/j.bbapap.2013.04.002|3. Jang H, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R (2013). Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment. J Phys Chem B  117, 11518-29.   https://doi.org/10.1021/jp405389n|4. Jang H, Connelly L, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R (2013). Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane. J Chem Theory Comput  9, 822-833.   https://doi.org/10.1021/ct300916f|5. Jang H, Connelly L, Arce FT, Ramachandran S, Lal R, Kagan BL, Nussinov R (2013). Alzheimer's disease: which type of amyloid-preventing drug agents to employ? Phys Chem Chem Phys  15, 8868-77.   https://doi.org/10.1039/c3cp00017f|6. Luo Y, Dinkel P, Yu X, Margittai M, Zheng J, Nussinov R, Wei G, Ma B (2013). Molecular insights into the reversible formation of tau protein fibrils. Chem Commun (Camb)  49, 3582-4.   https://doi.org/10.1039/c3cc00241a|7. Ma B, Nussinov R (2013). Structured crowding and its effects on enzyme catalysis. Top Curr Chem  337, 123-37.   https://doi.org/10.1007/128_2012_316|8. Ma B, Nussinov R (2014). Druggable orthosteric and allosteric hot spots to target protein-protein interactions. Curr Pharm Des  20, 1293-301.   https://doi.org/10.2174/13816128113199990073|9. Miller Y, Ma B, Nussinov R (2015). Polymorphism in self-assembly of peptide-based β-hairpin contributes to network morphology and hydrogel mechanical rigidity. J Phys Chem B  119, 482-90.   https://doi.org/10.1021/jp511485n|10. Nussinov R, Tsai CJ, Ma B (2013). The underappreciated role of allostery in the cellular network. Annu Rev Biophys  42, 169-89.   https://doi.org/10.1146/annurev-biophys-083012-130257|11. Xu Y, Wang H, Nussinov R, Ma B (2013). Protein charge and mass contribute to the spatio-temporal dynamics of protein-protein interactions in a minimal proteome. Proteomics  13, 1339-51.   https://doi.org/10.1002/pmic.201100540|12. Zanuy D, Kotla R, Nussinov R, Teesalu T, Sugahara KN, Alemán C, Haspel N (2013). Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. J Struct Biol  182, 78-86.   https://doi.org/10.1016/j.jsb.2013.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=83545
111,BC010441-13,"October 01, 2013 -  September 30, 2014",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Hyunbum  Jang|Ozlem Z Keskin|Buyong  Ma|Ruxi  Qi|Chung  Tsai,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Peter  Csermely (Semmelweis University)|J  Huang (Department of Medicine, National Jewish Medical and Research Center)|Show all 12",Sergey G Tarasov (Structural Biophysics Laboratory)|Nadya I Tarasova; PhD (Cancer Inflammation Program),"Zhong  Chen; MD, PhD (NIDCD) |Carter  Van Waes; MD, PhD (NIDCD)","1. Acuner Ozbabacan SE, Gursoy A, Nussinov R, Keskin O (2014). The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS Comput Biol  10, e1003470.   https://doi.org/10.1371/journal.pcbi.1003470|2. Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R (2013). Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther  138, 333-408.   https://doi.org/10.1016/j.pharmthera.2013.01.016|3. Kuzu G, Gursoy A, Nussinov R, Keskin O (2013). Exploiting conformational ensembles in modeling protein-protein interactions on the proteome scale. J Proteome Res  12, 2641-53.   https://doi.org/10.1021/pr400006k|4. Ma B, Nussinov R (2013). Structured crowding and its effects on enzyme catalysis. Top Curr Chem  337, 123-37.   https://doi.org/10.1007/128_2012_316|5. Ma B, Nussinov R (2014). Druggable orthosteric and allosteric hot spots to target protein-protein interactions. Curr Pharm Des  20, 1293-301.   https://doi.org/10.2174/13816128113199990073|6. Nussinov R (2013). The spatial structure of cell signaling systems. Phys Biol  10, 045004.   https://doi.org/10.1088/1478-3975/10/4/045004|7. Nussinov R, Jang H (2014). Dynamic multiprotein assemblies shape the spatial structure of cell signaling. Prog Biophys Mol Biol  116, 158-64.   https://doi.org/10.1016/j.pbiomolbio.2014.07.002|8. Nussinov R, Jang H, Tsai CJ (2015) Oligomerization and nanocluster organization render specificity. Biol Rev Camb Philos Soc 90:587-98|9. Nussinov R, Ma B, Tsai CJ, Csermely P (2013). Allosteric conformational barcodes direct signaling in the cell. Structure  21, 1509-21.   https://doi.org/10.1016/j.str.2013.06.002|10. Nussinov R, Tsai CJ, Ma B (2013). The underappreciated role of allostery in the cellular network. Annu Rev Biophys  42, 169-89.   https://doi.org/10.1146/annurev-biophys-083012-130257",https://intramural.nih.gov/search/searchview.taf?ipid=83546
112,BC010442-13,"October 01, 2013 -  September 30, 2014",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Rudy Charles Clausen|Ozlem Z Keskin|Buyong  Ma|Ruxi  Qi|Chung  Tsai,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Vadim  Gaponenko|Nurit  Haspel (University of Massachusetts,)|Show all 11",NULL,NULL,"1. Kuzu G, Gursoy A, Nussinov R, Keskin O (2013). Exploiting conformational ensembles in modeling protein-protein interactions on the proteome scale. J Proteome Res  12, 2641-53.   https://doi.org/10.1021/pr400006k|2. Luo Y, Dinkel P, Yu X, Margittai M, Zheng J, Nussinov R, Wei G, Ma B (2013). Molecular insights into the reversible formation of tau protein fibrils. Chem Commun (Camb)  49, 3582-4.   https://doi.org/10.1039/c3cc00241a",https://intramural.nih.gov/search/searchview.taf?ipid=83549
113,BC010446-13,"October 01, 2013 -  September 30, 2014",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83551
114,BC010448-13,"October 01, 2013 -  September 30, 2014",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Robert Mark Simpson; DVM, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83579
115,BC010449-13,"October 01, 2013 -  September 30, 2014",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Yan  Cai|Lei  Xu|Shigetoshi  Yokoyama|Mitsuhiro  Yoneda|Angela  Zhou,NULL,NULL,"Jerrold M Ward; DVM, PhD (NIAID)","1. Cai Y, Kimura S (2013). Noninvasive intratracheal intubation to study the pathology and physiology of mouse lung. J Vis Exp   e50601  https://doi.org/10.3791/50601|2. Cai Y, Zhu L, Zhang F, Niu G, Lee S, Kimura S, Chen X (2013). Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). Mol Pharm  10, 2237-47.   https://doi.org/10.1021/mp300613x",https://intramural.nih.gov/search/searchview.taf?ipid=83580
116,BC010451-13,"October 01, 2013 -  September 30, 2014",Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Shailesh Gulabrao Ambre; PhD|Mei-Li  Laracuente|Jeffrey  Gildersleeve,"Lugang  Yu (University of Liverpool)|Kate  Rittenhouse-Olson (Biotechnical and Clinical Laboratory Science, University of Buffalo)",Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Glinskii OV, Li F, Wilson LS, Barnes S, Rittenhouse-Olson K, Barchi JJ, Pienta KJ, Glinsky VV (2014). Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane. Oncotarget  5, 1382-9.   https://doi.org/10.18632/oncotarget.1837",https://intramural.nih.gov/search/searchview.taf?ipid=83656
117,BC010453-13,"October 01, 2013 -  September 30, 2014",Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Elena Valerie Fernandez|Douglas K Price|Kelie M Reece; PhD|Andrea Borghese Apolo|James L Gulley; MD, PhD|Show all 7",Romano  Danesi|Alan  Kristal (Fred Hutchinson Cancer Research Center)|Robin  Leach (UT Health Science Center San Antonio)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|M  Lucia (University of Colorado Denver)|Show all 14,"David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Ann  Hsing; PhD (Infection & Immunoepidemiology Branch)|Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)",NULL,"1. Martin TJ, Peer CJ, Figg WD (2013). Uncovering the genetic landscape driving castration-resistant prostate cancer. Cancer Biol Ther  14, 399-400.   https://doi.org/10.4161/cbt.24426|2. Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M (2013). Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prev Res (Phila)  6, 91-9.   https://doi.org/10.1158/1940-6207.CAPR-12-0250|3. Petrini I, Meltzer PS, Kim IK, Lucchi M, Park KS, Fontanini G, Gao J, Zucali PA, Calabrese F, Favaretto A, Rea F, Rodriguez-Canales J, Walker RL, Pineda M, Zhu YJ, Lau C, Killian KJ, Bilke S, Voeller D, Dakshanamurthy S, Wang Y, Giaccone G (2014). A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet  46, 844-9.   https://doi.org/10.1038/ng.3016|4. Roth JE, Peer CJ, Price DK, Figg WD (2014). The androgen receptor transcriptional program in castration-resistant prostate cancer: cell lines vs. tissue samples. Cancer Biol Ther  15, 16-8.   https://doi.org/10.4161/cbt.27149|5. Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G (2014). Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer. J Thorac Oncol  9, 567-71.   https://doi.org/10.1097/JTO.0000000000000089",https://intramural.nih.gov/search/searchview.taf?ipid=83581
118,BC010476-12,"October 01, 2013 -  September 30, 2014",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Calvin A Johnson; PhD (CIT) |Anthony R Fletcher; PhD (CIT) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83591
119,BC010477-12,"October 01, 2013 -  September 30, 2014",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",James B Mitchell; PhD,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83590
120,BC010481-12,"October 01, 2013 -  September 30, 2014",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Patrick K Clark|Linda L Dunn,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Gary T Pauly (Chemical Biology Laboratory)|William Gregory Alvord (Office Of The Director)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Craig Joseph Thomas (NCATS),"1. Das K, Arnold E, Hughes S (2013) HIV-1 reverse transcriptase structures, in Encyclopedia of Biological Chemistry. Lennarz W, Lane M, eds., pp. 548-553.|2. Dunn LL, Boyer PL, Clark PK, Hughes SH (2013). Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease. Virology  444, 241-9.   https://doi.org/10.1016/j.virol.2013.06.017",https://intramural.nih.gov/search/searchview.taf?ipid=83587
121,BC010483-12,"October 01, 2013 -  September 30, 2014",TEM5 Ligand Hunt,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83600
122,BC010484-12,"October 01, 2013 -  September 30, 2014",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Ekaterina  Posokhova|Mary B Hilton|Steven  Seaman|Christopher S Szot,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83601
123,BC010486-12,"October 01, 2013 -  September 30, 2014",Search for New Tumor Endothelial Markers,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Steven  Seaman,NULL,NULL,NULL,"1. Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, Kalen J, Haines DC, Zudaire E, St Croix B (2014). COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. Sci Transl Med  6, 242ra84.   https://doi.org/10.1126/scitranslmed.3008455",https://intramural.nih.gov/search/searchview.taf?ipid=83602
124,BC010487-12,"October 01, 2013 -  September 30, 2014",Cytoplasmic-Nuclear Trafficking of HIV-1,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Christopher Lee Case; PhD|Laura Minji Choi|Kyeongeun  Lee|Guangai  Xue; PhD|Hyun Jae  Yu|Wendy  Yuen|Show all 8,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Peter  Cherepanov (Imperial College London)",Xiaolin  Wu; PhD (Office Of The Director),NULL,"1. Koh Y, Wu X, Ferris AL, Matreyek KA, Smith SJ, Lee K, KewalRamani VN, Hughes SH, Engelman A (2013). Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration. J Virol  87, 648-58.   https://doi.org/10.1128/JVI.01148-12",https://intramural.nih.gov/search/searchview.taf?ipid=83588
125,BC010488-12,"October 01, 2013 -  September 30, 2014",Animal Models for HIV-1 Replication and Pathogenesis,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Christopher Lee Case; PhD|Kyeongeun  Lee|Guangai  Xue; PhD|Wendy  Yuen,"Paul  Bieniasz (Rockefeller University, Aaron Diamond AIDS Research Center)|Theodora  Hatziioannou (Aaron Diamond AIDS Research Center)",Jeffrey D Lifson; MD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83589
126,BC010493-12,"October 01, 2013 -  September 30, 2014",High-Resolution Protein and Nucleic Acid Footprinting,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Fardokht Assadi Abulwerdi|Jennifer T Miller|Jason William Rausch|Chringma  Sherpa|Joanna  Sztuba-Solinska; PhD|Humeyra  Taskent; PhD,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|John  Marino (Center for Advanced Research in Biotechnology)|Marie-Louise  Hammarskjold (University of Virginia)|David  Garfinkel (University of Georgia)|Jef  Boeke (Johns Hopkins University)|Andrew  Lever (University of Cambridge)|Show all 10",Barbara K Felber (Vaccine Branch)|John Stephen Schneekloth (Chemical Biology Laboratory)|Alexander  Wlodawer; PhD (Protein Structure Section)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Joseph M Ziegelbauer (HIV and AIDS Malignancy Branch),NULL,"1. Le Grice S, Nowotny M (2014) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., pp. 189-214.|2. Miller J, Le Grice S (2014) Reverse transcription, in Encyclopedia of AIDS. Hope T, Richman D, Stevenson M, eds., in press.|3. SztubaSolinska J, Le Grice S (2014) Insights into secondary and tertiary interactions of dengue virus RNA by SHAPE, in Dengue: Protocols and Methods  (R Padebanemabhan, ed.),, Methods in Molecular Biology., pp. 225-239.|4. Chamanian M, Purzycka KJ, Wille PT, Ha JS, McDonald D, Gao Y, Le Grice SF, Arts EJ (2013). A cis-acting element in retroviral genomic RNA links Gag-Pol ribosomal frameshifting to selective viral RNA encapsidation. Cell Host Microbe  13, 181-92.   https://doi.org/10.1016/j.chom.2013.01.007|5. Huang Q, Purzycka KJ, Lusvarghi S, Li D, Legrice SF, Boeke JD (2013) Retrotransposon Ty1 RNA contains a 5-terminal long-range pseudoknot required for efficient reverse transcription. RNA 19:320-32|6. Kenyon JC, Prestwood LJ, Le Grice SF, Lever AM (2013). In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res  41, e174.   https://doi.org/10.1093/nar/gkt690|7. Lapkouski M, Tian L, Miller JT, Le Grice SFJ, Yang W (2013). Complexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradation. Nat Struct Mol Biol  20, 230-236.   https://doi.org/10.1038/nsmb.2485|8. Lusvarghi S, Sztuba-Solinska J, Purzycka KJ, Pauly GT, Rausch JW, Grice SF (2013). The HIV-2 Rev-response element: determining secondary structure and defining folding intermediates. Nucleic Acids Res  41, 6637-49.   https://doi.org/10.1093/nar/gkt353|9. Lusvarghi S, Sztuba-Solinska J, Purzycka KJ, Rausch JW, Le Grice SF (2013). RNA secondary structure prediction using high-throughput SHAPE. J Vis Exp   e50243  https://doi.org/10.3791/50243|10. Nowak E, Potrzebowski W, Konarev PV, Rausch JW, Bona MK, Svergun DI, Bujnicki JM, Le Grice SF, Nowotny M (2013). Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA hybrid. Nucleic Acids Res  41, 3874-87.   https://doi.org/10.1093/nar/gkt053|11. Purzycka KJ, Garfinkel DJ, Boeke JD, Le Grice SF (2013). Influence of RNA structural elements on Ty1 retrotransposition. Mob Genet Elements  3, e25060.   https://doi.org/10.4161/mge.25060|12. Purzycka KJ, Legiewicz M, Matsuda E, Eizentstat LD, Lusvarghi S, Saha A, Le Grice SF, Garfinkel DJ (2013). Exploring Ty1 retrotransposon RNA structure within virus-like particles. Nucleic Acids Res  41, 463-73.   https://doi.org/10.1093/nar/gks983|13. Sztuba-Solinska J, Teramoto T, Rausch JW, Shapiro BA, Padmanabhan R, Le Grice SF (2013). Structural complexity of Dengue virus untranslated regions: cis-acting RNA motifs and pseudoknot interactions modulating functionality of the viral genome. Nucleic Acids Res  41, 5075-89.   https://doi.org/10.1093/nar/gkt203",https://intramural.nih.gov/search/searchview.taf?ipid=83594
127,BC010494-12,"October 01, 2013 -  September 30, 2014",HIV-1 RNase H  as  a Therapeutic Target,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Takashi  Masaoka|Jennifer T Miller|Jason William Rausch|Joanna  Sztuba-Solinska; PhD|Humeyra  Taskent; PhD,"Graziella  Tocco (University of Cagliari)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)|John  Tavis (Saint Louis University)|Angela Maria Gronenborn; PhD (Department of Structural Biology, University of Pittsburgh)|Nicolas  Sluis-Cremer; PhD (Department of Medicine, University of Pittsburgh)",John A Beutler (Molecular Targets Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS) |Wei  Yang; PhD (NIDDK),"1. Le Grice S (2013) Conformational dynamics of reverse transcription, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. (Le Grice S, Goette M, eds., pp. 77-95.|2. Le Grice S, Nowotny M (2014) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., pp. 189-214.|3. Rausch J (2013) Progress towards developing potent and specific inhibitors of HIV RT-associated ribonuclease H, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. (Le Grice S, Goette M, eds., in press.|4. Chung S, Miller JT, Lapkouski M, Tian L, Yang W, Le Grice SF (2013). Examining the role of the HIV-1 reverse transcriptase p51 subunit in positioning and hydrolysis of RNA/DNA hybrids. J Biol Chem  288, 16177-84.   https://doi.org/10.1074/jbc.M113.465641|5. Corona A, Masaoka T, Tocco G, Tramontano E, Le Grice SF (2013). Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase. Future Med Chem  5, 2127-39.   https://doi.org/10.4155/fmc.13.178|6. Masaoka T, Chung S, Caboni P, Rausch JW, Wilson JA, Taskent-Sezgin H, Beutler JA, Tocco G, Le Grice SF (2013). Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem  56, 5436-45.   https://doi.org/10.1021/jm400405z",https://intramural.nih.gov/search/searchview.taf?ipid=83592
128,BC010495-12,"October 01, 2013 -  September 30, 2014",Unnatural Amino Acids as Probes of Protein Structure and Function,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Marion Karla Bona; PhD|Vineet Narain KewalRamani; PhD,NULL,Deb  Chatterjee (Office Of The Director),NULL,"1. Le Grice S, Nowotny M (2014) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., pp. 189-214.",https://intramural.nih.gov/search/searchview.taf?ipid=83593
129,BC010499-12,"October 01, 2013 -  September 30, 2014",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Adrienne Michelle Starks|Wei  Tang; PhD,"Carlo  Croce (Ohio State University)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S (2013). Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer  12, 13.   https://doi.org/10.1186/1476-4598-12-13|2. Martin DN, Starks AM, Ambs S (2013). Biological determinants of health disparities in prostate cancer. Curr Opin Oncol  25, 235-41.   https://doi.org/10.1097/CCO.0b013e32835eb5d1",https://intramural.nih.gov/search/searchview.taf?ipid=83582
130,BC010504-12,"October 01, 2013 -  September 30, 2014",Elucidating the Mechanisms of Reverse Transcription and Recombination,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Malika  Kuzembayeva|Olga A Nikolaitchik|John Miller Coffin; PhD|Vinay K Pathak; PhD,NULL,Frank  Maldarelli (Host Virus Interaction Branch)|Mary  Kearney (Host Virus Interaction Branch),NULL,"1. Burdick RC, Hu WS, Pathak VK (2013). Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes. Proc Natl Acad Sci U S A  110, E4780-9.   https://doi.org/10.1073/pnas.1315996110|2. Chaipan C, Smith JL, Hu WS, Pathak VK (2013). APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages. J Virol  87, 444-53.   https://doi.org/10.1128/JVI.00676-12|3. Izumi T, Burdick R, Shigemi M, Plisov S, Hu WS, Pathak VK (2013). Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity. J Virol  87, 11047-62.   https://doi.org/10.1128/JVI.02070-13",https://intramural.nih.gov/search/searchview.taf?ipid=83586
131,BC010506-12,"October 01, 2013 -  September 30, 2014",Understanding Retroviral Gag and RNA Targeting and Virus Assembly,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Kari Ann Dilley|Malika  Kuzembayeva|Yang  Liu; PhD|Medha Satish Parulekar|Sheikh Abdul Rahman|Show all 10,David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|WE  Moerner (Stanford University),Kunio  Nagashima (Office Of The Director)|Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83585
132,BC010511-12,"October 01, 2013 -  September 30, 2014",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Siddhartha  Datta; PhD|Demetria P Harvin|Bridget Lynn Heeney|Jane  Mirro|Ina  O'Carroll|Show all 8,"Susan  Krueger (National Institute of Standards and Technology)|Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|Hung  Fan (University of California, Irvine)|Show all 10",Raul Eduardo Cachau (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. O'Carroll IP, Soheilian F, Kamata A, Nagashima K, Rein A (2013). Elements in HIV-1 Gag contributing to virus particle assembly. Virus Res  171, 341-5.   https://doi.org/10.1016/j.virusres.2012.10.016|2. Rein A (2013). Murine leukemia virus p12 functions include hitchhiking into the nucleus. Proc Natl Acad Sci U S A  110, 9195-6.   https://doi.org/10.1073/pnas.1307399110|3. Stavrou S, Nitta T, Kotla S, Ha D, Nagashima K, Rein AR, Fan H, Ross SR (2013). Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc Natl Acad Sci U S A  110, 9078-83.   https://doi.org/10.1073/pnas.1217399110",https://intramural.nih.gov/search/searchview.taf?ipid=83598
133,BC010512-12,"October 01, 2013 -  September 30, 2014",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Mauricio  Comas Garcia; PhD|Demetria P Harvin|Jane  Mirro|Ina  O'Carroll|Yashna  Thappeta|Wei-Shau  Hu; PhD,"Kevin  Weeks (University of North Carolina)|Karin  Musier-Forsyth (Ohio State University)|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)","Yun Xing M Wang (Structural Biophysics Laboratory)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Stephen J Lockett; PhD (Office Of The Director)",Judith Goldstein Levin; PhD (NICHD) |John Robert Hogg (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83599
134,BC010516-12,"October 01, 2013 -  September 30, 2014",Gated Optical DetectorsDose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|Ying  Zhuge,"Alan  Huston (Naval Research Laboratory)|Brian  Justus (Optical Sciences Division, Naval Research Lab (NRL))",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83605
135,BC010518-12,"October 01, 2013 -  September 30, 2014",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Cynthia M Elder|Maria  Kaltcheva|Ying  Zhang,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83608
136,BC010523-12,"October 01, 2013 -  September 30, 2014",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83451
137,BC010524-12,"October 01, 2013 -  September 30, 2014",HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Chenzhong  Liao|Alexey Vladimirovich Zakharov; PhD|Terrence R Burke; PhD,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Karen  Buckheit (ImQuest Biosciences)|Chenzhong  Liao",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,"1. Lagunin A, Filimonov D, Gloriozova T, Tarasova O, Zakharov A, GuaschPamies L, Nicklaus M, Poroikov V (2013) Virtual Screening of Potential Anti-HIV Agents in Libraries of Commercially Available Organic Compounds (Russ.). Chem Pharm J (Moscow) 47:3-21",https://intramural.nih.gov/search/searchview.taf?ipid=83606
138,BC010525-12,"October 01, 2013 -  September 30, 2014",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Alfred  Singer; MD (Lymphocyte Development Section)|Richard J Hodes; MD (Immune Regulation Section)|Jung-Hyun  Park (Experimental Immunology Branch)|Joy A Williams (Lymphocyte Development Section),NULL,"1. Farthing DE, Buxbaum NP, Bare CV, Treadwell SM, Kapoor V, Williams KM, Gress RE (2013). Sensitive GC-MS/MS method to measure deuterium labeled deoxyadenosine in DNA from limited mouse cell populations. Anal Chem  85, 4613-20.   https://doi.org/10.1021/ac400309d|2. Gress RE, Miller JS, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Landau DA, Wu CJ (2013). Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation. Biol Blood Marrow Transplant  19, 1537-45.   https://doi.org/10.1016/j.bbmt.2013.08.010|3. Williams JA, Zhang J, Jeon H, Nitta T, Ohigashi I, Klug D, Kruhlak MJ, Choudhury B, Sharrow SO, Granger L, Adams A, Eckhaus MA, Jenkinson SR, Richie ER, Gress RE, Takahama Y, Hodes RJ (2014). Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways. J Immunol  192, 630-40.   https://doi.org/10.4049/jimmunol.1302550",https://intramural.nih.gov/search/searchview.taf?ipid=83584
139,BC010538-12,"October 01, 2013 -  September 30, 2014",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",NULL,"Andreas  Stark (University of Schleswig-Holstein Medical Center)|George  Sledge Jr (Indiana University)|Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Paul  Lockman (Texas Tech University)|Renata  Duchnowska (Military Institute of Medicine,)|Jacek  Jassem (Medical University of Gdansk)|Show all 8",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Deedee Kay Smart (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Gril B, Palmieri D, Qian Y, Anwar T, Liewehr DJ, Steinberg SM, Andreu Z, Masana D, Fernández P, Steeg PS, Vidal-Vanaclocha F (2013). Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells. Am J Pathol  182, 2368-79.   https://doi.org/10.1016/j.ajpath.2013.02.043|2. Saldana SM, Lee HH, Lowery FJ, Khotskaya YB, Xia W, Zhang C, Chang SS, Chou CK, Steeg PS, Yu D, Hung MC (2013). Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis. PLoS One  8, e73406.   https://doi.org/10.1371/journal.pone.0073406|3. Zhang S, Huang WC, Zhang L, Zhang C, Lowery FJ, Ding Z, Guo H, Wang H, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D (2013). SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. Cancer Res  73, 5764-74.   https://doi.org/10.1158/0008-5472.CAN-12-1803",https://intramural.nih.gov/search/searchview.taf?ipid=83603
140,BC010539-12,"October 01, 2013 -  September 30, 2014",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",Lino  Tessarollo,"Office of the Director, NCI",Georgette Nicole Jones; PhD|Min-Hyung  Lee; PhD|Robert  Tuskan|Carrie Antoinette Williams,Karl  Broman (University of Michigan)|David  Gutmann (Washington University)|Joshua  Rubin (Washington University)|Keiko  Akagi (NCI)|Melissa  Bondy (MD Anderson)|Yanhong  Liu (MD Anderson),"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Uma  Shankavaram; PhD (Radiation Oncology Branch)","Thanh truc B Huynh (NICHD) |Karel  Pacak; MD, PhD (NICHD)","1. Jones G, Reilly K (2013) Dissection of Complex Genetic and Epigenetic Interactions Underlying NF1 Cancer Susceptibility Using Mouse Models, in Neurofirbomatosis Type 1. Upadhyaya M, Cooper D, eds., in press.|2. Reilly K (2013) Controlling Genetic Background in Crosses of Mouse Models of Cancer, in Mouse Models of Cancer. Abate-Shen C, Politi K, Chodosh L, Olive K, eds., in press.|3. Reilly K (2013) The Effect of Genetic Background of Mouse Models of Human Cancer: Friend or Foe?, in Mouse Models of Cancer. Abate-Shen C, Politi K, Chodosh L, Olive K, eds., in press.|4. Reilly K (2013) Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes, in Mouse Models of Cancer. Abate-Shen C, Politi K, Chodosh L, Olive K, eds., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83596
141,BC010540-12,"October 01, 2013 -  September 30, 2014",Molecular Mechanisms of Proliferation and Infiltration of MPNST and Astrocytoma,"Karlyne M Reilly; BS, PhD",Lino  Tessarollo,"Office of the Director, NCI",Robert  Tuskan|Min-Hyung  Lee; PhD|Carrie Antoinette Williams,David  Gutmann (Washington University)|Joshua  Rubin (Washington University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83597
142,BC010541-12,"October 01, 2013 -  September 30, 2014",Development of Mouse Neurofibromatosis Model for Preclinical Testing,"Karlyne M Reilly; BS, PhD",Lino  Tessarollo,"Office of the Director, NCI",Robert  Tuskan,"David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|Christophe  Echeverri (Cenix BioScience)",Brigitte  Widemann; MD (Pediatric Oncology Branch)|John A Beutler (Molecular Targets Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Thomas J Turbyville (Office Of The Director)|Curtis  Henrich (Molecular Targets Laboratory)|William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Zemp FJ, McKenzie BA, Lun X, Maxwell L, Reilly KM, McFadden G, Yong VW, Forsyth PA (2013). Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon. PLoS One  8, e65801.   https://doi.org/10.1371/journal.pone.0065801",https://intramural.nih.gov/search/searchview.taf?ipid=83595
143,BC010547-12,"October 01, 2013 -  September 30, 2014",Development of Drugs That Target Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Elena Valerie Fernandez|Douglas K Price|Kelie M Reece; PhD|Andrea Borghese Apolo|James L Gulley; MD, PhD|Show all 7",NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Frank Jess Gonzalez; PhD (Nucleic Acids Section)|William Laurence Dahut; MD (Office Of The Clinical Director),Clara Chi Chen; MD (CC),"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Fernández EV, Price DK, Figg WD (2013). Prostate cancer progression attributed to autonomic nerve development: potential for therapeutic prevention of localized and metastatic disease. Cancer Biol Ther  14, 1005-6.   https://doi.org/10.4161/cbt.26339|3. Figg WD, Chau CH, Madan RA, Gulley JL, Gao R, Sissung TM, Spencer S, Beatson M, Aragon-Ching J, Steinberg SM, Dahut WL (2013). Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity. Clin Genitourin Cancer  11, 229-37.   https://doi.org/10.1016/j.clgc.2013.04.007|4. Hall C, Troutman SM, Price DK, Figg WD, Kang MH (2013). Bcl-2 family of proteins as therapeutic targets in genitourinary neoplasms. Clin Genitourin Cancer  11, 10-9.   https://doi.org/10.1016/j.clgc.2012.09.002|5. Roth JE, Peer CJ, Price DK, Figg WD (2014). The androgen receptor transcriptional program in castration-resistant prostate cancer: cell lines vs. tissue samples. Cancer Biol Ther  15, 16-8.   https://doi.org/10.4161/cbt.27149|6. Vaishampayan UN, Fontana J, Heilbrun LK, Smith D, Heath E, Dickow B, Figg WD (2014). Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer. Urol Oncol  32, 31.e25-33.   https://doi.org/10.1016/j.urolonc.2012.11.017",https://intramural.nih.gov/search/searchview.taf?ipid=83583
144,BC010549-12,"October 01, 2013 -  September 30, 2014",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree,NULL,NULL,"Paul P. Liu; MD, PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83452
145,BC010562-11,"October 01, 2013 -  September 30, 2014",Molecular Interaction Maps and Analysis of Bioregulatory Networks,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Kurt  Kohn; PhD|Yves  Pommier; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83613
146,BC010566-11,"October 01, 2013 -  September 30, 2014",Tumor and Metastasis Biology,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Anita C Epps|Michael Mark Lizardo; PhD|Ling  Ren|Javed  Khan; MD,"Aykut  Uren (Georgetown University Medical Center)|Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Danny  Welch (Department of Pathology, University of Alabama, Birmingham)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)","Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83624
147,BC010578-11,"October 01, 2013 -  September 30, 2014",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Steven  Seaman|Christopher S Szot|Enrique  Zudaire Ubani; PhD,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries),Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program),NULL,"1. Stránecký V, Hoischen A, Hartmannová H, Zaki MS, Chaudhary A, Zudaire E, Nosková L, Barešová V, Přistoupilová A, Hodaňová K, Sovová J, Hůlková H, Piherová L, Hehir-Kwa JY, de Silva D, Senanayake MP, Farrag S, Zeman J, Martásek P, Baxová A, Afifi HH, St Croix B, Brunner HG, Temtamy S, Kmoch S (2013). Mutations in ANTXR1 cause GAPO syndrome. Am J Hum Genet  92, 792-9.   https://doi.org/10.1016/j.ajhg.2013.03.023|2. Dimitrov DS, Decrescenzo GS, Saha SS, St Croix BS, Welsch DS, Zhang XS, Zhu ZS, Zudaire Ubani ES (submitted in 2013) Tem8 Antibodies And Their Use In Treatment And Detection Of Tumors. Patent issued: 9,765,142 (US in 2017). Patents pending: 201480066451.3 (CN application); 14789480.2 (EP application); 2016-521982 (JP application); MX/A/2016/003744 (MX application); PCT/US2014/060299 (PC application); 15/680,177 (US application); 2014331667 (AU application); 2925393 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=83454
148,BC010579-11,"October 01, 2013 -  September 30, 2014",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",John  Schiller; PhD|Christopher  Buck,NULL,Lauren V Wood; MD (Vaccine Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,"1. Tripathi BK, Qian X, Mertins P, Wang D, Papageorge AG, Carr SA, Lowy DR (2014). CDK5 is a major regulator of the tumor suppressor DLC1. J Cell Biol  207, 627-42.   https://doi.org/10.1083/jcb.201405105",https://intramural.nih.gov/search/searchview.taf?ipid=83626
149,BC010580-11,"October 01, 2013 -  September 30, 2014",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters|Nalini M Jayaprakash,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83611
150,BC010595-11,"October 01, 2013 -  September 30, 2014",Structure and Function of APOBEC3 Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Belete Ayele Desimmie|Sanath Kumar  Janaka|Michael David Nekorchuk; PhD|Theodore A Nikolaitchik|Dongfei  Qi|Show all 8,Jean L Mbisa (NCI)|Yoshio  Koyanagi|Kei  Sato (Kyoto University)|Joseph  Wedekind (University of Rochester Medical Center)|Yong  Xiong (Yale University),Robert  Gorelick (Office Of The Director),James  Inglese (NCATS),"1. Burdick RC, Hu WS, Pathak VK (2013). Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes. Proc Natl Acad Sci U S A  110, E4780-9.   https://doi.org/10.1073/pnas.1315996110|2. Chaipan C, Smith JL, Hu WS, Pathak VK (2013). APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages. J Virol  87, 444-53.   https://doi.org/10.1128/JVI.00676-12|3. Izumi T, Burdick R, Shigemi M, Plisov S, Hu WS, Pathak VK (2013). Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity. J Virol  87, 11047-62.   https://doi.org/10.1128/JVI.02070-13",https://intramural.nih.gov/search/searchview.taf?ipid=83630
151,BC010598-11,"October 01, 2013 -  September 30, 2014",Human Immune Responses to Tumor Antigens for Cancer Vaccine Development,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jessa Nicole Bame|Renee Nicole Donahue|Benedetto Paolo Farsaci; PhD|Italia  Grenga|Lauren Marissa Lepone|Kwong Yok Tsang|Show all 8,"James  Breitmeyer (BN ImmunoTherapeutics)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Timothy  Rodell (GlobeImmune)|Mario  Roselli (Oncology, Tor Vergata)|Helen B Sabzevari","Jeffrey  Gildersleeve (Chemical Biology Laboratory)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. Bilusic M, Heery CR, Arlen PM, Rauckhorst M, Apelian D, Tsang KY, Tucker JA, Jochems C, Schlom J, Gulley JL, Madan RA (2014). Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma. Cancer Immunol Immunother  63, 225-34.   https://doi.org/10.1007/s00262-013-1505-8|2. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC (2013). Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clin Cancer Res  19, 1290-9.   https://doi.org/10.1158/1078-0432.CCR-12-2478|3. Gulley J, Madan R, Tsang K, Jochems C, Marte J, Farsaci B, Tucker J, Hodge J, Liewehr D, Steinberg S, Heery C, Schlom J (2013) Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer. Cancer Immunol Res 2:133-141|4. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|5. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013). Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol  190, 6250-8.   https://doi.org/10.4049/jimmunol.1300022|6. Huen NY, Pang AL, Tucker JA, Lee TL, Vergati M, Jochems C, Intrivici C, Cereda V, Chan WY, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY (2013). Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer  133, 373-82.   https://doi.org/10.1002/ijc.28026|7. Madan RA, Tsang KY, Bilusic M, Vergati M, Poole DJ, Jochems C, Tucker JA, Schlom J, Giaccone G, Gulley JL (2013). Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer. Oncologist  18, 821-2.   https://doi.org/10.1634/theoncologist.2013-0199|8. Schlom J (2013). Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid Rees. Expert Rev Vaccines  12, 1121-4.   https://doi.org/10.1586/14760584.2013.836913|9. Schlom J, Jochems C, Gulley JL, Huang J (2013). The role of soluble CD40L in immunosuppression. Oncoimmunology  2, e22546.   https://doi.org/10.4161/onci.22546",https://intramural.nih.gov/search/searchview.taf?ipid=83453
152,BC010600-11,"October 01, 2013 -  September 30, 2014",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,Michael  Maurizi; PhD (Biochemistry of Proteins Section),NULL,"1. Tang WK, Xia D (2013). Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants. J Biol Chem  288, 36624-35.   https://doi.org/10.1074/jbc.M113.488924",https://intramural.nih.gov/search/searchview.taf?ipid=83612
153,BC010607-11,"October 01, 2013 -  September 30, 2014",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Heather  Sheppard|Juanjuan  Yin,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Maria  Merino; PhD (Laboratory of Pathology)",Alan Paul Koretsky; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83621
154,BC010612-11,"October 01, 2013 -  September 30, 2014",The Role of miRNA-mediated RNAI in the Biology of Cancer,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sirisha  Chakka|Konrad  Huppi; MD, PhD|Tamara L Jones|Suntae  Kim|Ashish Kumar Lal",Siegfried  Janz (University of Iowa)|Patrick  Grohar,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83637
155,BC010613-11,"October 01, 2013 -  September 30, 2014",The Induction of Gene-specific RNAi Against Cancer-associated Genes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sirisha  Chakka|Sara Lynn Haddock|Konrad  Huppi; MD, PhD|Tamara L Jones|Suntae  Kim|Grace Elizabeth White|Show all 7",NULL,Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beissbarth T, Difilippantonio MJ, Caplen NJ, Ried T (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res  73, 2003-13.   https://doi.org/10.1158/0008-5472.CAN-12-3159|2. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013). Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer  49, 3020-8.   https://doi.org/10.1016/j.ejca.2013.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=83638
156,BC010615-11,"October 01, 2013 -  September 30, 2014",RNAi Screening for the Systematic Discovery of Cancer Gene Function,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Sirisha  Chakka|Sara Lynn Haddock|Tamara L Jones|Suntae  Kim|Karl Thomas Ried; MD,NULL,"Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Christina M Annunziata (Womens Malignancies Branch)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Scott E Martin (NCATS),"1. Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beissbarth T, Difilippantonio MJ, Caplen NJ, Ried T (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res  73, 2003-13.   https://doi.org/10.1158/0008-5472.CAN-12-3159|2. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013). Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer  49, 3020-8.   https://doi.org/10.1016/j.ejca.2013.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=83639
157,BC010620-11,"October 01, 2013 -  September 30, 2014",Clinical Studies to Circumvent Drug Resistance,Susan  Bates; MD,NULL,"Developmental Therapeutics Branch, NCI",Robert W Robey|Sanjeeve  Balasubramaniam|Wilfred D Stein|James Halpern Doroshow|Yves  Pommier; PhD|Christophe  Redon,"Thomas  Litman (University of Copenhagen)|Wilfred  Stein (Hebrew University, Jerusalem)|Alex  Sparreboom",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Jo Anne N Zujewski (Clinical Investigations Branch)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Karen A Kurdziel; MD (Molecular Imaging Program)|Michael  Dean; PhD (Laboratory of Experimental Immunology),Clara Chi Chen; MD (CC) |Robert  Innis; MD (NIMH),"1. Blagoev KB, Wilkerson J, Stein WD, Motzer RJ, Bates SE, Fojo AT (2013). Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma. Cell Rep  3, 277-81.   https://doi.org/10.1016/j.celrep.2013.01.015|2. Burotto M, Wilkerson J, Stein W, Motzer R, Bates S, Fojo T (2014). Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example. PLoS One  9, e96316.   https://doi.org/10.1371/journal.pone.0096316|3. Fojo AT, Bates SE (2014). Clinical trial results: a clinical trial bazaar! Oncologist  19, 313-4.   https://doi.org/10.1634/theoncologist.2014-0091|4. Fojo T, Bates S (2013). Mechanisms of resistance to PARP inhibitors--three and counting. Cancer Discov  3, 20-3.   https://doi.org/10.1158/2159-8290.CD-12-0514",https://intramural.nih.gov/search/searchview.taf?ipid=83616
158,BC010621-11,"October 01, 2013 -  September 30, 2014",Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,Susan  Bates; MD,NULL,"Developmental Therapeutics Branch, NCI",Sanjeeve  Balasubramaniam|Agnes Marie Therese Basseville|Victoria  Luchenko|Andrew Jacob McDonald|Robert W Robey|Yves  Pommier; PhD,"Stefania  Scala (Clinical Immunology, National Cancer Institute, G. Pascale Foundation)|Thomas  Litman (University of Copenhagen)|Giuseppe  Giaccone; MD|Owen  O'Connor (Columbia University Medical Center)|Louise  Showe (University of Pennsylvania)","Patricia A Fetsch (Laboratory of Pathology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)","Danny L Sackett; PhD (NICHD) |Douglas R Rosing; MD (NHLBI) |Alexander  Ling (CC) |David Theodore George; MD (NIAAA) |Markus Alexander Heilig; MD, PhD (NIAAA)","1. Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL (2013). Phase I trial of a new schedule of romidepsin in patients with advanced cancers. Clin Cancer Res  19, 4499-507.   https://doi.org/10.1158/1078-0432.CCR-13-0095|2. Chakraborty AR, Robey RW, Luchenko VL, Zhan Z, Piekarz RL, Gillet JP, Kossenkov AV, Wilkerson J, Showe LC, Gottesman MM, Collie NL, Bates SE (2013). MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor. Blood  121, 4115-25.   https://doi.org/10.1182/blood-2012-08-449140|3. Ierano C, Basseville A, To KK, Zhan Z, Robey RW, Wilkerson J, Bates SE, Scala S (2013). Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration. Cancer Biol Ther  14, 175-83.   https://doi.org/10.4161/cbt.22957|4. Ierano C, Chakraborty AR, Nicolae A, Bahr JC, Zhan Z, Pittaluga S, Bates SE, Robey RW (2013). Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors. Cell Cycle  12, 2829-38.   https://doi.org/10.4161/cc.25914|5. Noonan AM, Eisch RA, Liewehr DJ, Sissung TM, Venzon DJ, Flagg TP, Haigney MC, Steinberg SM, Figg WD, Piekarz RL, Bates SE (2013). Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel. Clin Cancer Res  19, 3095-104.   https://doi.org/10.1158/1078-0432.CCR-13-0109",https://intramural.nih.gov/search/searchview.taf?ipid=83614
159,BC010622-11,"October 01, 2013 -  September 30, 2014",Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,NULL,"Developmental Therapeutics Branch, NCI",Agnes Marie Therese Basseville|Robert W Robey|Yves  Pommier; PhD,"Thomas  Litman (University of Copenhagen)|Hendrik  van Veen (Department of Pharmacology, University of Cambridge)|Alex  Sparreboom",Patricia A Fetsch (Laboratory of Pathology)|Curtis  Henrich (Molecular Targets Laboratory)|Nadya I Tarasova; PhD (Cancer Inflammation Program)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael  Dean; PhD (Laboratory of Experimental Immunology),NULL,"1. Bakhsheshian J, Hall MD, Robey RW, Herrmann MA, Chen JQ, Bates SE, Gottesman MM (2013). Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos  41, 1805-12.   https://doi.org/10.1124/dmd.113.053140",https://intramural.nih.gov/search/searchview.taf?ipid=83615
160,BC010624-11,"October 01, 2013 -  September 30, 2014",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Robert Scott Hudson|Adrienne Michelle Starks|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Jun  Luo (Johns Hopkins University)|Arun  Sreekumar (Baylor College of Medicine)|Sharon  Glynn|Bernhard  Kwabi-Addo (Howard University)|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",NULL,NULL,"1. Martin DN, Starks AM, Ambs S (2013). Biological determinants of health disparities in prostate cancer. Curr Opin Oncol  25, 235-41.   https://doi.org/10.1097/CCO.0b013e32835eb5d1",https://intramural.nih.gov/search/searchview.taf?ipid=83633
161,BC010625-11,"October 01, 2013 -  September 30, 2014",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",NULL,"Genitourinary Malignancies Branch, NCI",William D Figg; PharmD,NULL,Susan  Bates; MD (Developmental Therapeutics Branch)|Yvona  Ward; PhD (Laboratory Of Genitourinary Cancer Pathogenesis),Danny L Sackett; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83618
162,BC010626-11,"October 01, 2013 -  September 30, 2014","Cancers with Unique Properties: Pheochromocytoma, Adrenal and Thyroid Cancer","Antonio  Fojo; MD, PhD",NULL,"Genitourinary Malignancies Branch, NCI",NULL,NULL,Susan  Bates; MD (Developmental Therapeutics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Electron  Kebebew; MD (Endocrine Oncology Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),"Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC) |Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83726
163,BC010627-11,"October 01, 2013 -  September 30, 2014",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Alesia J Holly|Linda Marie Johnson|Cody John Peer|Tristan  Sissung|Andrew Kiem Goey|Sheryl A Gere|Show all 8,Romano  Danesi|Alex  Sparreboom|Michael  Pacanowski (FDA)|Gilbert John Burckart,Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Heidi H Kong (Dermatology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Susan  Bates; MD (Developmental Therapeutics Branch),NULL,"1. Burckart GJ, Figg WD, Brooks MM, Green DJ, Troutman SM, Ferrell R, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Naftel D, Price DK, Sissung TM, Girnita DM, Zeevi A, Webber SA (2014). Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2. J Pediatr Pharmacol Ther  19, 16-24.   https://doi.org/10.5863/1551-6776-19.1.16|2. Figg WD, Chau CH, Madan RA, Gulley JL, Gao R, Sissung TM, Spencer S, Beatson M, Aragon-Ching J, Steinberg SM, Dahut WL (2013). Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity. Clin Genitourin Cancer  11, 229-37.   https://doi.org/10.1016/j.clgc.2013.04.007|3. Goldspiel BR, Flegel WA, DiPatrizio G, Sissung T, Adams SD, Penzak SR, Biesecker LG, Fleisher TA, Patel JJ, Herion D, Figg WD, Lertora JJ, McKeeby JW (2014). Integrating pharmacogenetic information and clinical decision support into the electronic health record. J Am Med Inform Assoc  21, 522-8.   https://doi.org/10.1136/amiajnl-2013-001873|4. Horenstein RB, Madabushi R, Zineh I, Yerges-Armstrong LM, Peer CJ, Schuck RN, Figg WD, Shuldiner AR, Pacanowski MA (2014). Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers. J Clin Pharmacol  54, 865-73.   https://doi.org/10.1002/jcph.293|5. Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR (2013). The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenet Genomics  23, 1-8.   https://doi.org/10.1097/FPC.0b013e32835aa8a2|6. Lewis JP, Stephens SH, Horenstein RB, O'Connell JR, Ryan K, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Mitchell BD, Shuldiner AR (2013). The CYP2C19*17 variant is not independently associated with clopidogrel response. J Thromb Haemost  11, 1640-6.   https://doi.org/10.1111/jth.12342|7. Vaishampayan UN, Fontana J, Heilbrun LK, Smith D, Heath E, Dickow B, Figg WD (2014). Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer. Urol Oncol  32, 31.e25-33.   https://doi.org/10.1016/j.urolonc.2012.11.017",https://intramural.nih.gov/search/searchview.taf?ipid=83617
164,BC010632-11,"October 01, 2013 -  September 30, 2014",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",Jerome Michel Izard; PhD|Cedric Nicolas Lionel Cagliero|Carolyn B McGill|Yan Ning H Zhou|Thomas Dana Schneider; PhD,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Jeffrey N Strathern (Genome Recombination and Regulation Section)|Stephen J Lockett; PhD (Office Of The Director)|Yun Xing M Wang (Structural Biophysics Laboratory),NULL,"1. Cagliero C, Grand RS, Jones MB, Jin DJ, O'Sullivan JM (2013). Genome conformation capture reveals that the Escherichia coli chromosome is organized by replication and transcription. Nucleic Acids Res  41, 6058-71.   https://doi.org/10.1093/nar/gkt325|2. Cagliero C, Jin DJ (2013). Dissociation and re-association of RNA polymerase with DNA during osmotic stress response in Escherichia coli. Nucleic Acids Res  41, 315-26.   https://doi.org/10.1093/nar/gks988|3. Jin DJ, Cagliero C, Zhou YN (2013). Role of RNA polymerase and transcription in the organization of the bacterial nucleoid. Chem Rev  113, 8662-82.   https://doi.org/10.1021/cr4001429|4. Strathern J, Malagon F, Irvin J, Gotte D, Shafer B, Kireeva M, Lubkowska L, Jin DJ, Kashlev M (2013). The fidelity of transcription: RPB1 (RPO21) mutations that increase transcriptional slippage in S. cerevisiae. J Biol Chem  288, 2689-99.   https://doi.org/10.1074/jbc.M112.429506|5. Zhou YN, Lubkowska L, Hui M, Court C, Chen S, Court DL, Strathern J, Jin DJ, Kashlev M (2013). Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. J Biol Chem  288, 2700-10.   https://doi.org/10.1074/jbc.M112.429464",https://intramural.nih.gov/search/searchview.taf?ipid=83620
165,BC010646-11,"October 01, 2013 -  September 30, 2014",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Hormone Action and Oncogenesis Section, NCI",Songjoon  Baek|Michael Joseph Guertin|Mary  Hawkins|Akhilesh Kumar Nagaich|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD|Show all 7,"Ken  Pearce (Gene Expression and Protein Biochemistry, GlaxoSmithKline Discovery Research)|Michael  Stallcup (Univ of Southern California)|Fyodor  Urnov; PhD",Charles  Vinson; PhD (Laboratory of Metabolism),Greti  Aguilera Harwood; MD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83619
166,BC010649-10,"October 01, 2013 -  September 30, 2014",Immunotherapy Strategies for Uveal Melanoma,Udai S Kammula,NULL,"Surgery Branch, NCI",Smita Sarat Chandran|Biman  Paria|Abhishek Kumar Srivastava,"Richard  Carvajal (Memorial Sloan-Kettering Cancer Center)|J  Harbour (Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine)",Mark  Raffeld; MD (Laboratory of Pathology)|Eric Alan Stahlberg (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83647
167,BC010652-10,"October 01, 2013 -  September 30, 2014",Lipid-based Nanocapsules and Triggered Chemotherapy,Robert  Blumenthal; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,Sara  Grinberg (Ben Gurion University)|Jeeseong  Hwang (NIST)|Michael  Nantz (University of Louisville),Joseph John Barchi (Chemical Biology Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),NULL,"1. Afonin KA, Viard M, Martins AN, Lockett SJ, Maciag AE, Freed EO, Heldman E, Jaeger L, Blumenthal R, Shapiro BA (2013). Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol  8, 296-304.   https://doi.org/10.1038/nnano.2013.44|2. Kim T, Afonin KA, Viard M, Koyfman AY, Sparks S, Heldman E, Grinberg S, Linder C, Blumenthal RP, Shapiro BA (2013). In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery. Mol Ther Nucleic Acids  2, e80.   https://doi.org/10.1038/mtna.2013.5|3. Yavlovich A, Viard M, Gupta K, Sine J, Vu M, Blumenthal R, Tata DB, Puri A (2013). Low-visibility light-intensity laser-triggered release of entrapped calcein from 1,2-bis (tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine liposomes is mediated through a type I photoactivation pathway. Int J Nanomedicine  8, 2575-87.   https://doi.org/10.2147/IJN.S44993",https://intramural.nih.gov/search/searchview.taf?ipid=83636
168,BC010654-10,"October 01, 2013 -  September 30, 2014",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,"Laureen  Sena (Dept of Radiology, Boston Childrens Hospital)|Steven  Fishman (Boston Childrens Hospital)",Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Nakajima T, Turkbey B, Sano K, Sato K, Bernardo M, Hoyt RF, Choyke PL, Kobayashi H (2014). MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates. J Magn Reson Imaging  40, 691-7.   https://doi.org/10.1002/jmri.24395|2. Turkbey B, Kobayashi H, Hoyt RF, Choyke PL, Nakajima T, Griffiths GL, Bernardo M, Rialon K, Fishman SJ, Sena LM (2014). Magnetic resonance lymphography of the thoracic duct after interstitial injection of gadofosveset trisodium: a pilot dosing study in a porcine model. Lymphat Res Biol  12, 32-6.   https://doi.org/10.1089/lrb.2013.0029",https://intramural.nih.gov/search/searchview.taf?ipid=83641
169,BC010655-10,"October 01, 2013 -  September 30, 2014",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital),William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch),Bradford J Wood; MD (CC),"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Grant K, Lindenberg ML, Shebel H, Pang Y, Agarwal HK, Bernardo M, Kurdziel KA, Turkbey B, Choyke PL (2013). Functional and molecular imaging of localized and recurrent prostate cancer. Eur J Nucl Med Mol Imaging  40 Suppl 1, S48-59.   https://doi.org/10.1007/s00259-013-2419-6|3. Hong CW, Rais-Bahrami S, Walton-Diaz A, Shakir N, Su D, George AK, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA (2015). Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches. BJU Int  115, 772-9.   https://doi.org/10.1111/bju.12871|4. Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2013). Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol  190, 1721-1727.   https://doi.org/10.1016/j.juro.2013.05.052|5. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013). Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol  64, 713-719.   https://doi.org/10.1016/j.eururo.2013.05.059|6. Turkbey B, Mena E, Aras O, Garvey B, Grant K, Choyke PL (2013). Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer. Clin Oncol (R Coll Radiol)  25, 451-60.   https://doi.org/10.1016/j.clon.2013.05.001|7. Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL (2014). Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging  39, 1443-8.   https://doi.org/10.1002/jmri.24317|8. Yang M, Li X, Turkbey B, Choyke PL, Yan P (2013). Prostate segmentation in MR images using discriminant boundary features. IEEE Trans Biomed Eng  60, 479-88.   https://doi.org/10.1109/TBME.2012.2228644",https://intramural.nih.gov/search/searchview.taf?ipid=83642
170,BC010656-10,"October 01, 2013 -  September 30, 2014",Growth Factor Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Mitsunaga M, Tajiri H, Choyke PL, Kobayashi H (2013). Monoclonal antibody-fluorescent probe conjugates for in vivo target-specific cancer imaging: toward clinical translation. Ther Deliv  4, 523-5.   https://doi.org/10.4155/tde.13.26|2. Nayak TK, Bernardo M, Milenic DE, Choyke PL, Brechbiel MW (2013). Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies. Radiology  267, 173-82.   https://doi.org/10.1148/radiol.12121021",https://intramural.nih.gov/search/searchview.taf?ipid=83643
171,BC010657-10,"October 01, 2013 -  September 30, 2014",Intracellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,NULL,Richard  Childs; MD (NHLBI) |Joshua  Farber; MD (NIAID),"1. Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O (2014). Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia  28, 413-6.   https://doi.org/10.1038/leu.2013.268|2. Wulfert S, Kratochwil C, Choyke PL, Afshar-Oromieh A, Mier W, Kauczor HU, Schenk JP, Haberkorn U, Giesel FL (2014). Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT. Mol Imaging Biol  16, 586-94.   https://doi.org/10.1007/s11307-014-0722-7",https://intramural.nih.gov/search/searchview.taf?ipid=83644
172,BC010661-10,"October 01, 2013 -  September 30, 2014",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,NULL,NULL,"1. Donahue RN, Duncan BB, Fry TJ, Jones B, Bachovchin WW, Kiritsy CP, Lai JH, Wu W, Zhao P, Liu Y, Tsang KY, Hodge JW (2014). A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines. Vaccine  32, 3223-31.   https://doi.org/10.1016/j.vaccine.2014.04.008|2. Farsaci B, Donahue RN, Coplin MA, Grenga I, Lepone LM, Molinolo AA, Hodge JW (2014). Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines. Cancer Immunol Res  2, 1090-102.   https://doi.org/10.1158/2326-6066.CIR-14-0076",https://intramural.nih.gov/search/searchview.taf?ipid=83655
173,BC010666-10,"October 01, 2013 -  September 30, 2014",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Andrea Borghese Apolo|William D Figg; PharmD|Ravi  Madan,"Robert  DiPaola (The Cancer Institute of New Jersey)|John  Marshall|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Douglas  McNeel (University of Wisconsin)|Jeannie  Giacchino (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter A Pinto; MD (Urologic Oncology Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|William Laurence Dahut; MD (Office Of The Clinical Director),NULL,"1. Bilusic M, Madan R, Gulley J (2013) Issues in pre-clinical models, clinical trial design and analytical considerations in developing and evaluating novel cancer immunotherapies, in Cancer Immunotherapy: Paradigms, Practice and Promise. Curiel T, ed., pp. 455-474.|2. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|3. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors, in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation. Lattime E, Gerson SL, eds., in press.|4. Singh N, Hodge J, Madan R, Gulley J (2013) Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing, in The Tumor Immunoenvironment. Shurin M, Umansky V, Malyguine A, eds., pp. 621-642, Chapter 27.|5. Bilusic M, Heery CR, Arlen PM, Rauckhorst M, Apelian D, Tsang KY, Tucker JA, Jochems C, Schlom J, Gulley JL, Madan RA (2014). Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma. Cancer Immunol Immunother  63, 225-34.   https://doi.org/10.1007/s00262-013-1505-8|6. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC (2013). Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clin Cancer Res  19, 1290-9.   https://doi.org/10.1158/1078-0432.CCR-12-2478|7. Gulley JL (2013). Therapeutic vaccines: the ultimate personalized therapy? Hum Vaccin Immunother  9, 219-21.   https://doi.org/10.4161/hv.22106|8. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|9. Gulley JL, Madan RA, Tsang KY, Jochems C, Marté JL, Farsaci B, Tucker JA, Hodge JW, Liewehr DJ, Steinberg SM, Heery CR, Schlom J (2014). Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer. Cancer Immunol Res  2, 133-41.   https://doi.org/10.1158/2326-6066.CIR-13-0108|10. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013). Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol  190, 6250-8.   https://doi.org/10.4049/jimmunol.1300022|11. Huen NY, Pang AL, Tucker JA, Lee TL, Vergati M, Jochems C, Intrivici C, Cereda V, Chan WY, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY (2013). Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer  133, 373-82.   https://doi.org/10.1002/ijc.28026|12. Madan RA, Gulley JL (2013). Prostate cancer: Intermediate efficacy end points to assess modern therapies. Nat Rev Urol  10, 686-7.   https://doi.org/10.1038/nrurol.2013.269|13. Madan RA, Gulley JL, Kantoff PW (2013). Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies. Cancer J  19, 50-8.   https://doi.org/10.1097/PPO.0b013e31828160a9|14. Madan RA, Tsang KY, Bilusic M, Vergati M, Poole DJ, Jochems C, Tucker JA, Schlom J, Giaccone G, Gulley JL (2013). Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer. Oncologist  18, 821-2.   https://doi.org/10.1634/theoncologist.2013-0199|15. Rojan A, Funches R, Regan MM, Gulley JL, Bubley GJ (2013). Dramatic and prolonged PSA response after retreatment with a PSA vaccine. Clin Genitourin Cancer  11, 362-4.   https://doi.org/10.1016/j.clgc.2013.01.003|16. Roselli M, Cereda V, di Bari MG, Formica V, Spila A, Jochems C, Farsaci B, Donahue R, Gulley JL, Schlom J, Guadagni F (2013). Effects of conventional therapeutic interventions on the number and function of regulatory T cells. Oncoimmunology  2, e27025.   https://doi.org/10.4161/onci.27025|17. Schlom J, Jochems C, Gulley JL, Huang J (2013). The role of soluble CD40L in immunosuppression. Oncoimmunology  2, e22546.   https://doi.org/10.4161/onci.22546|18. Singh BH, Gulley JL (2014). Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications. Asian J Androl  16, 364-71.   https://doi.org/10.4103/1008-682X.122585|19. Singh N, Madan RA, Gulley JL (2013). Ipilimumab  in prostate cancer. Expert Opin Biol Ther  13, 303-13.   https://doi.org/10.1517/14712598.2012.754421",https://intramural.nih.gov/search/searchview.taf?ipid=83654
174,BC010668-10,"October 01, 2013 -  September 30, 2014",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,NULL,Thomas J Pohida; MS (CIT),"1. Seidel J, Xi W, Kakareka JW, Pohida TJ, Jagoda EM, Green MV, Choyke PL (2013). Performance characteristics of a positron projection imager for mouse whole-body imaging. Nucl Med Biol  40, 321-30.   https://doi.org/10.1016/j.nucmedbio.2012.12.003",https://intramural.nih.gov/search/searchview.taf?ipid=83640
175,BC010670-10,"October 01, 2013 -  September 30, 2014",Molecular-Targeted Radiation Therapy,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Margeaux Driscoll Dionne,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University)|Sylvia  Formenti (NYU)|Stephen  Tuttle (University of Pennsylvania),James B Mitchell; PhD (Radiation Biology Branch)|Mansoor Mukhtar Ahmed; PhD (Radiotherapy Development Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|David Anderson Wink (Radiation Biology Branch),NULL,"1. Simone CB, John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN (2013). mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status. Transl Oncol  6, 573-85.   https://doi.org/10.1593/tlo.13241",https://intramural.nih.gov/search/searchview.taf?ipid=83632
176,BC010671-10,"October 01, 2013 -  September 30, 2014",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Andrea Christine Bohrer|Thomas  Ciucci|Sugata  Manna|Melanie S Vacchio; PhD|Linus  Williams|Qi  Xiao,Albert  Bendelac (University of Chicago)|Marc  Jenkins,Lionel  Feigenbaum (Office of the Director)|Lino  Tessarollo (Mouse Cancer Genetics Program),"Paul E Love; MD, PhD (NICHD) |Yasmine  Belkaid; PhD (NIAID) |John J O'Shea; MD (NIAMS)","1. Vacchio MS, Bosselut R (2013). T cell metabolism: microRNAs cap PTEN to feed the expanding crowd. Immunity  38, 847-8.   https://doi.org/10.1016/j.immuni.2013.05.006|2. Williams L, Bosselut R (2013). [Interleukin 22 may represent a new therapeutic tool towards thymic regeneration in vivo]. Med Sci (Paris)  29, 11-4.   https://doi.org/10.1051/medsci/2013291003|3. Xiong Y, Castro E, Yagi R, Zhu J, Lesourne R, Love PE, Feigenbaum L, Bosselut R (2013). Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus. Eur J Immunol  43, 918-28.   https://doi.org/10.1002/eji.201242944",https://intramural.nih.gov/search/searchview.taf?ipid=83631
177,BC010675-10,"October 01, 2013 -  September 30, 2014",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Ruslan  Gibadullin|Saddam Musleh Muthana; PhD|Eric Russell Sterner|Whitney Shea Wright|Li  Xia|Show all 7,NULL,Luis G Rodriguez (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83646
178,BC010677-10,"October 01, 2013 -  September 30, 2014",NADPH Oxidase 1: A Novel Target for Colon Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,"1. Doroshow JH, Gaur S, Markel S, Lu J, van Balgooy J, Synold TW, Xi B, Wu X, Juhasz A (2013). Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts. Free Radic Biol Med  57, 162-75.   https://doi.org/10.1016/j.freeradbiomed.2013.01.002|2. Meitzler JL, Antony S, Wu Y, Juhasz A, Liu H, Jiang G, Lu J, Roy K, Doroshow JH (2014). NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal  20, 2873-89.   https://doi.org/10.1089/ars.2013.5603|3. Steven Esworthy R, Kim BW, Wang Y, Gao Q, Doroshow JH, Leto TL, Chu FF (2013). The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene. Free Radic Biol Med  65, 1273-1283.   https://doi.org/10.1016/j.freeradbiomed.2013.09.013",https://intramural.nih.gov/search/searchview.taf?ipid=83645
179,BC010681-10,"October 01, 2013 -  September 30, 2014",Development of inhibitors targeting Plk1 polo-box domain,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jung Eun  Park,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)|Terrence R Burke; PhD (Chemical Biology Laboratory),NULL,"1. Kim SO, Sakchaisri K, Thimmegowda NR, N R T, Soung NK, Jang JH, Kim YS, Lee KS, Kwon YT, Asami Y, Ahn JS, Erikson RL, Kim BY (2013). STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage. PLoS One  8, e53908.   https://doi.org/10.1371/journal.pone.0053908",https://intramural.nih.gov/search/searchview.taf?ipid=83651
180,BC010683-10,"October 01, 2013 -  September 30, 2014",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Raju  Chelluri|Chengyuan  Li|Michael Anthony Moses|Toshiki  Kijima|William Marston Linehan; MD,Sunil  Sudarshan|YunJin  Jung (Pusan National University),NULL,NULL,"1. Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, Zhang H, Pommier Y (2014). Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res  20, 4873-81.   https://doi.org/10.1158/1078-0432.CCR-13-3373|2. Neckers L, Ricketts CJ, Marston Linehan W (2013). New insights into von Hippel-Lindau function highlighted by investigation of the trichloroethylene-induced p.P81S hotspot mutation. J Natl Cancer Inst  105, 1339-40.   https://doi.org/10.1093/jnci/djt240|3. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007",https://intramural.nih.gov/search/searchview.taf?ipid=83653
181,BC010692-10,"October 01, 2013 -  September 30, 2014",Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",NULL,NULL,Blanche P Alter (Clinical Genetics Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch),Irina  Maric; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83634
182,BC010696-10,"October 01, 2013 -  September 30, 2014",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Michael R Emmert-Buck; MD, PhD|David D Roberts; PhD",NULL,"Peter A Pinto; MD (Urologic Oncology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Marston Linehan; MD (Urologic Oncology Branch)",NULL,"1. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|2. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J (2013). A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res  11, 1061-1071.   https://doi.org/10.1158/1541-7786.MCR-13-0111|3. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|4. Merino M (2014) Hereditary leiomyomatosis and renal cell cancer. Orphanet, in press.|5. Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH (2014). Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol  32, 23.e9-13.   https://doi.org/10.1016/j.urolonc.2012.08.011|6. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|7. Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H, ISUP Renal Tumor Panel (2013). Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol  37, 1518-31.   https://doi.org/10.1097/PAS.0b013e318299f12e",https://intramural.nih.gov/search/searchview.taf?ipid=83652
183,BC010701-09,"October 01, 2013 -  September 30, 2014",Human Monoclonal Antibodies Against Cancer,Dimiter Stanchev Dimitrov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Howard A Young; PhD,Kurt  Ghelsen (RCT)|Philip  Low (Perdue University)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Rui  Gong; PhD|Yuxian  He (Chinese Academy of Medical Sciences)|Nancy  Ip (Hong University of Science and Technology)|Show all 11,Robert  Blumenthal; PhD (Basic Research Laboratory)|Ira H Pastan; MD (Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Bradley D St Croix (Mouse Cancer Genetics Program)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Jeffrey  Baron; MD (NICHD) |Peter D Kwong; PhD (NIAID),"1. Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M (2013). Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A  110, E1083-91.   https://doi.org/10.1073/pnas.1217868110|2. Gong R, Wang Y, Ying T, Feng Y, Streaker E, Prabakaran P, Dimitrov DS (2013). N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance. Mol Pharm  10, 2642-52.   https://doi.org/10.1021/mp400075f|3. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|4. Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, St Croix B, Qian M, Dimitrov DS, Ho M (2013). A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Mol Cancer Ther  12, 416-26.   https://doi.org/10.1158/1535-7163.MCT-12-0731|5. Ying T, Chen W, Feng Y, Wang Y, Gong R, Dimitrov DS (2013). Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics. J Biol Chem  288, 25154-64.   https://doi.org/10.1074/jbc.M113.484154|6. Dimitrov DS, Decrescenzo GS, Saha SS, St Croix BS, Welsch DS, Zhang XS, Zhu ZS, Zudaire Ubani ES (submitted in 2013) Tem8 Antibodies And Their Use In Treatment And Detection Of Tumors. Patent issued: 9,765,142 (US in 2017). Patents pending: 201480066451.3 (CN application); 14789480.2 (EP application); 2016-521982 (JP application); MX/A/2016/003744 (MX application); PCT/US2014/060299 (PC application); 15/680,177 (US application); 2014331667 (AU application); 2925393 (CA application).|7. Dimitrov DS, Qasba PS, Ramakrishna BS, Zhu ZS (submitted in 2013) Her2-specific Monoclonal Antibodies And Conjugates Thereof. Patent issued: 9,738,726 (US in 2017). Patent pending: PCT/US2014/041492 (PC application).|8. Orentas RJ, Dimitrov DJ, Mackall CJ, Saha SJ, St Croix BJ, Zhu ZJ (submitted in 2013) Anti-cd276 Polypeptides, Proteins, And Chimeric Antigen Receptors. Patent issued: 9,790,282 (US in 2018). Patents pending: 15/699,419 (US application); PCT/US2014/031543 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=83657
184,BC010707-09,"October 01, 2013 -  September 30, 2014",Role of T Regulatory Cell Suppression in Autoimmunity and Cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"Yinling  Hu (Laboratory of Experimental Immunology)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Michael  Bustin; PhD (Protein Section)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83660
185,BC010709-09,"October 01, 2013 -  September 30, 2014",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",John Walter Glod|Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Aradhana  Kaushal (Radiation Oncology Branch),NULL,"1. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW (2013). Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer  60, 1397-401.   https://doi.org/10.1002/pbc.24562",https://intramural.nih.gov/search/searchview.taf?ipid=83676
186,BC010714-09,"October 01, 2013 -  September 30, 2014",Angiogenesis imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,Frederick  Giesel (University of Heidelberg)|Michael  Knopp (Ohio State University)|Anwar  Padhani (Mt Vernon Hospital),William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|Shivaani  Kummar; PhD (Office of the Director),David M Thomasson; PhD (NIAID) |Thomas J Pohida; MS (CIT) |Chang Hum  Paik; PhD (CC),"1. Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013). Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics  12, 1621-31.   https://doi.org/10.1074/mcp.M112.026427|2. Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC (2013). Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatr Blood Cancer  60, 396-401.   https://doi.org/10.1002/pbc.24281",https://intramural.nih.gov/search/searchview.taf?ipid=83669
187,BC010717-09,"October 01, 2013 -  September 30, 2014",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83679
188,BC010719-09,"October 01, 2013 -  September 30, 2014",Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83680
189,BC010725-09,"October 01, 2013 -  September 30, 2014",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)",Jonathan  Keller; PhD (Mouse Cancer Genetics Program),"Yasmine  Belkaid; PhD (NIAID) |Ronald N Germain; MD, PhD (NIAID) |Philip M Murphy; MD (NIAID)","1. Arroyo DS, Soria JA, Gaviglio EA, Garcia-Keller C, Cancela LM, Rodriguez-Galan MC, Wang JM, Iribarren P (2013). Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J  27, 299-312.   https://doi.org/10.1096/fj.12-214312|2. Chen K, Liu M, Liu Y, Wang C, Yoshimura T, Gong W, Le Y, Tessarollo L, Wang JM (2013). Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation. J Biol Chem  288, 16262-73.   https://doi.org/10.1074/jbc.M113.450635|3. Schreiner J, Kretschmer D, Klenk J, Otto M, Bühring HJ, Stevanovic S, Wang JM, Beer-Hammer S, Peschel A, Autenrieth SE (2013). Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol  190, 3417-26.   https://doi.org/10.4049/jimmunol.1202563|4. Wantha S, Alard JE, Megens RT, van der Does AM, Döring Y, Drechsler M, Pham CT, Wang MW, Wang JM, Gallo RL, von Hundelshausen P, Lindbom L, Hackeng T, Weber C, Soehnlein O (2013). Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res  112, 792-801.   https://doi.org/10.1161/CIRCRESAHA.112.300666",https://intramural.nih.gov/search/searchview.taf?ipid=83667
190,BC010728-09,"October 01, 2013 -  September 30, 2014",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83681
191,BC010729-09,"October 01, 2013 -  September 30, 2014",Technology Development,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,"Benjamin  Shapiro (Engineering, University of Maryland)|Elisabeth  Smela (Engineering, University of Maryland)",NULL,Robert F Bonner; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83658
192,BC010735-09,"October 01, 2013 -  September 30, 2014",Structural studies of fimbriae of enterotoxigenic E. coli (ETEC),"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Rui  Bao,NULL,NULL,NULL,"1. Bao R, Nair MK, Tang WK, Esser L, Sadhukhan A, Holland RL, Xia D, Schifferli DM (2013). Structural basis for the specific recognition of dual receptors by the homopolymeric pH 6 antigen (Psa) fimbriae of Yersinia pestis. Proc Natl Acad Sci U S A  110, 1065-70.   https://doi.org/10.1073/pnas.1212431110|2. Liu Y, Esser L, Interlandi G, Kisiela DI, Tchesnokova V, Thomas WE, Sokurenko E, Xia D, Savarino SJ (2013). Tight conformational coupling between the domains of the enterotoxigenic Escherichia coli fimbrial adhesin CfaE regulates binding state transition. J Biol Chem  288, 9993-10001.   https://doi.org/10.1074/jbc.M112.413534",https://intramural.nih.gov/search/searchview.taf?ipid=83668
193,BC010736-09,"October 01, 2013 -  September 30, 2014",Using mouse knockouts to unravel endothelial gene function,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",Mary B Hilton|Steven  Seaman,NULL,NULL,NULL,"1. Yang MY, Hilton MB, Seaman S, Haines DC, Nagashima K, Burks CM, Tessarollo L, Ivanova PT, Brown HA, Umstead TM, Floros J, Chroneos ZC, St Croix B (2013). Essential regulation of lung surfactant homeostasis by the orphan G protein-coupled receptor GPR116. Cell Rep  3, 1457-64.   https://doi.org/10.1016/j.celrep.2013.04.019",https://intramural.nih.gov/search/searchview.taf?ipid=83675
194,BC010738-09,"October 01, 2013 -  September 30, 2014","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Brian Shao-Luen Chan|Hanhan  Liu,Xinhua  Lin (Children's Hospital Medical Center)|Teresa  Fan (University of Louisville)|Anne  Le (Johns Hopkins),Lino  Tessarollo (Mouse Cancer Genetics Program)|Peter F Johnson; PhD (Mouse Cancer Genetics Program)|Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program),NULL,"1. Liu W, Chen Z, Ma Y, Wu X, Jin Y, Hou S (2013) Genetic characterization of the Drosophila birt-hogg-dub syndrome gene. PLoS One 8:e65869|2. Zeng X, Lin X, Hou SX (2013). The Osa-containing SWI/SNF chromatin-remodeling complex regulates stem cell commitment in the adult Drosophila intestine. Development  140, 3532-40.   https://doi.org/10.1242/dev.096891",https://intramural.nih.gov/search/searchview.taf?ipid=83671
195,BC010740-09,"October 01, 2013 -  September 30, 2014",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Eric Russell Sterner|Whitney Shea Wright,"Lara  Mahal (Chemistry, University of Texas at Austin)|Cristina  Voss (Department of Chemistry, German Cancer Research Center)|Mai  Xu; PhD|Matthew  Zimmt (Brown University)|Mohamed  Shoreibah (Abeome Corp.)|Zeev  Pancer (University of Maryland School of Medicine)|Show all 8",Miriam R Anver (Office Of The Director),NULL,"1. Hong X, Ma MZ, Gildersleeve JC, Chowdhury S, Barchi JJ, Mariuzza RA, Murphy MB, Mao L, Pancer Z (2013). Sugar-binding proteins from fish: selection of high affinity ""lambodies"" that recognize biomedically relevant glycans. ACS Chem Biol  8, 152-60.   https://doi.org/10.1021/cb300399s|2. Luo M, Velikovsky CA, Yang X, Siddiqui MA, Hong X, Barchi JJ, Gildersleeve JC, Pancer Z, Mariuzza RA (2013). Recognition of the Thomsen-Friedenreich pancarcinoma carbohydrate antigen by a lamprey variable lymphocyte receptor. J Biol Chem  288, 23597-606.   https://doi.org/10.1074/jbc.M113.480467",https://intramural.nih.gov/search/searchview.taf?ipid=83670
196,BC010743-09,"October 01, 2013 -  September 30, 2014",Metabolic Mechanisms for Programmed Cell Death,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,"Chien-An  Hu (Biochemistry & Molecular Biology, U. New Mexico School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Andrew  Lane (U. of Louisville)",Michael L Nickerson (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83664
197,BC010744-09,"October 01, 2013 -  September 30, 2014",Regulation of Proline Oxidase for Bioenergetics during Nutrient Stress,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,David  Valle (Johns Hopkins University School of Medicine)|Chi V Dang|Teresa  Fan (University of Louisville)|Kristine  Glunde (Johns Hopkins),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83665
198,BC010746-09,"October 01, 2013 -  September 30, 2014",Extracellular Matrix and Stress Substrates: the Role of Prolidase,James Ming Phang; MD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",NULL,Antonella  Forlino (University of Pavia)|Teresa  Gunn (McLaughlin Research Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83666
199,BC010747-09,"October 01, 2013 -  September 30, 2014",Characterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Laura Ann R Quigley|Jonathan  Shakesprere|Stephen K Anderson; PhD|Mary  Carrington; MS, PhD","Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|Simon  Kollnberger (University of Oxford)|David  Price (Cardiff University)|Alain  Rook (University of Pennsylvania)",NULL,"Suk See De Ravin; MD, PhD (NIAID) |Robert A Colbert; MD, PhD (NIAMS) |Michael  Ward; MD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83659
200,BC010749-09,"October 01, 2013 -  September 30, 2014",DNA Vaccines,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Bhabadeb S Chowdhury; PhD|Bethany Anne Nagy|Margherita  Rosati|Antonio L Valentin|Rami Abdul Hafiz Doueiri; PhD|Show all 12,"Rama  Amara (Emory Vaccine Center)|Dan  Barouch (Harvard University)|Christian  Brander (AIDS Research Center, Massachusetts General Hospital)|Michael  Egan (Profectus Biosciences, Inc.)|John  Eldridge (Wyeth Lederle Vaccines)|Timothy  Fouts (Profectus BioSciences, Inc.)|Show all 27",Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director),Konstantinos  Petrovas (NIAID) |Richard A Koup; MD (NIAID) |Adrian Bernard McDermott; PhD (NIAID),"1. Jalah R, Rosati M, Ganneru B, Pilkington GR, Valentin A, Kulkarni V, Bergamaschi C, Chowdhury B, Zhang GM, Beach RK, Alicea C, Broderick KE, Sardesai NY, Pavlakis GN, Felber BK (2013). The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem  288, 6763-76.   https://doi.org/10.1074/jbc.M112.436675|2. Kulkarni V, Rosati M, Bear J, Pilkington GR, Jalah R, Bergamaschi C, Singh AK, Alicea C, Chowdhury B, Zhang GM, Kim EY, Wolinsky SM, Huang W, Guan Y, LaBranche C, Montefiori DC, Broderick KE, Sardesai NY, Valentin A, Felber BK, Pavlakis GN (2013). Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques. Hum Vaccin Immunother  9, 2081-94.   https://doi.org/10.4161/hv.25473|3. Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang GM, Le Gall S, Broderick KE, Sardesai NY, Heckerman D, Mothe B, Brander C, Weiner DB, Mullins JI, Pavlakis GN, Felber BK (2013). HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. PLoS One  8, e60245.   https://doi.org/10.1371/journal.pone.0060245|4. Kulkarni V, Rosati M, Valentin A, Jalah R, Alicea C, Yu L, Guan Y, Shen X, Tomaras GD, LaBranche C, Montefiori DC, Irene C, Prattipati R, Pinter A, Sullivan SM, Pavlakis GN, Felber BK (2013). Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia. Hum Vaccin Immunother  9, 2069-80.   https://doi.org/10.4161/hv.25442|5. Ng SS, Li A, Pavlakis GN, Ozato K, Kino T (2013). Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications. PLoS One  8, e63587.   https://doi.org/10.1371/journal.pone.0063587|6. Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, von Gegerfelt A, Huang W, Guan Y, Keele BF, Bess JW, Piatak M, Lifson JD, Williams WT, Shen X, Tomaras GD, Amara RR, Robinson HL, Johnson W, Broderick KE, Sardesai NY, Venzon DJ, Hirsch VM, Felber BK, Pavlakis GN (2013). DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A  110, 2975-80.   https://doi.org/10.1073/pnas.1215393110|7. Vaccari M, Halwani R, Patterson LJ, Boasso A, Beal J, Tryniszewska E, Hryniewicz A, Venzon D, Haddad EK, El-Far M, Rosati M, Pavlakis GN, Felber BK, Al-Muhsen S, Robert-Guroff M, Sekaly RP, Franchini G (2013). Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS. J Virol  87, 3526-37.   https://doi.org/10.1128/JVI.02686-12|8. Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, Pollara J, Hryniewicz A, Ferrari G, Guan Y, Forthal DN, Venzon D, Fenizia C, Morgan T, Montefiori D, Lifson JD, Miller CJ, Silvestri G, Rosati M, Felber BK, Pavlakis GN, Tartaglia J, Franchini G (2013). Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol  87, 3538-48.   https://doi.org/10.1128/JVI.02863-12|9. Virnik K, Hockenbury M, Ni Y, Beren J, Pavlakis GN, Felber BK, Berkower I (2013). Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques. Retrovirology  10, 99.   https://doi.org/10.1186/1742-4690-10-99",https://intramural.nih.gov/search/searchview.taf?ipid=83662
201,BC010750-09,"October 01, 2013 -  September 30, 2014",Cytokines in AIDS and Cancer,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Rachel Elizabeth Kelly Beach|Bhabadeb S Chowdhury; PhD|Konstantinos  Dimas; MD|Rami Abdul Hafiz Doueiri; PhD|Monica Ann Gouzoulis|Jinyao  Li; PhD|Show all 14,David  Weiner (University of Pennsylvania)|Dirk  Daelemans|Karen  Gaensler (University of California)|Peter  Katsikis (Drexel University College of Medicine)|John  Eldridge (Wyeth Lederle Vaccines),"Claes  Ohlen (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)","Tomoshige  Kino; MD, PhD (NICHD) |Richard A Koup; MD (NIAID) |Konstantinos  Petrovas (NIAID)","1. Bergamaschi C, Kulkarni V, Rosati M, Alicea C, Jalah R, Chen S, Bear J, Sardesai NY, Valentin A, Felber BK, Pavlakis GN (2015). Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells. Gene Ther  22, 76-86.   https://doi.org/10.1038/gt.2014.84|2. Chertova E, Bergamaschi C, Chertov O, Sowder R, Bear J, Roser JD, Beach RK, Lifson JD, Felber BK, Pavlakis GN (2013). Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15Rα cytokine compared to IL-15 monomer. J Biol Chem  288, 18093-103.   https://doi.org/10.1074/jbc.M113.461756|3. Jalah R, Rosati M, Ganneru B, Pilkington GR, Valentin A, Kulkarni V, Bergamaschi C, Chowdhury B, Zhang GM, Beach RK, Alicea C, Broderick KE, Sardesai NY, Pavlakis GN, Felber BK (2013). The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production. J Biol Chem  288, 6763-76.   https://doi.org/10.1074/jbc.M112.436675|4. Ng SS, Li A, Pavlakis GN, Ozato K, Kino T (2013). Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications. PLoS One  8, e63587.   https://doi.org/10.1371/journal.pone.0063587|5. Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, von Gegerfelt A, Huang W, Guan Y, Keele BF, Bess JW, Piatak M, Lifson JD, Williams WT, Shen X, Tomaras GD, Amara RR, Robinson HL, Johnson W, Broderick KE, Sardesai NY, Venzon DJ, Hirsch VM, Felber BK, Pavlakis GN (2013). DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge. Proc Natl Acad Sci U S A  110, 2975-80.   https://doi.org/10.1073/pnas.1215393110",https://intramural.nih.gov/search/searchview.taf?ipid=83663
202,BC010759-09,"October 01, 2013 -  September 30, 2014",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Kathryn Elizabeth Driest|Arthur A Glatfelter; MS|Chyau Yueh Christopher Lau|John E Lueders|Show all 12",Charles  Keller (University of Texas)|Heinrich  Kovar (St. Anna's Children's Hospital)|Jeffrey  Trent (TGen),Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Bilke S, Schwentner R, Yang F, Kauer M, Jug G, Walker RL, Davis S, Zhu YJ, Pineda M, Meltzer PS, Kovar H (2013). Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. Genome Res  23, 1797-809.   https://doi.org/10.1101/gr.151340.112|2. Kelly L, Bryan K, Kim SY, Janeway KA, Killian JK, Schildhaus HU, Miettinen M, Helman L, Meltzer PS, van de Rijn M, Debiec-Rychter M, O'Sullivan M, NIH Pediatric and Wild-Type GIST Clinic (2013). Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]. PLoS One  8, e64102.   https://doi.org/10.1371/journal.pone.0064102|3. Kikuchi K, Taniguchi E, Chen HH, Svalina MN, Abraham J, Huang ET, Nishijo K, Davis S, Louden C, Zarzabal LA, Recht O, Bajwa A, Berlow N, Suelves M, Perkins SL, Meltzer PS, Mansoor A, Michalek JE, Chen Y, Rubin BP, Keller C (2013). Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma. Skelet Muscle  3, 27.   https://doi.org/10.1186/2044-5040-3-27|4. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|5. Trucco MM, Awad O, Wilky BA, Goldstein SD, Huang R, Walker RL, Shah P, Katuri V, Gul N, Zhu YJ, McCarthy EF, Paz-Priel I, Meltzer PS, Austin CP, Xia M, Loeb DM (2013). A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology. PLoS One  8, e79950.   https://doi.org/10.1371/journal.pone.0079950",https://intramural.nih.gov/search/searchview.taf?ipid=83672
203,BC010763-09,"October 01, 2013 -  September 30, 2014",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI","Richard A Morgan; PhD|Steven Aaron Rosenberg; MD, PhD|Paul  Robbins|James Chung-Yin Yang; MD, PhD",Ton  Schumacher (Netherlands Cancer Institute)|Paul  Antony (Univeristy of Maryland)|Carl  June (Univesity of Pennsylvania)|Vincenzo  Bronte,Giorgio  Trinchieri (Laboratory of Experimental Immunology),Mario  Roederer; PhD (NIAID),"1. Klebanoff CA, Yamamoto TN, Restifo NP (2014). Immunotherapy: Treatment of aggressive lymphomas with anti-CD19 CAR T cells. Nat Rev Clin Oncol  11, 685-6.   https://doi.org/10.1038/nrclinonc.2014.190",https://intramural.nih.gov/search/searchview.taf?ipid=83674
204,BC010766-08,"October 01, 2013 -  September 30, 2014",High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy,Udai S Kammula,NULL,"Surgery Branch, NCI",Smita Sarat Chandran|Biman  Paria|Abhishek Kumar Srivastava,NULL,NULL,NULL,"1. Bartlett EK, Fetsch PA, Filie AC, Abati A, Steinberg SM, Wunderlich JR, White DE, Stephens DJ, Marincola FM, Rosenberg SA, Kammula US (2014). Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration. Clin Cancer Res  20, 2607-2616.   https://doi.org/10.1158/1078-0432.CCR-13-2690",https://intramural.nih.gov/search/searchview.taf?ipid=83735
205,BC010767-08,"October 01, 2013 -  September 30, 2014",Biosynthesis of Selenocysteine and Its Incorporation into Protein,Dolph Lee Hatfield; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Bradley A Carlson|Fang  Chen|Ryuta  Tobe,"Ulrich  Schweizer (Neuroscience Research Center and, Charit-Universittsmedizin Berlin)|Byeong Jae  Lee (Seoul National University)|Michael  Howard (University of Utah)|Vadim  Gladyshev (Brigham and Womenâs Hospital and Harvard Medical School)",Harold  Seifried; PhD (Nutritional Science Research Group),NULL,"1. Barroso M, Florindo C, Kalwa H, Silva Z, Turanov AA, Carlson BA, de Almeida IT, Blom HJ, Gladyshev VN, Hatfield DL, Michel T, Castro R, Loscalzo J, Handy DE (2014) Inhibition of cellular methyltransferases promotes endothelial cell activation by suppressing glutathione peroxidase 1 protein expression. J Biol Chem 289:15350-62|2. Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN (2014). Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci  39, 112-20.   https://doi.org/10.1016/j.tibs.2013.12.007|3. Howard MT, Carlson BA, Anderson CB, Hatfield DL (2013). Translational redefinition of UGA codons is regulated by selenium availability. J Biol Chem  288, 19401-13.   https://doi.org/10.1074/jbc.M113.481051|4. Kim M, Chen Z, Shim MS, Lee MS, Kim JE, Kwon YE, Yoo TJ, Kim JY, Bang JY, Carlson BA, Seol JH, Hatfield DL, Lee BJ (2013). SUMO modification of NZFP mediates transcriptional repression through TBP binding. Mol Cells  35, 70-8.   https://doi.org/10.1007/s10059-013-2281-1|5. Seeher S, Atassi T, Mahdi Y, Carlson BA, Braun D, Wirth EK, Klein MO, Reix N, Miniard AC, Schomburg L, Hatfield DL, Driscoll DM, Schweizer U (2014). Secisbp2 is essential for embryonic development and enhances selenoprotein expression. Antioxid Redox Signal  21, 835-49.   https://doi.org/10.1089/ars.2013.5358|6. Tobe R, Naranjo-Suarez S, Everley RA, Carlson BA, Turanov AA, Tsuji PA, Yoo MH, Gygi SP, Gladyshev VN, Hatfield DL (2013). High error rates in selenocysteine insertion in mammalian cells treated with the antibiotic doxycycline, chloramphenicol, or geneticin. J Biol Chem  288, 14709-15.   https://doi.org/10.1074/jbc.M112.446666|7. Turanov AA, Lobanov AV, Hatfield DL, Gladyshev VN (2013). UGA codon position-dependent incorporation of selenocysteine into mammalian selenoproteins. Nucleic Acids Res  41, 6952-9.   https://doi.org/10.1093/nar/gkt409",https://intramural.nih.gov/search/searchview.taf?ipid=83736
206,BC010770-08,"October 01, 2013 -  September 30, 2014",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,"Maria  Rugeles (Immunovirology, Unversidad de Antioquia)|Vernon  Walker (University of Vermont)",NULL,NULL,"1. Olivero OA, Torres LR, Gorjifard S, Momot D, Marrogi E, Divi RL, Liu Y, Woodward RA, Sowers MJ, Poirier MC (2013). Perinatal exposure of patas monkeys to antiretroviral nucleoside reverse-transcriptase inhibitors induces genotoxicity persistent for up to 3 years of age. J Infect Dis  208, 244-8.   https://doi.org/10.1093/infdis/jit146",https://intramural.nih.gov/search/searchview.taf?ipid=83738
207,BC010773-08,"October 01, 2013 -  September 30, 2014",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Demetria P Harvin|Jane  Mirro|Yashna  Thappeta,"John  Coffin (Tufts University)|Hung  Fan (University of California, Irvine)|Susan R Ross|Delphine  Muriaux (Centre Nationale de Recherche Scientifique)",Xinhua  Ji; PhD (Biomolecular Structure Section),Judith Goldstein Levin; PhD (NICHD),"1. Stavrou S, Nitta T, Kotla S, Ha D, Nagashima K, Rein AR, Fan H, Ross SR (2013). Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc Natl Acad Sci U S A  110, 9078-83.   https://doi.org/10.1073/pnas.1217399110",https://intramural.nih.gov/search/searchview.taf?ipid=83737
208,BC010774-08,"October 01, 2013 -  September 30, 2014",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong|Debjani  Dutta; PhD|Sean Robert Rossi|Prahlad  Sarma,Al  Fornace (Georgetown University)|Oded  Livnah (Hebrew University of Jerusalem),Ettore  Appella; MD (Chemical Immunology Section)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83682
209,BC010775-08,"October 01, 2013 -  September 30, 2014","Retroviral Gag Trafficking, Env Incorporation, and Virus Assembly",Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Robert Walter Buckheit|Maisha Zahin Khan|Scott William Macdonald|Angelica Nascimento Martins; PhD|Mariia  Novikova; PhD|Show all 12,"Michael  Summers (University of Maryland, Baltimore County)|Tatyana  Polenova; PhD (University of Delaware)|Scott  Morham (Myriad Pharmaceuticals)|Simon  Cocklin (Drexel University)",Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Stewart  Durell (Laboratory of Cell Biology)|Ferri  Soheilian (Office Of The Director),Jennifer A Lippincott Schwartz; PhD (NICHD),"1. Freed E, Martin M (2013) HIVs and their replication, in Fields Virology, 6th Edition. Knipe DM, Howley PM, eds., pp. 1502-1560.|2. Kuo L, Freed E (2013) HIV-1 assembly cofactors, in Encyclopedia of AIDS., in press.|3. Tedbury P, Freed E (2013) Virus assembly, in Encyclopedia of AIDS., in press.|4. Afonin KA, Viard M, Martins AN, Lockett SJ, Maciag AE, Freed EO, Heldman E, Jaeger L, Blumenthal R, Shapiro BA (2013). Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol  8, 296-304.   https://doi.org/10.1038/nnano.2013.44|5. Checkley MA, Luttge BG, Mercredi PY, Kyere SK, Donlan J, Murakami T, Summers MF, Cocklin S, Freed EO (2013). Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation. J Virol  87, 3561-70.   https://doi.org/10.1128/JVI.03299-12|6. Luttge BG, Panchal P, Puri V, Checkley MA, Freed EO (2014) Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission. Biochim Biophys Acta 1838:1143-52|7. Tedbury PR, Ablan SD, Freed EO (2013). Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog  9, e1003739.   https://doi.org/10.1371/journal.ppat.1003739|8. Tedbury PR, Freed EO (2014) Role of matrix in HIV-1 envelope glycoprotein incorporation. Trends Microbiol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83691
210,BC010776-08,"October 01, 2013 -  September 30, 2014",Retrovirus Budding and Endosomal Sorting,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Robert Walter Buckheit|Maisha Zahin Khan|Scott William Macdonald|Angelica Nascimento Martins; PhD|Mariia  Novikova; PhD|Show all 9,"Michael  Summers (University of Maryland, Baltimore County)|Scott  Morham (Myriad Pharmaceuticals)|James H Hurley; PhD (NIDDK)|Shan-Lu  Liu (University of Missouri)",Stewart  Durell (Laboratory of Cell Biology)|Ferri  Soheilian (Office Of The Director),Juan S Bonifacino; PhD (NICHD),"1. Freed E, Martin M (2013) HIVs and their replication, in Fields Virology, 6th Edition. Knipe DM, Howley PM, eds., pp. 1502-1560.|2. Keren-Kaplan T, Attali I, Estrin M, Kuo LS, Farkash E, Jerabek-Willemsen M, Blutraich N, Artzi S, Peri A, Freed EO, Wolfson HJ, Prag G (2013). Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding. EMBO J  32, 538-51.   https://doi.org/10.1038/emboj.2013.4",https://intramural.nih.gov/search/searchview.taf?ipid=83692
211,BC010778-08,"October 01, 2013 -  September 30, 2014",Inhibition of HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Sherimay  Ablan|Emiko  Urano; PhD|Abdul Latheef Abdul Waheed|Rebecca Elizabeth Mandt|Alan  Rein; PhD,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Tatyana  Polenova; PhD (University of Delaware)|Feng  Li; PhD|Ritu  Gaur",Stewart  Durell (Laboratory of Cell Biology)|Ferri  Soheilian (Office Of The Director),Alasdair C Steven; PhD (NIAMS),"1. Freed E, Martin M (2013) HIVs and their replication, in Fields Virology, 6th Edition. Knipe DM, Howley PM, eds., pp. 1502-1560.|2. Keller PW, Huang RK, England MR, Waki K, Cheng N, Heymann JB, Craven RC, Freed EO, Steven AC (2013). A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition. J Virol  87, 13655-64.   https://doi.org/10.1128/JVI.01408-13|3. Zhang H, Curreli F, Waheed AA, Mercredi PY, Mehta M, Bhargava P, Scacalossi D, Tong X, Lee S, Cooper A, Summers MF, Freed EO, Debnath AK (2013). Dual-acting stapled peptides target both HIV-1 entry and assembly. Retrovirology  10, 136.   https://doi.org/10.1186/1742-4690-10-136",https://intramural.nih.gov/search/searchview.taf?ipid=83690
212,BC010779-08,"October 01, 2013 -  September 30, 2014",Regulation and Consequences of Ubiquitination,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Maria Letizia  Giardino Torchia,NULL,NULL,Dragana  Jankovic; PhD (NIAID) |Dorian  McGavern (NINDS),"1. Giardino Torchia ML, Conze DB, Ashwell JD (2013). c-IAP1 and c-IAP2 redundancy differs between T and B cells. PLoS One  8, e66161.   https://doi.org/10.1371/journal.pone.0066161|2. Giardino Torchia ML, Conze DB, Jankovic D, Ashwell JD (2013). Balance between NF-κB p100 and p52 regulates T cell costimulation dependence. J Immunol  190, 549-55.   https://doi.org/10.4049/jimmunol.1201697|3. Munitic I, Giardino Torchia ML, Meena NP, Zhu G, Li CC, Ashwell JD (2013). Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells. J Immunol  191, 6231-40.   https://doi.org/10.4049/jimmunol.1301696",https://intramural.nih.gov/search/searchview.taf?ipid=83683
213,BC010782-08,"October 01, 2013 -  September 30, 2014",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Inn-Inn  Chen|Michael Joseph Diprima|Georgina  Espigol Frigole|Hyeong Il  Kwak|Arianna  Caprioli|Hidetaka  Ohnuki|Show all 9,"James  Stone (Dept. of Cardiology, University of Alberta)|Catherine  Porcher (Oxford Univ)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Maria  Cid (Univ. of Barcelona Medical School)|Elena  Pasquale (Burnham Inst)|Show all 7",Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|David  Levens; PhD (Laboratory of Pathology)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program),"William E Paul; MD (NIAID) |Joshua  Farber; MD (NIAID) |Yosuke  Mukoyama; PhD (NHLBI) |Roberto  Weigert; MSc Chemistry, PhD (NIDCR) |Dragan  Maric; PhD (NINDS) |Jinfang  Zhu; PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83697
214,BC010783-08,"October 01, 2013 -  September 30, 2014","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Moran  Choe|Ilona  Linnoila; MD,NULL,NULL,J Silvio  Gutkind; PhD (NIDCR),"1. Zhang Y, Choksi S, Chen K, Pobezinskaya Y, Linnoila I, Liu ZG (2013). ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages. Cell Res  23, 898-914.   https://doi.org/10.1038/cr.2013.75|2. Zhang Y, Choksi S, Liu ZG (2013). Butylated hydroxyanisole blocks the occurrence of tumor associated macrophages in tobacco smoke carcinogen-induced lung tumorigenesis. Cancers (Basel)  5, 1643-54.   https://doi.org/10.3390/cancers5041643",https://intramural.nih.gov/search/searchview.taf?ipid=83698
215,BC010784-08,"October 01, 2013 -  September 30, 2014",Biochemistry of Melanins and Photoprotection of the Skin,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Sergio  Coelho|Lanlan  Yin,"Janusz  Beer (Center for Devices & Radiological Health, Food & Drug Administration)|Shosuke  Ito (Department of Chemistry, Fujita Health University)|Yuji  Yamaguchi|Ludger  Kolbe (Beiersdorf AG)",NULL,NULL,"1. Coelho SG, Yin L, Smuda C, Mahns A, Kolbe L, Hearing VJ (2015) Photobiological implications of melanin photoprotection after UVB-induced tanning of human skin but not UVA-induced tanning. Pigment Cell Melanoma Res 28:210-6",https://intramural.nih.gov/search/searchview.taf?ipid=83699
216,BC010785-08,"October 01, 2013 -  September 30, 2014",Characterization of Pigmentary Disorders and Melanoma Targeting,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Dominik David Ebsen; PhD|Lanlan  Yin|Julio C Valencia; MD,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Takeshi  Namiki|Thierry  Passeron",Michael Marc Gottesman; MD (Multidrug Resistence Section)|Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Kevin G Chen; MD (NINDS) |David R Adams (NHGRI) |Joseph A Mindell; BS, MD, PhD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83700
217,BC010786-08,"October 01, 2013 -  September 30, 2014",The Regulation of Mammalian Pigmentation,Vincent J. Hearing; PhD,NULL,"Pigment Cell Biology Section, NCI",Dominik David Ebsen; PhD|Lanlan  Yin|Julio C Valencia; MD,"Yuji  Yamaguchi|Michael  Pickart (Department of Biology, University of Wisconsin)|Ludger  Kolbe (Beiersdorf AG)|Takeshi  Namiki|Thierry  Passeron",NULL,NULL,"1. Coelho SG, Valencia JC, Yin L, Smuda C, Mahns A, Kolbe L, Miller SA, Beer JZ, Zhang G, Tuma PL, Hearing VJ (2015) UV exposure modulates hemidesmosome plasticity, contributing to long-term pigmentation in human skin. J Pathol 236:17-29",https://intramural.nih.gov/search/searchview.taf?ipid=83701
218,BC010788-08,"October 01, 2013 -  September 30, 2014",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Deblina  Banerjee|Norris Lio Lam|Seiichi  Odate|Veronica  Veschi|Zhihui  Liu|Luke Allister Wylie|Show all 8,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)",Susan  Bates; MD (Developmental Therapeutics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program),Kai  Ge; PhD (NIDDK) |Yosuke  Mukoyama; PhD (NHLBI),"1. He S, Liu Z, Oh DY, Thiele CJ (2013). MYCN and the epigenome. Front Oncol  3, 1.   https://doi.org/10.3389/fonc.2013.00001|2. Liu Z, Rader J, He S, Phung T, Thiele CJ (2013). CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity. Cell Cycle  12, 2210-8.   https://doi.org/10.4161/cc.25265|3. Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ, Li Z (2013) Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci 104:1586-92.",https://intramural.nih.gov/search/searchview.taf?ipid=83702
219,BC010789-08,"October 01, 2013 -  September 30, 2014",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Norris Lio Lam|Seiichi  Odate|Javed  Khan; MD|Chand  Khanna; MD,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|Zhjie  Li (Shengjing Hospital of China Medical University)",Susan  Bates; MD (Developmental Therapeutics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,"1. Yan S, Li Z, Thiele CJ (2013). Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. Oncotarget  4, 433-45.   https://doi.org/10.18632/oncotarget.930",https://intramural.nih.gov/search/searchview.taf?ipid=83703
220,BC010791-08,"October 01, 2013 -  September 30, 2014","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Danillo  Gardenal Augusto; PhD|Maureen P Martin|Show all 10,"Amalio  Telenti (University Hospital of Lausanne)|Howard  Strickler (Albert Einstein College of Medicine)|Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Show all 28","Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Lynn Rachel Goldin; PhD (Genetic Epidemiology Branch)|Denise  Whitby (Office Of The Director)",Daniel C Douek; MD (NIAID),"1. Apps R, Carrington M (2013). Response to Comment on ""Influence of HLA-C expression level on HIV control"". Science  341, 1175.   https://doi.org/10.1126/science.1241854|2. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, Yuki Y, Del Prete GQ, Goulder P, Brumme ZL, Brumme CJ, John M, Mallal S, Nelson G, Bosch R, Heckerman D, Stein JL, Soderberg KA, Moody MA, Denny TN, Zeng X, Fang J, Moffett A, Lifson JD, Goedert JJ, et al. [12 more authors] (2013). Influence of HLA-C expression level on HIV control. Science  340, 87-91.   https://doi.org/10.1126/science.1232685|3. Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Tobler LH, Busch MP, Alexander G, Rosen HR, Gao X, Abdel-Hamid M, Apps R, et al. [2 more authors] (2013). Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med  158, 235-45.   https://doi.org/10.7326/0003-4819-158-4-201302190-00003|4. Janes H, Friedrich DP, Krambrink A, Smith RJ, Kallas EG, Horton H, Casimiro DR, Carrington M, Geraghty DE, Gilbert PB, McElrath MJ, Frahm N (2013). Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. J Infect Dis  208, 1231-9.   https://doi.org/10.1093/infdis/jit322|5. Kuniholm MH, Anastos K, Kovacs A, Gao X, Marti D, Sette A, Greenblatt RM, Peters M, Cohen MH, Minkoff H, Gange SJ, Thio CL, Young MA, Xue X, Carrington M, Strickler HD (2013). Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus. Genes Immun  14, 330-5.   https://doi.org/10.1038/gene.2013.25|6. Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, et al. [33 more authors] (2013) A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet 22:1903-10|7. Martin MP, Carrington M (2013). Immunogenetics of HIV disease. Immunol Rev  254, 245-64.   https://doi.org/10.1111/imr.12071|8. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, et al. [21 more authors] (2013). Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog  9, e1003515.   https://doi.org/10.1371/journal.ppat.1003515|9. Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, Raj T, IMSGC, ANZgene, Gourraud PA, Stranger BE, Oksenberg J, Olsson T, Taylor BV, Sawcer S, Hafler DA, Carrington M, De Jager PL, de Bakker PI (2013). Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet  9, e1003926.   https://doi.org/10.1371/journal.pgen.1003926|10. Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M, Kuhl B, Alter G, Deeks SG, Walker BD, Gao X, Sette A, Carrington M, Streeck H (2013). Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control. Nat Med  19, 930-3.   https://doi.org/10.1038/nm.3229|11. Salie M, van der Merwe L, Möller M, Daya M, van der Spuy GD, van Helden PD, Martin MP, Gao XJ, Warren RM, Carrington M, Hoal EG (2014). Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. J Infect Dis  209, 216-23.   https://doi.org/10.1093/infdis/jit443|12. Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E, Hemophilia Inhibitor Genetics Study Combined Cohort (2013). F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Haemophilia  19, 113-8.   https://doi.org/10.1111/hae.12004|13. Shea PR, Shianna KV, Carrington M, Goldstein DB (2013). Host genetics of HIV acquisition and viral control. Annu Rev Med  64, 203-17.   https://doi.org/10.1146/annurev-med-052511-135400|14. Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M (2013). Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology  10, 139.   https://doi.org/10.1186/1742-4690-10-139",https://intramural.nih.gov/search/searchview.taf?ipid=83687
221,BC010792-08,"October 01, 2013 -  September 30, 2014",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Laboratory of Experimental Immunology, NCI",Richard  Apps; PhD|Arman A Bashirova|Fuh-Mei  Duh|Xiaojiang  Gao|Danillo  Gardenal Augusto; PhD|Maureen P Martin|Show all 11,John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Bruce  Walker (Harvard Medical School)|Daniel  Geraghty (Fred Hutchinson Cancer Research Center)|Judith  Kidd (Yale University)|Kenneth  Kidd (Yale University)|Show all 8,NULL,NULL,"1. Pyo CW, Wang R, Vu Q, Cereb N, Yang SY, Duh FM, Wolinsky S, Martin MP, Carrington M, Geraghty DE (2013). Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics  14, 89.   https://doi.org/10.1186/1471-2164-14-89",https://intramural.nih.gov/search/searchview.taf?ipid=83686
222,BC010793-08,"October 01, 2013 -  September 30, 2014","Role of inflammation, innate resistance, and immunity in carcinogenesis.",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Sarah Delia Cramer|Ren Ming  Dai|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Natasha Delia Lejbman|Rosalba  Salcedo|Show all 10,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Mario  Colombo (Experimental Oncology, National Institute of Surgery and Cure of Tumors)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Dominique  Kaiserlian (U404, INSERM)|Sergey  Grivennikov (Fox Chase Cancer Center)",David Anderson Wink (Radiation Biology Branch)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Alan  Sher; PhD (NIAID) |Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID),"1. Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, et al. [13 more authors] (2013). Future perspectives in melanoma research. Meeting report from the Melanoma Bridge. Napoli, December 2nd-4th 2012. J Transl Med  11, 137.   https://doi.org/10.1186/1479-5876-11-137|2. Hasan UA, Zannetti C, Parroche P, Goutagny N, Malfroy M, Roblot G, Carreira C, Hussain I, Müller M, Taylor-Papadimitriou J, Picard D, Sylla BS, Trinchieri G, Medzhitov R, Tommasino M (2013). The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J Exp Med  210, 1369-87.   https://doi.org/10.1084/jem.20122394|3. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science  342, 967-70.   https://doi.org/10.1126/science.1240527|4. Molloy MJ, Grainger JR, Bouladoux N, Hand TW, Koo LY, Naik S, Quinones M, Dzutsev AK, Gao JL, Trinchieri G, Murphy PM, Belkaid Y (2013). Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe  14, 318-28.   https://doi.org/10.1016/j.chom.2013.08.003|5. Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW (2013). LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells. PLoS Pathog  9, e1003357.   https://doi.org/10.1371/journal.ppat.1003357|6. Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP, Weiss JM, Trinchieri G, Morris JC, Yang L (2013). TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov  3, 936-51.   https://doi.org/10.1158/2159-8290.CD-12-0527|7. Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G (2013). MyD88 and its divergent toll in carcinogenesis. Trends Immunol  34, 379-89.   https://doi.org/10.1016/j.it.2013.03.008|8. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S, Hieny S, Caspar P, Yamasaki S, Lin X, Ting JP, Trinchieri G, Besra GS, Cerundolo V, Sher A (2013). Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome. J Immunol  190, 5722-30.   https://doi.org/10.4049/jimmunol.1203343|9. Stewart CA, Metheny H, Iida N, Smith L, Hanson M, Steinhagen F, Leighty RM, Roers A, Karp CL, Müller W, Trinchieri G (2013). Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. J Clin Invest  123, 4859-74.   https://doi.org/10.1172/JCI65180|10. Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y (2013). The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell  23, 527-40.   https://doi.org/10.1016/j.ccr.2013.03.009",https://intramural.nih.gov/search/searchview.taf?ipid=83704
223,BC010795-08,"October 01, 2013 -  September 30, 2014",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",NULL,"Zachary  Burton (Department of Biochemistry and Molecular Biology, Michigan State University)|Jianhua  Fu (Cornell University)|Charles  Turnbough (Unversity of Alabama)|Max  Gottesman (Institute of Cancer Research, Columbia University)|Benoit  Coulombe (Institut de recherches cliniques de Montreal)|Carlos  Bustamante (University of California - Berkeley)|Show all 7",Donald L Court; PhD (Molecular Control and Genetics Section)|Bruce Allen Shapiro; PhD (Center for Cancer Research Nanobiology Program)|Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Jeffrey N Strathern (Genome Recombination and Regulation Section),NULL,"1. Dangkulwanich M, Ishibashi T, Liu S, Kireeva ML, Lubkowska L, Kashlev M, Bustamante CJ (2013). Complete dissection of transcription elongation reveals slow translocation of RNA polymerase II in a linear ratchet mechanism. Elife  2, e00971.   https://doi.org/10.7554/eLife.00971|2. Imashimizu M, Oshima T, Lubkowska L, Kashlev M (2013). Direct assessment of transcription fidelity by high-resolution RNA sequencing. Nucleic Acids Res  41, 9090-104.   https://doi.org/10.1093/nar/gkt698|3. Kireeva ML, Kashlev M, Burton ZF (2013). RNA polymerase structure, function, regulation, dynamics, fidelity, and roles in gene expression. Chem Rev  113, 8325-30.   https://doi.org/10.1021/cr400436m|4. Nedialkov YA, Opron K, Assaf F, Artsimovitch I, Kireeva ML, Kashlev M, Cukier RI, Nudler E, Burton ZF (2013). The RNA polymerase bridge helix YFI motif in catalysis, fidelity and translocation. Biochim Biophys Acta  1829, 187-98.   https://doi.org/10.1016/j.bbagrm.2012.11.005|5. Strathern J, Malagon F, Irvin J, Gotte D, Shafer B, Kireeva M, Lubkowska L, Jin DJ, Kashlev M (2013). The fidelity of transcription: RPB1 (RPO21) mutations that increase transcriptional slippage in S. cerevisiae. J Biol Chem  288, 2689-99.   https://doi.org/10.1074/jbc.M112.429506",https://intramural.nih.gov/search/searchview.taf?ipid=83705
224,BC010800-08,"October 01, 2013 -  September 30, 2014",Convection enhanced delivery of agents into the brainstem of glioma patients,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,NULL,NULL,Russell R Lonser; MD (NINDS) |Joelle  Sarlls; PhD (NINDS) |John D Heiss; MD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83706
225,BC010801-08,"October 01, 2013 -  September 30, 2014",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Srivandana  Akshintala|Andrea Maria Baldwin|Diane  Cole|Eva  Dombi|David Emanuel Janhofer|Nalini M Jayaprakash|Show all 14,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Bruce  Korf (University of Alabama)|Regina  Jakacki (Neuropathology, Children's Hospital of Pittsburgh)|Victor  Mautner (Genetics, Hamburg University)|Jaishri  Blakeley (Johns Hopkins)|Ludwine  Messiaen; PhD (Dept of Genetics, University of Alabama)|Show all 15","Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Karlyne M Reilly; BS, PhD (Office of the Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Abby  Sandler (Office Of The Director)","Nicholas  Patronas; MD (CC) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Jeffrey M Solomon; BS, MS, PhD (CC) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI) |Clara Chi Chen; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83707
226,BC010802-08,"October 01, 2013 -  September 30, 2014",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal|Caitlyn Nicole Fuller|Keith Henry Jansson|Heather  Sheppard,George  Petrovics (CPDR/ USUHS)|Charles L Sawyers,NULL,NULL,"1. Yin X, Xiang T, Li L, Su X, Shu X, Luo X, Huang J, Yuan Y, Peng W, Oberst M, Kelly K, Ren G, Tao Q (2013). DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Res  15, R23.   https://doi.org/10.1186/bcr3399",https://intramural.nih.gov/search/searchview.taf?ipid=83708
227,BC010806-08,"October 01, 2013 -  September 30, 2014",Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sivasubramanian  Baskar|Dominik  Bogen|Wen-I  Chang; MD|Li  Chen|Berkley Eric Gryder|Jianbin Na He|Show all 11,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)",NULL,Scott E Martin (NCATS) |Craig Joseph Thomas (NCATS),"1. Li SQ, Cheuk AT, Shern JF, Song YK, Hurd L, Liao H, Wei JS, Khan J (2013). Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS One  8, e76551.   https://doi.org/10.1371/journal.pone.0076551|2. Patel PR, Sun H, Li SQ, Shen M, Khan J, Thomas CJ, Davis MI (2013). Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorg Med Chem Lett  23, 4398-403.   https://doi.org/10.1016/j.bmcl.2013.05.072|3. Wei JS, Johansson P, Chen L, Song YK, Tolman C, Li S, Hurd L, Patidar R, Wen X, Badgett TC, Cheuk AT, Marshall JC, Steeg PS, Vaqué Díez JP, Yu Y, Gutkind JS, Khan J (2013). Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma. PLoS One  8, e77731.   https://doi.org/10.1371/journal.pone.0077731|4. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene  32, 5429-38.   https://doi.org/10.1038/onc.2012.590",https://intramural.nih.gov/search/searchview.taf?ipid=83711
228,BC010808-08,"October 01, 2013 -  September 30, 2014",Nucleosome Dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Jingjun  Hong|Rui  Wang|Bing-Rui  Zhou|Carl  Wu; PhD,NULL,NULL,Rodolfo  Ghirlando; PhD (NIDDK) |Tsan  Xiao; PhD (NIAID),"1. Hong J, Feng H, Wang F, Ranjan A, Chen J, Jiang J, Ghirlando R, Xiao TS, Wu C, Bai Y (2014). The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer. Mol Cell  53, 498-505.   https://doi.org/10.1016/j.molcel.2014.01.010",https://intramural.nih.gov/search/searchview.taf?ipid=83684
229,BC010814-08,"October 01, 2013 -  September 30, 2014",Regulation of Retroviral RNA Packaging and Dynamics of HIV-1 RNA Export,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Kari Ann Dilley|Malika  Kuzembayeva|Yang  Liu; PhD|Olga A Nikolaitchik|Medha Satish Parulekar|Sheikh Abdul Rahman|Show all 9,William W Fu|Roger  Ptak (Southern Research Institute)|David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|Andrea  Galli|WE  Moerner (Stanford University),Stephen J Lockett; PhD (Office Of The Director)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Chen J, Nikolaitchik O, Dilley K, Hu W (2013) Packaging of the HIV-1 RNA genome, in Advances in HIV-1 Assembly and Release. Freed E, ed., pp. 55-73.|2. Chen J, Grunwald D, Sardo L, Galli A, Plisov S, Nikolaitchik OA, Chen D, Lockett S, Larson DR, Pathak VK, Hu WS (2014). Cytoplasmic HIV-1 RNA is mainly transported by diffusion in the presence or absence of Gag protein. Proc Natl Acad Sci U S A  111, E5205-13.   https://doi.org/10.1073/pnas.1413169111|3. Nikolaitchik OA, Dilley KA, Fu W, Gorelick RJ, Tai SH, Soheilian F, Ptak RG, Nagashima K, Pathak VK, Hu WS (2013). Dimeric RNA recognition regulates HIV-1 genome packaging. PLoS Pathog  9, e1003249.   https://doi.org/10.1371/journal.ppat.1003249",https://intramural.nih.gov/search/searchview.taf?ipid=83712
230,BC010816-08,"October 01, 2013 -  September 30, 2014","Immunotherapy for  Malignant Mesothelioma, Lung Cancer and Thymic Malignancies",Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Lisa Ann Bengtson|Arlene Wendy Berman|Yuanbin  Chen; MD|Corrine Marie Keen|Swati  Khanna|Yvonne D Mallory|Show all 13,NULL,Ira H Pastan; MD (Molecular Biology Section)|Peter L Choyke; MD (Molecular Imaging Program)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Markku Martti Miettinen (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),NULL,"1. Hassan R, Miller AC, Sharon E, Thomas A, Reynolds JC, Ling A, Kreitman RJ, Miettinen MM, Steinberg SM, Fowler DH, Pastan I (2013). Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression. Sci Transl Med  5, 208ra147.   https://doi.org/10.1126/scitranslmed.3006941|2. Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R (2013). New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. Am J Pathol  182, 1065-77.   https://doi.org/10.1016/j.ajpath.2012.12.028|3. Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK, Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital I (2013). A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol  20, 555-61.   https://doi.org/10.1245/s10434-012-2651-5|4. Thomas A, Maltzman J, Hassan R (2013). Farletuzumab in lung cancer. Lung Cancer  80, 15-8.   https://doi.org/10.1016/j.lungcan.2012.12.021",https://intramural.nih.gov/search/searchview.taf?ipid=83713
231,BC010819-08,"October 01, 2013 -  September 30, 2014",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Zehava  Grossman; PhD|Shawn A Hill|Sarah Anne Watters|Sophie Allende Dean|Charmaine Elisabeth Joanna Peters,John W Mellors|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|James Coston Brooks|John  Coffin (Tufts University),Paul L Boyer (Retroviral Replication Laboratory)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joseph A Kovacs; MD (CC) |Joann  Mican; MD (NIAID)","1. Andersson E, Shao W, Bontell I, Cham F, Cuong do D, Wondwossen A, Morris L, Hunt G, Sönnerborg A, Bertagnolio S, Maldarelli F, Jordan MR (2013). Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infect Genet Evol  18, 125-31.   https://doi.org/10.1016/j.meegid.2013.03.050|2. Josefsson L, Palmer S, Faria NR, Lemey P, Casazza J, Ambrozak D, Kearney M, Shao W, Kottilil S, Sneller M, Mellors J, Coffin JM, Maldarelli F (2013). Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog  9, e1003432.   https://doi.org/10.1371/journal.ppat.1003432|3. Maldarelli F, Kearney M, Palmer S, Stephens R, Mican J, Polis MA, Davey RT, Kovacs J, Shao W, Rock-Kress D, Metcalf JA, Rehm C, Greer SE, Lucey DL, Danley K, Alter H, Mellors JW, Coffin JM (2013). HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J Virol  87, 10313-23.   https://doi.org/10.1128/JVI.01225-12|4. Shao W, Boltz VF, Spindler JE, Kearney MF, Maldarelli F, Mellors JW, Stewart C, Volfovsky N, Levitsky A, Stephens RM, Coffin JM (2013). Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. Retrovirology  10, 18.   https://doi.org/10.1186/1742-4690-10-18|5. Sloan EA, Kearney MF, Gray LR, Anastos K, Daar ES, Margolick J, Maldarelli F, Hammarskjold ML, Rekosh D (2013). Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization. J Virol  87, 11173-86.   https://doi.org/10.1128/JVI.01392-13",https://intramural.nih.gov/search/searchview.taf?ipid=83714
232,BC010822-08,"October 01, 2013 -  September 30, 2014",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Lars  Bockmann|Lauren Elizabeth Dittman|Prashant  Mishra|Kentaro  Ohkuni|Natasha  Caplen|Show all 7,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Maitreya  Dunham (Genome Sciences, Univ of Washington,)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Melissa  Gardner (Univ of Minnesota)|Show all 8",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Ainsworth WB, Hughes BT, Au WC, Sakelaris S, Kerscher O, Benton MG, Basrai MA (2013). Cytoplasmic localization of Hug1p, a negative regulator of the MEC1 pathway, coincides with the compartmentalization of Rnr2p-Rnr4p. Biochem Biophys Res Commun  439, 443-8.   https://doi.org/10.1016/j.bbrc.2013.08.089|2. Au WC, Dawson AR, Rawson DW, Taylor SB, Baker RE, Basrai MA (2013). A novel role of the N terminus of budding yeast histone H3 variant Cse4 in ubiquitin-mediated proteolysis. Genetics  194, 513-8.   https://doi.org/10.1534/genetics.113.149898|3. Boeckmann L, Takahashi Y, Au WC, Mishra PK, Choy JS, Dawson AR, Szeto MY, Waybright TJ, Heger C, McAndrew C, Goldsmith PK, Veenstra TD, Baker RE, Basrai MA (2013). Phosphorylation of centromeric histone H3 variant regulates chromosome segregation in Saccharomyces cerevisiae. Mol Biol Cell  24, 2034-44.   https://doi.org/10.1091/mbc.E12-12-0893|4. Choy JS, O'Toole E, Schuster BM, Crisp MJ, Karpova TS, McNally JG, Winey M, Gardner MK, Basrai MA (2013). Genome-wide haploinsufficiency screen reveals a novel role for γ-TuSC in spindle organization and genome stability. Mol Biol Cell  24, 2753-63.   https://doi.org/10.1091/mbc.E12-12-0902|5. Haase J, Mishra PK, Stephens A, Haggerty R, Quammen C, Taylor RM, Yeh E, Basrai MA, Bloom K (2013). A 3D map of the yeast kinetochore reveals the presence of core and accessory centromere-specific histone. Curr Biol  23, 1939-44.   https://doi.org/10.1016/j.cub.2013.07.083|6. Lai X, Beilharz T, Au WC, Hammet A, Preiss T, Basrai MA, Heierhorst J (2013). Yeast hEST1A/B (SMG5/6)-like proteins contribute to environment-sensing adaptive gene expression responses. G3 (Bethesda)  3, 1649-59.   https://doi.org/10.1534/g3.113.006924|7. Mishra PK, Ottmann AR, Basrai MA (2013). Structural integrity of centromeric chromatin and faithful chromosome segregation requires Pat1. Genetics  195, 369-79.   https://doi.org/10.1534/genetics.113.155291",https://intramural.nih.gov/search/searchview.taf?ipid=83685
233,BC010824-08,"October 01, 2013 -  September 30, 2014",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Soojay  Banerjee; PhD|Veronica Marie Falconieri|Gabriel Abraham Frank|Doreen  Matthies|Joel Reuben Meyerson|Prashant Arkalgud Rao|Show all 7,"Judy  Armitage (University of Oxford)|Christopher  Broder (Uniformed Services University of the Health Sciences)|Frank  McCormick (UCSF School of Medicine)|Peter  Palese (Mount Sinai School of Medicine)|Eduardo  Perozo (University of Chicago)|Michael G. Rossmann; PhD (Dept. of Biological Sciences, Purdue University)|Show all 7","Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)","Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NICHD) |Kanta  Subbarao; MD, MPH (NIAID) |Xiongwu  Wu; PhD (NHLBI)","1. Harris AK, Meyerson JR, Matsuoka Y, Kuybeda O, Moran A, Bliss D, Das SR, Yewdell JW, Sapiro G, Subbarao K, Subramaniam S (2013). Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A  110, 4592-7.   https://doi.org/10.1073/pnas.1214913110|2. Schauder DM, Kuybeda O, Zhang J, Klymko K, Bartesaghi A, Borgnia MJ, Mayer ML, Subramaniam S (2013). Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A  110, 5921-6.   https://doi.org/10.1073/pnas.1217549110",https://intramural.nih.gov/search/searchview.taf?ipid=83715
234,BC010825-08,"October 01, 2013 -  September 30, 2014",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Gabriel Abraham Frank|Erin E Tran|Thao Phuong Do|Veronica Marie Falconieri|Joel Reuben Meyerson,"Thomas  Hope (University of Illinois-Chicago)|David C Montefiori; PhD (Department of Surgery, NIAID)|Venigalla  Rao (Catholic University)|Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Quentin J. Sattentau|(Department of Pathology)",Jeffrey D Lifson; MD (Office Of The Director)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Alexander  Wlodawer; PhD (Protein Structure Section)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory),"G. Marius  Clore; PhD, MD (NIDDK) |Avindra  Nath; MD (NINDS) |Donald F Bliss (NLM)","1. Bartesaghi A, Merk A, Borgnia MJ, Milne JL, Subramaniam S (2013). Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol  20, 1352-7.   https://doi.org/10.1038/nsmb.2711|2. Earl LA, Lifson JD, Subramaniam S (2013). Catching HIV 'in the act' with 3D electron microscopy. Trends Microbiol  21, 397-404.   https://doi.org/10.1016/j.tim.2013.06.004|3. Gustchina E, Li M, Ghirlando R, Schuck P, Louis JM, Pierson J, Rao P, Subramaniam S, Gustchina A, Clore GM, Wlodawer A (2013). Complexes of neutralizing and non-neutralizing affinity matured Fabs with a mimetic of the internal trimeric coiled-coil of HIV-1 gp41. PLoS One  8, e78187.   https://doi.org/10.1371/journal.pone.0078187|4. Harris AK, Bartesaghi A, Milne JL, Subramaniam S (2013). HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1. J Virol  87, 7191-6.   https://doi.org/10.1128/JVI.03284-12|5. Harris AK, Meyerson JR, Matsuoka Y, Kuybeda O, Moran A, Bliss D, Das SR, Yewdell JW, Sapiro G, Subbarao K, Subramaniam S (2013). Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A  110, 4592-7.   https://doi.org/10.1073/pnas.1214913110|6. Merk A, Subramaniam S (2013). HIV-1 envelope glycoprotein structure. Curr Opin Struct Biol  23, 268-76.   https://doi.org/10.1016/j.sbi.2013.03.007|7. Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S (2013). Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc Natl Acad Sci U S A  110, 513-8.   https://doi.org/10.1073/pnas.1214810110|8. Subramaniam S (2013). Structure of trimeric HIV-1 envelope glycoproteins. Proc Natl Acad Sci U S A  110, E4172-4.   https://doi.org/10.1073/pnas.1313802110",https://intramural.nih.gov/search/searchview.taf?ipid=83716
235,BC010826-08,"October 01, 2013 -  September 30, 2014",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Lesley Ann Earl; PhD|Giovanna  Grandinetti|Kedar  Narayan|Prashant Arkalgud Rao,"Michael  Phaneuf (Fibics Inc.)|Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)",NULL,Bernard R Brooks; PhD (NHLBI) |Xiongwu  Wu; PhD (NHLBI) |Terry S Yoo; PhD (NLM) |Donald F Bliss (NLM),"1. Bartesaghi A, Merk A, Borgnia MJ, Milne JL, Subramaniam S (2013). Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat Struct Mol Biol  20, 1352-7.   https://doi.org/10.1038/nsmb.2711|2. Harris AK, Bartesaghi A, Milne JL, Subramaniam S (2013). HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1. J Virol  87, 7191-6.   https://doi.org/10.1128/JVI.03284-12|3. Harris AK, Meyerson JR, Matsuoka Y, Kuybeda O, Moran A, Bliss D, Das SR, Yewdell JW, Sapiro G, Subbarao K, Subramaniam S (2013). Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc Natl Acad Sci U S A  110, 4592-7.   https://doi.org/10.1073/pnas.1214913110|4. Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S (2013). Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc Natl Acad Sci U S A  110, 513-8.   https://doi.org/10.1073/pnas.1214810110|5. Narayan K, Danielson CM, Lagarec K, Lowekamp BC, Coffman P, Laquerre A, Phaneuf MW, Hope TJ, Subramaniam S (2014). Multi-resolution correlative focused ion beam scanning electron microscopy: applications to cell biology. J Struct Biol  185, 278-84.   https://doi.org/10.1016/j.jsb.2013.11.008|6. Schauder DM, Kuybeda O, Zhang J, Klymko K, Bartesaghi A, Borgnia MJ, Mayer ML, Subramaniam S (2013). Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A  110, 5921-6.   https://doi.org/10.1073/pnas.1217549110|7. Subramaniam S (2013). Structure of trimeric HIV-1 envelope glycoproteins. Proc Natl Acad Sci U S A  110, E4172-4.   https://doi.org/10.1073/pnas.1313802110|8. Wu X, Subramaniam S, Case DA, Wu KW, Brooks BR (2013). Targeted conformational search with map-restrained self-guided Langevin dynamics: application to flexible fitting into electron microscopic density maps. J Struct Biol  183, 429-440.   https://doi.org/10.1016/j.jsb.2013.07.006",https://intramural.nih.gov/search/searchview.taf?ipid=83717
236,BC010827-08,"October 01, 2013 -  September 30, 2014",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Mario J Borgnia; PhD|Alan Anthony Merk|Sriram  Subramaniam; PhD|Victor  Zhurkin; PhD,NULL,NULL,NULL,"1. Bartesaghi A, Matthies D, Banerjee S, Merk A, Subramaniam S (2014) 3.2 Angstrom resolution structure of beta-galactosidase obtained by cryo-electron microscopy. Proc Natl Acad Sci, in press.|2. Schauder DM, Kuybeda O, Zhang J, Klymko K, Bartesaghi A, Borgnia MJ, Mayer ML, Subramaniam S (2013). Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain. Proc Natl Acad Sci U S A  110, 5921-6.   https://doi.org/10.1073/pnas.1217549110",https://intramural.nih.gov/search/searchview.taf?ipid=83718
237,BC010830-08,"October 01, 2013 -  September 30, 2014",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Multidrug Resistence Section, NCI",Carol O Cardarelli|James Martin Greene|Matthew David Hall|Orit  Lavi; PhD|James Patrick Madigan|Rajalakshm L Padmanabhan|Show all 9,Jacob  Hochman (Hebrew University)|Ram  Ganapathy (Cleveland Clinic)|JeanPierre  Gillet (University of Namur)|Doron  Levy (University of Maryland),Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Vincent J. Hearing; PhD (Pigment Cell Biology Section),"Kevin G Chen; MD (NINDS) |Joshua  Zimmerberg; PhD, MD (NICHD) |Chava  Kimchi-Sarfaty (OD) |Thomas J Pohida; MS (CIT)","1. Chakraborty AR, Robey RW, Luchenko VL, Zhan Z, Piekarz RL, Gillet JP, Kossenkov AV, Wilkerson J, Showe LC, Gottesman MM, Collie NL, Bates SE (2013). MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor. Blood  121, 4115-25.   https://doi.org/10.1182/blood-2012-08-449140|2. Gillet JP, Varma S, Gottesman MM (2013). The clinical relevance of cancer cell lines. J Natl Cancer Inst  105, 452-8.   https://doi.org/10.1093/jnci/djt007|3. Jaeger AA, Das CK, Morgan NY, Pursley RH, McQueen PG, Hall MD, Pohida TJ, Gottesman MM (2013). Microfabricated polymeric vessel mimetics for 3-D cancer cell culture. Biomaterials  34, 8301-13.   https://doi.org/10.1016/j.biomaterials.2013.07.013|4. Lavi O, Greene JM, Levy D, Gottesman MM (2013). The role of cell density and intratumoral heterogeneity in multidrug resistance. Cancer Res  73, 7168-75.   https://doi.org/10.1158/0008-5472.CAN-13-1768|5. Patel C, Stenke L, Varma S, Lindberg ML, Björkholm M, Sjöberg J, Viktorsson K, Lewensohn R, Landgren O, Gottesman MM, Gillet JP (2013). Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity. Cancer  119, 3076-83.   https://doi.org/10.1002/cncr.28098|6. Xue X, Hall MD, Zhang Q, Wang PC, Gottesman MM, Liang XJ (2013). Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking. ACS Nano  7, 10452-64.   https://doi.org/10.1021/nn405004f",https://intramural.nih.gov/search/searchview.taf?ipid=83719
238,BC010832-08,"October 01, 2013 -  September 30, 2014",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Waruna Thac Yapa,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Iwona Elzbieta Weidlich|Steve  Heller (NIST)|Markus  Sitzmann,Raul Eduardo Cachau (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83720
239,BC010833-08,"October 01, 2013 -  September 30, 2014",Identification and functional characterization of colorectal cancer genes,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Nicole E Mcneil|Hesed M Padilla Nash|Damrong M Wangsa|Show all 7,"Michael  Ghadimi (Surgery, U. of Goettingen)|Daniel Paul Rosenberg",NULL,NULL,"1. Bowen S, Wangsa D, Ried T, Livak F, Hodes RJ (2013). Concurrent V(D)J recombination and DNA end instability increase interchromosomal trans-rearrangements in ATM-deficient thymocytes. Nucleic Acids Res  41, 4535-48.   https://doi.org/10.1093/nar/gkt154|2. Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beissbarth T, Difilippantonio MJ, Caplen NJ, Ried T (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res  73, 2003-13.   https://doi.org/10.1158/0008-5472.CAN-12-3159|3. Case CM, Sackett DL, Wangsa D, Karpova T, McNally JG, Ried T, Camps J (2013). CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites. PLoS One  8, e64575.   https://doi.org/10.1371/journal.pone.0064575|4. Tang J, Li Y, Lyon K, Camps J, Dalton S, Ried T, Zhao S (2014). Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer. Oncogene  33, 814-22.   https://doi.org/10.1038/onc.2013.17|5. Zhang G, He P, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Hanna N, Alexander HR, Hussain SP (2013). FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Cancer Res  73, 5416-25.   https://doi.org/10.1158/0008-5472.CAN-13-0362|6. Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP (2013). Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res  19, 4983-93.   https://doi.org/10.1158/1078-0432.CCR-13-0209",https://intramural.nih.gov/search/searchview.taf?ipid=83721
240,BC010834-08,"October 01, 2013 -  September 30, 2014","Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer",Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|David  Fiedler|Leanora Sierra Hernandez|Kerstin  Heselmeyer|Yue  Hu|Show all 10,Gert  Auer|David E Symer,NULL,Alejandro Alberto Schaffer; PhD (NLM),"1. Chowdhury SA, Shackney SE, Heselmeyer-Haddad K, Ried T, Schäffer AA, Schwartz R (2013). Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations. Bioinformatics  29, i189-98.   https://doi.org/10.1093/bioinformatics/btt205|2. Winkler T, Hong SG, Decker JE, Morgan MJ, Wu C, Hughes WM, Yang Y, Wangsa D, Padilla-Nash HM, Ried T, Young NS, Dunbar CE, Calado RT (2013). Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest  123, 1952-63.   https://doi.org/10.1172/JCI67146",https://intramural.nih.gov/search/searchview.taf?ipid=83722
241,BC010835-08,"October 01, 2013 -  September 30, 2014",Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Eric  Cardin|Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Nicole E Mcneil|Show all 10,NULL,NULL,Danny L Sackett; PhD (NICHD),"1. Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beissbarth T, Difilippantonio MJ, Caplen NJ, Ried T (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res  73, 2003-13.   https://doi.org/10.1158/0008-5472.CAN-12-3159|2. Camps J, Wangsa D, Falke M, Brown M, Case CM, Erdos MR, Ried T (2014). Loss of lamin B1 results in prolongation of S phase and decondensation of chromosome territories. FASEB J  28, 3423-34.   https://doi.org/10.1096/fj.14-250456|3. Case CM, Sackett DL, Wangsa D, Karpova T, McNally JG, Ried T, Camps J (2013). CKAP2 ensures chromosomal stability by maintaining the integrity of microtubule nucleation sites. PLoS One  8, e64575.   https://doi.org/10.1371/journal.pone.0064575|4. Gemoll T, Habermann JK, Becker S, Szymczak S, Upender MB, Bruch HP, Hellman U, Ried T, Auer G, Jörnvall H, Roblick UJ (2013). Chromosomal aneuploidy affects the global proteome equilibrium of colorectal cancer cells. Anal Cell Pathol (Amst)  36, 149-61.   https://doi.org/10.3233/ACP-140088|5. Padilla-Nash HM, McNeil NE, Yi M, Nguyen QT, Hu Y, Wangsa D, Mack DL, Hummon AB, Case C, Cardin E, Stephens R, Difilippantonio MJ, Ried T (2013). Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells. Carcinogenesis  34, 1929-39.   https://doi.org/10.1093/carcin/bgt138|6. Zhang G, He P, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Hanna N, Alexander HR, Hussain SP (2013). FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Cancer Res  73, 5416-25.   https://doi.org/10.1158/0008-5472.CAN-13-0362",https://intramural.nih.gov/search/searchview.taf?ipid=83723
242,BC010837-08,"October 01, 2013 -  September 30, 2014",Prediction of Therapy Response in Colorectal Cancer,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Chi Chung  Cheng|Yue  Hu|Damrong M Wangsa|Natasha  Caplen,NULL,NULL,NULL,"1. Camps J, Pitt JJ, Emons G, Hummon AB, Case CM, Grade M, Jones TL, Nguyen QT, Ghadimi BM, Beissbarth T, Difilippantonio MJ, Caplen NJ, Ried T (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res  73, 2003-13.   https://doi.org/10.1158/0008-5472.CAN-12-3159",https://intramural.nih.gov/search/searchview.taf?ipid=83725
243,BC010839-08,"October 01, 2013 -  September 30, 2014",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83688
244,BC010844-08,"October 01, 2013 -  September 30, 2014",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)",Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),"1. Zhurkin VB, Olson WK (2013). Can nucleosomal DNA be described by an elastic model?: comment on ""Sequence-dependent collective properties of DNAs and their role in biological systems"" by Pasquale De Santis and Anita Scipioni. Phys Life Rev  10, 70-2; discussion 82-4.   https://doi.org/10.1016/j.plrev.2013.01.009",https://intramural.nih.gov/search/searchview.taf?ipid=83727
245,BC010845-08,"October 01, 2013 -  September 30, 2014",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Igor  Panyutin; PhD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83695
246,BC010846-08,"October 01, 2013 -  September 30, 2014",Mechanisms of Transcriptional Control by p300,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD",NULL,William D Figg; PharmD (Genitourinary Malignancies Branch),Dan L Longo; MD (NIA),"1. Byun JS, Gardner K (2013). C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer. Int J Cell Biol  2013, 647975.   https://doi.org/10.1155/2013/647975|2. De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES, De Siervi A (2013). BRCA1 and p53 regulate critical prostate cancer pathways. Prostate Cancer Prostatic Dis  16, 233-8.   https://doi.org/10.1038/pcan.2013.12",https://intramural.nih.gov/search/searchview.taf?ipid=83693
247,BC010847-08,"October 01, 2013 -  September 30, 2014",Molecular linkages between epigenetic regulation and metabolism in breast cancer,"Kevin  Gardner; MD, PhD",NULL,"Cancer Genetics Branch, NCI","Paul S Meltzer; MD, PhD",NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),Dan L Longo; MD (NIA),"1. Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, Xiao Z, Andresson T, Esposito D, Smithers N, Lugo D, Prinjha R, Day A, Crawford NP, Ozato K, Gardner K, Hunter KW (2013). BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane. PLoS One  8, e80746.   https://doi.org/10.1371/journal.pone.0080746|2. Byun JS, Gardner K (2013). C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer. Int J Cell Biol  2013, 647975.   https://doi.org/10.1155/2013/647975|3. Byun JS, Gardner K (2013). Wounds that will not heal: pervasive cellular reprogramming in cancer. Am J Pathol  182, 1055-64.   https://doi.org/10.1016/j.ajpath.2013.01.009|4. De Luca P, Moiola CP, Zalazar F, Gardner K, Vazquez ES, De Siervi A (2013). BRCA1 and p53 regulate critical prostate cancer pathways. Prostate Cancer Prostatic Dis  16, 233-8.   https://doi.org/10.1038/pcan.2013.12|5. Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K (2013). Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun  4, 1449.   https://doi.org/10.1038/ncomms2438",https://intramural.nih.gov/search/searchview.taf?ipid=83694
248,BC010850-08,"October 01, 2013 -  September 30, 2014",Mechanisms of Normal Tissue Toxicity,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Luz Marina Giordano|Grace B McKay-Corkum|Ayla Oksuz White,NULL,James B Mitchell; PhD (Radiation Biology Branch),Pamela Gehron Robey; PhD (NIDCR),"1. Citrin DE, Shankavaram U, Horton JA, Shield W, Zhao S, Asano H, White A, Sowers A, Thetford A, Chung EJ (2013). Role of type II pneumocyte senescence in radiation-induced lung fibrosis. J Natl Cancer Inst  105, 1474-84.   https://doi.org/10.1093/jnci/djt212|2. Horton JA, Li F, Chung EJ, Hudak K, White A, Krausz K, Gonzalez F, Citrin D (2013). Quercetin inhibits radiation-induced skin fibrosis. Radiat Res  180, 205-15.   https://doi.org/10.1667/RR3237.1",https://intramural.nih.gov/search/searchview.taf?ipid=83728
249,BC010852-08,"October 01, 2013 -  September 30, 2014",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Defne  Bayik Watson|Christian Hans Bode; MD|Julia  Scheiermann|Isaac Joseph Soltz|Debra  Tross|Jing  Wang|Show all 8,"Ihsan  Gursel|Jay  Hooper (USAMRIID)|Yoshiaki  Ishigatsubo; MD, PhD (Yokohama City Univ Medical School)|Sven  Klaschik|Hirak  Biswas (Washington University)|Christian Hans Bode; MD|Show all 12","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Igal  Gery; PhD (NEI) |Danielle A Springer; VMD (NHLBI),"1. Gursel M, Klinman D (2014) Use of CpG Oligonucleotides as Mucosal Adjuvants, in Mucosal Immunology., in press.|2. Gursel M, Klinman DM, Gursel I (2013). Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL. Mediators Inflamm  2013, 312590.   https://doi.org/10.1155/2013/312590|3. Kobayashi N, Hong C, Klinman DM, Shirota H (2013). Oligodeoxynucleotides expressing polyguanosine motifs promote antitumor activity through the upregulation of IL-2. J Immunol  190, 1882-9.   https://doi.org/10.4049/jimmunol.1201063|4. Shi G, Vistica BP, Nugent LF, Tan C, Wawrousek EF, Klinman DM, Gery I (2013). Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands. J Immunol  191, 415-23.   https://doi.org/10.4049/jimmunol.1201732|5. Shimada M, Abe S, Takahashi T, Shiozaki K, Okuda M, Mizukami H, Klinman DM, Ozawa K, Okuda K (2013). Prophylaxis and treatment of Alzheimer's disease by delivery of an adeno-associated virus encoding a monoclonal antibody targeting the amyloid Beta protein. PLoS One  8, e57606.   https://doi.org/10.1371/journal.pone.0057606|6. Shirota H, Klinman DM (2013). Use of CpG oligonucleotides for cancer immunotherapy and their effect on immunity in the tumor microenvironment. Immunotherapy  5, 787-9.   https://doi.org/10.2217/imt.13.70|7. Steinhagen F, McFarland AP, Rodriguez LG, Tewary P, Jarret A, Savan R, Klinman DM (2013). IRF-5 and NF-κB p50 co-regulate IFN-β and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. Eur J Immunol  43, 1896-906.   https://doi.org/10.1002/eji.201242792|8. Tewary P, de la Rosa G, Sharma N, Rodriguez LG, Tarasov SG, Howard OM, Shirota H, Steinhagen F, Klinman DM, Yang D, Oppenheim JJ (2013). β-Defensin 2 and 3 promote the uptake of self or CpG DNA, enhance IFN-α production by human plasmacytoid dendritic cells, and promote inflammation. J Immunol  191, 865-74.   https://doi.org/10.4049/jimmunol.1201648",https://intramural.nih.gov/search/searchview.taf?ipid=83733
250,BC010853-08,"October 01, 2013 -  September 30, 2014",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Experimental Immunology, NCI",Julia  Scheiermann|Debra  Tross|Christian Hans Bode; MD|Giorgio  Trinchieri,NULL,Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),Igal  Gery; PhD (NEI),"1. Bode C, Yang XP, Kiu H, Klinman DM (2013). Suppressive oligodeoxynucleotides promote the development of Th17 cells. PLoS One  8, e67991.   https://doi.org/10.1371/journal.pone.0067991|2. Kaminski JJ, Schattgen SA, Tzeng TC, Bode C, Klinman DM, Fitzgerald KA (2013). Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation. J Immunol  191, 3876-83.   https://doi.org/10.4049/jimmunol.1300530|3. Shimada M, Yoshizaki S, Ichino M, Klinman DM, Okuda K (2014). Apoptosis of antigen-specific CTLs contributes to low immune response in gut-associated lymphoid tissue post vaccination. Vaccine  32, 5198-205.   https://doi.org/10.1016/j.vaccine.2014.07.046|4. Takahashi R, Sato T, Klinman DM, Shimosato T, Kaneko T, Ishigatsubo Y (2013). Suppressive oligodeoxynucleotides synergistically enhance antiproliferative             effects of anticancer drugs in A549 human lung cancer cells. Int J Oncol  42, 429-36.   https://doi.org/10.3892/ijo.2012.1755",https://intramural.nih.gov/search/searchview.taf?ipid=83734
251,BC010870-07,"October 01, 2013 -  September 30, 2014",Hematopoietic Stem Cell Transplant for GATA2 Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Robert R West,NULL,NULL,Steven M Holland; MD (NIAID),"1. Hsu AP, Johnson KD, Falcone EL, Sanalkumar R, Sanchez L, Hickstein DD, Cuellar-Rodriguez J, Lemieux JE, Zerbe CS, Bresnick EH, Holland SM (2013). GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood  121, 3830-7, S1-7.   https://doi.org/10.1182/blood-2012-08-452763|2. West RR, Hsu AP, Holland SM, Cuellar-Rodriguez J, Hickstein DD (2014). Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica  99, 276-81.   https://doi.org/10.3324/haematol.2013.090217",https://intramural.nih.gov/search/searchview.taf?ipid=83784
252,BC010871-07,"October 01, 2013 -  September 30, 2014",Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yanlin  Yu,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|Miriam R Anver (Office Of The Director)|Melinda  Hollingshead (Biological Testing Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83884
253,BC010872-07,"October 01, 2013 -  September 30, 2014",High throughput screen for small molecule inhibitors of Ran regulated functions,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83854
254,BC010876-07,"October 01, 2013 -  September 30, 2014",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI","Anuradha Samantha Budhu|Marshonna J Forgues|Takamitsu  Sasaki|Atsushi  Takai; MD, PhD|Zhipeng  Yu|Bowranigan  Tharmalingam",Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute)|Show all 9,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology)|James  McMahon; PhD (Molecular Targets Laboratory)",NULL,"1. Henrich CJ, Budhu A, Yu Z, Evans JR, Goncharova EI, Ransom TT, Wang XW, McMahon JB (2013). High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells. Chem Biol Drug Des  82, 131-9.   https://doi.org/10.1111/cbdd.12146|2. Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, Reid LM, Nakauchi H (2013) Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 57:1469-83|3. Yamashita T, Wang XW (2013). Cancer stem cells in the development of liver cancer. J Clin Invest  123, 1911-8.   https://doi.org/10.1172/JCI66024",https://intramural.nih.gov/search/searchview.taf?ipid=83834
255,BC010877-07,"October 01, 2013 -  September 30, 2014",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Anuradha Samantha Budhu|Marshonna J Forgues|Zhipeng  Yu,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Carlo  Croce (Ohio State University)|Qinghai  Ye (Liver Cancer Insitute)|Yidong  Chen; PhD|Hui-Chuan  Sun (Liver Cancer Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83833
256,BC010880-07,"October 01, 2013 -  September 30, 2014",Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Debra J Gilbert|Stephanie L Henderson|Theresa N O'Sullivan|Yurong  Song; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83828
257,BC010881-07,"October 01, 2013 -  September 30, 2014",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Jeffrey E Green; MD|Robert Mark Simpson; DVM, PhD|Li  Yang; PhD","Scott  Lonning (Gene Therapy, Genzyme Corp.)|John  McPherson (Genzyme Corp.)|Amer  Mirza (XOMA (US) LLC)","Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Miriam R Anver (Office Of The Director)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Jinqiu  Chen (Pigment Cell Biology Section)|Maxwell P Lee; PhD (Basic Research Laboratory)",NULL,"1. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM, Hunter KW (2013). Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One  8, e72287.   https://doi.org/10.1371/journal.pone.0072287|2. Luger D, Yang YA, Raviv A, Weinberg D, Banerjee S, Lee MJ, Trepel J, Yang L, Wakefield LM (2013). Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLoS One  8, e76115.   https://doi.org/10.1371/journal.pone.0076115",https://intramural.nih.gov/search/searchview.taf?ipid=83831
258,BC010885-07,"October 01, 2013 -  September 30, 2014",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Holda Awah Anagho|David A Davis; MD|Caitlin Mary Keenan|Ravindra P Veeranna|Coralie  Viollet-Djelassi|Victoria Y Wang,NULL,Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83847
259,BC010886-07,"October 01, 2013 -  September 30, 2014",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Robert Scott Hudson,NULL,Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs S (2013). Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer  12, 13.   https://doi.org/10.1186/1476-4598-12-13",https://intramural.nih.gov/search/searchview.taf?ipid=83739
260,BC010887-07,"October 01, 2013 -  September 30, 2014",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Prachi  Mishra|Adrienne Michelle Starks|Wei  Tang; PhD,"Arun  Sreekumar (Baylor College of Medicine)|Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Olufunmilayo  Olopade (University of Chicago)|Bernhard  Kwabi-Addo (Howard University)|Feng  Wang-Johanning (University of Texas MD Anderson Cancer Center)",David Anderson Wink (Radiation Biology Branch),NULL,"1. Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Ruiz-Narvaez EA, Deming SL, Rodriguez-Gil JL, Demichele A, Chanock SJ, Blot W, Signorello L, Cai Q, Li G, et al. [28 more authors] (2013) A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 132:39-48|2. Downey RF, Sullivan FJ, Wang-Johanning F, Ambs S, Giles FJ, Glynn SA (2015). Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? Int J Cancer  137, 1249-57.   https://doi.org/10.1002/ijc.29003|3. Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Liu Y, Lu Y, Nalls MA, Sun YV, Wojczynski MK, Yanek LR, Aldrich MC, Ademola A, Amos CI, NABEC Consortium, UKBEC Consortium, BioBank Japan Project, AGEN Consortium, et al. [183 more authors] (2013). A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet  45, 690-6.   https://doi.org/10.1038/ng.2608|4. Ridnour LA, Cheng RY, Switzer CH, Heinecke JL, Ambs S, Glynn S, Young HA, Trinchieri G, Wink DA (2013). Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity. Clin Cancer Res  19, 1340-6.   https://doi.org/10.1158/1078-0432.CCR-12-0408|5. Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S (2013). Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother  62, 829-37.   https://doi.org/10.1007/s00262-013-1393-y|6. Starks AM, Martin DN, Dorsey TH, Boersma BJ, Wallace TA, Ambs S (2013). Household income is associated with the p53 mutation frequency in human breast tumors. PLoS One  8, e57361.   https://doi.org/10.1371/journal.pone.0057361|7. Terunuma A, Putluri N, Mishra P, Mathé EA, Dorsey TH, Yi M, Wallace TA, Issaq HJ, Zhou M, Killian JK, Stevenson HS, Karoly ED, Chan K, Samanta S, Prieto D, Hsu TY, Kurley SJ, Putluri V, Sonavane R, Edelman DC, Wulff J, Starks AM, Yang Y, Kittles RA, Yfantis HG, et al. [9 more authors] (2014). MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest  124, 398-412.   https://doi.org/10.1172/JCI71180|8. Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, Zhang J, Afolabi C, Gamazon ER, Cox NJ, Olopade CO, Olopade OI, Huo D (2013). Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis  34, 1520-8.   https://doi.org/10.1093/carcin/bgt090",https://intramural.nih.gov/search/searchview.taf?ipid=83740
261,BC010888-07,"October 01, 2013 -  September 30, 2014",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Karen O Aleman|Thomas S Uldrick|Victoria Y Wang|Kathleen M Wyvill,NULL,"Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|George N Pavlakis; MD, PhD (Vaccine Branch)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)",Amir Hossein Gandjbakhche; PhD (NICHD) |H. Clifford  Lane; MD (NIAID) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID),"1. Polizzotto M, Undrick T, Yarchoan R (2014) Multicentric Castleman Disease, in Cancers in People with HIV and AIDS:  Progress and Challenges., pp. 245-260.|2. Yarchoan R, Undrick T, Polizzotto M (2014) HIV-Associated Cancers, in Cancers in People with HIV and AIDS:  Progress and Challenges. Yarchoan R, ed., pp. 1-15.|3. Uldrick TS, Pipkin S, Scheer S, Hessol NA (2014). Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma. AIDS  28, 397-405.   https://doi.org/10.1097/QAD.0000000000000030",https://intramural.nih.gov/search/searchview.taf?ipid=83846
262,BC010891-07,"October 01, 2013 -  September 30, 2014",Development of antibody-based cancer therapies,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Mingqian  Feng|Wei  Gao|Sophia  Gauthiere|Hannah N Jacobs|Nan  Li|Min  Ni|Show all 7,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Bradley D St Croix (Mouse Cancer Genetics Program)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)|William D Figg; PharmD (Genitourinary Malignancies Branch)",NULL,"1. Feng M, Gao W, Wang R, Chen W, Man YG, Figg WD, Wang XW, Dimitrov DS, Ho M (2013). Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A  110, E1083-91.   https://doi.org/10.1073/pnas.1217868110|2. Feng M, Ho M (2014). Glypican-3 antibodies: a new therapeutic target for liver cancer. FEBS Lett  588, 377-82.   https://doi.org/10.1016/j.febslet.2013.10.002|3. Kim H, Gao W, Ho M (2013). Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice. PLoS One  8, e81919.   https://doi.org/10.1371/journal.pone.0081919|4. Tang Z, Feng M, Gao W, Phung Y, Chen W, Chaudhary A, St Croix B, Qian M, Dimitrov DS, Ho M (2013). A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface. Mol Cancer Ther  12, 416-26.   https://doi.org/10.1158/1535-7163.MCT-12-0731",https://intramural.nih.gov/search/searchview.taf?ipid=83785
263,BC010892-07,"October 01, 2013 -  September 30, 2014",Characterization of the interaction between inflammation and cancer progression,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Seyedeh B Saleh|Jeffrey J Subleski|John R Ortaldo; PhD|Howard A Young; PhD,NULL,Syed Perwez  Hussain (Laboratory of Human Carcinogenesis),NULL,"1. Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y (2013). The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell  23, 527-40.   https://doi.org/10.1016/j.ccr.2013.03.009",https://intramural.nih.gov/search/searchview.taf?ipid=83839
264,BC010893-07,"October 01, 2013 -  September 30, 2014",Tumor models for the study of inflammation and oncogenesis,Robert  Wiltrout; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Timothy  Back|Qun  Jiang|John R Ortaldo; PhD|Anthony J Scarzello|Howard A Young; PhD,NULL,"Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Snorri S. Thorgeirsson; MD, PhD (Cellular and Molecular Biology Section)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Syed Perwez  Hussain (Laboratory of Human Carcinogenesis)",NULL,"1. Xiao Z, Jiang Q, Willette-Brown J, Xi S, Zhu F, Burkett S, Back T, Song NY, Datla M, Sun Z, Goldszmid R, Lin F, Cohoon T, Pike K, Wu X, Schrump DS, Wong KK, Young HA, Trinchieri G, Wiltrout RH, Hu Y (2013). The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. Cancer Cell  23, 527-40.   https://doi.org/10.1016/j.ccr.2013.03.009",https://intramural.nih.gov/search/searchview.taf?ipid=83840
265,BC010898-07,"October 01, 2013 -  September 30, 2014",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Lisa Ann Ridnour|Murali  Krishna; PhD,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83841
266,BC010899-07,"October 01, 2013 -  September 30, 2014",Inflammation and cancer treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Xinyi  Li|Lisa Ann Ridnour|James B Mitchell; PhD|Murali  Krishna; PhD,"Bruce  King (Department of Chemistry, Wake Forest University)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",Larry K Keefer; PhD (Chemical Biology Laboratory)|David D Roberts; PhD (Laboratory of Pathology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Basudhar D, Bharadwaj G, Cheng RY, Jain S, Shi S, Heinecke JL, Holland RJ, Ridnour LA, Caceres VM, Spadari-Bratfisch RC, Paolocci N, Velázquez-Martínez CA, Wink DA, Miranda KM (2013). Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives. J Med Chem  56, 7804-20.   https://doi.org/10.1021/jm400196q|2. Miranda KM, Wink DA (2014). Persulfides and the cellular thiol landscape. Proc Natl Acad Sci U S A  111, 7505-6.   https://doi.org/10.1073/pnas.1405665111",https://intramural.nih.gov/search/searchview.taf?ipid=83842
267,BC010910-07,"October 01, 2013 -  September 30, 2014",Genomic Rearrangements in Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Yulia  Demchenko|Peter D Aplan; MD,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|Jonathan  Keats (TGen (Translational Genomics Research Institute))",NULL,NULL,"1. Bergsagel P, Kuehl W (2014) Immunoglobulin and MYC rearrangements in multiple myeloma pathogenesis, in Chromosomal Translocations and Gene Rearrangements in Cancer. Rabbitts T, Rowley J, LeBeau M, eds., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83865
268,BC010914-07,"October 01, 2013 -  September 30, 2014",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83862
269,BC010932-07,"October 01, 2013 -  September 30, 2014",Functional and developmental T cell subsets,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Maria Letizia  Giardino Torchia,NULL,NULL,Dragana  Jankovic; PhD (NIAID),"1. Allam A, Swiecki M, Vermi W, Ashwell JD, Colonna M (2014). Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses. J Immunol  193, 871-8.   https://doi.org/10.4049/jimmunol.1302429|2. Kuka M, Ashwell JD (2013). A method for high purity sorting of rare cell subsets applied to TDC. J Immunol Methods  400-401, 111-6.   https://doi.org/10.1016/j.jim.2013.10.002|3. Kuka M, Munitic I, Giardino Torchia ML, Ashwell JD (2013). CD70 is downregulated by interaction with CD27. J Immunol  191, 2282-9.   https://doi.org/10.4049/jimmunol.1300868",https://intramural.nih.gov/search/searchview.taf?ipid=83744
270,BC010938-07,"October 01, 2013 -  September 30, 2014",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Martin  Glatz; MD|Amanda Keli Johnson|Radhika N Nakrani|Sharon M Osgood|Sheila E Phang|Amynah  Pradhan,NULL,NULL,Julia A Segre; PhD (NHGRI) |Hirsh David Komarow; MD (NIAID) |Robert A Sokolic (NHGRI) |Alexandra  Freeman (NIAID) |Yasmine  Belkaid; PhD (NIAID) |Steven M Holland; MD (NIAID),"1. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, NIH Intramural Sequencing Center Comparative Sequencing Program, Kong HH, Segre JA (2013). Topographic diversity of fungal and bacterial communities in human skin. Nature  498, 367-70.   https://doi.org/10.1038/nature12171|2. Oh J, Freeman AF, NISC Comparative Sequencing Program, Park M, Sokolic R, Candotti F, Holland SM, Segre JA, Kong HH (2013). The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res  23, 2103-14.   https://doi.org/10.1101/gr.159467.113",https://intramural.nih.gov/search/searchview.taf?ipid=83863
271,BC010939-07,"October 01, 2013 -  September 30, 2014",RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Sirisha  Chakka|Tamara L Jones,John  Weinstein (MD Anderson)|Philip L Lorenzi|Patrick  Grohar,"Lee Jay Helman; MD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Scott E Martin (NCATS),"1. Tandle AT, Kramp T, Kil WJ, Halthore A, Gehlhaus K, Shankavaram U, Tofilon PJ, Caplen NJ, Camphausen K (2013). Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation. Eur J Cancer  49, 3020-8.   https://doi.org/10.1016/j.ejca.2013.05.013",https://intramural.nih.gov/search/searchview.taf?ipid=83756
272,BC010940-07,"October 01, 2013 -  September 30, 2014",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Sharon M Osgood|Amynah  Pradhan,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83861
273,BC010944-07,"October 01, 2013 -  September 30, 2014",Strategies for Cancer Vaccine Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Romaine Ingrid Fernando|Sofia Ribeiro Gameiro|Duane Howard Hamilton|Peter Sungwhan Kim; PhD|Curtis  Randolph|Kwong Yok Tsang|Show all 10,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|Helen B Sabzevari|James  Breitmeyer (BN ImmunoTherapeutics)|Timothy  Rodell (GlobeImmune)",NULL,NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines (Chapter 20), in Cancer Immunotherapy: Immune Suppression and Tumor Growth, 2nd Edition. Prendergast G, Jaffee E, eds., pp. 309-332.|2. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors (Chapter 22), in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation, 3rd Edition. Lattime E, Gerson SL, eds., pp. 315-334.|3. Hamilton DH, Litzinger MT, Jales A, Huang B, Fernando RI, Hodge JW, Ardiani A, Apelian D, Schlom J, Palena C (2013) Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget 4:1777-90|4. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013). Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol  190, 6250-8.   https://doi.org/10.4049/jimmunol.1300022|5. Huen NY, Pang AL, Tucker JA, Lee TL, Vergati M, Jochems C, Intrivici C, Cereda V, Chan WY, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY (2013). Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer  133, 373-82.   https://doi.org/10.1002/ijc.28026|6. Schlom J, Jochems C, Gulley JL, Huang J (2013). The role of soluble CD40L in immunosuppression. Oncoimmunology  2, e22546.   https://doi.org/10.4161/onci.22546|7. Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW (2013). Inhibition of TGF-β1 signaling promotes central memory T cell differentiation. J Immunol  191, 2299-307.   https://doi.org/10.4049/jimmunol.1300472",https://intramural.nih.gov/search/searchview.taf?ipid=83797
274,BC010945-07,"October 01, 2013 -  September 30, 2014",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Geraldine Helen O'Sullivan Coyne; MD|Bonnie Harpreet Singh; MD|Jennifer L Marte|Sheri A Mcmahon|Myrna B Rauckhorst|William D Figg; PharmD|Show all 7,"Robert  DiPaola (The Cancer Institute of New Jersey)|William  Carson (Molecular Virology, Immunology and Medical Genetics, Ohio State University)|Nuhad  Ibrahim (MD Anderson Cancer Center)|Douglas  McNeel (University of Wisconsin)|Walter  Stadler (University of Chicago)|Jeannie  Giacchino (Bavarian Nordic Immunotherapeutics)",William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Aradhana  Kaushal (Radiation Oncology Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|William Laurence Dahut; MD (Office Of The Clinical Director),NULL,"1. Bilusic M, Madan R, Gulley J (2013) Issues in pre-clinical models, clinical trial design and analytical considerations in developing and evaluating novel cancer immunotherapies, in Cancer Immunotherapy: Paradigms, Practice and Promise. Curiel T, ed., pp. 455-474.|2. Singh N, Hodge J, Madan R, Gulley J (2013) Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing, in The Tumor Immunoenvironment. Shurin M, Umansky V, Malyguine A, eds., pp. 621-642, Chapter 27.|3. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013). Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol  190, 6250-8.   https://doi.org/10.4049/jimmunol.1300022|4. Madan RA, Gulley JL, Kantoff PW (2013). Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies. Cancer J  19, 50-8.   https://doi.org/10.1097/PPO.0b013e31828160a9|5. Roselli M, Cereda V, di Bari MG, Formica V, Spila A, Jochems C, Farsaci B, Donahue R, Gulley JL, Schlom J, Guadagni F (2013). Effects of conventional therapeutic interventions on the number and function of regulatory T cells. Oncoimmunology  2, e27025.   https://doi.org/10.4161/onci.27025|6. Singh N, Madan RA, Gulley JL (2013). Ipilimumab  in prostate cancer. Expert Opin Biol Ther  13, 303-13.   https://doi.org/10.1517/14712598.2012.754421",https://intramural.nih.gov/search/searchview.taf?ipid=83780
275,BC010946-07,"October 01, 2013 -  September 30, 2014",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Anastasia L Sowers|Angela  Thetford|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83885
276,BC010954-07,"October 01, 2013 -  September 30, 2014",Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Devikala  Gurusamy|Jennifer Lynne Shoe|Katherine  Stagliano|Joost J Oppenheim; MD,NULL,Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83851
277,BC010955-07,"October 01, 2013 -  September 30, 2014",The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity,Arthur A Hurwitz,NULL,"Laboratory of Molecular Immunoregulation, NCI",Steven Martin Cuss|Devikala  Gurusamy|Jennifer Lynne Shoe|Katherine  Stagliano|Ziqiang  Zhu,Vincenzo  Bronte|Mary Jo  Turk (Dartmouth Medical School)|Viktor  Umansky (DKFZ),Lionel  Feigenbaum (Office of the Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,"1. Hurwitz AA, Cuss SM, Stagliano KE, Zhu Z (2014). T cell avidity and tumor immunity: problems and solutions. Cancer Microenviron  7, 1-9.   https://doi.org/10.1007/s12307-013-0143-1",https://intramural.nih.gov/search/searchview.taf?ipid=83850
278,BC010956-07,"October 01, 2013 -  September 30, 2014",EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Xu  Feng; PhD|Michael C Lu|Yoichi  Ogawa|Takeshi  Ouchi; MD|Chuanjin  Wu|Gaku  Nakato,"Daniel M Kaplan|Frank  Costanti (Columbia University Medical Center)|Nicholas  Greene (Institute of Child Health, UCL)",Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory),Maria Irene Morasso; PhD (NIAMS),"1. Wu CJ, Mannan P, Lu M, Udey MC (2013). Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions. J Biol Chem  288, 12253-68.   https://doi.org/10.1074/jbc.M113.457499",https://intramural.nih.gov/search/searchview.taf?ipid=83826
279,BC010957-07,"October 01, 2013 -  September 30, 2014",Transplant Models,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,Michael  Eckhaus; DVM (OD),"1. Bodogai M, Lee Chang C, Wejksza K, Lai J, Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C, Biragyn A (2013). Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res  73, 2127-38.   https://doi.org/10.1158/0008-5472.CAN-12-4184|2. Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN (2013). B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res  19, 2048-60.   https://doi.org/10.1158/1078-0432.CCR-12-2422|3. Farthing DE, Buxbaum NP, Bare CV, Treadwell SM, Kapoor V, Williams KM, Gress RE (2013). Sensitive GC-MS/MS method to measure deuterium labeled deoxyadenosine in DNA from limited mouse cell populations. Anal Chem  85, 4613-20.   https://doi.org/10.1021/ac400309d|4. Gress RE, Miller JS, Battiwalla M, Bishop MR, Giralt SA, Hardy NM, Kröger N, Wayne AS, Landau DA, Wu CJ (2013). Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of relapse after transplantation. Biol Blood Marrow Transplant  19, 1537-45.   https://doi.org/10.1016/j.bbmt.2013.08.010|5. Williams JA, Zhang J, Jeon H, Nitta T, Ohigashi I, Klug D, Kruhlak MJ, Choudhury B, Sharrow SO, Granger L, Adams A, Eckhaus MA, Jenkinson SR, Richie ER, Gress RE, Takahama Y, Hodes RJ (2014). Thymic medullary epithelium and thymocyte self-tolerance require cooperation between CD28-CD80/86 and CD40-CD40L costimulatory pathways. J Immunol  192, 630-40.   https://doi.org/10.4049/jimmunol.1302550",https://intramural.nih.gov/search/searchview.taf?ipid=83778
280,BC010958-07,"October 01, 2013 -  September 30, 2014","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Hee Jun  Cho; PhD|Yoo-Seok  Hwang|Kathleen T Soria|Jaeho  Yoon; PhD,Herbert  Steinbeisser (University of Heidelberg)|Sally  Moody (George Washington University Medical Center)|Helene  Cousin (University of Massachusetts - Amherst)|Hyun-Shik  Lee,NULL,NULL,"1. Hwang YS, Lee HS, Kamata T, Mood K, Cho HJ, Winterbottom E, Ji YJ, Singh A, Daar IO (2013). The Smurf ubiquitin ligases regulate tissue separation via antagonistic interactions with ephrinB1. Genes Dev  27, 491-503.   https://doi.org/10.1101/gad.208355.112|2. Klein SL, Neilson KM, Orban J, Yaklichkin S, Hoffbauer J, Mood K, Daar IO, Moody SA (2013). Conserved structural domains in FoxD4L1, a neural forkhead box transcription factor, are required to repress or activate target genes. PLoS One  8, e61845.   https://doi.org/10.1371/journal.pone.0061845|3. Singh A, Winterbottom EF, Ji YJ, Hwang YS, Daar IO (2013). Abelson interactor 1 (ABI1) and its interaction with Wiskott-Aldrich syndrome protein (wasp) are critical for proper eye formation in Xenopus embryos. J Biol Chem  288, 14135-46.   https://doi.org/10.1074/jbc.M112.445643",https://intramural.nih.gov/search/searchview.taf?ipid=83757
281,BC010959-07,"October 01, 2013 -  September 30, 2014",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Andre  Stanlie,NULL,NULL,NULL,"1. Barlow JH, Nussenzweig A (2014). Replication initiation and genome instability: a crossroads for DNA and RNA synthesis. Cell Mol Life Sci  71, 4545-59.   https://doi.org/10.1007/s00018-014-1721-1|2. Wessendorf P, Vijg J, Nussenzweig A, Digweed M (2014). Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo. Mutat Res  769, 11-6.   https://doi.org/10.1016/j.mrfmmm.2014.07.001",https://intramural.nih.gov/search/searchview.taf?ipid=83892
282,BC010960-07,"October 01, 2013 -  September 30, 2014",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Foglietta M, Neelapu SS, Kwak LW, Jiang Y, Nattamai D, Lee ST, Fowler DH, Sportes C, Gress RE, Steinberg SM, Vence LM, Radvanyi L, Dwyer KC, Qazilbash MH, Bryant RN, Bishop MR (2013). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplant  48, 269-77.   https://doi.org/10.1038/bmt.2012.132",https://intramural.nih.gov/search/searchview.taf?ipid=83779
283,BC010970-07,"October 01, 2013 -  September 30, 2014",The connection of innate and adaptive anti-cancer immunity,John  Greiner; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Garland M Davis|Jonathan Kroemer Fallon; PhD|Bertina L Gibbs|Amanda Jayne Lyon; PhD|James W Hodge; PhD|Show all 9,Helen B Sabzevari|James  Breitmeyer (BN ImmunoTherapeutics)|Timothy  Rodell (GlobeImmune),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL (2014). Therapeutic cancer vaccines. Adv Cancer Res  121, 67-124.   https://doi.org/10.1016/B978-0-12-800249-0.00002-0|2. Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW (2013). Inhibition of TGF-β1 signaling promotes central memory T cell differentiation. J Immunol  191, 2299-307.   https://doi.org/10.4049/jimmunol.1300472",https://intramural.nih.gov/search/searchview.taf?ipid=83776
284,BC010972-07,"October 01, 2013 -  September 30, 2014",Identification of human tumor-associated antigens,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Benjamin  Boyerinas|Caroline Mikaela Maria Jochems; PhD|Diane J Poole|Claudia Mercedes Palena|James W Hodge; PhD|Christopher Ryan Heery; MD,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|James  Breitmeyer (BN ImmunoTherapeutics)|Timothy  Rodell (GlobeImmune)|Helen B Sabzevari","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Schlom J, Palena C, Gulley J, Greiner J, Tsang K, Madan R, Hodge J (2013) The use of T-cell costimulation to enhance the immunogenicity of tumors, in Gene Therapy of Cancer: Translational Approaches from Preclinical Studies to Clinical Implementation. Lattime E, Gerson SL, eds., in press.|3. Bilusic M, Heery CR, Arlen PM, Rauckhorst M, Apelian D, Tsang KY, Tucker JA, Jochems C, Schlom J, Gulley JL, Madan RA (2014). Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma. Cancer Immunol Immunother  63, 225-34.   https://doi.org/10.1007/s00262-013-1505-8|4. Donahue RN, Duncan BB, Fry TJ, Jones B, Bachovchin WW, Kiritsy CP, Lai JH, Wu W, Zhao P, Liu Y, Tsang KY, Hodge JW (2014). A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing: implications for combination therapy with cancer vaccines. Vaccine  32, 3223-31.   https://doi.org/10.1016/j.vaccine.2014.04.008|5. Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW (2014). Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget  5, 403-16.   https://doi.org/10.18632/oncotarget.1719|6. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|7. Hodge JW, Garnett CT, Farsaci B, Palena C, Tsang KY, Ferrone S, Gameiro SR (2013). Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death. Int J Cancer  133, 624-36.   https://doi.org/10.1002/ijc.28070|8. Huang J, Jochems C, Anderson AM, Talaie T, Jales A, Madan RA, Hodge JW, Tsang KY, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J (2013). Soluble CD27-pool in humans may contribute to T cell activation and tumor immunity. J Immunol  190, 6250-8.   https://doi.org/10.4049/jimmunol.1300022|9. Madan RA, Tsang KY, Bilusic M, Vergati M, Poole DJ, Jochems C, Tucker JA, Schlom J, Giaccone G, Gulley JL (2013). Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer. Oncologist  18, 821-2.   https://doi.org/10.1634/theoncologist.2013-0199|10. Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL (2014). Therapeutic cancer vaccines. Adv Cancer Res  121, 67-124.   https://doi.org/10.1016/B978-0-12-800249-0.00002-0",https://intramural.nih.gov/search/searchview.taf?ipid=83824
285,BC010973-07,"October 01, 2013 -  September 30, 2014",Analyses of human T regulatory cells,Kwong Yok Tsang,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Benjamin  Boyerinas|Caroline Mikaela Maria Jochems; PhD|Diane J Poole|James W Hodge; PhD|Claudia Mercedes Palena|Christopher Ryan Heery; MD,"James  Breitmeyer (BN ImmunoTherapeutics)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Timothy  Rodell (GlobeImmune)|Mario  Roselli (Oncology, Tor Vergata)|Helen B Sabzevari","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)",NULL,"1. Schlom J, Hodge J, Palena C, Greiner J, Tsang K, Farsaci B, Madan R, Gulley J (2013) Recombinant TRICOM-based therapeutic cancer vaccines: lessons learned, in Cancer Immunotherapy. Prendergast G, Jaffee E, eds., in press.|2. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|3. Huen NY, Pang AL, Tucker JA, Lee TL, Vergati M, Jochems C, Intrivici C, Cereda V, Chan WY, Rennert OM, Madan RA, Gulley JL, Schlom J, Tsang KY (2013). Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer. Int J Cancer  133, 373-82.   https://doi.org/10.1002/ijc.28026|4. Schlom J, Hodge JW, Palena C, Tsang KY, Jochems C, Greiner JW, Farsaci B, Madan RA, Heery CR, Gulley JL (2014). Therapeutic cancer vaccines. Adv Cancer Res  121, 67-124.   https://doi.org/10.1016/B978-0-12-800249-0.00002-0|5. Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW (2013). Inhibition of TGF-β1 signaling promotes central memory T cell differentiation. J Immunol  191, 2299-307.   https://doi.org/10.4049/jimmunol.1300472",https://intramural.nih.gov/search/searchview.taf?ipid=83825
286,BC010975-07,"October 01, 2013 -  September 30, 2014",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Jeffrey  Schlom; PhD,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),Bradford J Wood; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83848
287,BC010976-07,"October 01, 2013 -  September 30, 2014",Role of MFG-E8 in Tumor Biology and Immunophysiology,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu,George  Hajishengallis (University of Pennsylvanis School of Dental Medicine)|Seiichiro  Motegi (Gunma University School of Medicine)|Harvey  Florman (Universty of Massachusetts Medical School)|Nicholas  Marsh-Armstrong (Johns Hopkins University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83827
288,BC010977-07,"October 01, 2013 -  September 30, 2014",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Mariya Sergeyevna Liyasova; PhD|Ke  Ma|Marion M Nau,Marcus Ramsay Clark|Jian  Zhang (University of Chicago),"Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Barry R O'Keefe (Molecular Targets Laboratory)",Anna  Panchenko; PhD (NLM),"1. Ma K, Kales S, Lipkowitz S (2013) Cbl as a master regulator of RTK trafficking, in Vesicle trafficking and cancer. Yarden Y, Tarcic G, eds., pp. 219-244.|2. Wedam S, Lipkowitz S (2013) HER-2 as a prognostic and predictive biomarker in cancer, in Handbook of therapuetic biomarkers in cancer. Yang S, Dancey J, eds., pp. 77-120.",https://intramural.nih.gov/search/searchview.taf?ipid=83875
289,BC010982-07,"October 01, 2013 -  September 30, 2014",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Subhadip  Kundu|Rachel  Pierce|Paul S Meltzer; MD, PhD",Donald  Small (Johns Hopkins University School of Medicine)|Steven  Nimer (MSKCC)|Trang  Hoang (U. Montreal)|Shai  Izraeli (Sheba University),Linda  Wolff; PhD (Laboratory of Cellular Oncology)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,"1. Bailey EJ, Duffield AS, Greenblatt SM, Aplan PD, Small D (2013). Effect of FLT3 ligand on survival and disease phenotype in murine models harboring a FLT3 internal tandem duplication mutation. Comp Med  63, 218-26.|2. Goldberg L, Tijssen MR, Birger Y, Hannah RL, Kinston SJ, Schütte J, Beck D, Knezevic K, Schiby G, Jacob-Hirsch J, Biran A, Kloog Y, Marcucci G, Bloomfield CD, Aplan PD, Pimanda JE, Göttgens B, Izraeli S (2013). Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia. Blood  122, 2694-703.   https://doi.org/10.1182/blood-2013-01-477133|3. Gough SM, Lee F, Yang F, Walker RL, Zhu YJ, Pineda M, Onozawa M, Chung YJ, Bilke S, Wagner EK, Denu JM, Ning Y, Xu B, Wang GG, Meltzer PS, Aplan PD (2014). NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function. Cancer Discov  4, 564-77.   https://doi.org/10.1158/2159-8290.CD-13-0419|4. Lacombe J, Krosl G, Tremblay M, Gerby B, Martin R, Aplan PD, Lemieux S, Hoang T (2013). Genetic interaction between Kit and Scl. Blood  122, 1150-61.   https://doi.org/10.1182/blood-2011-01-331819",https://intramural.nih.gov/search/searchview.taf?ipid=83742
290,BC010983-07,"October 01, 2013 -  September 30, 2014",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Eun Sil  Park,Steven  Nimer (MSKCC)|JP  Issa (MD Anderson)|Chris  Slape (Monash University),Terry J Fry (Pediatric Oncology Branch),NULL,"1. Gough SM, Lee F, Yang F, Walker RL, Zhu YJ, Pineda M, Onozawa M, Chung YJ, Bilke S, Wagner EK, Denu JM, Ning Y, Xu B, Wang GG, Meltzer PS, Aplan PD (2014). NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function. Cancer Discov  4, 564-77.   https://doi.org/10.1158/2159-8290.CD-13-0419",https://intramural.nih.gov/search/searchview.taf?ipid=83743
291,BC010984-07,"October 01, 2013 -  September 30, 2014",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Alena - Gros; PhD|Lien T Ngo|Mary Ann  Toomey|Mojgan  Ahmadzadeh|Anna  Pasetto; PhD|Eric  Tran|Show all 13,NULL,NULL,NULL,"1. Rosenberg SA (2014). Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment. Nat Rev Clin Oncol  11, 630-2.   https://doi.org/10.1038/nrclinonc.2014.174|2. Turcotte S, Gros A, Hogan K, Tran E, Hinrichs CS, Wunderlich JR, Dudley ME, Rosenberg SA (2013). Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy. J Immunol  191, 2217-25.   https://doi.org/10.4049/jimmunol.1300538",https://intramural.nih.gov/search/searchview.taf?ipid=83795
292,BC010985-07,"October 01, 2013 -  September 30, 2014",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Lien T Ngo|Mary Ann  Toomey|Drew Caldwell Deniger; PhD|Eric  Tran|Richard  Sherry; MD|Udai S Kammula|Show all 8,NULL,NULL,NULL,"1. Abate-Daga D, Hanada K, Davis JL, Yang JC, Rosenberg SA, Morgan RA (2013). Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes. Blood  122, 1399-410.   https://doi.org/10.1182/blood-2013-04-495531|2. Beard RE, Abate-Daga D, Rosati SF, Zheng Z, Wunderlich JR, Rosenberg SA, Morgan RA (2013). Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy. Clin Cancer Res  19, 4941-50.   https://doi.org/10.1158/1078-0432.CCR-13-1253|3. Casati A, Varghaei-Nahvi A, Feldman SA, Assenmacher M, Rosenberg SA, Dudley ME, Scheffold A (2013). Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients. Cancer Immunol Immunother  62, 1563-73.   https://doi.org/10.1007/s00262-013-1459-x|4. Kerkar SP, Leonardi AJ, van Panhuys N, Zhang L, Yu Z, Crompton JG, Pan JH, Palmer DC, Morgan RA, Rosenberg SA, Restifo NP (2013). Collapse of the tumor stroma is triggered by IL-12 induction of Fas. Mol Ther  21, 1369-77.   https://doi.org/10.1038/mt.2013.58|5. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath A, Wang T, Bielekova B, Wuest SC, Akula N, et al. [6 more authors] (2013). Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother  36, 133-51.   https://doi.org/10.1097/CJI.0b013e3182829903|6. Robbins PF, Kassim SH, Tran TL, Crystal JS, Morgan RA, Feldman SA, Yang JC, Dudley ME, Wunderlich JR, Sherry RM, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CC, Li YF, El-Gamil M, Rosenberg SA (2015). A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clin Cancer Res  21, 1019-27.   https://doi.org/10.1158/1078-0432.CCR-14-2708|7. Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, Samuels Y, Rosenberg SA (2013). Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med  19, 747-52.   https://doi.org/10.1038/nm.3161|8. Hinrichs CS, Rosenberg SS (submitted in 2013) Anti-human Papillomavirus 16 E6 T Cell Receptors. Patent issued: 9,822,162 (US in 2018). Patents pending: 201480044286.1 (CN application); 14748353.1 (EP application); 2016-527006 (JP application); PCT/US2014/046480 (PC application); 15/786,966 (US application); 2014290288 (AU application); 2918216 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=83794
293,BC010992-07,"October 01, 2013 -  September 30, 2014",Fidelity of Transcription,Jeffrey N Strathern,NULL,"Genome Recombination and Regulation Section, NCI",NULL,"Zachory  Burton (Biochemistry and Molecular Biology, Michigan State University)|Maria  Kilfoil (U Mass Amherst)|Marc  Vermulst (GENOME RECOMBINATION & REGULATION SECTION)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory)|Donald L Court; PhD (Molecular Control and Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83819
294,BC010998-07,"October 01, 2013 -  September 30, 2014",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD|Carol J Thiele|Chand  Khanna; MD,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|David  Azorsa (NHGRI)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Show all 7","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen J Chanock; MD, PhD (Office of the Director)",James G Taylor; MD (NHLBI),"1. Abdul-Karim R, Berkman BE, Wendler D, Rid A, Khan J, Badgett T, Hull SC (2013). Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics  131, 564-71.   https://doi.org/10.1542/peds.2012-0084|2. Li SQ, Cheuk AT, Shern JF, Song YK, Hurd L, Liao H, Wei JS, Khan J (2013). Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS One  8, e76551.   https://doi.org/10.1371/journal.pone.0076551|3. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, et al. [35 more authors] (2013). The genetic landscape of high-risk neuroblastoma. Nat Genet  45, 279-84.   https://doi.org/10.1038/ng.2529|4. Shah N, Wang J, Selich-Anderson J, Graham G, Siddiqui H, Li X, Khan J, Toretsky J (2014). PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma. Clin Cancer Res  20, 4400-12.   https://doi.org/10.1158/1078-0432.CCR-13-1486",https://intramural.nih.gov/search/searchview.taf?ipid=83857
295,BC010999-07,"October 01, 2013 -  September 30, 2014","Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma",Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sivasubramanian  Baskar|Nityashree  Shivaprasad|Marielle Elizabeth Yohe|Chand  Khanna; MD,NULL,"Stephen J Chanock; MD, PhD (Office of the Director)",James G Taylor; MD (NHLBI),"1. Li SQ, Cheuk AT, Shern JF, Song YK, Hurd L, Liao H, Wei JS, Khan J (2013). Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534). PLoS One  8, e76551.   https://doi.org/10.1371/journal.pone.0076551|2. Patel PR, Sun H, Li SQ, Shen M, Khan J, Thomas CJ, Davis MI (2013). Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorg Med Chem Lett  23, 4398-403.   https://doi.org/10.1016/j.bmcl.2013.05.072|3. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene  32, 5429-38.   https://doi.org/10.1038/onc.2012.590",https://intramural.nih.gov/search/searchview.taf?ipid=83858
296,BC011002-07,"October 01, 2013 -  September 30, 2014",BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Wen-I  Chang; MD|Li  Chen|Berkley Eric Gryder|Jianbin Na He|Rajesh  Patidar|Sivasish  Sindiri|Show all 10,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Jason  Shohet (Baylor College of Medicine)|Jeffrey  Trent (TGen)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Wei JS, Johansson P, Chen L, Song YK, Tolman C, Li S, Hurd L, Patidar R, Wen X, Badgett TC, Cheuk AT, Marshall JC, Steeg PS, Vaqué Díez JP, Yu Y, Gutkind JS, Khan J (2013). Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma. PLoS One  8, e77731.   https://doi.org/10.1371/journal.pone.0077731",https://intramural.nih.gov/search/searchview.taf?ipid=83856
297,BC011006-07,"October 01, 2013 -  September 30, 2014",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",NULL,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 10,"Elaine S Jaffe; MD (Laboratory of Pathology)|Wenming  Xiao; PhD (Lymphoid Malignancies Branch)|George W Wright (Biometrics Research Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Stefania  Pittaluga (Laboratory of Pathology)",John I Powell (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83812
298,BC011007-07,"October 01, 2013 -  September 30, 2014",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",James Daniel Phelan|Arthur L Shaffer|Wenming  Xiao; PhD|Yandan  Yang; PhD|Yibin  Yang|Xin H Yu|Show all 7,NULL,George W Wright (Biometrics Research Branch),John I Powell (CIT),"1. Lamy L, Ngo VN, Emre NC, Shaffer AL, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, Staudt LM (2013). Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell  23, 435-49.   https://doi.org/10.1016/j.ccr.2013.02.017",https://intramural.nih.gov/search/searchview.taf?ipid=83813
299,BC011008-07,"October 01, 2013 -  September 30, 2014",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",NULL,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 12,"Elaine S Jaffe; MD (Laboratory of Pathology)|Wenming  Xiao; PhD (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stefania  Pittaluga (Laboratory of Pathology)|George W Wright (Biometrics Research Branch)",John I Powell (CIT),"1. Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM (2013). Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma. Proc Natl Acad Sci U S A  110, 3943-8.   https://doi.org/10.1073/pnas.1217271110|2. Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM (2014). Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med  4.   https://doi.org/10.1101/cshperspect.a014282|3. Staudt L, Bernal F, Yang Y (submitted in 2013) Inhibitors Of The Linear Ubiquitin Chain Assembly Complex (lubac) And Related Methods. Patent issued: 9,783,586 (US in 2018). Patent pending: PCT/US2014/023006 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=83810
300,BC011010-07,"October 01, 2013 -  September 30, 2014",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Weihong  Xu|Yandan  Yang; PhD,NULL,Ola Anders Landgren (Lymphoid Malignancies Branch),NULL,"1. Lamy L, Ngo VN, Emre NC, Shaffer AL, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, Staudt LM (2013). Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell  23, 435-49.   https://doi.org/10.1016/j.ccr.2013.02.017",https://intramural.nih.gov/search/searchview.taf?ipid=83811
301,BC011011-07,"October 01, 2013 -  September 30, 2014",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Laura  Baranello|Fedor Edmundovich Kouzine|Suzanne Laurie Sanford,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83869
302,BC011017-07,"October 01, 2013 -  September 30, 2014",The study of underlying mechanism of EGFR-Ras signaling in glioblastoma,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Debra J Gilbert|Theresa N O'Sullivan|Yurong  Song; PhD,NULL,NULL,NULL,"1. Song Y, Zhang Q, Kutlu B, Difilippantonio S, Bash R, Gilbert D, Yin C, O'Sullivan TN, Yang C, Kozlov S, Bullitt E, McCarthy KD, Kafri T, Louis DN, Miller CR, Hood L, Van Dyke T (2013). Evolutionary etiology of high-grade astrocytomas. Proc Natl Acad Sci U S A  110, 17933-8.   https://doi.org/10.1073/pnas.1317026110",https://intramural.nih.gov/search/searchview.taf?ipid=83829
303,BC011028-07,"October 01, 2013 -  September 30, 2014",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)","1. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM (2014). Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol  11, 465-75.   https://doi.org/10.1038/nrurol.2014.162|2. Linehan WM, Ricketts CJ (2014) Decade in review-kidney cancer: discoveries, therapies and opportunities. Nat Rev Urol 11:614-6",https://intramural.nih.gov/search/searchview.taf?ipid=83873
304,BC011031-07,"October 01, 2013 -  September 30, 2014",Cancer stem cells and human liver cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI",Jesper B Andersen; PhD|Marian E Durkin|Valentina  Factor|Tanya N Hoang|Kosuke  Kaji|Jens Uwe Marquardt|Show all 8,"Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)|Jens Uwe Marquardt","Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Holczbauer Á, Factor VM, Andersen JB, Marquardt JU, Kleiner DE, Raggi C, Kitade M, Seo D, Akita H, Durkin ME, Thorgeirsson SS (2013). Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology  145, 221-231.   https://doi.org/10.1053/j.gastro.2013.03.013|2. Kitade M, Factor VM, Andersen JB, Tomokuni A, Kaji K, Akita H, Holczbauer A, Seo D, Marquardt JU, Conner EA, Lee SB, Lee YH, Thorgeirsson SS (2013). Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling. Genes Dev  27, 1706-17.   https://doi.org/10.1101/gad.214601.113|3. Marquardt JU, Thorgeirsson SS (2013). Sall4 in ""stemness""-driven hepatocarcinogenesis. N Engl J Med  368, 2316-8.   https://doi.org/10.1056/NEJMe1303026|4. Marquardt JU, Thorgeirsson SS (2014). SnapShot: Hepatocellular carcinoma. Cancer Cell  25, 550.e1.   https://doi.org/10.1016/j.ccr.2014.04.002|5. Raggi C, Factor VM, Seo D, Holczbauer A, Gillen MC, Marquardt JU, Andersen JB, Durkin M, Thorgeirsson SS (2014). Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology  59, 2251-62.   https://doi.org/10.1002/hep.27026|6. Xin HW, Ambe CM, Ray S, Kim BK, Koizumi T, Wiegand GW, Hari D, Mullinax JE, Jaiswal KR, Garfield SH, Stojadinovic A, Rudloff U, Thorgeirsson SS, Avital I (2013). Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division. J Cancer  4, 447-57.   https://doi.org/10.7150/jca.6896",https://intramural.nih.gov/search/searchview.taf?ipid=83822
305,BC011032-07,"October 01, 2013 -  September 30, 2014",Post-translational modifications of Hsp90 that impact drug efficacy,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Toshiki  Kijima|Chengyuan  Li|Michael Anthony Moses|Thomas L Prince|Harvey Grant Schwartz|Show all 10,"Brian  Blagg (Chemistry, University of Kansas)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Nicolas  Winssinger (University of Strassbourg)|Gabriela X Chiosis|Show all 11",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)|Jane Beth Trepel (Developmental Therapeutics Branch),NULL,"1. Beebe K, Mollapour M, Scroggins B, Prodromou C, Xu W, Tokita M, Taldone T, Pullen L, Zierer BK, Lee MJ, Trepel J, Buchner J, Bolon D, Chiosis G, Neckers L (2013). Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors. Oncotarget  4, 1065-74.   https://doi.org/10.18632/oncotarget.1099",https://intramural.nih.gov/search/searchview.taf?ipid=83891
306,BC011033-07,"October 01, 2013 -  September 30, 2014",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI),Lionel  Feigenbaum (Office of the Director),NULL,"1. Bosch B, Berger AC, Khandelwal S, Heipertz EL, Scharf B, Santambrogio L, Roche PA (2013). Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells. J Biol Chem  288, 24286-92.   https://doi.org/10.1074/jbc.M113.461996|2. Bosch B, Heipertz EL, Drake JR, Roche PA (2013). Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters. J Biol Chem  288, 13236-42.   https://doi.org/10.1074/jbc.M112.442640",https://intramural.nih.gov/search/searchview.taf?ipid=83792
307,BC011035-07,"October 01, 2013 -  September 30, 2014",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Lionel  Feigenbaum (Office of the Director),Katherine Walton Roche; PhD (NINDS),"1. Karim ZA, Zhang J, Banerjee M, Chicka MC, Al Hawas R, Hamilton TR, Roche PA, Whiteheart SW (2013). IκB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood  121, 4567-74.   https://doi.org/10.1182/blood-2012-11-470468",https://intramural.nih.gov/search/searchview.taf?ipid=83791
308,BC011037-07,"October 01, 2013 -  September 30, 2014",Developing new immunotherapies based of CD4+ T cells,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83786
309,BC011038-07,"October 01, 2013 -  September 30, 2014",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|James  McMahon; PhD (Molecular Targets Laboratory),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Bradford J Wood; MD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83874
310,BC011043-07,"October 01, 2013 -  September 30, 2014",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Leonard  Neckers; PhD|Donald P Bottaro; PhD,Yoshihiko  Kakinuma (Kochi Medical School)|Junichi  Sadoshima (UMDNJ),Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program)|Serguei V Kozlov (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83870
311,BC011053-07,"October 01, 2013 -  September 30, 2014",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83855
312,BC011054-07,"October 01, 2013 -  September 30, 2014",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Kristen Paige Bunch|Anna Maartje Aalbers|Carrie D House|Marianne K-H Kim,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Natasha  Caplen (Cancer Genetics Branch)|Elise C Kohn; MD (Clinical Investigations Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83741
313,BC011055-07,"October 01, 2013 -  September 30, 2014",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Whitney Shea Wright|Li  Xia|Saddam Musleh Muthana; PhD,Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases)|Elizabeth M Jaffee,"Lisa  Mcshane (Biometrics Research Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Mei-Yin Chen Polley; PhD (Biometrics Research Branch)",NULL,"1. Campbell CT, Gulley JL, Oyelaran O, Hodge JW, Schlom J, Gildersleeve JC (2013). Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clin Cancer Res  19, 1290-9.   https://doi.org/10.1158/1078-0432.CCR-12-2478|2. Campbell CT, Llewellyn SR, Demberg T, Damberg T, Morgan IL, Robert-Guroff M, Gildersleeve JC (2013). High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge. PLoS One  8, e75302.   https://doi.org/10.1371/journal.pone.0075302|3. Yin Z, Comellas-Aragones M, Chowdhury S, Bentley P, Kaczanowska K, Benmohamed L, Gildersleeve JC, Finn MG, Huang X (2013). Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids. ACS Chem Biol  8, 1253-62.   https://doi.org/10.1021/cb400060x",https://intramural.nih.gov/search/searchview.taf?ipid=83775
314,BC011056-07,"October 01, 2013 -  September 30, 2014",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Laboratory of Experimental Immunology, NCI",Poonam  Tewary,"William  Murphy (University of Nevada)|Hideo  Yagita (Immunology, Juntendo University)|Avi  Ashkenazi (Genentech, Inc.)|Noako  Seki (Kurume University)|Neil  Cross (Sheffield Hallam University)|Brian  Blagg (Chemistry, University of Kansas)|Show all 8","James  McMahon; PhD (Molecular Targets Laboratory)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)",NULL,"1. Weiss JM, Subleski JJ, Back T, Chen X, Watkins SK, Yagita H, Sayers TJ, Murphy WJ, Wiltrout RH (2014). Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy. J Immunol  192, 5821-9.   https://doi.org/10.4049/jimmunol.1400404",https://intramural.nih.gov/search/searchview.taf?ipid=83796
315,BC011058-07,"October 01, 2013 -  September 30, 2014",Development of a Vaccine for HIVAIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Thorsten  Demberg|Janet M Dipasquale|Evin Samuel Feldman|Leia Kaye Miller; PhD|Venkatramanan  Mohanram; PhD|Thomas Anthony Musich; PhD|Show all 14,"Susan  Barnett (Chiron Corporation)|Ruth  Ruprecht (Dana Farber Cancer Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Timothy  Fouts (Profectus BioSciences, Inc.)|David C Montefiori; PhD (Department of Surgery, NIAID)|Qingsheng  Li (University of Nebraska Lincoln)|Show all 11",David J Venzon; PhD (Biostatistics and Data Management Section)|Jacob D Estes (Office Of The Director),NULL,"1. Demberg T, Brocca-Cofano E, Kuate S, Aladi S, Vargas-Inchaustegui DA, Venzon D, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, DiPasquale J, Ruprecht RM, Montefiori DC, Srivastava I, Barnett SW, Robert-Guroff M (2013). Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques. Virology  440, 210-21.   https://doi.org/10.1016/j.virol.2013.02.024|2. Vaccari M, Halwani R, Patterson LJ, Boasso A, Beal J, Tryniszewska E, Hryniewicz A, Venzon D, Haddad EK, El-Far M, Rosati M, Pavlakis GN, Felber BK, Al-Muhsen S, Robert-Guroff M, Sekaly RP, Franchini G (2013). Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS. J Virol  87, 3526-37.   https://doi.org/10.1128/JVI.02686-12",https://intramural.nih.gov/search/searchview.taf?ipid=83789
316,BC011061-07,"October 01, 2013 -  September 30, 2014",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Center for Cancer Research Nanobiology Program, NCI",Kirill Andreevich Afonin|Eckart  Bindewald|Kshitij  Gupta|Kazimierz Wojcieck Kasprzak|Hugo Murua Martinez; PhD,"Hugo  Martinez (Consultant, SAIC)|Juan  Arroyo (Developmental Biology, Mitre Corporation)|Luc  Jaeger (University of California Santa Barbara)|Roderick  Melnik (M2Net Laboratory, Wilfrid Laurier University)|Robert L Jernigan; PhD (NCI)|Hanan  Samet (University of Maryland)|Show all 9",Yun Xing M Wang (Structural Biophysics Laboratory)|Marina A Dobrovolskaia (Office Cancer Nanotechnology Research)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Robert  Blumenthal; PhD (Basic Research Laboratory)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),Jakob  Reiser (OD),"1. Kasprzak W, Shapiro B (2013) Role of dynamics in RNA nanostructure design, in RNA Nanotechnology and Therapeutics. Guo P, Haque F, eds., pp. 139-158.|2. Afonin K, Linsay B, Shapiro B (2013) Engineered RNA nanodesigns for applications in RNA nanotechnology. RNA Nanotechnology 1:1-15|3. Afonin KA, Kasprzak W, Bindewald E, Puppala PS, Diehl AR, Hall KT, Kim TJ, Zimmermann MT, Jernigan RL, Jaeger L, Shapiro BA (2014). Computational and experimental characterization of RNA cubic nanoscaffolds. Methods  67, 256-65.   https://doi.org/10.1016/j.ymeth.2013.10.013|4. Afonin KA, Viard M, Martins AN, Lockett SJ, Maciag AE, Freed EO, Heldman E, Jaeger L, Blumenthal R, Shapiro BA (2013). Activation of different split functionalities on re-association of RNA-DNA hybrids. Nat Nanotechnol  8, 296-304.   https://doi.org/10.1038/nnano.2013.44|5. Kim T, Afonin KA, Viard M, Koyfman AY, Sparks S, Heldman E, Grinberg S, Linder C, Blumenthal RP, Shapiro BA (2013). In Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs Delivery. Mol Ther Nucleic Acids  2, e80.   https://doi.org/10.1038/mtna.2013.5",https://intramural.nih.gov/search/searchview.taf?ipid=83800
317,BC011062-07,"October 01, 2013 -  September 30, 2014",Development of a Vaccine for HIVAIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Janet M Dipasquale|Leia Kaye Miller; PhD|Iskra  Tuero; PhD|Diego Antonio Vargas-Inchaustegui; PhD|Jay Arthur Berzofsky; MD, PhD","Qingsheng  Li (University of Nebraska Lincoln)|Sol  Langermann (Amplimmune)|Susan  Barnett (Chiron Corporation)|Christopher  Miller (University of California, Davis)",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Qureshi H, Genesca M, Fritts L, McChesney M, Robert-Guroff M, Miller C (2014) Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques. PLoS One, in press.|2. Vargas-Inchaustegui DA, Robert-Guroff M (2013). Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention. Curr HIV Res  11, 407-20.   https://doi.org/10.2174/1570162x113116660063|3. Vargas-Inchaustegui DA, Xiao P, Hogg AE, Demberg T, McKinnon K, Venzon D, Brocca-Cofano E, Dipasquale J, Lee EM, Hudacik L, Pal R, Sui Y, Berzofsky JA, Liu L, Langermann S, Robert-Guroff M (2013). Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques. Virology  447, 274-84.   https://doi.org/10.1016/j.virol.2013.09.015",https://intramural.nih.gov/search/searchview.taf?ipid=83790
318,BC011063-07,"October 01, 2013 -  September 30, 2014",Development of a Vaccine for HIVAIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Janet M Dipasquale|Michael Anthony Thomas; PhD,"Robert  Gallo; MD (Institute of Human Virology, Maryland University)|Christopher  Miller (University of California, Davis)|Timothy  Fouts (Profectus BioSciences, Inc.)|Anthony L Devico; PhD (Maryland Biotechnical Center, Institute of Human Virology, University of Maryland)",NULL,Mark  Connors; MD (NIAID),"1. Qureshi H, Genesca M, Fritts L, McChesney M, Robert-Guroff M, Miller C (2014) Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques. PLoS One, in press.|2. Thomas MA, Song R, Demberg T, Vargas-Inchaustegui DA, Venzon D, Robert-Guroff M (2013). Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors. PLoS One  8, e76344.   https://doi.org/10.1371/journal.pone.0076344",https://intramural.nih.gov/search/searchview.taf?ipid=83788
319,BC011064-07,"October 01, 2013 -  September 30, 2014",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","John K Simmons|Ke  Zhang|Shuling  Zhang; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83888
320,BC011065-07,"October 01, 2013 -  September 30, 2014",Preclinical Testing of HDAC and mTOR Inhibitors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Kenneth Michael Felsenstein|John K Simmons|Nicholas Jeremy Watson|Robert Mark Simpson; DVM, PhD",NULL,Ola Anders Landgren (Lymphoid Malignancies Branch)|Natasha  Caplen (Cancer Genetics Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83889
321,BC011069-07,"October 01, 2013 -  September 30, 2014",Biology and Therapy of Lymphopenia,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Hua  Zhang,Jan  Hillert (Karolinska Institute)|David  Haussler (Howard Hughes Medical Institute)|Michael  Verneris (University of Minnesota),Ronald E Gress; MD (Experimental Transplantation and Immunology Branch),NULL,"1. Lundström W, Highfill S, Walsh ST, Beq S, Morse E, Kockum I, Alfredsson L, Olsson T, Hillert J, Mackall CL (2013). Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity. Proc Natl Acad Sci U S A  110, E1761-70.   https://doi.org/10.1073/pnas.1222303110|2. van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM (2013). Enhancing immune reconstitution: from bench to bedside. Biol Blood Marrow Transplant  19, S79-83.   https://doi.org/10.1016/j.bbmt.2012.09.016",https://intramural.nih.gov/search/searchview.taf?ipid=83877
322,BC011070-07,"October 01, 2013 -  September 30, 2014",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Shahed  Abdullah|Tapan Mahendra Bhavsar|Theresa M Davies Hill|Nancy Ellen Diener|Shunyou  Gong|Stephanie Lee Nara|Show all 14,NULL,NULL,NULL,"1. Bajor-Dattilo EB, Pittaluga S, Jaffe ES (2013). Pathobiology of T-cell and NK-cell lymphomas. Best Pract Res Clin Haematol  26, 75-87.   https://doi.org/10.1016/j.beha.2013.04.007|2. Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH (2013). Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med  368, 1408-16.   https://doi.org/10.1056/NEJMoa1214561|3. Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH (2013). Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med  369, 1915-25.   https://doi.org/10.1056/NEJMoa1308392|4. Huppmann AR, Roullet MR, Raffeld M, Jaffe ES (2013). Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol  31, e28-30.   https://doi.org/10.1200/JCO.2012.43.3797|5. Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES (2013). Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer  60, 1165-70.   https://doi.org/10.1002/pbc.24462|6. Iqbal J, Wright G, Wang C, Rosenwald A, Gascoyne RD, Weisenburger DD, Greiner TC, Smith L, Guo S, Wilcox RA, Teh BT, Lim ST, Tan SY, Rimsza LM, Jaffe ES, Campo E, Martinez A, Delabie J, Braziel RM, Cook JR, Tubbs RR, Ott G, Geissinger E, Gaulard P, Piccaluga PP, Lymphoma Leukemia Molecular Profiling Project and the International Peripheral T-cell Lymphoma Project, et al. [11 more authors] (2014). Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood  123, 2915-23.   https://doi.org/10.1182/blood-2013-11-536359|7. Jaffe ES (2013). Follicular lymphomas: a tapestry of common and contrasting threads. Haematologica  98, 1163-5.   https://doi.org/10.3324/haematol.2013.086678|8. Jaffe ES, Nicolae A, Pittaluga S (2013). Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol  26 Suppl 1, S71-87.   https://doi.org/10.1038/modpathol.2012.181|9. Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES (2013). Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall. Histopathology  63, 877-80.   https://doi.org/10.1111/his.12213|10. Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaïde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B (2014). Early lesions of follicular lymphoma: a genetic perspective. Haematologica  99, 481-8.   https://doi.org/10.3324/haematol.2013.094474|11. Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S (2014). A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology  64, 455-9.   https://doi.org/10.1111/his.12274|12. Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA (2013). Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma. J Clin Oncol  31, e53-6.   https://doi.org/10.1200/JCO.2012.43.2377|13. Mirsaeidi M, Syed F, Jaffe ES (2013) Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein - Barr virus in the Setting of HIV Infection. Infect Dis Clin Pract (Baltim Md) 21:50-53|14. Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES (2013). Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol  37, 816-26.   https://doi.org/10.1097/PAS.0b013e3182785610|15. Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, Chan WC (2013). Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood  122, 3599-606.   https://doi.org/10.1182/blood-2013-07-512830|16. Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Beà S (2013). CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood  121, 1394-402.   https://doi.org/10.1182/blood-2012-08-452284|17. Song JY, Jaffe ES (2013). HHV-8-positive but EBV-negative primary effusion lymphoma. Blood  122, 3712.   https://doi.org/10.1182/blood-2013-07-515882|18. Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, Harris NL, Pileri S, Weiss LM, International Lymphoma Study Group (2014). Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol  38, e60-71.   https://doi.org/10.1097/PAS.0000000000000295|19. Valera A, Colomo L, Martínez A, de Jong D, Balagué O, Matheu G, Martínez M, Taddesse-Heath L, Jaffe ES, Bacchi CE, Campo E (2013). ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol  26, 1329-37.   https://doi.org/10.1038/modpathol.2013.73|20. Vo P, Jaffe ES, Cook L, Ramos C, Childs R (2013). Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon. Clin Lymphoma Myeloma Leuk  13, e1-5.   https://doi.org/10.1016/j.clml.2013.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=83852
323,BC011073-07,"October 01, 2013 -  September 30, 2014",Immunobiology and Immunotherapy of Pediatric Cancer,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Sarah Abdoalatif Alsomairy|Yongzhi  Cui; MD|Sabine  Heitzeneder; MD|Steven Lorenz Highfill|Adrienne Hart Smith|Rimas Jonas Orentas|Show all 11,Malcolm  Brenner (Baylor College of Medicine)|Carl  June (University of Pennsylvania)|Michel  Sadelain (Memorial Sloan-Kettering Cancer Institute)|Nabil F Ahmed (Information Resource & Technology Management Branch)|Mads  Duguard (University of British Columbia)|Steven  Grupp (Children's Hospital of Philadelphia)|Show all 13,"Peter D Aplan; MD (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Dimiter Stanchev Dimitrov; PhD (Center for Cancer Research Nanobiology Program)",NULL,"1. Brehm C, Huenecke S, Pfirrmann V, Rossig C, Mackall CL, Bollard CM, Gottschalk S, Schlegel PG, Klingebiel T, Bader P (2013). Highlights of the third International Conference on Immunotherapy in Pediatric Oncology. Pediatr Hematol Oncol  30, 349-66.   https://doi.org/10.3109/08880018.2013.802106|2. Duncan BB, Highfill SL, Qin H, Bouchkouj N, Larabee S, Zhao P, Woznica I, Liu Y, Li Y, Wu W, Lai JH, Jones B, Mackall CL, Bachovchin WW, Fry TJ (2013). A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy. J Immunother  36, 400-11.   https://doi.org/10.1097/CJI.0b013e3182a80213|3. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|4. Mackall C, Maris J (2013). Q&A: Crystal Mackall, John Maris on pediatrics. Cancer Discov  3, 961.   https://doi.org/10.1158/2159-8290.CD-ND2013-020|5. Orentas RJ, Dimitrov DJ, Mackall CJ, Saha SJ, St Croix BJ, Zhu ZJ (submitted in 2013) Anti-cd276 Polypeptides, Proteins, And Chimeric Antigen Receptors. Patent issued: 9,790,282 (US in 2018). Patents pending: 15/699,419 (US application); PCT/US2014/031543 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=83876
324,BC011076-07,"October 01, 2013 -  September 30, 2014",Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,"1. Antony S, Wu Y, Hewitt SM, Anver MR, Butcher D, Jiang G, Meitzler JL, Liu H, Juhasz A, Lu J, Roy KK, Doroshow JH (2013). Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody. Free Radic Biol Med  65, 497-508.   https://doi.org/10.1016/j.freeradbiomed.2013.07.005|2. Doroshow JH, Gaur S, Markel S, Lu J, van Balgooy J, Synold TW, Xi B, Wu X, Juhasz A (2013). Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts. Free Radic Biol Med  57, 162-75.   https://doi.org/10.1016/j.freeradbiomed.2013.01.002|3. Meitzler JL, Antony S, Wu Y, Juhasz A, Liu H, Jiang G, Lu J, Roy K, Doroshow JH (2014). NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal  20, 2873-89.   https://doi.org/10.1089/ars.2013.5603|4. Steven Esworthy R, Kim BW, Wang Y, Gao Q, Doroshow JH, Leto TL, Chu FF (2013). The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene. Free Radic Biol Med  65, 1273-1283.   https://doi.org/10.1016/j.freeradbiomed.2013.09.013|5. Wu Y, Antony S, Hewitt SM, Jiang G, Yang SX, Meitzler JL, Juhasz A, Lu J, Liu H, Doroshow JH, Roy K (2013). Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody. Int J Oncol  42, 1229-38.   https://doi.org/10.3892/ijo.2013.1821|6. Wu Y, Antony S, Meitzler JL, Doroshow JH (2014). Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer Lett  345, 164-73.   https://doi.org/10.1016/j.canlet.2013.08.014|7. Wu Y, Lu J, Antony S, Juhasz A, Liu H, Jiang G, Meitzler JL, Hollingshead M, Haines DC, Butcher D, Roy K, Doroshow JH (2013). Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines. J Immunol  190, 1859-72.   https://doi.org/10.4049/jimmunol.1201725",https://intramural.nih.gov/search/searchview.taf?ipid=83758
325,BC011078-07,"October 01, 2013 -  September 30, 2014",Phase 01 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",William M Bonner; PhD|Yves  Pommier; PhD,NULL,Joseph E Tomaszewski (Office of the Director)|Ralph  Parchment (Office of the Director),NULL,"1. Abrams J, Mooney M, Zweibel J, Christian M, Doroshow J (2013) Structures Supporting Cancer Clinical Trials, in Abeloff's Clinical Oncology., in press.|2. Kummar S, Murgo A, Tomaszewski J, Doroshow J (2013) Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents, in Abeloff's Clinical Oncology., in press.|3. Weil M, Kummar S, Doroshow J, Chen A (2013) BRCA Mtations and PARP Inhibitors, in Handbook of Therapeutic Biomarkers in Cancer. Yang S, ed., pp. 417-448.|4. Abrams JS, Mooney MM, Zwiebel JA, Korn EL, Friedman SH, Finnigan SR, Schettino PR, Denicoff AM, Kruhm MG, Montello M, Misra RR, Ansher SS, DiPiazza KJ, Souhan EM, Wickerham DL, Giantonio BJ, O'Donnell RT, Sullivan DM, Soto NI, Fleming GF, Prindiville SA, Petryshyn RA, Hautala JA, Grad O, Zuckerman BL, et al. [6 more authors] (2013) Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst 105:954-9|5. Bhattacharyya S, Kurdziel K, Wei L, Riffle L, Kaur G, Hill GC, Jacobs PM, Tatum JL, Doroshow JH, Kalen JD (2013). Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas. Nucl Med Biol  40, 451-7.   https://doi.org/10.1016/j.nucmedbio.2013.01.007|6. Do K, Doroshow JH, Kummar S (2013). Wee1 kinase as a target for cancer therapy. Cell Cycle  12, 3159-64.   https://doi.org/10.4161/cc.26062|7. Doroshow JH, Sleijfer S, Stupp R, Anderson K (2013). Cancer clinical trials--do we need a new algorithm in the age of stratified medicine? Oncologist  18, 651-2.   https://doi.org/10.1634/theoncologist.2013-0190|8. Jeong W, Doroshow JH, Kummar S (2013). United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies. Curr Probl Cancer  37, 110-44.   https://doi.org/10.1016/j.currproblcancer.2013.06.001|9. Kummar S, Allen D, Monks A, Polley EC, Hose CD, Ivy SP, Turkbey IB, Lawrence S, Kinders RJ, Choyke P, Simon R, Steinberg SM, Doroshow JH, Helman L (2013). Cediranib for metastatic alveolar soft part sarcoma. J Clin Oncol  31, 2296-302.   https://doi.org/10.1200/JCO.2012.47.4288|10. Kummar S, Anderson L, Hill K, Majerova E, Allen D, Horneffer Y, Ivy SP, Rubinstein L, Harris P, Doroshow JH, Collins JM (2013). First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies. Clin Cancer Res  19, 1852-7.   https://doi.org/10.1158/1078-0432.CCR-12-3118|11. McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MY, Kim KY, Tricoli JV, Taylor JM, Shuman DJ, Simon RM, Doroshow JH, Conley BA (2013). Criteria for the use of omics-based predictors in clinical trials. Nature  502, 317-20.   https://doi.org/10.1038/nature12564|12. McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MY, Kim KY, Tricoli JV, Taylor JM, Shuman DJ, Simon RM, Doroshow JH, Conley BA (2013). Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Med  11, 220.   https://doi.org/10.1186/1741-7015-11-220|13. Murai J, Huang SY, Renaud A, Zhang Y, Ji J, Takeda S, Morris J, Teicher B, Doroshow JH, Pommier Y (2014). Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. Mol Cancer Ther  13, 433-43.   https://doi.org/10.1158/1535-7163.MCT-13-0803|14. Park SR, Speranza G, Piekarz R, Wright JJ, Kinders RJ, Wang L, Pfister T, Trepel JB, Lee MJ, Alarcon S, Steinberg SM, Collins J, Doroshow JH, Kummar S (2013). A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas. Cancer Chemother Pharmacol  71, 981-90.   https://doi.org/10.1007/s00280-013-2091-3",https://intramural.nih.gov/search/searchview.taf?ipid=83759
326,BC011081-07,"October 01, 2013 -  September 30, 2014",Prostate Section,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Julian  Custer|Kathleen G Hilburn|Donald P Bottaro; PhD|Leonard  Neckers; PhD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Aradhana  Kaushal (Radiation Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",Bradford J Wood; MD (CC),"1. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|2. Hong CW, Amalou H, Xu S, Turkbey B, Yan P, Kruecker J, Pinto PA, Choyke PL, Wood BJ (2014). Prostate biopsy for the interventional radiologist. J Vasc Interv Radiol  25, 675-84.   https://doi.org/10.1016/j.jvir.2013.12.568|3. Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2014). Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol  20, 234-8.   https://doi.org/10.5152/dir.2014.13345|4. Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA (2014). Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression. J Comput Assist Tomogr  38, 565-7.   https://doi.org/10.1097/RCT.0000000000000069|5. Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA (2014). Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int  114, 641-52.   https://doi.org/10.1111/bju.12593|6. Metwalli AR, Pinto PA (2013). Commentary on: ""Focal cryosurgical ablation of the prostate: a single institute's perspective"". BMC Urol  13, 39.   https://doi.org/10.1186/1471-2490-13-39|7. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med  69, 553-62.   https://doi.org/10.1002/mrm.24277|8. Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA (2013). Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds. BJU Int  112, 508-16.   https://doi.org/10.1111/bju.12126|9. Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2013). Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol  190, 1721-1727.   https://doi.org/10.1016/j.juro.2013.05.052|10. Rothwax JT, George AK, Wood BJ, Pinto PA (2014). Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided. Biomed Res Int  2014, 439171.   https://doi.org/10.1155/2014/439171|11. Shakir NA, George AK, Siddiqui MM, Rothwax JT, Rais-Bahrami S, Stamatakis L, Su D, Okoro C, Raskolnikov D, Walton-Diaz A, Simon R, Turkbey B, Choyke PL, Merino MJ, Wood BJ, Pinto PA (2014). Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. J Urol  192, 1642-8.   https://doi.org/10.1016/j.juro.2014.08.002|12. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013). Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol  64, 713-719.   https://doi.org/10.1016/j.eururo.2013.05.059|13. Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA (2013). Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer  119, 3359-66.   https://doi.org/10.1002/cncr.28216|14. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology  268, 144-52.   https://doi.org/10.1148/radiol.13121325|15. Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA (2014). Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers. BJU Int  114, E43-E49.   https://doi.org/10.1111/bju.12670|16. Walter BA, Valera VA, Pinto PA, Merino MJ (2013). Comprehensive microRNA Profiling of Prostate Cancer. J Cancer  4, 350-7.   https://doi.org/10.7150/jca.6394|17. Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013). Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol  190, 2020-2025.   https://doi.org/10.1016/j.juro.2013.05.118|18. Wood BJ, Choyke P, Turkbey B, Pinto P (2013). Editorial comment. J Urol  189, 92.   https://doi.org/10.1016/j.juro.2012.08.261|19. Xu H, Lasso A, Guion P, Krieger A, Kaushal A, Singh AK, Pinto PA, Coleman J, Grubb RL, Lattouf JB, Menard C, Whitcomb LL, Fichtinger G (2013). Accuracy analysis in MRI-guided robotic prostate biopsy. Int J Comput Assist Radiol Surg  8, 937-44.   https://doi.org/10.1007/s11548-013-0831-9",https://intramural.nih.gov/search/searchview.taf?ipid=83896
327,BC011084-07,"October 01, 2013 -  September 30, 2014",Cellular functions of Ran GTPase,Petr  Kalab; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Pavol  Cekan; PhD|Jaehyung  Lee,Mirek  Dundr (Rosalin Franklin University)|Daniela  Cimini (VirginiaTech College of Science)|David  Odde (University of Minnesota),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83853
328,BC011090-07,"October 01, 2013 -  September 30, 2014",Molecular biology of human polyomaviruses,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Eileen Michelle Geoghegan|Upasana  Ray|Rachel  Schowalter; PhD|Diana  Pastrana,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School)|Jianxin  You (U Penn),Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Alison Anne McBride; PhD (NIAID),"1. Pastrana DV, Fitzgerald PC, Phan GQ, Raiji MT, Murphy PM, McDermott DH, Velez D, Bliskovsky V, McBride AA, Buck CB (2013). A divergent variant of the eleventh human polyomavirus species, saint louis polyomavirus. Genome Announc  1.   https://doi.org/10.1128/genomeA.00812-13|2. Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB (2013). BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. J Virol  87, 10105-13.   https://doi.org/10.1128/JVI.01189-13|3. Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, Buck CB, De Baets MH, Zur Hausen A (2015). Detection of human polyomavirus 7 in human thymic epithelial tumors. J Thorac Oncol  10, 360-6.   https://doi.org/10.1097/JTO.0000000000000390|4. Schowalter RM, Buck CB (2013). The Merkel cell polyomavirus minor capsid protein. PLoS Pathog  9, e1003558.   https://doi.org/10.1371/journal.ppat.1003558",https://intramural.nih.gov/search/searchview.taf?ipid=83749
329,BC011091-07,"October 01, 2013 -  September 30, 2014",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Munira A Basrai; PhD|Peter D Aplan; MD|Ashish Kumar Lal,NULL,"Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Elaine S Jaffe; MD (Laboratory of Pathology)|James Halpern Doroshow (Developmental Therapeutics Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",Jeffery L Miller; MD (NIDDK) |Leslie Glenn Biesecker; MD (NHGRI),"1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|3. Kim DW, Walker RL, Meltzer PS, Cheng SY (2013). Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. Carcinogenesis  34, 2389-400.   https://doi.org/10.1093/carcin/bgt175|4. Klorin G, Rozenblum E, Glebov O, Walker RL, Park Y, Meltzer PS, Kirsch IR, Kaye FJ, Roschke AV (2013). Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines. Cancer Genet  206, 191-205.   https://doi.org/10.1016/j.cancergen.2013.04.006|5. Moreno-Smith M, Halder JB, Meltzer PS, Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM, Kang Y, Rodriguez-Aguayo C, Vivas-Mejia PE, Zand B, Schmandt R, Wang H, Langley RR, Jennings NB, Ivan C, Coffin JE, Armaiz GN, Bottsford-Miller J, Kim SB, Halleck MS, Hendrix MJ, Bornman W, et al. [5 more authors] (2013). ATP11B mediates platinum resistance in ovarian cancer. J Clin Invest  123, 2119-30.   https://doi.org/10.1172/JCI65425|6. Petrini I, Wang Y, Zucali PA, Lee HS, Pham T, Voeller D, Meltzer PS, Giaccone G (2013). Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors. Clin Cancer Res  19, 1960-71.   https://doi.org/10.1158/1078-0432.CCR-12-3260|7. Praetorius C, Grill C, Stacey SN, Metcalf AM, Gorkin DU, Robinson KC, Van Otterloo E, Kim RS, Bergsteinsdottir K, Ogmundsdottir MH, Magnusdottir E, Mishra PJ, Davis SR, Guo T, Zaidi MR, Helgason AS, Sigurdsson MI, Meltzer PS, Merlino G, Petit V, Larue L, Loftus SK, Adams DR, Sobhiafshar U, Emre NC, et al. [8 more authors] (2013). A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell  155, 1022-33.   https://doi.org/10.1016/j.cell.2013.10.022|8. Tan X, Anzick SL, Khan SG, Ueda T, Stone G, Digiovanna JJ, Tamura D, Wattendorf D, Busch D, Brewer CC, Zalewski C, Butman JA, Griffith AJ, Meltzer PS, Kraemer KH (2013). Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency. Hum Mutat  34, 1250-9.   https://doi.org/10.1002/humu.22354|9. Teer JK, Johnston JJ, Anzick SL, Pineda M, Stone G, NISC Comparative Sequencing Program, Meltzer PS, Mullikin JC, Biesecker LG (2013). Massively-parallel sequencing of genes on a single chromosome: a comparison of solution hybrid selection and flow sorting. BMC Genomics  14, 253.   https://doi.org/10.1186/1471-2164-14-253|10. Zhang H, Meltzer P, Davis S (2013). RCircos: an R package for Circos 2D track plots. BMC Bioinformatics  14, 244.   https://doi.org/10.1186/1471-2105-14-244|11. Zhu Y, Stephens RM, Meltzer PS, Davis SR (2013). SRAdb: query and use public next-generation sequencing data from within R. BMC Bioinformatics  14, 19.   https://doi.org/10.1186/1471-2105-14-19",https://intramural.nih.gov/search/searchview.taf?ipid=83883
330,BC011095-07,"October 01, 2013 -  September 30, 2014",Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Young Hwan Lee|Mitchell Kai-Sern Ng|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Peter A Pinto; MD",NULL,"Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83746
331,BC011101-07,"October 01, 2013 -  September 30, 2014",Identifying New Glioma-Associated Tumor Suppressors and Oncogenes,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83769
332,BC011105-07,"October 01, 2013 -  September 30, 2014",Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Garimella  Harisha|Ravikiran S Yedidi|David A Davis; MD|Robert  Yarchoan; MD|Kenji  Maeda,"Arun  Ghosh|Masayuki  Amano (Kumamoto University School of Medicine)|Irene  Weber (Department of Biology, Georgia State University)|Hiroanori  Hayashi (Kumamoto University School of Medicine)|Hiromi  Ogata-Aoki (Kumamoto University School of Medicine)",NULL,NULL,"1. Amano M, Tojo Y, Salcedo-Gómez PM, Campbell JR, Das D, Aoki M, Xu CX, Rao KV, Ghosh AK, Mitsuya H (2013). GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro. Antimicrob Agents Chemother  57, 2036-46.   https://doi.org/10.1128/AAC.02189-12|2. Ghosh AK, Parham GL, Martyr CD, Nyalapatla PR, Osswald HL, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2013) Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies. J Med Chem 56:6792-802|3. Salcedo Gómez PM, Amano M, Yashchuk S, Mizuno A, Das D, Ghosh AK, Mitsuya H (2013). GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration. Antimicrob Agents Chemother  57, 6110-21.   https://doi.org/10.1128/AAC.01420-13|4. Yedidi RS, Maeda K, Fyvie WS, Steffey M, Davis DA, Palmer I, Aoki M, Kaufman JD, Stahl SJ, Garimella H, Das D, Wingfield PT, Ghosh AK, Mitsuya H (2013). P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety. Antimicrob Agents Chemother  57, 4920-7.   https://doi.org/10.1128/AAC.00868-13",https://intramural.nih.gov/search/searchview.taf?ipid=83886
333,BC011106-07,"October 01, 2013 -  September 30, 2014",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)","Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Lionel  Feigenbaum (Office of the Director)","Paul E Love; MD, PhD (NICHD)","1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83808
334,BC011107-07,"October 01, 2013 -  September 30, 2014",Role of Protein Scaffolds in RTKRas-dependent Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Pradeep  Kota|Daniel A Ritt|Elizabeth Mclean Terrell|Ira  Daar; PhD,Robert  Rottapel (University of Toronto)|Rueben  Shaw (Salk Institute)|Michael  White (UT Southwestern Medical Center),Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83890
335,BC011108-07,"October 01, 2013 -  September 30, 2014",MAP Kinase signal transduction disruption in cancer,Jonathan S Wiest; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83838
336,BC011109-07,"October 01, 2013 -  September 30, 2014",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Kenji  Maeda,Arun  Ghosh|Hiromi  Ogata-Aoki (Kumamoto University School of Medicine),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83887
337,BC011111-07,"October 01, 2013 -  September 30, 2014",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,NULL,Lionel  Feigenbaum (Office of the Director)|Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Katz G, Pobezinsky LA, Jeurling S, Shinzawa M, Van Laethem F, Singer A (2014). T cell receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1. Sci Signal  7, ra83.   https://doi.org/10.1126/scisignal.2005221|2. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|3. Tai X, Singer A (2014). Basis of Treg development in the thymus. Cell Cycle  13, 501-2.   https://doi.org/10.4161/cc.27787|4. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83809
338,BC011112-07,"October 01, 2013 -  September 30, 2014",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,NULL,Lionel  Feigenbaum (Office of the Director)|Dinah  Singer; PhD (Molecular Regulation Section),NULL,"1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Tai X, Singer A (2014). Basis of Treg development in the thymus. Cell Cycle  13, 501-2.   https://doi.org/10.4161/cc.27787|3. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83805
339,BC011113-07,"October 01, 2013 -  September 30, 2014",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Tai X, Singer A (2014). Basis of Treg development in the thymus. Cell Cycle  13, 501-2.   https://doi.org/10.4161/cc.27787|3. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83806
340,BC011114-07,"October 01, 2013 -  September 30, 2014",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,NULL,Lionel  Feigenbaum (Office of the Director),"Paul E Love; MD, PhD (NICHD)","1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Tai X, Singer A (2014). Basis of Treg development in the thymus. Cell Cycle  13, 501-2.   https://doi.org/10.4161/cc.27787|3. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83807
341,BC011115-07,"October 01, 2013 -  September 30, 2014",Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Said Charbel Azoury|Emily Reardon Peroutka|Mahadev  Rao|Vivek  Shukla; BSc, MSc|David Michael Straughan|Sichuan  Xi|Show all 10","Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|David  Beer (Thoracic Surgery, University of Michigan)","Victor  Marquez; PhD (Chemical Biology Laboratory)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Xi S, Xu H, Shan J, Tao Y, Hong JA, Inchauste S, Zhang M, Kunst TF, Mercedes L, Schrump DS (2013). Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis. J Clin Invest  123, 1241-61.   https://doi.org/10.1172/JCI61271",https://intramural.nih.gov/search/searchview.taf?ipid=83798
342,BC011116-07,"October 01, 2013 -  September 30, 2014",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,Gunter  Bernhardt (Hannover Medical School)|Batu M Erman,Lionel  Feigenbaum (Office of the Director)|Jung-Hyun  Park (Experimental Immunology Branch),Peter D Sun; PhD (NIAID),"1. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, Guinter T, McCaughtry T, Etzensperger R, Feigenbaum L, Singer DS, Singer A (2013). Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity  38, 1116-28.   https://doi.org/10.1016/j.immuni.2013.02.022|2. Tai X, Singer A (2014). Basis of Treg development in the thymus. Cell Cycle  13, 501-2.   https://doi.org/10.4161/cc.27787|3. Van Laethem F, Tikhonova AN, Pobezinsky LA, Tai X, Kimura MY, Le Saout C, Guinter TI, Adams A, Sharrow SO, Bernhardt G, Feigenbaum L, Singer A (2013). Lck availability during thymic selection determines the recognition specificity of the T cell repertoire. Cell  154, 1326-41.   https://doi.org/10.1016/j.cell.2013.08.009",https://intramural.nih.gov/search/searchview.taf?ipid=83803
343,BC011117-07,"October 01, 2013 -  September 30, 2014",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Lymphocyte Development Section, NCI",Amala Shenai Alag|Ruth  Etzensperger; PhD|Terry I Guinter|Tejas Bharat Kadakia|Motoko  Kimura|Leonid  Popezinsky|Show all 10,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83804
344,BC011118-07,"October 01, 2013 -  September 30, 2014",Role of Shh in developmental patterning and growth of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Shaimar Roselyn Gonzalez|Jianjian  Zhu|Xiaozhong  Bao,"Gerard  Evan (UCSF)|Steve  Vokes (U. Texas, Austin)",Stephen J Lockett; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83880
345,BC011119-07,"October 01, 2013 -  September 30, 2014",Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Pei-Yi Peggy Lin|Patricia Saiz Lopez|Anna Marie Trofka,"Denis  Duboule (Zoology and Animal Biology, Univ. of Geneva)|John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Steve  Vokes (U. Texas, Austin)|Dagmar  Iber (ETH Zurich)|Show all 7",Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),"Richa  Agarwala; BTech, MS, PhD (NLM) |Ivan  Ovcharenko; PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83881
346,BC011120-07,"October 01, 2013 -  September 30, 2014",Genome-wide target analysis of Shh-activated transcription network in limb bud,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka,NULL,NULL,"Ivan  Ovcharenko; PhD (NLM) |Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83878
347,BC011121-07,"October 01, 2013 -  September 30, 2014",Role of Brachyury in regulating notochord development and neoplasia,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83879
348,BC011123-07,"October 01, 2013 -  September 30, 2014",Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Fabiola  Cecchi|Peter A Pinto; MD,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Melinda  Hollingshead (Biological Testing Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Jane Beth Trepel (Developmental Therapeutics Branch),NULL,"1. Zhang M, Luo Z, Liu H, Croce CM, Burke TR, Bottaro DP (2014). Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist. Leukemia  28, 948-51.   https://doi.org/10.1038/leu.2013.323",https://intramural.nih.gov/search/searchview.taf?ipid=83747
349,BC011124-07,"October 01, 2013 -  September 30, 2014",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Fabiola  Cecchi|Young Hwan Lee|Mitchell Kai-Sern Ng|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Laura  Schmidt","Angela  Coxon (Amgen)|Regina  Day (NCI)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Anne-Marie  Martin (GlaxoSmithKline)|Freidmann  Muller (Curacyte AG)|Andreas  van de Locht (Department of Pathology, Curacyte AG)|Show all 11","Maria  Merino; PhD (Laboratory of Pathology)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Sandra  Ruscetti; PhD (Basic Research Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)",NULL,"1. Cecchi F, Lee Y, Bottaro D (2014) HGFMet Signaling in Cancer, in Molecular Oncology: Causes of Cancer and Targets for Treatment. Gelman E, Sawyers C, Rauscher F, eds., pp. 204-217.|2. Cecchi F, Lee Y, Peruzzi B, Lattouf J, Bottaro D (2014) The Role of Hepatocyte Growth Factor Pathway Signaling in Renal Cell Carcinoma, in Renal Cell Carcinoma: Molecular Targets and Clinical Applications. Bukowski R, Figlin R, Motzer R, eds., in press.|3. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|4. McNeil B, Sorbellini M, Grubb R, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal P, Coleman J, Getzenberg R, Netto G, Shih J, Linehan W, Pinto P, Bottaro D (2014) Preliminary Evaluation of Urinary Soluble Met as a Biomarker for Urothelial Carcinoma of the Bladder. J Trans Med, in press.|5. Shah MA, Wainberg ZA, Catenacci DV, Hochster HS, Ford J, Kunz P, Lee FC, Kallender H, Cecchi F, Rabe DC, Keer H, Martin AM, Liu Y, Gagnon R, Bonate P, Liu L, Gilmer T, Bottaro DP (2013). Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. PLoS One  8, e54014.   https://doi.org/10.1371/journal.pone.0054014",https://intramural.nih.gov/search/searchview.taf?ipid=83748
350,BC011126-07,"October 01, 2013 -  September 30, 2014",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Melvin Nelson Doster|Namal Prasanna Malimbada-Liyanage|Luca  Schifanella|Monica  Vaccari|Marjorie  Robert-Guroff; PhD,"Donald  Forthal (School of Medicine, Univ of CA)|Eckhard  Podack (Department of Microbiology, University of Miami)|Chris  Miller; MS|David C Montefiori; PhD (Department of Surgery, NIAID)|Guido  Ferrari (Duke University)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Show all 8",John  Schiller; PhD (Laboratory of Cellular Oncology)|Christopher  Buck (Laboratory of Cellular Oncology),Nancy R Miller (NIAID) |Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |Daniel C Douek; MD (NIAID),"1. Berzofsky J, Franchini G (2014) HumanSimian immunodeficiency virus transmission and infection at mucosal sites, in Mucosal Immunology., in press.|2. Dunham RM, Gordon SN, Vaccari M, Piatak M, Huang Y, Deeks SG, Lifson J, Franchini G, McCune JM (2013). Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase. AIDS Res Hum Retroviruses  29, 207-14.   https://doi.org/10.1089/AID.2012.0162|3. Fenizia C, Fiocchi M, Jones K, Parks RW, Ceribelli M, Chevalier SA, Edwards D, Ruscetti F, Pise-Masison CA, Franchini G (2014) Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells. J Virol 88:393-402|4. Liyanage NP, Gordon SN, Doster MN, Pegu P, Vaccari M, Shukur N, Schifanella L, Pise-Masison CA, Lipinska D, Grubczak K, Moniuszko M, Franchini G (2014). Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques. Virology  450-451, 359-68.   https://doi.org/10.1016/j.virol.2013.12.003|5. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M (2013). Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest  123, 594-9.   https://doi.org/10.1172/JCI66327|6. Mendoza D, Migueles SA, Rood JE, Peterson B, Johnson S, Doria-Rose N, Schneider D, Rakasz E, Trivett MT, Trubey CM, Coalter V, Hallahan CW, Watkins D, Franchini G, Lifson JD, Connors M (2013). Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques. PLoS Pathog  9, e1003195.   https://doi.org/10.1371/journal.ppat.1003195|7. Pegu P, Vaccari M, Gordon S, Keele BF, Doster M, Guan Y, Ferrari G, Pal R, Ferrari MG, Whitney S, Hudacik L, Billings E, Rao M, Montefiori D, Tomaras G, Alam SM, Fenizia C, Lifson JD, Stablein D, Tartaglia J, Michael N, Kim J, Venzon D, Franchini G (2013). Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial. J Virol  87, 1708-19.   https://doi.org/10.1128/JVI.02544-12|8. Strbo N, Vaccari M, Pahwa S, Kolber MA, Doster MN, Fisher E, Gonzalez L, Stablein D, Franchini G, Podack ER (2013). Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus. J Immunol  190, 2495-9.   https://doi.org/10.4049/jimmunol.1202655|9. Sui Y, Gordon S, Franchini G, Berzofsky JA (2013). Nonhuman primate models for HIV/AIDS vaccine development. Curr Protoc Immunol  102, Unit 12.14.   https://doi.org/10.1002/0471142735.im1214s102|10. Sui Y, Hogg A, Wang Y, Frey B, Yu H, Xia Z, Venzon D, McKinnon K, Smedley J, Gathuka M, Klinman D, Keele BF, Langermann S, Liu L, Franchini G, Berzofsky JA (2014). Vaccine-induced myeloid cell population dampens protective immunity to SIV. J Clin Invest  124, 2538-49.   https://doi.org/10.1172/JCI73518|11. Teigler JE, Phogat S, Franchini G, Hirsch VM, Michael NL, Barouch DH (2014). The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys. J Virol  88, 1809-14.   https://doi.org/10.1128/JVI.02386-13|12. Vaccari M, Fenizia C, Ma ZM, Hryniewicz A, Boasso A, Doster MN, Miller CJ, Lindegardh N, Tarning J, Landay AL, Shearer GM, Franchini G (2014). Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques. AIDS Res Hum Retroviruses  30, 355-62.   https://doi.org/10.1089/AID.2013.0218|13. Vaccari M, Halwani R, Patterson LJ, Boasso A, Beal J, Tryniszewska E, Hryniewicz A, Venzon D, Haddad EK, El-Far M, Rosati M, Pavlakis GN, Felber BK, Al-Muhsen S, Robert-Guroff M, Sekaly RP, Franchini G (2013). Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS. J Virol  87, 3526-37.   https://doi.org/10.1128/JVI.02686-12|14. Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, Pollara J, Hryniewicz A, Ferrari G, Guan Y, Forthal DN, Venzon D, Fenizia C, Morgan T, Montefiori D, Lifson JD, Miller CJ, Silvestri G, Rosati M, Felber BK, Pavlakis GN, Tartaglia J, Franchini G (2013). Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol  87, 3538-48.   https://doi.org/10.1128/JVI.02863-12",https://intramural.nih.gov/search/searchview.taf?ipid=83772
351,BC011131-07,"October 01, 2013 -  September 30, 2014",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li|Eric Young Shon,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Byrd RA, Weissman AM (2013). Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase. EMBO J  32, 2087-9.   https://doi.org/10.1038/emboj.2013.158|2. Das R, Liang YH, Mariano J, Li J, Huang T, King A, Tarasov SG, Weissman AM, Ji X, Byrd RA (2013). Allosteric regulation of E2:E3 interactions promote a processive ubiquitination machine. EMBO J  32, 2504-16.   https://doi.org/10.1038/emboj.2013.174|3. Huang T, Li J, Byrd RA (2014). Solution structure of lysine-free (K0) ubiquitin. Protein Sci  23, 662-7.   https://doi.org/10.1002/pro.2450|4. Metzger MB, Liang YH, Das R, Mariano J, Li S, Li J, Kostova Z, Byrd RA, Ji X, Weissman AM (2013). A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms. Mol Cell  50, 516-27.   https://doi.org/10.1016/j.molcel.2013.04.004",https://intramural.nih.gov/search/searchview.taf?ipid=83751
352,BC011132-07,"October 01, 2013 -  September 30, 2014",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li|Eric Young Shon|Shangjin  Sun|Yun Xing M Wang,NULL,NULL,NULL,"1. Fang X, Wang J, O'Carroll IP, Mitchell M, Zuo X, Wang Y, Yu P, Liu Y, Rausch JW, Dyba MA, Kjems J, Schwieters CD, Seifert S, Winans RE, Watts NR, Stahl SJ, Wingfield PT, Byrd RA, Le Grice SF, Rein A, Wang YX (2013). An unusual topological structure of the HIV-1 Rev response element. Cell  155, 594-605.   https://doi.org/10.1016/j.cell.2013.10.008",https://intramural.nih.gov/search/searchview.taf?ipid=83750
353,BC011150-06,"October 01, 2013 -  September 30, 2014",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,Lothar  Steidler (ActoGenix)|Juergen  Willmann (Stanford University),Howard A Young; PhD (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Barbara K Felber (Vaccine Branch),Sandip  Datta (NIAID),"1. Chen K, Liu M, Liu Y, Yoshimura T, Shen W, Le Y, Durum S, Gong W, Wang C, Gao JL, Murphy PM, Wang JM (2013). Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis. J Clin Invest  123, 1694-704.   https://doi.org/10.1172/JCI65569",https://intramural.nih.gov/search/searchview.taf?ipid=83914
354,BC011152-06,"October 01, 2013 -  September 30, 2014",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Maria Alejandra Clavijo Salomon|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Anna T Mason|Loretta R Smith|Robin T Winkler Pickett|Show all 7,"Xiaojing  Ma (Microbiology and Immunology, Weill Medical College)|Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Franca  Gerosa (Pathology/Immunology, University of Verona)",NULL,Francesco M. Marincola; MD (CC) |Alan  Sher; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83952
355,BC011153-06,"October 01, 2013 -  September 30, 2014",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Sarah Delia Cramer|Ren Ming  Dai|Amiran  Dzutsev; PhD|Silvana Romina Goldszmid|Natasha Delia Lejbman|Hannah Elizabeth Metheny|Show all 10,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)",NULL,"Francesco M. Marincola; MD (CC) |Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC)","1. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science  342, 967-70.   https://doi.org/10.1126/science.1240527|2. Molloy MJ, Grainger JR, Bouladoux N, Hand TW, Koo LY, Naik S, Quinones M, Dzutsev AK, Gao JL, Trinchieri G, Murphy PM, Belkaid Y (2013). Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe  14, 318-28.   https://doi.org/10.1016/j.chom.2013.08.003|3. Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G (2013). MyD88 and its divergent toll in carcinogenesis. Trends Immunol  34, 379-89.   https://doi.org/10.1016/j.it.2013.03.008",https://intramural.nih.gov/search/searchview.taf?ipid=83951
356,BC011154-06,"October 01, 2013 -  September 30, 2014",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Victor Jose Amaral|Bing  He,"Joseph  Orly (Hebrew University)|Eran  Meshorer (Hebrew University)|Sanjoy  Das (Pediatrics and Cancer Biology, Vanderbilt University Medical Center)|Andrew  Lane (U. of Louisville)",Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,"1. Deng T, Zhu ZI, Zhang S, Leng F, Cherukuri S, Hansen L, Mariño-Ramírez L, Meshorer E, Landsman D, Bustin M (2013). HMGN1 modulates nucleosome occupancy and DNase I hypersensitivity at the CpG island promoters of embryonic stem cells. Mol Cell Biol  33, 3377-89.   https://doi.org/10.1128/MCB.00435-13|2. Kugler JE, Horsch M, Huang D, Furusawa T, Rochman M, Garrett L, Becker L, Bohla A, Hölter SM, Prehn C, Rathkolb B, Racz I, Aguilar-Pimentel JA, Adler T, Adamski J, Beckers J, Busch DH, Eickelberg O, Klopstock T, Ollert M, Stöger T, Wolf E, Wurst W, Yildirim AÖ, Zimmer A, et al. [7 more authors] (2013). High mobility group N proteins modulate the fidelity of the cellular transcriptional profile in a tissue- and variant-specific manner. J Biol Chem  288, 16690-703.   https://doi.org/10.1074/jbc.M113.463315|3. Mine KL, Shulzhenko N, Yambartsev A, Rochman M, Sanson GF, Lando M, Varma S, Skinner J, Volfovsky N, Deng T, Brenna SM, Carvalho CR, Ribalta JC, Bustin M, Matzinger P, Silva ID, Lyng H, Gerbase-DeLima M, Morgun A (2013). Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun  4, 1806.   https://doi.org/10.1038/ncomms2693|4. Postnikov YV, Furusawa T, Haines DC, Factor VM, Bustin M (2014). Loss of the nucleosome-binding protein HMGN1 affects the rate of N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Mol Cancer Res  12, 82-90.   https://doi.org/10.1158/1541-7786.MCR-13-0392|5. Zhang S, Schones DE, Malicet C, Rochman M, Zhou M, Foisner R, Bustin M (2013). High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization. J Biol Chem  288, 18104-9.   https://doi.org/10.1074/jbc.C113.469544",https://intramural.nih.gov/search/searchview.taf?ipid=83905
357,BC011155-06,"October 01, 2013 -  September 30, 2014",Antibody-based therapeutics and vaccines against AIDS,Dimiter Stanchev Dimitrov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,"Christopher  Broder (Uniformed Services University of the Health Sciences)|Shibo  Jiang (Virology, New York Blood Center)|Barton  Haynes (Duke University)|MeiYun  Zhang (University of Hong Kong)|Rui  Gong; PhD|Yuxian  He (Chinese Academy of Medical Sciences)",Robert  Blumenthal; PhD (Basic Research Laboratory)|Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Peter D Kwong; PhD (NIAID),"1. Chen W, Ying T, Dimitrov DS (2013). Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design. Expert Opin Biol Ther  13, 657-71.   https://doi.org/10.1517/14712598.2013.761969|2. Meyerson JR, Tran EE, Kuybeda O, Chen W, Dimitrov DS, Gorlani A, Verrips T, Lifson JD, Subramaniam S (2013). Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc Natl Acad Sci U S A  110, 513-8.   https://doi.org/10.1073/pnas.1214810110|3. Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD, Dimitrov DS, Nussenzweig MC, Martin MA (2013). Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature  503, 277-80.   https://doi.org/10.1038/nature12746|4. Wan C, Sun J, Chen W, Yuan X, Chong H, Prabakaran P, Dimitrov DS, He Y (2013). Epitope mapping of M36, a human antibody domain with potent and broad HIV-1 inhibitory activity. PLoS One  8, e66638.   https://doi.org/10.1371/journal.pone.0066638|5. Xiao M, Prabakaran P, Chen W, Kessing B, Dimitrov DS (2013). Deep sequencing and Circos analyses of antibody libraries reveal antigen-driven selection of Ig VH genes during HIV-1 infection. Exp Mol Pathol  95, 357-63.   https://doi.org/10.1016/j.yexmp.2013.10.004",https://intramural.nih.gov/search/searchview.taf?ipid=83913
358,BC011156-06,"October 01, 2013 -  September 30, 2014",Antibody therapeutics against biodefense-related diseases,Dimiter Stanchev Dimitrov; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,Christopher  Broder (Uniformed Services University of the Health Sciences)|Linfa  Wang (Duke-NUS Graduate Medical School),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83912
359,BC011158-06,"October 01, 2013 -  September 30, 2014",Study the role(s) of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Jianxin  Shi (Biostatistics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program),Guokai  Chen (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS),"1. Shi J, Marconett CN, Duan J, Hyland PL, Li P, Wang Z, Wheeler W, Zhou B, Campan M, Lee DS, Huang J, Zhou W, Triche T, Amundadottir L, Warner A, Hutchinson A, Chen PH, Chung BS, Pesatori AC, Consonni D, Bertazzi PA, Bergen AW, Freedman M, Siegmund KD, Berman BP, et al. [7 more authors] (2014). Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Nat Commun  5, 3365.   https://doi.org/10.1038/ncomms4365|2. Shin MH, He Y, Huang J (2013). Embryonic stem cells shed new light on the developmental roles of p53. Cell Biosci  3, 42.   https://doi.org/10.1186/2045-3701-3-42|3. Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J (2013). Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle  12, 1279-91.   https://doi.org/10.4161/cc.24364",https://intramural.nih.gov/search/searchview.taf?ipid=83924
360,BC011162-06,"October 01, 2013 -  September 30, 2014",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Jian  Wang|Shouhui  Yang; PhD,"Jochen  Gaedcke|H Richard  Alexander (University of Maryland Medical System)|Frank  Bergmann (University of Heidelberg)|Michael  Ghadimi (Surgery, U. of Goettingen)|Nader  Hanna (University of Maryland Medical System)|Katsuhiko  Yanaga (Jikei University School of Medicine)|Show all 7",Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Budhu A, Terunuma A, Zhang G, Hussain S, Ambs S, Wang X (2014) Metabolic profiles are principally different between cancers of the liver, pancreas and breast. Int J Biosciences, in press.|2. Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SP (2013). Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res  19, 4983-93.   https://doi.org/10.1158/1078-0432.CCR-13-0209",https://intramural.nih.gov/search/searchview.taf?ipid=83925
361,BC011163-06,"October 01, 2013 -  September 30, 2014",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mary  Hollander|Jian  Jiang|Suman Kumar Vodnala|Hangyi  Yan,"Scott  Lonning (Gene Therapy, Genzyme Corp.)|John  Morris (University of Cincinnati)",Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)|Chand  Khanna; MD (Pediatric Oncology Branch)|Ashish Kumar Lal (Cancer Genetics Branch)|Pengnian Charles Lin; PhD (Mouse Cancer Genetics Program),NULL,"1. Luger D, Yang YA, Raviv A, Weinberg D, Banerjee S, Lee MJ, Trepel J, Yang L, Wakefield LM (2013). Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLoS One  8, e76115.   https://doi.org/10.1371/journal.pone.0076115|2. Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP, Weiss JM, Trinchieri G, Morris JC, Yang L (2013). TGF-β signaling in myeloid cells is required for tumor metastasis. Cancer Discov  3, 936-51.   https://doi.org/10.1158/2159-8290.CD-12-0527",https://intramural.nih.gov/search/searchview.taf?ipid=83957
362,BC011165-06,"October 01, 2013 -  September 30, 2014",Role of inflammation in epigenetic alterations of metastatic cancer cells,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mary  Hollander|Nicolas  Skrypek,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Achyut BR, Bader DA, Robles AI, Wangsa D, Harris CC, Ried T, Yang L (2013). Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling. PLoS Genet  9, e1003251.   https://doi.org/10.1371/journal.pgen.1003251|2. Yang L, Karin M (2014). Roles of tumor suppressors in regulating tumor-associated inflammation. Cell Death Differ  21, 1677-86.   https://doi.org/10.1038/cdd.2014.131",https://intramural.nih.gov/search/searchview.taf?ipid=83958
363,BC011167-06,"October 01, 2013 -  September 30, 2014",A novel preclinical model of spontaneous metastasis,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Heather Marie Farthing|Kerrie Leanne Marie,Martin  McMahon (University of Californial at San Francisco)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School),Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,"1. Merlino G, Flaherty K, Acquavella N, Day CP, Aplin A, Holmen S, Topalian S, Van Dyke T, Herlyn M (2013). Meeting report: The future of preclinical mouse models in melanoma treatment is now. Pigment Cell Melanoma Res  26, E8-E14.   https://doi.org/10.1111/pcmr.12099|2. Wilson W, Merlino G (2013). Flipping the phenotypic switch on a novel antimelanoma differentiation strategy. Pigment Cell Melanoma Res  26, 791-3.   https://doi.org/10.1111/pcmr.12160",https://intramural.nih.gov/search/searchview.taf?ipid=83937
364,BC011168-06,"October 01, 2013 -  September 30, 2014",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Liuya  Tang|Yi  Tang|Adam Michael Thomas|Xuan  Xu,Beth  Levine; MD (UT Southwestern Medical Center)|MarieDominique  Filippi (Cincinnati Children's Research Foundation)|Steven  Cheng (Nanjing Medical University),Miriam R Anver (Office Of The Director)|Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis),Chuxia  Deng; PhD (NIDDK) |Chengyu  Liu; PhD (NHLBI),"1. Wang X, Jin C, Tang Y, Tang LY, Zhang YE (2013). Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells. J Biol Chem  288, 21784-92.   https://doi.org/10.1074/jbc.M113.472704",https://intramural.nih.gov/search/searchview.taf?ipid=83959
365,BC011173-06,"October 01, 2013 -  September 30, 2014",Genomic Classification of Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI",Jesper B Andersen; PhD|Marian E Durkin|Valentina  Factor|Tanya N Hoang|Phuongnga  Ton,"Tania  Roskams (Dpt. Pathology, K.U.Leuven University)|Ju-Seog  Lee; PhD (NCI)|Peter  Galle|Derek  Chiang (University of North Carolina)|Jens Uwe Marquardt|Young  Park (Yonsei University College of Medicine)|Show all 7",Xin Wei Wang; PhD (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Laufey Thora Amundadottir (Laboratory Translational Genomics),NULL,"1. Andersen JB, Thorgeirsson SS (2014). A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. Hepat Oncol  1, 143-157.   https://doi.org/10.2217/hep.13.4|2. Jia J, Parikh H, Xiao W, Hoskins JW, Pflicke H, Liu X, Collins I, Zhou W, Wang Z, Powell J, Thorgeirsson SS, Rudloff U, Petersen GM, Amundadottir LT (2013). An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. BMC Med Genomics  6, 33.   https://doi.org/10.1186/1755-8794-6-33|3. Marquardt JU, Seo D, Andersen JB, Gillen MC, Kim MS, Conner EA, Galle PR, Factor VM, Park YN, Thorgeirsson SS (2014) Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. J Hepatol 60:346-53|4. Marquardt JU, Thorgeirsson SS (2013). Sall4 in ""stemness""-driven hepatocarcinogenesis. N Engl J Med  368, 2316-8.   https://doi.org/10.1056/NEJMe1303026|5. Marquardt JU, Thorgeirsson SS (2014). Next-generation genomic profiling of hepatocellular adenomas: a new era of individualized patient care. Cancer Cell  25, 409-11.   https://doi.org/10.1016/j.ccr.2014.03.032|6. Marquardt JU, Thorgeirsson SS (2014). SnapShot: Hepatocellular carcinoma. Cancer Cell  25, 550.e1.   https://doi.org/10.1016/j.ccr.2014.04.002|7. Matter MS, Decaens T, Andersen JB, Thorgeirsson SS (2014). Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol  60, 855-65.   https://doi.org/10.1016/j.jhep.2013.11.031",https://intramural.nih.gov/search/searchview.taf?ipid=83949
366,BC011175-06,"October 01, 2013 -  September 30, 2014",Validation of Therapeutic Target Genes in Human Liver Cancer,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Cellular and Molecular Biology Section, NCI",Jesper B Andersen; PhD|Marian E Durkin|Valentina  Factor|Tanya N Hoang|Phuongnga  Ton,"Ian  MacLachlan (Protiva, Protiva Biotherapeutics, Inc)|Lars  Zender (University of Tubingen)","Udai S Kammula (Surgery Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83950
367,BC011176-06,"October 01, 2013 -  September 30, 2014",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Christine  Happel; PhD|Dhivya  Ramalingam|Anna  Serquina|Thomas S Uldrick,NULL,NULL,NULL,"1. Gallaher AM, Das S, Xiao Z, Andresson T, Kieffer-Kwon P, Happel C, Ziegelbauer J (2013). Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis. PLoS Pathog  9, e1003584.   https://doi.org/10.1371/journal.ppat.1003584",https://intramural.nih.gov/search/searchview.taf?ipid=83960
368,BC011177-06,"October 01, 2013 -  September 30, 2014",Botulinum Toxin for Painful Cutaneous Leiomyomas,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Sharon M Osgood|Edward W Cowen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83931
369,BC011181-06,"October 01, 2013 -  September 30, 2014",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Kajal  Biswas|Aashish  Dewan|Suzanne A Hartford|Susan L North|Stacey S Stauffer|Thirthagiri  Eswary,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)|Stephen  Byers (Georgetown University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Mark H Greene; MD (Clinical Genetics Branch)|Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),Chuxia  Deng; PhD (NIDDK),"1. Bakker JL, Thirthagiri E, van Mil SE, Adank MA, Ikeda H, Verheul HM, Meijers-Heijboer H, de Winter JP, Sharan SK, Waisfisz Q (2014). A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics. Hum Mutat  35, 442-6.   https://doi.org/10.1002/humu.22505|2. Biswas K, Sharan S (2013) Manipulating the mouse genome using recombineering. Advancements in Genetic Engineering 4:1-5",https://intramural.nih.gov/search/searchview.taf?ipid=83945
370,BC011185-06,"October 01, 2013 -  September 30, 2014",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Jian  Wang|Shouhui  Yang; PhD,"Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Anirban  Maitra (Johns Hopkins University School of Medicine)|Richard  Bucala (Yale University)|Michael  Ghadimi (Surgery, U. of Goettingen)",David Anderson Wink (Radiation Biology Branch)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83926
371,BC011187-06,"October 01, 2013 -  September 30, 2014",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Laboratory of Cell and Developmental Signaling, NCI",Parthibane  Velayoudame,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program)|Shyam K Sharan (Mouse Cancer Genetics Program)|Sarangan  Ravichandran (Office Of The Director)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83901
372,BC011188-06,"October 01, 2013 -  September 30, 2014",Diazeniumdiolates as Broad-Spectrum Anticancer Agents,Larry K Keefer; PhD,NULL,"Chemical Biology Laboratory, NCI",NULL,"Paul  Shami (Medical Oncology, U of Utah)|Astrid  Weyerbrock (UNIVERSITÃTSKLINIKUM FREIBURG)",Xinhua  Ji; PhD (Biomolecular Structure Section)|Jonathan  Weiss (Laboratory of Experimental Immunology),NULL,"1. Kaczmarek MZ, Holland RJ, Lavanier SA, Troxler JA, Fesenkova VI, Hanson CA, Cmarik JL, Saavedra JE, Keefer LK, Ruscetti SK (2014). Mechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cells. Leuk Res  38, 377-82.   https://doi.org/10.1016/j.leukres.2013.12.002|2. Maciag AE, Holland RJ, Robert Cheng YS, Rodriguez LG, Saavedra JE, Anderson LM, Keefer LK (2013). Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balance. Redox Biol  1, 115-24.   https://doi.org/10.1016/j.redox.2012.12.002|3. Weidensteiner C, Reichardt W, Shami PJ, Saavedra JE, Keefer LK, Baumer B, Werres A, Jasinski R, Osterberg N, Weyerbrock A (2013). Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRI. Nitric Oxide  30, 17-25.   https://doi.org/10.1016/j.niox.2013.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=83930
373,BC011189-06,"October 01, 2013 -  September 30, 2014",Molecular Pathogenic Mechanism of Rhabdomyosarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,NULL,Lee Jay Helman; MD (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83906
374,BC011190-06,"October 01, 2013 -  September 30, 2014",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Xinyi  Li|Lisa Ann Ridnour|James B Mitchell; PhD|Murali  Krishna; PhD,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Larry K Keefer; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83956
375,BC011191-06,"October 01, 2013 -  September 30, 2014",Preclinical Mouse Model of Thyroid Carcinogenesis,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Cho Rong  Han|Jeong-Won  Park|Sunmi  Park|Mark Cauthen Willingham|Li  Zhao|Xuguang  Zhu,"Young  Jo (Chungnam national University Hospital)|THOMAS  KLONISCH (University of Manitoba)|Matthew D Ringel; MD (Lab. of Molec. Endocrinol., Washington Hospital Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Electron  Kebebew; MD (Endocrine Oncology Branch)",NULL,"1. Fozzatti L, Kim DW, Park JW, Willingham MC, Hollenberg AN, Cheng SY (2013). Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α. Proc Natl Acad Sci U S A  110, 7850-5.   https://doi.org/10.1073/pnas.1222334110|2. Fozzatti L, Park JW, Zhao L, Willingham MC, Cheng SY (2013). Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer. PLoS One  8, e67954.   https://doi.org/10.1371/journal.pone.0067954|3. Kim DW, Walker RL, Meltzer PS, Cheng SY (2013). Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. Carcinogenesis  34, 2389-400.   https://doi.org/10.1093/carcin/bgt175|4. Kim WG, Park JW, Willingham MC, Cheng SY (2013). Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology  154, 2936-47.   https://doi.org/10.1210/en.2013-1128|5. Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng SY (2013). Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression. Endocrinology  154, 25-35.   https://doi.org/10.1210/en.2012-1728|6. Park JW, Zhao L, Cheng SY (2013). Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models. Am J Cancer Res  3, 302-11.|7. Wark L, Danescu A, Natarajan S, Zhu X, Cheng SY, Hombach-Klonisch S, Mai S, Klonisch T (2014). Three-dimensional telomere dynamics in follicular thyroid cancer. Thyroid  24, 296-304.   https://doi.org/10.1089/thy.2013.0118",https://intramural.nih.gov/search/searchview.taf?ipid=83907
376,BC011192-06,"October 01, 2013 -  September 30, 2014",The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Yurong  Song; PhD|Jonathan  Keller; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83955
377,BC011197-06,"October 01, 2013 -  September 30, 2014",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Subrata  Debnath; PhD|Yantenew  Gete|Joshua Thomas Lange|Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD,Oleg  Demidov|Eric Henry Huang (INTRAMURAL RESEARCH PROGRAMS),Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Daniel  Appella; PhD (NIDDK),"1. Dudgeon C, Shreeram S, Tanoue K, Mazur SJ, Sayadi A, Robinson RC, Appella E, Bulavin DV (2013). Genetic variants and mutations of PPM1D control the response to DNA damage. Cell Cycle  12, 2656-64.   https://doi.org/10.4161/cc.25694|2. Tanoue K, Miller Jenkins LM, Durell SR, Debnath S, Sakai H, Tagad HD, Ishida K, Appella E, Mazur SJ (2013). Binding of a third metal ion by the human phosphatases PP2Cα and Wip1 is required for phosphatase activity. Biochemistry  52, 5830-43.   https://doi.org/10.1021/bi4005649",https://intramural.nih.gov/search/searchview.taf?ipid=83902
378,BC011199-06,"October 01, 2013 -  September 30, 2014",Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells,John M Jessup,NULL,"Cellular and Molecular Biology Section, NCI","Nikolay  Korokhov|Abid Rasheed Mattoo; PhD|Snorri S. Thorgeirsson; MD, PhD",Dean  Tang (UT M D Anderson Cancer Center)|Karine  Breckpot (Vrije Universiteit Brussel)|Jakob  Reiser (FDA),"Robert  Kinders (Office of the Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83928
379,BC011202-06,"October 01, 2013 -  September 30, 2014",Mechanism of the initial steps in transcription-coupled DNA repair (TCR),Mikhail V Kashlev|IRP Faculty Profile,NULL,"Molecular Mechanisms of Transcription Section, NCI",NULL,Michelle  Wang (Cornell University)|Patrick  Cramer (LM University)|Averell  Gnatt (Biopolcore Inc.),Jeffrey N Strathern (Genome Recombination and Regulation Section)|Yun Xing M Wang (Structural Biophysics Laboratory),Philip John Brooks; PhD (NIAAA),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83929
380,BC011203-06,"October 01, 2013 -  September 30, 2014",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Nadim  Majdalani|Song  Tong|Aurelia  Battesti,NULL,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Gene Regulation and Chromosome Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Michael  Maurizi; PhD (Biochemistry of Proteins Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Battesti A, Gottesman S (2013). Roles of adaptor proteins in regulation of bacterial proteolysis. Curr Opin Microbiol  16, 140-7.   https://doi.org/10.1016/j.mib.2013.01.002|2. Battesti A, Hoskins JR, Tong S, Milanesio P, Mann JM, Kravats A, Tsegaye YM, Bougdour A, Wickner S, Gottesman S (2013). Anti-adaptors provide multiple modes for regulation of the RssB adaptor protein. Genes Dev  27, 2722-35.   https://doi.org/10.1101/gad.229617.113",https://intramural.nih.gov/search/searchview.taf?ipid=83918
381,BC011204-06,"October 01, 2013 -  September 30, 2014",Preclinical development of TIMP-2 as a biologic therapy for cancer,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Mona  Abraham|Ananda  Chowdhury; PhD|Huiying  Han|Sandra  Jensen-Taubman|Sarvesh  Kumar|Silvia Francesca Noonan|Show all 8,"Dong-Wan  Seo (Laboratory of Molecular Biochemistry, Kangwon National University)|Alfredo  Martinez Ramirez (Center For Biomedical Research of LaRioja (CIBIR))","Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)",NULL,"1. Mollapour M, Bourboulia D, Beebe K, Woodford MR, Polier S, Hoang A, Chelluri R, Li Y, Guo A, Lee MJ, Fotooh-Abadi E, Khan S, Prince T, Miyajima N, Yoshida S, Tsutsumi S, Xu W, Panaretou B, Stetler-Stevenson WG, Bratslavsky G, Trepel JB, Prodromou C, Neckers L (2014). Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Mol Cell  53, 317-29.   https://doi.org/10.1016/j.molcel.2013.12.007|2. Shuman Moss LA, Jensen-Taubman S, Rubinstein D, Viole G, Stetler-Stevenson WG (2014). Dietary intake of a plant phospholipid/lipid conjugate reduces lung cancer growth and tumor angiogenesis. Carcinogenesis  35, 1556-63.   https://doi.org/10.1093/carcin/bgu039|3. Shuman Moss LA, Stetler-Stevenson WG (2013). Influence of Stromal Components on Lung Cancer Carcinogenesis. J Carcinog Mutagen  13.   https://doi.org/10.4172/2157-2518.S13-008|4. Stetler-Stevenson WG, Gavil NV (2014). Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic. Connect Tissue Res  55, 13-9.   https://doi.org/10.3109/03008207.2013.867339",https://intramural.nih.gov/search/searchview.taf?ipid=83948
382,BC011205-06,"October 01, 2013 -  September 30, 2014",Population based studies,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",NULL,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Magnus  Bjorkholm (Karolinska)|Sigurdur  Kristinsson (Karolinska),"Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83933
383,BC011206-06,"October 01, 2013 -  September 30, 2014",Genome wide profiling of histone variants in tumors,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Catherine Burke Volle|Marcin Piotr Walkiewicz,NULL,Karl Thomas Ried; MD (Cancer Genetics Branch),Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Walkiewicz M, Bui M, Quenet D, Dalal Y (2014) Tracking Histone Variant Nucleosomes Across the Human Cell Cycle Using Biophysical, Biochemical, and Cytological Analyses, in Methods in Molecular Biology., pp. 589-615.",https://intramural.nih.gov/search/searchview.taf?ipid=83909
384,BC011207-06,"October 01, 2013 -  September 30, 2014",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Andrew Russell Grand-Pierre|Delphine Chantal Anne Marie Quenet; PhD|Catherine Burke Volle|Marcin Piotr Walkiewicz|Haiqing  Zhao,Stephan  Diekmann (Leibniz Institute for Aging/Fritz Lippman Institute)|Jennifer  Otteson (Ohio State University)|Cees  Dekker (Delft University of Technology)|Garegin  Papaoin (University of Maryland)|Michael  Poirier (Ohio State University)|Sean  Taverna (Johns Hopkins University),NULL,Emilios K Dimitriadis; PhD (NIBIB),"1. Walkiewicz M, Bui M, Quenet D, Dalal Y (2014) Tracking Histone Variant Nucleosomes Across the Human Cell Cycle Using Biophysical, Biochemical, and Cytological Analyses, in Methods in Molecular Biology., pp. 589-615.|2. Bui M, Walkiewicz MP, Dimitriadis EK, Dalal Y (2013). The CENP-A nucleosome: a battle between Dr Jekyll and Mr Hyde. Nucleus  4, 37-42.   https://doi.org/10.4161/nucl.23588",https://intramural.nih.gov/search/searchview.taf?ipid=83910
385,BC011208-06,"October 01, 2013 -  September 30, 2014",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,Ee Sin  Chen|Job  Dekker; PhD (University of Massachusetts)|Leonid  Mirny (Massachusetts Institute of Technology),Peter C Fitzgerald (Office of the Director)|Ming  Zhou (Nucleic Acids Section),Henry L Levin; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83920
386,BC011209-06,"October 01, 2013 -  September 30, 2014",Formation of Centromeres in vivo,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Delphine Chantal Anne Marie Quenet; PhD|Marcin Piotr Walkiewicz|Catherine Burke Volle,NULL,NULL,NULL,"1. Walkiewicz M, Bui M, Quenet D, Dalal Y (2014) Tracking Histone Variant Nucleosomes Across the Human Cell Cycle Using Biophysical, Biochemical, and Cytological Analyses, in Methods in Molecular Biology., pp. 589-615.|2. Bui M, Walkiewicz MP, Dimitriadis EK, Dalal Y (2013). The CENP-A nucleosome: a battle between Dr Jekyll and Mr Hyde. Nucleus  4, 37-42.   https://doi.org/10.4161/nucl.23588|3. Quénet D, Dalal Y (2014) A long non-coding RNA is required for centromeric protein A targeting to human centromeres. eLife, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83911
387,BC011210-06,"October 01, 2013 -  September 30, 2014",Magnetic Drug Delivery for Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83915
388,BC011211-06,"October 01, 2013 -  September 30, 2014",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Jenny  Barriga|I-Lin  Wu|Prahathees  Eswara Moorthy|Irene S Tan|Edward Y Kim,"Douglas  Weibel (University of Wisconsin-Madison)|Fang  Tian (Penn State University, College of Medicine)|Kerwyn  Huang (Stanford University)",Sriram  Subramaniam; PhD (Laboratory of Cell Biology),Aravind L Iyer; PhD (NLM) |Hari  Shroff; PhD (NIBIB),"1. Castaing JP, Nagy A, Anantharaman V, Aravind L, Ramamurthi KS (2013). ATP hydrolysis by a domain related to translation factor GTPases drives polymerization of a static bacterial morphogenetic protein. Proc Natl Acad Sci U S A  110, E151-60.   https://doi.org/10.1073/pnas.1210554110|2. Renner LD, Eswaramoorthy P, Ramamurthi KS, Weibel DB (2013). Studying biomolecule localization by engineering bacterial cell wall curvature. PLoS One  8, e84143.   https://doi.org/10.1371/journal.pone.0084143|3. Tan IS, Ramamurthi KS (2013). Membrane remodeling: FisB will do in a pinch. Curr Biol  23, R251-3.   https://doi.org/10.1016/j.cub.2013.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=83943
389,BC011212-06,"October 01, 2013 -  September 30, 2014",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Howard A Young; PhD|Robert  Wiltrout; PhD|Giorgio  Trinchieri,NULL,"Ji Ming  Wang; MD, PhD (Laboratory of Molecular Immunoregulation)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83923
390,BC011214-06,"October 01, 2013 -  September 30, 2014",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Davinna Lachelle Ligons|Megan A Luckey|Joo Young  Park|Adam Tully Waickman,Thomas  Hunig (University of Wuerzburg)|Scott  Walsh (University of Maryland)|Batu M Erman,NULL,Marta Liliana Catalfamo; PhD (NIAID) |Bibiana  Bielekova; MD (NINDS),"1. Hong C, Nam AS, Keller HR, Ligons DL, Park JY, Yoon HW, Park JJ, Luckey MA, Park JH (2013). Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine  64, 532-40.   https://doi.org/10.1016/j.cyto.2013.08.001|2. Um JH, Brown AL, Singh SK, Chen Y, Gucek M, Lee BS, Luckey MA, Kim MK, Park JH, Sleckman BP, Gellert M, Chung JH (2013). Metabolic sensor AMPK directly phosphorylates RAG1 protein and regulates V(D)J recombination. Proc Natl Acad Sci U S A  110, 9873-8.   https://doi.org/10.1073/pnas.1307928110",https://intramural.nih.gov/search/searchview.taf?ipid=83941
391,BC011215-06,"October 01, 2013 -  September 30, 2014",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Davinna Lachelle Ligons|Megan A Luckey|Joo Young  Park|Adam Tully Waickman,NULL,Alfred  Singer; MD (Lymphocyte Development Section),NULL,"1. Tinsley KW, Hong C, Luckey MA, Park JY, Kim GY, Yoon HW, Keller HR, Sacks AJ, Feigenbaum L, Park JH (2013). Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus. Blood  122, 2358-68.   https://doi.org/10.1182/blood-2012-12-472076",https://intramural.nih.gov/search/searchview.taf?ipid=83942
392,BC011216-06,"October 01, 2013 -  September 30, 2014",CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATION,Carole A Parent; PhD,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Paul W Kriebel|Rachel Mary Lee|Wolfgang  Losert; PhD|Ritankar  Majumdar|Konstadinos  Moissoglu|Christina  Stuelten|Show all 8,Wolfgang  Losert (University of Maryland)|Marcus  Cicerone (NIST)|Alessio  Fasano (MassGeneral Hospital),Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),"Robert Simon Adelstein; MD (NHLBI) |James Robert Sellers; PhD (NHLBI) |J Silvio  Gutkind; PhD (NIDCR) |Hari  Shroff; PhD (NIBIB) |Ronald N Germain; MD, PhD (NIAID)","1. Afonso PV, McCann CP, Kapnick SM, Parent CA (2013). Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices. Blood  121, 1644-50.   https://doi.org/10.1182/blood-2012-08-451575|2. Afonso PV, Parent CA (2013). [Leukotriene B(4): a lipid at the heart of inflammation]. Med Sci (Paris)  29, 1083-5.   https://doi.org/10.1051/medsci/20132912007|3. Lämmermann T, Afonso PV, Angermann BR, Wang JM, Kastenmüller W, Parent CA, Germain RN (2013). Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature  498, 371-5.   https://doi.org/10.1038/nature12175|4. Weiger MC, Vedham V, Stuelten CH, Shou K, Herrera M, Sato M, Losert W, Parent CA (2013). Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression. PLoS One  8, e58859.   https://doi.org/10.1371/journal.pone.0058859",https://intramural.nih.gov/search/searchview.taf?ipid=83940
393,BC011217-06,"October 01, 2013 -  September 30, 2014",Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Rajaa  Elmeskini|Theresa Mae Guerin|Anthony Joseph Iacovelli|Zoe W Ohler,"David  Gandara (University of Califormia at Davis)|Colin  Hill (GNS Healthcare, Inc.)|Annette  Walter (Clovis Oncology, Inc.)",NULL,NULL,"1. Walter AO, Sjin RT, Haringsma HJ, Ohashi K, Sun J, Lee K, Dubrovskiy A, Labenski M, Zhu Z, Wang Z, Sheets M, St Martin T, Karp R, van Kalken D, Chaturvedi P, Niu D, Nacht M, Petter RC, Westlin W, Lin K, Jaw-Tsai S, Raponi M, Van Dyke T, Etter J, Weaver Z, et al. [5 more authors] (2013). Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov  3, 1404-15.   https://doi.org/10.1158/2159-8290.CD-13-0314",https://intramural.nih.gov/search/searchview.taf?ipid=83953
394,BC011219-06,"October 01, 2013 -  September 30, 2014",Combination Gene Therapy and Th1Th2 Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Jeffrey A. Medin; PhD (University of Toronto)",NULL,David F Stroncek; MD (CC),"1. Felizardo TC, Foley J, Steed K, Dropulic B, Amarnath S, Medin JA, Fowler DH (2013). Harnessing autophagy for cell fate control gene therapy. Autophagy  9, 1069-79.   https://doi.org/10.4161/auto.24639|2. Wang JC, Felizardo TC, Au BC, Fowler DH, Dekaban GA, Medin JA (2013). Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways. Virol J  10, 240.   https://doi.org/10.1186/1743-422X-10-240",https://intramural.nih.gov/search/searchview.taf?ipid=83916
395,BC011220-06,"October 01, 2013 -  September 30, 2014",Understanding T Cell Rapamycin Resistance,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)",NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83917
396,BC011222-06,"October 01, 2013 -  September 30, 2014",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,Jane Beth Trepel (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83947
397,BC011223-06,"October 01, 2013 -  September 30, 2014",Function of O-GlcNAc-modified Human RNA Polymerase II in Transcription,Brian  Lewis,NULL,"Lymphoid Malignancies Branch, NCI","Jason Alexander Piotrowski; BA, MS|Melissa  Resto",Gerald  Hart (Johns Hopkins University School of Medicine)|Alma  Burlingame (UCSF),Pradman  Qasba; PhD (Center for Cancer Research Nanobiology Program),John Allan Hanover; PhD (NIDDK) |Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83936
398,BC011224-06,"October 01, 2013 -  September 30, 2014",Casein Kinase 1 Delta in Wnt Signaling and Beyond,"Jeffrey S Rubin; MD, PhD",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yoshimi Endo Greer|Charles Peter Xavier,"Anthony  Brown (Weill Cornell Medical College)|Gregory  Pazour (University of Massachusetts Medical School)|Alan  Fields (Pharmacology, Mayo Clinic)",Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),Kapil  Bharti; PhD (NEI) |Yingzi  Yang; PhD (NHGRI),"1. González-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM (2013). Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling. J Biol Chem  288, 9428-37.   https://doi.org/10.1074/jbc.M112.448480|2. Greer YE, Fields AP, Brown AM, Rubin JS (2013). Atypical protein kinase Cι is required for Wnt3a-dependent neurite outgrowth and binds to phosphorylated dishevelled 2. J Biol Chem  288, 9438-46.   https://doi.org/10.1074/jbc.M112.448282|3. Greer YE, Westlake CJ, Gao B, Bharti K, Shiba Y, Xavier CP, Pazour GJ, Yang Y, Rubin JS (2014). Casein kinase 1δ functions at the centrosome and Golgi to promote ciliogenesis. Mol Biol Cell  25, 1629-40.   https://doi.org/10.1091/mbc.E13-10-0598",https://intramural.nih.gov/search/searchview.taf?ipid=83944
399,BC011229-06,"October 01, 2013 -  September 30, 2014",Mechanisms of Tumor Cell Dormancy and Tumor Recurrence,Jeffrey E Green; MD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Lara Helmi el Touny|Ryan  Nini|Laura  Vera Ramirez|Aleksandra M Michalowska,Dalit  Barkan (Haifa University)|Roland  Rad (Technical University of Munich),"Chand  Khanna; MD (Pediatric Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM, Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, Lee HD, Green JE (2013). LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. Breast Cancer Res Treat  141, 89-99.   https://doi.org/10.1007/s10549-013-2662-3",https://intramural.nih.gov/search/searchview.taf?ipid=83919
400,BC011232-06,"October 01, 2013 -  September 30, 2014",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",M A Siddiqui,"Susan  Keay|Alex  Mackerell Jr (University of Maryland)|Inka  Brockhausen (Queen's University, Human Mobility Research Centre)|Myriam Louise Cotten",NULL,Daron  Freedberg (OD),"1. Luo M, Velikovsky CA, Yang X, Siddiqui MA, Hong X, Barchi JJ, Gildersleeve JC, Pancer Z, Mariuzza RA (2013). Recognition of the Thomsen-Friedenreich pancarcinoma carbohydrate antigen by a lamprey variable lymphocyte receptor. J Biol Chem  288, 23597-606.   https://doi.org/10.1074/jbc.M113.480467|2. Mallajosyula SS, Adams KM, Barchi JJ, MacKerell AD (2013). Conformational determinants of the activity of antiproliferative factor glycopeptide. J Chem Inf Model  53, 1127-37.   https://doi.org/10.1021/ci400147s",https://intramural.nih.gov/search/searchview.taf?ipid=83904
401,BC011233-06,"October 01, 2013 -  September 30, 2014",Structural Bioinformatics,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",NULL,"Andriy  Kryshtafovych (University of California, Davis)|Gaetano  Montelione (Northeast Structural Genomics Consortium, CABM, Rutgers University)|John  Moult (University of Maryland Biotechnology Institute)|Jean  Garnier; PhD",Ira H Pastan; MD (Molecular Biology Section),Warren J Leonard; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83935
402,BC011238-06,"October 01, 2013 -  September 30, 2014",Computational Biology,Byungkook  Lee; PhD|IRP Faculty Profile,NULL,"Molecular Modeling Section, NCI",NULL,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83934
403,BC011240-06,"October 01, 2013 -  September 30, 2014",Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Rajaa  Elmeskini|Zoe W Ohler,Leroy E Hood|KuoChen  Wei (Chang Gung Memorial Hospital),Scott E McNeil (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83954
404,BC011255-05,"October 01, 2013 -  September 30, 2014",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ling  Bai|Farhoud  Faraji|Ngoc-Han  Ha|Anjali  Shukla|Xinyl  Zhu|Jeffrey E Green; MD|Show all 8,Pier Paolo  Pandolfi (Harvard University)|Nicholas  Smithers (GlaxoSmithKline)|David R Adams|Thomas  Keane (Welcome Trust Sanger Institute)|Fernando  Pardo-Manuel de la Villena (UNC),"Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Ying  Hu; PhD (Center For Biomedical Informatics & Information Technology)|Maxwell P Lee; PhD (Basic Research Laboratory)",NULL,"1. Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K (2013). Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun  4, 1449.   https://doi.org/10.1038/ncomms2438|2. Goldberger N, Walker RC, Kim CH, Winter S, Hunter KW (2013). Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Res  73, 2671-81.   https://doi.org/10.1158/0008-5472.CAN-12-3513|3. Ha NH, Hunter KW (2014). Using a systems biology approach to understand and study the mechanisms of metastasis. Wiley Interdiscip Rev Syst Biol Med  6, 107-14.   https://doi.org/10.1002/wsbm.1237|4. Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM, Hunter KW (2013). Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS One  8, e72287.   https://doi.org/10.1371/journal.pone.0072287",https://intramural.nih.gov/search/searchview.taf?ipid=83962
405,BC011261-05,"October 01, 2013 -  September 30, 2014",Biological Implications and Translational Applications of HDMX Inhibition,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",NULL,Jean-Christophe  Marine (KU Leuven)|Paul  Neilsen (University of Adelaide)|Aart  Jochemsen (Leiden University Medical Center),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83965
406,BC011262-05,"October 01, 2013 -  September 30, 2014",Broadening the Utility of Stapled Peptides through Chemical Optimization,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD|Amanda Lee Whiting,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83966
407,BC011264-05,"October 01, 2013 -  September 30, 2014",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Paul  Mittelstadt; PhD,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section),Dragana  Jankovic; PhD (NIAID),"1. Kugler DG, Mittelstadt PR, Ashwell JD, Sher A, Jankovic D (2013). CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med  210, 1919-27.   https://doi.org/10.1084/jem.20122300",https://intramural.nih.gov/search/searchview.taf?ipid=83967
408,BC011267-05,"October 01, 2013 -  September 30, 2014",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,Umesh  Bhanot (Memorial Sloan-Kettering Cancer Center)|Duncan  Jodrell (CRUK Cambridge Research Institute)|Sui  Huang (Northwestern University)|Jesse  Jaynes (Tuskegee University),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Scott E Martin (NCATS) |Craig Joseph Thomas (NCATS) |George R Martin (NIDCR) |Juan  Marugan (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83969
409,BC011275-05,"October 01, 2013 -  September 30, 2014",Genomic and genetic studies of endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Myriem  Boufraqech; PhD|Ryan Joseph Ellis|Sudheer Kumar Gara|Mei  He|Brandi La'Shae Howard|Yi  Liu-Chittenden; PhD,NULL,NULL,NULL,"1. Desai SS, Modali SD, Parekh VI, Kebebew E, Agarwal SK (2014). GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation. J Biol Chem  289, 5386-98.   https://doi.org/10.1074/jbc.M113.533612|2. Jain M, Zhang L, He M, Zhang YQ, Shen M, Kebebew E (2013). TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma. Endocr Relat Cancer  20, 361-70.   https://doi.org/10.1530/ERC-12-0403|3. Kim WG, Zhu X, Kim DW, Zhang L, Kebebew E, Cheng SY (2013). Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression. Endocrinology  154, 25-35.   https://doi.org/10.1210/en.2012-1728|4. Patel D, Boufraqech M, Jain M, Zhang L, He M, Gesuwan K, Gulati N, Nilubol N, Fojo T, Kebebew E (2013). MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery  154, 1224-8; discussion 1229.   https://doi.org/10.1016/j.surg.2013.06.022|5. Rahbari R, Kitano M, Zhang L, Bommareddi S, Kebebew E (2013). RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function. J Clin Endocrinol Metab  98, E446-54.   https://doi.org/10.1210/jc.2012-3180|6. Weisbrod AB, Zhang L, Jain M, Barak S, Quezado MM, Kebebew E (2013). Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors. Horm Cancer  4, 165-75.   https://doi.org/10.1007/s12672-013-0134-1",https://intramural.nih.gov/search/searchview.taf?ipid=83972
410,BC011278-05,"October 01, 2013 -  September 30, 2014",Mechanisms of Early Stage Mammary Tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Theresa N O'Sullivan|Yurong  Song; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83974
411,BC011282-05,"October 01, 2013 -  September 30, 2014",RNAi screen for chromatin modifiers in DNA repair and aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Simran  Khurana|Jinping  Liu|David  Sturgill|Andy Dong-Anh Tran; PhD|Zacharia  Hosseinipour|Ofir  Hakim|Show all 7,NULL,Michael John Kruhlak; PhD (Experimental Immunology Branch),NULL,"1. Khurana S, Kruhlak M, Kim J, Tran A, Liu J, Nyswaner K, Shi L, Jailwala P, Sung M, Hakim O, Oberdoerffer P (2014) A macro-histone variant links dynamic chromatin compaction to BRCA1-dependent genome maintenance. Cell Rep, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83977
412,BC011283-05,"October 01, 2013 -  September 30, 2014",Investigating the role of DNA breaks in mammalian aging,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",David  Sturgill|Jeongkyu  Kim; PhD|Andy Dong-Anh Tran; PhD,NULL,NULL,NULL,"1. Khurana S, Kruhlak M, Kim J, Tran A, Liu J, Nyswaner K, Shi L, Jailwala P, Sung M, Hakim O, Oberdoerffer P (2014) A macro-histone variant links dynamic chromatin compaction to BRCA1-dependent genome maintenance. Cell Rep, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=83978
413,BC011286-05,"October 01, 2013 -  September 30, 2014",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Rachel Dawn Aufforth|Myriem  Boufraqech; PhD|Sudheer Kumar Gara|Yi  Liu-Chittenden; PhD|Amit  Mehta|Vladimir Kostadinov Neychev|Show all 9,NULL,NULL,NULL,"1. Desai SS, Modali SD, Parekh VI, Kebebew E, Agarwal SK (2014). GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation. J Biol Chem  289, 5386-98.   https://doi.org/10.1074/jbc.M113.533612|2. Jain M, Zhang L, He M, Zhang YQ, Shen M, Kebebew E (2013). TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma. Endocr Relat Cancer  20, 361-70.   https://doi.org/10.1530/ERC-12-0403",https://intramural.nih.gov/search/searchview.taf?ipid=83980
414,BC011287-05,"October 01, 2013 -  September 30, 2014",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Sudheer Kumar Gara|Mei  He,NULL,NULL,NULL,"1. Sadowski SM, He M, Gesuwan K, Gulati N, Celi F, Merino MJ, Nilubol N, Kebebew E (2013). Prospective screening in familial nonmedullary thyroid cancer. Surgery  154, 1194-8.   https://doi.org/10.1016/j.surg.2013.06.019",https://intramural.nih.gov/search/searchview.taf?ipid=83981
415,BC011293-05,"October 01, 2013 -  September 30, 2014",Epigenetic regulation of alternative pre-mRNA splicing,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Marc Andre Bailly; PhD|Ryan Jared Marina|Maria Fernanda Prigge|Garima  Varma,NULL,Mikhail V Kashlev (Molecular Mechanisms of Transcription Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83983
416,BC011294-05,"October 01, 2013 -  September 30, 2014",Conditional manipulation of hnRNPLL expression in murine models,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Ryan Jared Marina|Maria Fernanda Prigge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83984
417,BC011295-05,"October 01, 2013 -  September 30, 2014",ALL immunobiology and the bone marrow niche,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Ekta K Kapadia; MD|Yinmeng  Yang|Crystal L. Mackall; MD,"Janetta  Bijl (HÃ´pital Maisonneuve-Rosemont)|SYD  JOHNSON (MacroGenics, Inc.)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83985
418,BC011298-05,"October 01, 2013 -  September 30, 2014",Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",John Walter Glod,"Sean Joseph Hipp|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)",Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83986
419,BC011299-05,"October 01, 2013 -  September 30, 2014",Noninvasive Evaluation of Pediatric CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James C Pascual,"Darren  Hargrave (Great ormond Street Hospital for Children)|Sean Joseph Hipp|Mark  Kieran (Children's Hospital)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Roger  Packer (CNMC)|Gilbert  Vezina (Children's National Medical Center)|Show all 7",NULL,"Peter  Herscovitch; MD (CC) |Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Carlo  Pierpaoli; MD, PhD (NICHD) |Joelle  Sarlls; PhD (NINDS)","1. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW (2013). Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer  60, 1397-401.   https://doi.org/10.1002/pbc.24562",https://intramural.nih.gov/search/searchview.taf?ipid=83987
420,BC011300-05,"October 01, 2013 -  September 30, 2014",CANCER AND INFLAMMATION GENETICS,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Lisa  Maslan|Albert M Gold|Maria Rodriguez J Herrera|Gabriela Monserrat Mimendi; BS|Karobi  Moitra|Michael L Nickerson|Show all 10,Lorena  Orozco (INMEGEN)|Federico  Antillon (UNOP)|Ana  Ortiz (University of Puerto Rico Comprehensive Cancer Center)|Walter  Guerra (Instituto Cancerologia)|Taras K Oleksyk|Dan  Theodorescu (University of Colorado)|Show all 12,"Nadya I Tarasova; PhD (Cancer Inflammation Program)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. Boland JF, Chung CC, Roberson D, Mitchell J, Zhang X, Im KM, He J, Chanock SJ, Yeager M, Dean M (2013) The new sequencer on the block: comparison of Life Technologys Proton sequencer to an Illumina HiSeq for whole-exome sequencing. Hum Genet 132:1153-63|2. Dean M, Lou H (2013). Genetics and genomics of prostate cancer. Asian J Androl  15, 309-13.   https://doi.org/10.1038/aja.2013.29|3. Garrido C, Santizo VG, Müllers P, Soriano DR, Avila GB, Dean M, Jimenez-Morales S (2013). Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia. Med Oncol  30, 474.   https://doi.org/10.1007/s12032-013-0474-2|4. Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen IM, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CR, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, et al. [13 more authors] (2013) Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet 45:1494-8|5. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, et al. [2 more authors] (2013). Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst  105, 733-42.   https://doi.org/10.1093/jnci/djt042",https://intramural.nih.gov/search/searchview.taf?ipid=83988
421,BC011301-05,"October 01, 2013 -  September 30, 2014",CANCER AND INFLAMMATION: FUNCTION AND THERAPY,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Lisa  Maslan|Albert M Gold|Maria Rodriguez J Herrera|Michael L Nickerson|Julie  Sawitzke|Sevilay  Turan|Show all 7,NULL,"Nadya I Tarasova; PhD (Cancer Inflammation Program)|Susan  Bates; MD (Developmental Therapeutics Branch)|Meredith  Yeager (Office of the Director)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. Nickerson ML, Bosley AD, Weiss JS, Kostiha BN, Hirota Y, Brandt W, Esposito D, Kinoshita S, Wessjohann L, Morham SG, Andresson T, Kruth HS, Okano T, Dean M (2013). The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum Mutat  34, 317-29.   https://doi.org/10.1002/humu.22230|2. Nickerson ML, Im KM, Misner KJ, Tan W, Lou H, Gold B, Wells DW, Bravo HC, Fredrikson KM, Harkins TT, Milos P, Zbar B, Linehan WM, Yeager M, Andresson T, Dean M, Bova GS (2013). Somatic alterations contributing to metastasis of a castration-resistant prostate cancer. Hum Mutat  34, 1231-41.   https://doi.org/10.1002/humu.22346",https://intramural.nih.gov/search/searchview.taf?ipid=83989
422,BC011302-05,"October 01, 2013 -  September 30, 2014",Screen for Ras inhibitors,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Joseph Orion Carver,NULL,NULL,Anton  Simeonov (NCATS) |Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83990
423,BC011303-05,"October 01, 2013 -  September 30, 2014",Role of the protein SUMOylation pathway in Ras-driven oncogenesis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Bing  Yu,NULL,John Stephen Schneekloth (Chemical Biology Laboratory)|William D Figg; PharmD (Genitourinary Malignancies Branch),Marjan  Gucek; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83991
424,BC011304-05,"October 01, 2013 -  September 30, 2014",New shRNA vectors for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jordan Leigh Smith,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83992
425,BC011306-05,"October 01, 2013 -  September 30, 2014",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Benjamin C Freed|Lyuba Aleksandrovna Khavrutskii|Karen Marie Stefanisko,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  Gonzalez-Juarrero (Colorado State University),Michael  Dean; PhD (Laboratory of Experimental Immunology)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Susan  Bates; MD (Developmental Therapeutics Branch)|Howard A Young; PhD (Laboratory of Experimental Immunology),NULL,"1. Khavrutskii L, Yeh J, Timofeeva O, Tarasov S, Pritt S, Stefanisko K, Tarasova N (2013) Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis. J Vis Exp 78:e50541|2. Timofeeva OA, Tarasova NI, Zhang X, Chasovskikh S, Cheema AK, Wang H, Brown ML, Dritschilo A (2013). STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain. Proc Natl Acad Sci U S A  110, 1267-72.   https://doi.org/10.1073/pnas.1211805110",https://intramural.nih.gov/search/searchview.taf?ipid=83993
426,BC011307-05,"October 01, 2013 -  September 30, 2014",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Yuhong  Chen; PhD|Lyuba Aleksandrovna Khavrutskii|Karen Marie Stefanisko,Joseph R Kates|Vadim  Gaponenko,Sriram  Subramaniam; PhD (Laboratory of Cell Biology)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83994
427,BC011311-05,"October 01, 2013 -  September 30, 2014",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Kajal  Biswas|Aashish  Dewan|Xia  Ding,"Stephen  Byers (Georgetown University)|William  Foulkes (McGill University)|Keiko  Agaki (Ohio State University Wexner Medical Center and Comprehensive Cancer Center)|Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)",Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),Scott E Martin (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83997
428,BC011313-05,"October 01, 2013 -  September 30, 2014",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Scott Hammond Medina; PhD|Katelyn Jean Nagy|Emily Nicole Sevcik|Cem  Sonmez,Darrin  Pochan (University of Delaware)|Norm  Wagner (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Yifat  Miller|Scott  Walsh (University of Maryland),Scott K Durum; PhD (Laboratory of Molecular Immunoregulation),Robert  Tycko; PhD (NIDDK),"1. Gupta K, Jang H, Harlen K, Puri A, Nussinov R, Schneider JP, Blumenthal R (2013). Mechanism of membrane permeation induced by synthetic β-hairpin peptides. Biophys J  105, 2093-103.   https://doi.org/10.1016/j.bpj.2013.09.040|2. Veiga AS, Schneider JP (2013). Antimicrobial hydrogels for the treatment of infection. Biopolymers  100, 637-44.   https://doi.org/10.1002/bip.22412",https://intramural.nih.gov/search/searchview.taf?ipid=83998
429,BC011314-05,"October 01, 2013 -  September 30, 2014",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Scott Hammond Medina; PhD|Yuji  Yamada; PhD,NULL,Robert  Blumenthal; PhD (Basic Research Laboratory),NULL,"1. Schneider J (2014) Injectable Bioadhesive Hydrogels with Innate Antibacterial Properties. Nature Communications 6:in press|2. Veiga AS, Schneider JP (2013). Antimicrobial hydrogels for the treatment of infection. Biopolymers  100, 637-44.   https://doi.org/10.1002/bip.22412",https://intramural.nih.gov/search/searchview.taf?ipid=83999
430,BC011315-05,"October 01, 2013 -  September 30, 2014",Molecular characterization of endometrial cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",NULL,NULL,Elise C Kohn; MD (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84000
431,BC011319-05,"October 01, 2013 -  September 30, 2014",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Bau Lin Huang|Xiaozhong  Bao,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84003
432,BC011321-05,"October 01, 2013 -  September 30, 2014",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Ying  Zhang,NULL,NULL,NULL,"1. Buckley DM, Burroughs-Garcia J, Lewandoski M, Waters ST (2013). Characterization of the Gbx1-/- mouse mutant: a requirement for Gbx1 in normal locomotion and sensorimotor circuit development. PLoS One  8, e56214.   https://doi.org/10.1371/journal.pone.0056214",https://intramural.nih.gov/search/searchview.taf?ipid=84005
433,BC011324-05,"October 01, 2013 -  September 30, 2014",Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Lingjun  Meng,Kunsoo  Rhee (Seoul National University)|Raymond L Erikson|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology),NULL,NULL,"1. Chang J, Seo SG, Lee KH, Nagashima K, Bang JK, Kim BY, Erikson RL, Lee KW, Lee HJ, Park JE, Lee KS (2013). Essential role of Cenexin1, but not Odf2, in ciliogenesis. Cell Cycle  12, 655-62.   https://doi.org/10.4161/cc.23585|2. González-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM (2013). Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling. J Biol Chem  288, 9428-37.   https://doi.org/10.1074/jbc.M112.448480|3. Zou J, Rezvani K, Wang H, Lee KS, Zhang D (2013) BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress. Cell Cycle, in press (e-pub ahead of print)",https://intramural.nih.gov/search/searchview.taf?ipid=84006
434,BC011325-05,"October 01, 2013 -  September 30, 2014",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Jane  Mirro,"Edward  Gabrielson (Johns Hopkins Medical Institution)|Sarah  Woodson (Department of Biophysics, Johns Hopkins University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84007
435,BC011328-05,"October 01, 2013 -  September 30, 2014",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Ogan D Abaan|Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|Yuan  Jiang; MD|Chyau Yueh Christopher Lau|John E Lueders|Show all 12",NULL,Chand  Khanna; MD (Pediatric Oncology Branch)|Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, Barkauskas DA, Marina N, de Toledo SR, Petrilli AS, et al. [25 more authors] (2013). Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet  45, 799-803.   https://doi.org/10.1038/ng.2645",https://intramural.nih.gov/search/searchview.taf?ipid=84009
436,BC011330-05,"October 01, 2013 -  September 30, 2014",Tumor heterogeneity in breast cancer brain metastasis after brain radiation,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,Patricia  Steeg; PhD (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84010
437,BC011332-05,"October 01, 2013 -  September 30, 2014",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Justin D Evans|Amber Jin Giles|Miki B Kasai|Meera  Murgai|Caitlin Marie Reid|Javed  Khan; MD|Show all 11,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Show all 7",NULL,NULL,"1. Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, et al. [1 more author] (2013). The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia  15, 848-62.   https://doi.org/10.1593/neo.13706",https://intramural.nih.gov/search/searchview.taf?ipid=84012
438,BC011333-05,"October 01, 2013 -  September 30, 2014",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84013
439,BC011334-05,"October 01, 2013 -  September 30, 2014",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Justin D Evans|Amber Jin Giles|Miki B Kasai|Meera  Murgai|Caitlin Marie Reid|Javed  Khan; MD|Show all 12,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 7",Sharon Ann Savage (Clinical Genetics Branch),NULL,"1. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL (2013). Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood  122, 1105-13.   https://doi.org/10.1182/blood-2012-08-449413",https://intramural.nih.gov/search/searchview.taf?ipid=84014
440,BC011336-05,"October 01, 2013 -  September 30, 2014",Tools for Prediction of ADMETox Properties,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Alexey Vladimirovich Zakharov; PhD,NULL,NULL,"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84015
441,BC011337-05,"October 01, 2013 -  September 30, 2014",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Christopher Alex Chow|Kenichi  Hanada|Krishna Bharat Patel|Qiong J Wang,NULL,NULL,NULL,"1. Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, Hanada K, Almeida JR, Darko S, Douek DC, Yang JC, Rosenberg SA (2014). PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors. J Clin Invest  124, 2246-59.   https://doi.org/10.1172/JCI73639|2. Lu YC, Yao X, Li YF, El-Gamil M, Dudley ME, Yang JC, Almeida JR, Douek DC, Samuels Y, Rosenberg SA, Robbins PF (2013). Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression. J Immunol  190, 6034-42.   https://doi.org/10.4049/jimmunol.1202830",https://intramural.nih.gov/search/searchview.taf?ipid=84016
442,BC011340-05,"October 01, 2013 -  September 30, 2014",Preclinical evaluation of novel therapeutics for CNS tumor therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James C Pascual|Cynthia M Lester mccully|Peter Lukas Ronner|Nalini M Jayaprakash|Srivandana  Akshintala|Diane  Cole|Show all 8,"Paul  Hergenrother (Chemistry, University of Illinois)|Charles  Keller (University of Texas)|Jack  Kovach (Lixte)|Sil  Lutkewitte (Targepeutics)|Siddarth  Mittra (Stanford)",NULL,"John D. Bacher; BS, DVM, MS (OD)","1. McCully CM, Pastakia D, Bacher J, Thomas ML, Steffen-Smith EA, Saleem K, Murphy RF, Walbridge S, Brinster L, Widemann BC, Warren KE (2013). Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta). Comp Med  63, 355-60.",https://intramural.nih.gov/search/searchview.taf?ipid=84017
443,BC011343-05,"October 01, 2013 -  September 30, 2014",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Stefanie Rae Carey|Austin Gerard Duffy|Suzanne E Fioravanti|Melissa A Walker,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Liang  Cao (Cancer Genetics Branch)|Douglas K Price (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Sean Fitzgerald Altekruse (Cancer Statistics Branch),Bradford J Wood; MD (CC) |Aradhana M Venkatesan (CC) |Nadine  Abi Jaoudeh (CC),"1. Abi-Jaoudeh N, Duffy AG, Greten TF, Kohn EC, Clark TW, Wood BJ (2013). Personalized oncology in interventional radiology. J Vasc Interv Radiol  24, 1083-92; quiz 1093.   https://doi.org/10.1016/j.jvir.2013.04.019|2. Boeck S, Jung A, Laubender RP, Neumann J, Egg R, Goritschan C, Vehling-Kaiser U, Winkelmann C, Fischer von Weikersthal L, Clemens MR, Gauler TC, Märten A, Klein S, Kojouharoff G, Barner M, Geissler M, Greten TF, Mansmann U, Kirchner T, Heinemann V (2013). EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer  108, 469-76.   https://doi.org/10.1038/bjc.2012.495|3. Duffy A, Rahma O, Greten TF (2013). Prognostic value of cetuximab-related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: results from a randomized trial of the GERMAN AIO CRC Study Group. Int J Cancer  132, 1718.   https://doi.org/10.1002/ijc.27805|4. Eggert T, McGlynn K, Greten TF, Altekruse S (2014). Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology? Gut  63, 1524.   https://doi.org/10.1136/gutjnl-2013-306407|5. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF (2013). Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10. Gut  62, 1667-8.   https://doi.org/10.1136/gutjnl-2013-305164|6. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF (2013). Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J  1, 351-7.   https://doi.org/10.1177/2050640613501507|7. Greten TF, Malek NP, Schmidt S, Arends J, Bartenstein P, Bechstein W, Bernatik T, Bitzer M, Chavan A, Dollinger M, Domagk D, Drognitz O, Düx M, Farkas S, Folprecht G, Galle P, Geißler M, Gerken G, Habermehl D, Helmberger T, Herfarth K, Hoffmann RT, Holtmann M, Huppert P, Jakobs T, et al. [45 more authors] (2013). [Diagnosis of and therapy for hepatocellular carcinoma]. Z Gastroenterol  51, 1269-326.   https://doi.org/10.1055/s-0033-1355841|8. Heinemann V, Vehling-Kaiser U, Waldschmidt D, Kettner E, Märten A, Winkelmann C, Klein S, Kojouharoff G, Gauler TC, von Weikersthal LF, Clemens MR, Geissler M, Greten TF, Hegewisch-Becker S, Rubanov O, Baake G, Höhler T, Ko YD, Jung A, Neugebauer S, Boeck S (2013). Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104). Gut  62, 751-9.   https://doi.org/10.1136/gutjnl-2012-302759|9. Malek NP, Schmidt S, Huber P, Manns MP, Greten TF (2014). The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arztebl Int  111, 101-6.   https://doi.org/10.3238/arztebl.2014.0101|10. Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardière C, Boucher E, Fartoux L, Faivre S, Blanc JF, Viret F, Assenat E, Seufferlein T, Herrmann T, Grenier J, Hammel P, Dollinger M, André T, Hahn P, Heinemann V, Rousseau V, Ducreux M, Pignon JP, Wendum D, Rosmorduc O, Greten TF, BINGO investigators (2014). Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Lancet Oncol  15, 819-28.   https://doi.org/10.1016/S1470-2045(14)70212-8|11. Rahma OE, Duffy A, Liewehr DJ, Steinberg SM, Greten TF (2013). Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials. Ann Oncol  24, 1972-9.   https://doi.org/10.1093/annonc/mdt166",https://intramural.nih.gov/search/searchview.taf?ipid=84018
444,BC011344-05,"October 01, 2013 -  September 30, 2014",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Austin Gerard Duffy|Suzanne E Fioravanti|Chi  Ma|Melissa A Walker,NULL,NULL,NULL,"1. Duffy A, Zhao F, Haile L, Gamrekelashvili J, Fioravanti S, Ma C, Kapanadze T, Compton K, Figg WD, Greten TF (2013). Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies. Cancer Immunol Immunother  62, 299-307.   https://doi.org/10.1007/s00262-012-1332-3|2. Duffy AG, Greten TF (2014). Immunological off-target effects of standard treatments in gastrointestinal cancers. Ann Oncol  25, 24-32.   https://doi.org/10.1093/annonc/mdt349",https://intramural.nih.gov/search/searchview.taf?ipid=84019
445,BC011345-05,"October 01, 2013 -  September 30, 2014",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Chi  Ma|Jose  Medina Echeverz|Tobias  Eggert|Miaojun  Han|Nina Kim Min,NULL,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Silvana Romina Goldszmid (Laboratory of Experimental Immunology)|Nicholas Phillip Restifo; MD (Surgery Branch)|Jimmy  Stauffer (Laboratory of Cell and Developmental Signaling)|William G Telford (Experimental Transplantation and Immunology Branch)|Masaki  Terabe (Vaccine Branch)",Cynthia E Dunbar; MD (NHLBI) |Francesco M. Marincola; MD (CC) |Ena  Wang (CC),"1. Kapanadze T, Gamrekelashvili J, Ma C, Chan C, Zhao F, Hewitt S, Zender L, Kapoor V, Felsher DW, Manns MP, Korangy F, Greten TF (2013). Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J Hepatol  59, 1007-13.   https://doi.org/10.1016/j.jhep.2013.06.010",https://intramural.nih.gov/search/searchview.taf?ipid=84020
446,BC011346-05,"October 01, 2013 -  September 30, 2014",Immune suppressor mechanism in a murine model of hepatitis and liver cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Jose  Medina Echeverz,NULL,"Masaki  Terabe (Vaccine Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Silvana Romina Goldszmid (Laboratory of Experimental Immunology)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Robert  Wiltrout; PhD (Laboratory of Experimental Immunology)",Francesco M. Marincola; MD (CC) |Ena  Wang (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84021
447,BC011351-05,"October 01, 2013 -  September 30, 2014",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","William D Figg; PharmD|James L Gulley; MD, PhD|Ravi  Madan",Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Dan  Theodorescu (University of Colorado)|Jean  Hoffman-Censits (Jefferson University Hospital),Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Mark  Raffeld; MD (Laboratory of Pathology)|William Laurence Dahut; MD (Office Of The Clinical Director),NULL,"1. Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y (2015). Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward. Urol Oncol  33, 53-64.   https://doi.org/10.1016/j.urolonc.2014.06.013|2. Apolo AB, Kwiatkowski DJ (2013). Targeting molecular aberrations in urothelial carcinoma: are we almost there? Am Soc Clin Oncol Educ Book  2013, 195-9.   https://doi.org/10.1200/EdBook_AM.2013.33.195|3. Apolo AB, Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF (2013). Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. J Natl Cancer Inst  105, 499-503.   https://doi.org/10.1093/jnci/djt015|4. Cowan NG, Chen Y, Downs TM, Bochner BH, Apolo AB, Porter MP, La Rochelle JC, Amling CL, Koppie TM (2014). Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions. Adv Urol  2014, 746298.   https://doi.org/10.1155/2014/746298|5. Ghosh M, Brancato SJ, Agarwal PK, Apolo AB (2014). Targeted therapies in urothelial carcinoma. Curr Opin Oncol  26, 305-20.   https://doi.org/10.1097/CCO.0000000000000064",https://intramural.nih.gov/search/searchview.taf?ipid=84024
448,BC011352-05,"October 01, 2013 -  September 30, 2014",Molecular and clinical profiling,Ola Anders Landgren,NULL,"Lymphoid Malignancies Branch, NCI",NULL,Vincent  Rajkumar (Mayo Clinic)|Robert  Kyle (Mayo Clinic)|Sigurdur  Kristinsson (Karolinska),Peter L Choyke; MD (Molecular Imaging Program)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Richard  Childs; MD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84025
449,BC011353-05,"October 01, 2013 -  September 30, 2014",Development and validation of preclinical mouse model for serous ovarian cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Maureen Baran Gearheart|Theresa Mae Guerin|Anthony Joseph Iacovelli|Philip L Martin|Ludmila  Szabova; MS, PhD|Zoe W Ohler",NULL,Christina M Annunziata (Womens Malignancies Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group),"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84026
450,BC011354-05,"October 01, 2013 -  September 30, 2014",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84027
451,BC011372-04,"October 01, 2013 -  September 30, 2014",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Beatriz  Aldaz Arrieta; PhD|Muhammad  Jamal|Barbara Helen Rath|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84028
452,BC011373-04,"October 01, 2013 -  September 30, 2014",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Lance Frederick Dasilva|Marwa Wahba Foreman|Barbara Helen Rath|Kevin A Camphausen; MD|Uma  Shankavaram; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84029
453,BC011374-04,"October 01, 2013 -  September 30, 2014",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Jeanelle M Spencer|Laura M Tuschong,NULL,NULL,"Steven M Holland; MD (NIAID) |Harry Lewis Malech; MD (NIAID) |Helen C Su; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84030
454,BC011376-04,"October 01, 2013 -  September 30, 2014",Structural and Biochemical Studies of p53 Family Function,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Bethanie Lynn Morrison; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84031
455,BC011378-04,"October 01, 2013 -  September 30, 2014",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Mary Elizabeth Olanich|Wenyue  Sun|Ming  Zhao|Bishwanath  Chatterjee; PhD|Stephen M Hewitt; MD, PhD|Svetlana Dmitriyevna Pack; PhD",NULL,Javed  Khan; MD (Pediatric Oncology Branch)|Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84032
456,BC011379-04,"October 01, 2013 -  September 30, 2014",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),"1. Tanoue K, Miller Jenkins LM, Durell SR, Debnath S, Sakai H, Tagad HD, Ishida K, Appella E, Mazur SJ (2013). Binding of a third metal ion by the human phosphatases PP2Cα and Wip1 is required for phosphatase activity. Biochemistry  52, 5830-43.   https://doi.org/10.1021/bi4005649",https://intramural.nih.gov/search/searchview.taf?ipid=84033
457,BC011381-04,"October 01, 2013 -  September 30, 2014",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",NULL,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics)|Brian  Lewis (Lymphoid Malignancies Branch),Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |S Stoney  Simons; PhD (NIDDK),"1. Devaiah BN, Singer DS (2013). Two faces of brd4: mitotic bookmark and transcriptional lynchpin. Transcription  4, 13-7.   https://doi.org/10.4161/trns.22542",https://intramural.nih.gov/search/searchview.taf?ipid=84035
458,BC011382-04,"October 01, 2013 -  September 30, 2014",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian Eric Fisher|Moody D Amie; PhD|Joshua R Porter|Amy  Sun|Mark  Raffeld; MD,NULL,NULL,NULL,"1. Batchelor E, Kann MG, Przytycka TM, Raphael BJ, Wojtowicz D (2013). Modeling cell heterogeneity: from single-cell variations to mixed cells. Pac Symp Biocomput   445-50|2. Moody AD, Batchelor E (2013). Promoter decoding of transcription factor dynamics. Mol Syst Biol  9, 703.   https://doi.org/10.1038/msb.2013.63",https://intramural.nih.gov/search/searchview.taf?ipid=84036
459,BC011383-04,"October 01, 2013 -  September 30, 2014",Transcription and Splicing Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Huimin  Chen|Christopher Robert Day|Tineke Laura Lenstra|Murali  Palangat; PhD|Joseph  Rodriguez,Eric  Drier (Mad City Labs)|Robert  Singer (Albert Einstein College of Medicine),Dinah  Singer; PhD (Molecular Regulation Section),"Carson C Chow; BASc, PhD (NIDDK)","1. Coulon A, Chow CC, Singer RH, Larson DR (2013). Eukaryotic transcriptional dynamics: from single molecules to cell populations. Nat Rev Genet  14, 572-84.   https://doi.org/10.1038/nrg3484|2. Ferguson ML, Larson DR (2013). Measuring transcription dynamics in living cells using fluctuation analysis. Methods Mol Biol  1042, 47-60.   https://doi.org/10.1007/978-1-62703-526-2_4|3. Larson DR, Fritzsch C, Sun L, Meng X, Lawrence DS, Singer RH (2013). Direct observation of frequency modulated transcription in single cells using light activation. Elife  2, e00750.   https://doi.org/10.7554/eLife.00750",https://intramural.nih.gov/search/searchview.taf?ipid=84037
460,BC011387-04,"October 01, 2013 -  September 30, 2014",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Mary Elizabeth Olanich|Puspa Raj Pandey; PhD|Eric  Batchelor; PhD|Markku Martti Miettinen|Svetlana Dmitriyevna Pack; PhD,"James  Anderson (University of Nebraska Medical Center)|Julia  Bridge (University of Nebraska Medical Center)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|David  Parham (University of Oklahoma Health Sciences Center)|Erin  Rudzinski (Oregon Health and Science University)|Stephen  Skapek (The University of Chicago)|Show all 10",Javed  Khan; MD (Pediatric Oncology Branch)|Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,"1. Olanich ME, Barr FG (2013). A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opin Ther Targets  17, 607-23.   https://doi.org/10.1517/14728222.2013.772136|2. Parham DM, Barr FG (2013). Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol  20, 387-97.   https://doi.org/10.1097/PAP.0b013e3182a92d0d|3. Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM (2013). Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Am J Clin Pathol  140, 82-90.   https://doi.org/10.1309/AJCPA1WN7ARPCMKQ|4. Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS (2013). PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer  60, 1411-7.   https://doi.org/10.1002/pbc.24532|5. Wilson RA, Teng L, Bachmeyer KM, Bissonnette ML, Husain AN, Parham DM, Triche TJ, Wing MR, Gastier-Foster JM, Barr FG, Hawkins DS, Anderson JR, Skapek SX, Volchenboum SL (2013) A novel algorithm for simplification of complex gene classifiers in cancer. Cancer Res 73:5625-32",https://intramural.nih.gov/search/searchview.taf?ipid=84040
461,BC011390-04,"October 01, 2013 -  September 30, 2014",Vascular Biology in Cancer,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Shyam K Sharan|Jonathan  Keller; PhD,Xiaolin  He (Northwestern University)|Deyu  Li (Vanderbilt University)|Kevin  Peters (Akebia Therapeutics),Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84041
462,BC011391-04,"October 01, 2013 -  September 30, 2014",Role of IKK alpha in lung squamous cell carcinoma development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Na-Young  Song; PhD|Jami D Willette brown|Zuoxiang  Xiao|Robert  Wiltrout; PhD|Howard A Young; PhD|Giorgio  Trinchieri,Ellen  Richie (MD Anderson Cancer Center)|Nancy  Jenkins (Houston Methodist Research Institute),David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84042
463,BC011393-04,"October 01, 2013 -  September 30, 2014",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Ying  Xiao|Eric A Wang|Jonathan Stephen Williams|Amy B Coxon|Keisuke  Nagao,NULL,NULL,Yosuke  Mukoyama; PhD (NHLBI),"1. Williams JS, Xiao Y, Brownell I (2014). Low pH reprograms somatic murine cells into pluripotent stem cells: a novel technique with therapeutic implications. Cancer Biol Ther  15, 675-7.   https://doi.org/10.4161/cbt.28414|2. Xiao Y, Woo WM, Nagao K, Li W, Terunuma A, Mukouyama YS, Oro AE, Vogel JC, Brownell I (2013). Perivascular hair follicle stem cells associate with a venule annulus. J Invest Dermatol  133, 2324-2331.   https://doi.org/10.1038/jid.2013.167",https://intramural.nih.gov/search/searchview.taf?ipid=84044
464,BC011394-04,"October 01, 2013 -  September 30, 2014",Molecular pathogenesis of Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",Tiffany Monique Alexander|Amy B Coxon|Kenneth Michael Daily|Jonathan Stephen Williams,"Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Clayton  Green (Marshfield Clinic)|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)","Eric Alan Stahlberg (Biostatistics and Data Management Section)|Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Mark  Raffeld; MD (Laboratory of Pathology)",Amir Hossein Gandjbakhche; PhD (NICHD) |Jay Robert Knutson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84045
465,BC011397-04,"October 01, 2013 -  September 30, 2014",The role of RNA splicing factors in Ras transformed cells,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Valentin  Giroux,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84046
466,BC011398-04,"October 01, 2013 -  September 30, 2014",Regulation of Ciliogenesis and Ciliary-related signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI","Adrian Alejandro Cuenca; MHS, PhD|Christine Antoinette Kettenhofen; PhD|Quanlong  Lu; PhD|Jimmy  Stauffer|Vijay  Walia|Peter Alex John|Show all 7",NULL,Ulrich  Baxa; PhD (Office Of The Director)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),Jennifer A Lippincott Schwartz; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84047
467,BC011399-04,"October 01, 2013 -  September 30, 2014",Regulation of microRNA expression by Mutant p53,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Matthew Fletcher Jones|Xiao Ling  Li|Murugan  Subramanian|Sven  Bilke|Paul S Meltzer; MD, PhD",Karen H Vousden|Sudha  Sharma,Stefan  Ambs (Laboratory of Human Carcinogenesis)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Subramanian M, Li X, Hara T, Lal A (2013) A biochemical approach to identify direct microRNA targets, in Methods in Molecular Biology, Regulatory noncoding RNAs (Humana Press-Springer Sciences)., in press.|2. Li XL, Jones MF, Subramanian M, Lal A (2014). Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks. FEBS Lett  588, 2610-5.   https://doi.org/10.1016/j.febslet.2014.03.054|3. Subramanian M, Francis P, Bilke S, Li XL, Hara T, Lu X, Jones MF, Walker RL, Zhu Y, Pineda M, Lee C, Varanasi L, Yang Y, Martinez LA, Luo J, Ambs S, Sharma S, Wakefield LM, Meltzer PS, Lal A (2015). A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis. Oncogene  34, 1094-104.   https://doi.org/10.1038/onc.2014.46",https://intramural.nih.gov/search/searchview.taf?ipid=84048
468,BC011400-04,"October 01, 2013 -  September 30, 2014",Function of Mutant p53-regulated microRNAs in cancer cells,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Sven  Bilke|Paul S Meltzer; MD, PhD",NULL,Stefan  Ambs (Laboratory of Human Carcinogenesis)|Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,"1. Li XL, Jones MF, Subramanian M, Lal A (2014). Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks. FEBS Lett  588, 2610-5.   https://doi.org/10.1016/j.febslet.2014.03.054|2. Subramanian M, Francis P, Bilke S, Li XL, Hara T, Lu X, Jones MF, Walker RL, Zhu Y, Pineda M, Lee C, Varanasi L, Yang Y, Martinez LA, Luo J, Ambs S, Sharma S, Wakefield LM, Meltzer PS, Lal A (2015). A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis. Oncogene  34, 1094-104.   https://doi.org/10.1038/onc.2014.46",https://intramural.nih.gov/search/searchview.taf?ipid=84049
469,BC011402-04,"October 01, 2013 -  September 30, 2014",MicroRNA phenotypic screening for the discovery of novel anti-cancer microRNAs,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Matthew Fletcher Jones|Xiao Ling  Li|Murugan  Subramanian|Natasha  Caplen,NULL,Ji  Luo (Laboratory of Cancer Biology and Genetics)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84051
470,BC011405-04,"October 01, 2013 -  September 30, 2014",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",David D Roberts; PhD,NULL,William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Alimchandani M, Lara K, Tsokos M, Linehan WM, Merino MJ (2014). Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma. Urol Case Rep  2, 39-62.   https://doi.org/10.1016/j.eucr.2013.12.008|2. Diker-Cohen T, Abraham SB, Rauschecker M, Papadakis GZ, Munir KM, Brown E, Lyssikatos C, Belyavskaya E, Merino M, Stratakis CA (2014). Reninoma presenting in pregnancy. J Clin Endocrinol Metab  99, 2625-6.   https://doi.org/10.1210/jc.2014-1730|3. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM (2014). Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol  11, 465-75.   https://doi.org/10.1038/nrurol.2014.162|4. Merino M (2014) Hereditary leiomyomatosis and renal cell cancer. Orphanet, in press.|5. Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM (2014). Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol  32, 431-7.   https://doi.org/10.1200/JCO.2013.50.8192",https://intramural.nih.gov/search/searchview.taf?ipid=84053
471,BC011406-04,"October 01, 2013 -  September 30, 2014",miRNA profiling  of prostate cancer in young and older male patients,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,Peter A Pinto; MD (Urologic Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|William Marston Linehan; MD (Urologic Oncology Branch),NULL,"1. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013). Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol  64, 713-719.   https://doi.org/10.1016/j.eururo.2013.05.059|2. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology  268, 144-52.   https://doi.org/10.1148/radiol.13121325|3. Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL (2014). Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging  39, 1443-8.   https://doi.org/10.1002/jmri.24317|4. Walter BA, Valera VA, Pinto PA, Merino MJ (2013). Comprehensive microRNA Profiling of Prostate Cancer. J Cancer  4, 350-7.   https://doi.org/10.7150/jca.6394|5. Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013). Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol  190, 2020-2025.   https://doi.org/10.1016/j.juro.2013.05.118",https://intramural.nih.gov/search/searchview.taf?ipid=84054
472,BC011407-04,"October 01, 2013 -  September 30, 2014",Establishment of an International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",James C Pascual,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Jacques  Grill (Gustave Roussy Institute)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Dannis  van Vuurden (VU University medical Center)|Gilbert  Vezina (Children's National Medical Center)|Show all 7,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84055
473,BC011408-04,"October 01, 2013 -  September 30, 2014",Compare substrate specificities of wild type and mutant EGFR kinases.,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Natalya  Belkina|Romi  Biswas,Heng  Zhu (Johns Hopkins Medical Institute)|Ileana  Cristea (Princeton University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84056
474,BC011410-04,"October 01, 2013 -  September 30, 2014",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Natalya  Belkina|Tapan Kumar Maity|Xu  Zhang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84058
475,BC011411-04,"October 01, 2013 -  September 30, 2014",Development of ESiPSC approach for non-germline GEM modeling,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Theresa Mae Guerin|Serguei V Kozlov,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84059
476,BC011412-04,"October 01, 2013 -  September 30, 2014",Role of MIG6 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Romi  Biswas|Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan,NULL,"Harold  Varmus; MD (Office Of The Director)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Ilona  Linnoila; MD (Laboratory Of Genitourinary Cancer Pathogenesis)",Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84060
477,BC011413-04,"October 01, 2013 -  September 30, 2014",Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,Andre  Goy (Hackensack University Medical Center)|David  Spaner (Sunybrook Health Sciences Center),"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Steven A Feldman (Surgery Branch)",NULL,"1. Kochenderfer JN, Rosenberg SA (2013). Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol  10, 267-76.   https://doi.org/10.1038/nrclinonc.2013.46",https://intramural.nih.gov/search/searchview.taf?ipid=84061
478,BC011414-04,"October 01, 2013 -  September 30, 2014",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Tapan Kumar Maity,Todd  Golub (Broad Institute of MIT and Harvard)|Marc  Ladanyi (Memorial Sloan-Kettering Cancer Center),"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84062
479,BC011415-04,"October 01, 2013 -  September 30, 2014",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ronald E Gress; MD|Frances  Hakim; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA (2013). Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood  122, 4129-39.   https://doi.org/10.1182/blood-2013-08-519413|2. Kochenderfer JN, Rosenberg SA (2013). Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol  10, 267-76.   https://doi.org/10.1038/nrclinonc.2013.46",https://intramural.nih.gov/search/searchview.taf?ipid=84063
480,BC011417-04,"October 01, 2013 -  September 30, 2014",New Chimeric Antigen Receptors for Treating Hematologic Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ronald E Gress; MD|Frances  Hakim; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84065
481,BC011418-04,"October 01, 2013 -  September 30, 2014",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Julie A Hong|Mahadev  Rao|Vivek  Shukla; BSc, MSc|Sichuan  Xi|Mary R Zhang|Colleen Donahue Bond|Show all 8",NULL,"Susan  Bates; MD (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)",NULL,"1. Peer CJ, Rao M, Spencer SD, Shahbazi S, Steeg PS, Schrump DS, Figg WD (2013). A rapid ultra HPLC-MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice. J Chromatogr B Analyt Technol Biomed Life Sci  927, 142-6.   https://doi.org/10.1016/j.jchromb.2013.01.003",https://intramural.nih.gov/search/searchview.taf?ipid=84066
482,BC011419-04,"October 01, 2013 -  September 30, 2014",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yifei  Li|Eric Young Shon|Shangjin  Sun,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84067
483,BC011422-03,"October 01, 2013 -  September 30, 2014",Role of IKKalpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI","Dennis M Klinman; MD, PhD|Giorgio  Trinchieri|Robert  Wiltrout; PhD",Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences)|Denis  Guttridge (Ohio State University)|Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Ellen  Richie (MD Anderson Cancer Center),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84094
484,BC011423-03,"October 01, 2013 -  September 30, 2014",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Bishwanath  Chatterjee; PhD|Wenyue  Sun|David  Levens; PhD,NULL,"Javed  Khan; MD (Pediatric Oncology Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Schneider G, Bowser MJ, Shin DM, Barr FG, Ratajczak MZ (2014). The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas. Int J Oncol  44, 295-300.   https://doi.org/10.3892/ijo.2013.2153",https://intramural.nih.gov/search/searchview.taf?ipid=84102
485,BC011424-03,"October 01, 2013 -  September 30, 2014",Bone Marrow Stromal Cells as Mitigators of Radiation Injury,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Grace B McKay-Corkum|Jason Andrew Horton; PhD|Bradley T Scroggins,NULL,NULL,Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84089
486,BC011425-03,"October 01, 2013 -  September 30, 2014",Expression of class I in Treg cells,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",Jie  Mu|Jocelyn D Weissman,NULL,Susan  Sharrow (Experimental Immunology Branch)|Alfred  Singer; MD (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section),NULL,"1. Mu J, Tai X, Iyer SS, Weissman JD, Singer A, Singer DS (2014). Regulation of MHC class I expression by Foxp3 and its effect on regulatory T cell function. J Immunol  192, 2892-903.   https://doi.org/10.4049/jimmunol.1302847",https://intramural.nih.gov/search/searchview.taf?ipid=84073
487,BC011426-03,"October 01, 2013 -  September 30, 2014",Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Abdul  Akram|Andrea L Ferris|Mary J McWilliams|Steven J Smith|David  Wells|Vineet Narain KewalRamani; PhD,"Zandrea  Ambrose (University of Pittsburgh)|Peter  Cherepanov (Imperial College London)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Milne (Oxford University)|Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|C  Allis (Rockefeller University)|Show all 9",Frank  Maldarelli (Host Virus Interaction Branch)|Xiaolin  Wu; PhD (Office Of The Director)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Henry L Levin; PhD (NICHD),"1. Johnson BC, Métifiot M, Ferris A, Pommier Y, Hughes SH (2013). A homology model of HIV-1 integrase and analysis of mutations designed to test the model. J Mol Biol  425, 2133-46.   https://doi.org/10.1016/j.jmb.2013.03.027|2. Koh Y, Wu X, Ferris AL, Matreyek KA, Smith SJ, Lee K, KewalRamani VN, Hughes SH, Engelman A (2013). Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration. J Virol  87, 648-58.   https://doi.org/10.1128/JVI.01148-12|3. Lauberth SM, Nakayama T, Wu X, Ferris AL, Tang Z, Hughes SH, Roeder RG (2013). H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation. Cell  152, 1021-36.   https://doi.org/10.1016/j.cell.2013.01.052|4. Varadarajan J, McWilliams MJ, Hughes SH (2013). Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Proc Natl Acad Sci U S A  110, 14747-52.   https://doi.org/10.1073/pnas.1305066110",https://intramural.nih.gov/search/searchview.taf?ipid=84068
488,BC011427-03,"October 01, 2013 -  September 30, 2014",Immunohistochemical analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jerzy P Lasota|Zengfeng  Wang; PhD,NULL,NULL,NULL,"1. Laskin WB, Lasota JP, Fetsch JF, Felisiak-Golabek A, Wang ZF, Miettinen M (2015). Intranodal palisaded myofibroblastoma: another mesenchymal neoplasm with CTNNB1 (β-catenin gene) mutations: clinicopathologic, immunohistochemical, and molecular genetic study of 18 cases. Am J Surg Pathol  39, 197-205.   https://doi.org/10.1097/PAS.0000000000000299",https://intramural.nih.gov/search/searchview.taf?ipid=84103
489,BC011429-03,"October 01, 2013 -  September 30, 2014",Zbtb family members in lymphocyte differentiation and function,Damian  Kovalovsky; PhD,NULL,"Experimental Immunology Branch, NCI",Xin  Cao|Ying  Lu|Xianyu  Zhang; MS,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84109
490,BC011431-03,"October 01, 2013 -  September 30, 2014",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",John C Flickinger,NULL,NULL,Dorian  McGavern (NINDS) |Keji  Zhao; PhD (NHLBI),"1. Lazarevic V, Glimcher LH, Lord GM (2013). T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol  13, 777-89.   https://doi.org/10.1038/nri3536",https://intramural.nih.gov/search/searchview.taf?ipid=84107
491,BC011432-03,"October 01, 2013 -  September 30, 2014",Regulation of T-bet expression in TH17 cells by microRNAs,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84108
492,BC011433-03,"October 01, 2013 -  September 30, 2014",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Benjamin Henry Blehm|Alexus Seniqua Eunique Devine|Nancy Ziyan Jiang,NULL,Gilbert  Smith; PhD (Basic Research Laboratory),NULL,"1. Brownfield DG, Venugopalan G, Lo A, Mori H, Tanner K, Fletcher DA, Bissell MJ (2013). Patterned collagen fibers orient branching mammary epithelium through distinct signaling modules. Curr Biol  23, 703-9.   https://doi.org/10.1016/j.cub.2013.03.032",https://intramural.nih.gov/search/searchview.taf?ipid=84111
493,BC011435-03,"October 01, 2013 -  September 30, 2014",Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Krista A Delviks-Frankenberry|Belete Ayele Desimmie|Colleen Patricia Furey,Yoshio  Koyanagi|Kei  Sato (Kyoto University)|Yong  Xiong (Yale University),NULL,James  Inglese (NCATS) |Scott E Martin (NCATS),"1. Desimmie BA, Delviks-Frankenberrry KA, Burdick RC, Qi D, Izumi T, Pathak VK (2014). Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol  426, 1220-45.   https://doi.org/10.1016/j.jmb.2013.10.033|2. Smith JL, Izumi T, Borbet TC, Hagedorn AN, Pathak VK (2014) HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants. J Virol 88:9893-908",https://intramural.nih.gov/search/searchview.taf?ipid=84071
494,BC011436-03,"October 01, 2013 -  September 30, 2014","Mechanisms of Antiviral Drug Resistance, Host Factors and Retroviral Replication",Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Ryan C Burdick|Krista A Delviks-Frankenberry|Wei-Shau  Hu; PhD,"Jean L Mbisa (NCI)|Julie  Overbaugh (Fred Hutchinson Cancer Research Center)|Dalton  Wamalwa (University of Nairobi)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",NULL,NULL,"1. Delviks-Frankenberry K, Paprotka T, Cingöz O, Wildt S, Hu WS, Coffin JM, Pathak VK (2013). Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2. J Virol  87, 11525-37.   https://doi.org/10.1128/JVI.01787-13|2. Hatch SC, Sardo L, Chen J, Burdick R, Gorelick R, Fivash MJ, Pathak VK, Hu WS (2013) Gag-dependent enrichment of HIV-1 RNA near the uropod membrane of polarized T cells. J Virol 87:11912-5|3. Murgai M, Thomas J, Cherepanova O, Delviks-Frankenberry K, Deeble P, Pathak VK, Rekosh D, Owens G (2013). Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels. Retrovirology  10, 34.   https://doi.org/10.1186/1742-4690-10-34|4. Nikolaitchik OA, Dilley KA, Fu W, Gorelick RJ, Tai SH, Soheilian F, Ptak RG, Nagashima K, Pathak VK, Hu WS (2013). Dimeric RNA recognition regulates HIV-1 genome packaging. PLoS Pathog  9, e1003249.   https://doi.org/10.1371/journal.ppat.1003249",https://intramural.nih.gov/search/searchview.taf?ipid=84072
495,BC011437-03,"October 01, 2013 -  September 30, 2014",Focused siRNA screening using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee,Scott  Lowe (Cold Spring Harbor Laboratory)|Frank  McCormick (UCSF School of Medicine),Natasha  Caplen (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84098
496,BC011438-03,"October 01, 2013 -  September 30, 2014",Pooled shRNA screens for target discoveries in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jordan Leigh Smith,NULL,Jayne M Stommel (Radiation Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),J Silvio  Gutkind; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84099
497,BC011439-03,"October 01, 2013 -  September 30, 2014",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Ronald E Gress; MD|Frances  Hakim; PhD,NULL,Steven A Feldman (Surgery Branch),Irina  Maric; MD (CC) |David F Stroncek; MD (CC),"1. Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN (2013). B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res  19, 2048-60.   https://doi.org/10.1158/1078-0432.CCR-12-2422",https://intramural.nih.gov/search/searchview.taf?ipid=84090
498,BC011441-03,"October 01, 2013 -  September 30, 2014",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Matthew Francis Brown|Diane Marie Kambach|Carlos A Tristan|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84100
499,BC011443-03,"October 01, 2013 -  September 30, 2014",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jennifer T Miller,"Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)|Jodi  Puglisi (Stanford University)|Nicolas  Sluis-Cremer; PhD (Department of Medicine, University of Pittsburgh)",Genoveffa  Franchini; MD (Vaccine Branch),NULL,"1. Le Grice S (2013) Conformational dynamics of reverse transcription, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. (Le Grice S, Goette M, eds., pp. 77-95.|2. Le Grice S, Nowotny M (2014) Reverse transcriptases, in Nucleic Acid Polymerases (K Murakami and M Takselis, eds.)., pp. 189-214.",https://intramural.nih.gov/search/searchview.taf?ipid=84070
500,BC011446-03,"October 01, 2013 -  September 30, 2014",The ClpP protease as a therapeutic target in bacterial and mammalian cells,Michael  Maurizi; PhD|IRP Faculty Profile,NULL,"Biochemistry of Proteins Section, NCI",Luke Evan Diorio-Toth|Ramatoulaye Kane Deme,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Alexander  Wlodawer; PhD (Protein Structure Section),Anton  Simeonov (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84074
501,BC011447-03,"October 01, 2013 -  September 30, 2014",Early Clinical Trials for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",John Walter Glod|Brigitte  Widemann; MD|Crystal L. Mackall; MD|Melinda S Merchant|Pamela  Wolters,"Susan  Blaney (Baylor University/TCCC)|James  Boyett (St Jude Children's Research Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Larry  Kun (Radiation Oncology, St. Jude Children's Research Hospital)|Roger  Packer (CNMC)|Show all 16",Aradhana  Kaushal (Radiation Oncology Branch),"Russell R Lonser; MD (NINDS) |John D Heiss; MD (NINDS) |Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC)","1. Fangusaro J, Gururangan S, Poussaint TY, McLendon RE, Onar-Thomas A, Warren KE, Wu S, Packer RJ, Banerjee A, Gilbertson RJ, Jakacki R, Gajjar A, Goldman S, Pollack IF, Friedman HS, Boyett JM, Kun LE, Fouladi M (2013). Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer  119, 4180-7.   https://doi.org/10.1002/cncr.28343|2. Fangusaro J, Warren KE (2013). Unclear standard of care for pediatric high grade glioma patients. J Neurooncol  113, 341-2.   https://doi.org/10.1007/s11060-013-1104-8|3. Steffen-Smith EA, Baker EH, Venzon D, Shandilya S, Bent RS, Warren KE (2014). Measurements of the pons as a biomarker of progression for pediatric DIPG. J Neurooncol  116, 127-33.   https://doi.org/10.1007/s11060-013-1266-4|4. Warren K (2013) Novel therapeutic delivery approaches in development for pediatric gliomas. Future Oncol 2:427-35|5. Warren KE (2013). Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncol  2, 427-35.   https://doi.org/10.2217/cns.13.37|6. Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW (2013). Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer  60, 1397-401.   https://doi.org/10.1002/pbc.24562",https://intramural.nih.gov/search/searchview.taf?ipid=84086
502,BC011449-03,"October 01, 2013 -  September 30, 2014",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,"1. Kim YS, Nagy K, Keyser S, Schneekloth JS (2013). An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation. Chem Biol  20, 604-13.   https://doi.org/10.1016/j.chembiol.2013.04.001",https://intramural.nih.gov/search/searchview.taf?ipid=84104
503,BC011450-03,"October 01, 2013 -  September 30, 2014",Clinical treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Jedd  Wolchok (Memorial Sloan-Kettering),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84101
504,BC011456-03,"October 01, 2013 -  September 30, 2014",Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Amit Shrikant Adhikari; PhD|Teresa L Sullivan,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84091
505,BC011458-03,"October 01, 2013 -  September 30, 2014",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Hisataka  Kobayashi (Molecular Imaging Program)|John  Schiller; PhD (Laboratory of Cellular Oncology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84110
506,BC011459-03,"October 01, 2013 -  September 30, 2014",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Allan M Weissman; MD,NULL,Kyung  Lee; PhD (Chemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84106
507,BC011460-03,"October 01, 2013 -  September 30, 2014",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Upasana  Ray,NULL,NULL,NULL,"1. Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB (2013). BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. J Virol  87, 10105-13.   https://doi.org/10.1128/JVI.01189-13",https://intramural.nih.gov/search/searchview.taf?ipid=84076
508,BC011461-03,"October 01, 2013 -  September 30, 2014",The Role of RISC Proteins in HIV-1 Replication,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Christopher Lee Case; PhD|Ioannis N Kagiampakis|Kyeongeun  Lee|Hyun Jae  Yu|Wendy  Yuen|Eric O Freed; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84069
509,BC011462-03,"October 01, 2013 -  September 30, 2014",Establishing the Preclinical Model for Metastatic Melanoma,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Maureen Baran Gearheart|Rajaa  Elmeskini|Theresa Mae Guerin|Michelle Leann Gumprecht|Alan Edward Kulaga|Philip L Martin|Show all 7,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Arthur A Hurwitz (Laboratory of Molecular Immunoregulation),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84092
510,BC011463-03,"October 01, 2013 -  September 30, 2014",Adoption and Retooling of GEM model for Pancreatic Cancer,Terry Anne Van Dyke,NULL,"Office of the Director, NCI","Maureen Baran Gearheart|Theresa Mae Guerin|Serguei V Kozlov|Philip L Martin|Jerome  Schlomer|Ludmila  Szabova; MS, PhD",Ron  Evans (Salk Institute)|Mila  McCurrack (Lustgarten Foundation),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84093
511,BC011464-03,"October 01, 2013 -  September 30, 2014",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Sophie Allende Dean|Junko  Hattori|Shawn A Hill|Francesco Roberto Simonetti; MD|Sarah Anne Watters|Monica Ann Gouzoulis,Anuradha  Ganesan (Henry M. Jackson Foundation)|Deborah  McMahon (University of Pittsburgh)|John W Mellors|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Indira  Hewlett (U.S. Food and Drug Administration)|Show all 7,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Richard T Davey; MD (NIAID) |Michael  Proschan; PhD (NIAID) |H. Clifford  Lane; MD (NIAID) |Henry  Masur; MD (CC) |Irini  Sereti; MD (NIAID),"1. Casazza JP, Bowman KA, Adzaku S, Smith EC, Enama ME, Bailer RT, Price DA, Gostick E, Gordon IJ, Ambrozak DR, Nason MC, Roederer M, Andrews CA, Maldarelli FM, Wiegand A, Kearney MF, Persaud D, Ziemniak C, Gottardo R, Ledgerwood JE, Graham BS, Koup RA, VRC 101 Study Team (2013). Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire. J Infect Dis  207, 1829-40.   https://doi.org/10.1093/infdis/jit098",https://intramural.nih.gov/search/searchview.taf?ipid=84077
512,BC011465-03,"October 01, 2013 -  September 30, 2014",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Zuqin  Nie; PhD|Suzanne Laurie Sanford|Lipeng  Wu|Ying  Zheng,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Rafael Cristian Casellas; PhD (NIAMS) |Keji  Zhao; PhD (NHLBI),"1. Kaur S, Soto-Pantoja DR, Stein EV, Liu C, Elkahloun AG, Pendrak ML, Nicolae A, Singh SP, Nie Z, Levens D, Isenberg JS, Roberts DD (2013). Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors. Sci Rep  3, 1673.   https://doi.org/10.1038/srep01673|2. Levens D, Aplan PD (2013). Notching up MYC gives a LIC. Cell Stem Cell  13, 8-9.   https://doi.org/10.1016/j.stem.2013.06.008|3. Rosales T, Nie Z, Kapoor V, Casellas R, Knutson JR, Levens D (2013). Partition of Myc into immobile vs. mobile complexes within nuclei. Sci Rep  3, 1953.   https://doi.org/10.1038/srep01953",https://intramural.nih.gov/search/searchview.taf?ipid=84075
513,BC011466-03,"October 01, 2013 -  September 30, 2014",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Junko  Hattori|Shawn A Hill|Francesco Roberto Simonetti; MD|Charmaine Elisabeth Joanna Peters,Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University)|Anuradha  Ganesan (Henry M. Jackson Foundation)|Deborah  McMahon (University of Pittsburgh)|John W Mellors|Helene  Mens (Copenhagen University)|Show all 7,Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Joseph P Casazza (NIAID) |Richard T Davey; MD (NIAID) |Michele  Di Mascio; PhD (NIAID) |Dean  Follmann; PhD (NIAID) |Joseph A Kovacs; MD (CC) |Mark  Connors; MD (NIAID),"1. Casazza JP, Bowman KA, Adzaku S, Smith EC, Enama ME, Bailer RT, Price DA, Gostick E, Gordon IJ, Ambrozak DR, Nason MC, Roederer M, Andrews CA, Maldarelli FM, Wiegand A, Kearney MF, Persaud D, Ziemniak C, Gottardo R, Ledgerwood JE, Graham BS, Koup RA, VRC 101 Study Team (2013). Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire. J Infect Dis  207, 1829-40.   https://doi.org/10.1093/infdis/jit098|2. Josefsson L, Palmer S, Faria NR, Lemey P, Casazza J, Ambrozak D, Kearney M, Shao W, Kottilil S, Sneller M, Mellors J, Coffin JM, Maldarelli F (2013). Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog  9, e1003432.   https://doi.org/10.1371/journal.ppat.1003432|3. Shao W, Boltz VF, Spindler JE, Kearney MF, Maldarelli F, Mellors JW, Stewart C, Volfovsky N, Levitsky A, Stephens RM, Coffin JM (2013). Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. Retrovirology  10, 18.   https://doi.org/10.1186/1742-4690-10-18",https://intramural.nih.gov/search/searchview.taf?ipid=84078
514,BC011469-03,"October 01, 2013 -  September 30, 2014",Building Libraries with Chemical Diversity for Screening,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Jason R Evans|Ekaterina  Goncharo|Cheryl L Thomas,Sergazy  Adekenov (International Research and Production Holding Phytochemistry)|Jeff  Aube (University of Kansas)|Darkan  Balpanaov (Biomedpreparat)|Young Ho  Kim|John  Porco (Boston University)|B.  Shen (Scripps Research Institute)|Show all 7,NULL,NULL,"1. Henrich CJ, Beutler JA (2013). Matching the power of high throughput screening to the chemical diversity of natural products. Nat Prod Rep  30, 1284-98.   https://doi.org/10.1039/c3np70052f|2. Winter DK, Endoma-Arias MA, Hudlicky T, Beutler JA, Porco JA (2013). Enantioselective total synthesis and biological evaluation of (+)-kibdelone A and a tetrahydroxanthone analogue. J Org Chem  78, 7617-26.   https://doi.org/10.1021/jo401169z",https://intramural.nih.gov/search/searchview.taf?ipid=84082
515,BC011470-03,"October 01, 2013 -  September 30, 2014",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"William  Chain (University of Hawaii)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Kathlyn  Parker (Stony Brook University)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)","William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Karlyne M Reilly; BS, PhD (Office of the Director)",NULL,"1. Devkota KP, Wilson JA, Henrich CJ, McMahon JB, Reilly KM, Beutler JA (2014). Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells. Phytochem Lett  7, 42-45.   https://doi.org/10.1016/j.phytol.2013.09.007|2. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007",https://intramural.nih.gov/search/searchview.taf?ipid=84083
516,BC011471-03,"October 01, 2013 -  September 30, 2014",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Kirk R Gustafson; PhD,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|John Stephen Schneekloth (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84084
517,BC011472-03,"October 01, 2013 -  September 30, 2014",Isolation of antiviral proteins from natural product extracts.,Barry R O'Keefe,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",NULL,"Paul  Christou (Universitat de Lleida)|Edward  Karamov (Ivanovsky Institute of Virology)|Lynn  Morris (National Institute for Communicable Diseases)|Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Melissa  Robbiani (The Population Council)|Show all 7",Alexander  Wlodawer; PhD (Protein Structure Section),Darryl Lee Falzarano (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84085
518,BC011476-02,"October 01, 2013 -  September 30, 2014",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Sherry Jones Coulter; BS|Gabriel Arther Knudsen|Abdella Mohammed Sadik|J Michael Sanders; PhD,Marian  Pavuk (CDC)|Hoang  Quynh (University of Hanoi)|Arnold  Schecter (NIEHS)|Steven T Szabo,NULL,Stavros  Garantziotis; MD (NIEHS) |Gaylia Jean Harry; PhD (NIEHS) |Kristina Thayer Chialton; PhD (NIEHS),"1. Burns KA, Zorrilla LM, Hamilton KJ, Reed CE, Birnbaum LS, Korach KS (2013). A single gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin disrupts the adult uterine response to estradiol in mice. Toxicol Sci  136, 514-26.   https://doi.org/10.1093/toxsci/kft208|2. Emond C, Sanders JM, Wikoff D, Birnbaum LS (2013). Proposed mechanistic description of dose-dependent BDE-47 urinary elimination in mice using a physiologically based pharmacokinetic model. Toxicol Appl Pharmacol  273, 335-44.   https://doi.org/10.1016/j.taap.2013.09.007|3. Frawley R, DeVito M, Walker NJ, Birnbaum L, White K, Smith M, Maynor T, Recio L, Germolec D (2014). Relative potency for altered humoral immunity induced by polybrominated and polychlorinated dioxins/furans in female B6C3F1/N mice. Toxicol Sci  139, 488-500.   https://doi.org/10.1093/toxsci/kfu041|4. Hoffman K, Fang M, Horman B, Patisaul HB, Garantziotis S, Birnbaum LS, Stapleton HM (2014). Urinary tetrabromobenzoic acid (TBBA) as a biomarker of exposure to the flame retardant mixture Firemaster® 550. Environ Health Perspect  122, 963-9.   https://doi.org/10.1289/ehp.1308028|5. Knudsen GA, Sanders JM, Sadik AM, Birnbaum LS (2014). TITLE Disposition and kinetics of Tetrabromobisphenol A in female Wistar Han rats. Toxicol Rep  1, 214-223.   https://doi.org/10.1016/j.toxrep.2014.03.005|6. Sueyoshi T, Li L, Wang H, Moore R, Kodavanti PR, Lehmler HJ, Negishi M, Birnbaum LS (2014). Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes. Toxicol Sci  137, 292-302.   https://doi.org/10.1093/toxsci/kft243",https://intramural.nih.gov/search/searchview.taf?ipid=84162
519,BC011478-02,"October 01, 2013 -  September 30, 2014",Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Tracy Erin Campbell|Sanja  Stevanovic; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84145
520,BC011479-02,"October 01, 2013 -  September 30, 2014",T-cell receptor gene therapy for human papillomavirus-positive cancers,Christian S Hinrichs|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Tracy Erin Campbell|Sanja  Stevanovic; PhD,NULL,NULL,NULL,"1. Hinrichs CS, Rosenberg SA (2014). Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol Rev  257, 56-71.   https://doi.org/10.1111/imr.12132",https://intramural.nih.gov/search/searchview.taf?ipid=84146
521,BC011480-02,"October 01, 2013 -  September 30, 2014",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Sanjivan  Gautam|Jinhui  Hu|Yun  Ji|Semele Hillary Liu|Chien Yuan Zhou|James N Kochenderfer,"Carl  June (University of Pennsylavnia)|Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Dietmar  Zehn (Swiss Vaccine Research Institute)|Philip  Brohawn (Medimmune)",Nicholas Phillip Restifo; MD (Surgery Branch),"Toren  Finkel; MD, PhD (NHLBI) |Stefan Adi Muljo; PhD (NIAID) |Mario  Roederer; PhD (NIAID) |David F Stroncek; MD (CC) |John S Tsang; PhD (NIAID) |Ena  Wang (CC)","1. Dudda JC, Salaun B, Ji Y, Palmer DC, Monnot GC, Merck E, Boudousquie C, Utzschneider DT, Escobar TM, Perret R, Muljo SA, Hebeisen M, Rufer N, Zehn D, Donda A, Restifo NP, Held W, Gattinoni L, Romero P (2013). MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity  38, 742-53.   https://doi.org/10.1016/j.immuni.2012.12.006|2. Lugli E, Dominguez MH, Gattinoni L, Chattopadhyay PK, Bolton DL, Song K, Klatt NR, Brenchley JM, Vaccari M, Gostick E, Price DA, Waldmann TA, Restifo NP, Franchini G, Roederer M (2013). Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest  123, 594-9.   https://doi.org/10.1172/JCI66327|3. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M (2013). Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc  8, 33-42.   https://doi.org/10.1038/nprot.2012.143|4. Restifo NP, Gattinoni L (2013). Lineage relationship of effector and memory T cells. Curr Opin Immunol  25, 556-63.   https://doi.org/10.1016/j.coi.2013.09.003|5. Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG, Yu Z, Roychoudhuri R, Palmer DC, Muranski P, Karoly ED, Mohney RP, Klebanoff CA, Lal A, Finkel T, Restifo NP, Gattinoni L (2013). Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest  123, 4479-88.   https://doi.org/10.1172/JCI69589|6. Thaventhiran JE, Fearon DT, Gattinoni L (2013). Transcriptional regulation of effector and memory CD8+ T cell fates. Curr Opin Immunol  25, 321-8.   https://doi.org/10.1016/j.coi.2013.05.010",https://intramural.nih.gov/search/searchview.taf?ipid=84122
522,BC011482-02,"October 01, 2013 -  September 30, 2014",Evaluation of the Natural History of Patients withTumors of the Central Nervous,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),"John Anthony Butman; MD, PhD (CC) |John Keenam Park (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84133
523,BC011484-02,"October 01, 2013 -  September 30, 2014",Develop novel therapeutics for patients with treatment resistant glioma,Teri Nguyen Kreisl; MD,NULL,"Neuro-Oncology Branch, NCI",NULL,NULL,"Cody John Peer (Office Of The Clinical Director)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84134
524,BC011485-02,"October 01, 2013 -  September 30, 2014",Forkhead-box (FOX) Transcription Factors in the Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Peijun  He|Shouhui  Yang; PhD,"Jochen  Gaedcke|H Richard  Alexander (University of Maryland Medical System)|Michael  Ghadimi (Surgery, U. of Goettingen)|Nader  Hanna (University of Maryland Medical System)|Harris  Yfantis (Veteran Affairs Medical Center)",Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Zhang G, He P, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Hanna N, Alexander HR, Hussain SP (2013). FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Cancer Res  73, 5416-25.   https://doi.org/10.1158/0008-5472.CAN-13-0362",https://intramural.nih.gov/search/searchview.taf?ipid=84121
525,BC011486-02,"October 01, 2013 -  September 30, 2014",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Nicole  Delino|Kenji  Maeda|Shota  Ono|Yuki  Takamatsu; MD,Masayuki  Amano (Kumamoto University School of Medicine)|Manabu  Aoki (Kumamoto Health Science University)|Hiroyuki  Hayakawa (Yamasa Corporation)|Hiromi  Ogata-Aoki (Kumamoto University School of Medicine),NULL,NULL,"1. Hachiya A, Reeve AB, Marchand B, Michailidis E, Ong YT, Kirby KA, Leslie MD, Oka S, Kodama EN, Rohan LC, Mitsuya H, Parniak MA, Sarafianos SG (2013). Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral Drugs. Antimicrob Agents Chemother  57, 4554-4558.   https://doi.org/10.1128/AAC.00283-13|2. Kirby KA, Michailidis E, Fetterly TL, Steinbach MA, Singh K, Marchand B, Leslie MD, Hagedorn AN, Kodama EN, Marquez VE, Hughes SH, Mitsuya H, Parniak MA, Sarafianos SG (2013). Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosine. Antimicrob Agents Chemother  57, 6254-64.   https://doi.org/10.1128/AAC.01703-13|3. Michailidis E, Ryan EM, Hachiya A, Kirby KA, Marchand B, Leslie MD, Huber AD, Ong YT, Jackson JC, Singh K, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG (2013). Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. Retrovirology  10, 65.   https://doi.org/10.1186/1742-4690-10-65",https://intramural.nih.gov/search/searchview.taf?ipid=84114
526,BC011487-02,"October 01, 2013 -  September 30, 2014",Systems-level analysis of the regulation and function of c-Myc,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian Eric Fisher|David  Levens; PhD|David D Roberts; PhD,NULL,Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84148
527,BC011488-02,"October 01, 2013 -  September 30, 2014",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Julie Marie Garlick|Rhushikesh Arun Kulkarni; PhD|David Church Montgomery|Alexander William Sorum|Neil Kamal Tiwari|Thomas Tineyi Zengeya,Andrew  Andrews (Fox Chase Cancer Center)|Ian  Blair (University of Pennsylvania Perelman School of Medicine)|Masoud  Vedadi (University of Toronto),Murali  Krishna; PhD (Radiation Biology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),Ajit  Jadhav (NCATS) |David J Maloney (NCATS) |Anton  Simeonov (NCATS),"1. Meier JL (2013). Metabolic mechanisms of epigenetic regulation. ACS Chem Biol  8, 2607-21.   https://doi.org/10.1021/cb400689r",https://intramural.nih.gov/search/searchview.taf?ipid=84158
528,BC011490-02,"October 01, 2013 -  September 30, 2014",Ubiquitin signaling,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,Daniel  Finley (Harvard Medical School)|Simona  Polo (University of Milan)|Aaron  Ehlinger (University of Minnesota)|Richard  Roden (The Johns Hopkins University),NULL,NULL,"1. Anchoori RK, Karanam B, Peng S, Wang JW, Jiang R, Tanno T, Orlowski RZ, Matsui W, Zhao M, Rudek MA, Hung CF, Chen X, Walters KJ, Roden RB (2013). A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell  24, 791-805.   https://doi.org/10.1016/j.ccr.2013.11.001|2. Ehlinger A, Park S, Fahmy A, Lary JW, Cole JL, Finley D, Walters KJ (2013). Conformational dynamics of the Rpt6 ATPase in proteasome assembly and Rpn14 binding. Structure  21, 753-65.   https://doi.org/10.1016/j.str.2013.02.021|3. Ehlinger A, Walters KJ (2013). Structural insights into proteasome activation by the 19S regulatory particle. Biochemistry  52, 3618-28.   https://doi.org/10.1021/bi400417a",https://intramural.nih.gov/search/searchview.taf?ipid=84159
529,BC011491-02,"October 01, 2013 -  September 30, 2014",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Mary Kate  Bonner; PhD|Hyunmi Kim Halas; PhD|Justin Xuan Zhang,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84157
530,BC011492-02,"October 01, 2013 -  September 30, 2014","Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Matthew J Blackburn|Elise Dawn Bowman|Tomer  Cooks|Kristen Leigh Greathouse|Majda  Haznadar|Teruhide  Ishigame; PhD, MD|Show all 19",William J Blot|Markus  Mohler (University of Mainz)|Bert R Vogelstein|Wataru  Yasui (Hiroshima University)|Jun  Yokota (National Cancer Center Research Institute)|Lorne J Hofseth|Show all 7,"Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Julia A Segre; PhD (NHGRI),"1. Akagi I, Okayama H, Schetter AJ, Robles AI, Kohno T, Bowman ED, Kazandjian D, Welsh JA, Oue N, Saito M, Miyashita M, Uchida E, Takizawa T, Takenoshita S, Skaug V, Mollerup S, Haugen A, Yokota J, Harris CC (2013). Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. Cancer Res  73, 3821-32.   https://doi.org/10.1158/0008-5472.CAN-13-0031|2. Nakaoku T, Tsuta K, Ichikawa H, Shiraishi K, Sakamoto H, Enari M, Furuta K, Shimada Y, Ogiwara H, Watanabe S, Nokihara H, Yasuda K, Hiramoto M, Nammo T, Ishigame T, Schetter AJ, Okayama H, Harris CC, Kim YH, Mishima M, Yokota J, Yoshida T, Kohno T (2014). Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res  20, 3087-93.   https://doi.org/10.1158/1078-0432.CCR-14-0107|3. Olivo-Marston SE, Hursting SD, Perkins SN, Schetter A, Khan M, Croce C, Harris CC, Lavigne J (2014). Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression. PLoS One  9, e94765.   https://doi.org/10.1371/journal.pone.0094765|4. Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, Khan MA, Bowman ED, Mueller A, Schad A, Shimomura M, Hinoi T, Aoyagi K, Sasaki H, Okajima M, Ohdan H, Galle PR, Yasui W, Harris CC (2014). High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer  134, 1926-34.   https://doi.org/10.1002/ijc.28522|5. Poudyal D, Cui X, Le PM, Hofseth AB, Windust A, Nagarkatti M, Nagarkatti PS, Schetter AJ, Harris CC, Hofseth LJ (2013). A key role of microRNA-29b for the suppression of colon cancer cell migration by American ginseng. PLoS One  8, e75034.   https://doi.org/10.1371/journal.pone.0075034|6. Robles AI, Harris CC (2013). A primate-specific microRNA enters the lung cancer landscape. Proc Natl Acad Sci U S A  110, 18748-9.   https://doi.org/10.1073/pnas.1318740110|7. Ui A, Ogiwara H, Nakajima S, Kanno S, Watanabe R, Harata M, Okayama H, Harris CC, Yokota J, Yasui A, Kohno T (2014). Possible involvement of LKB1-AMPK signaling in non-homologous end joining. Oncogene  33, 1640-8.   https://doi.org/10.1038/onc.2013.125|8. Yanaihara N, Harris CC (2013). MicroRNA Involvement in Human Cancers. Clin Chem  59, 1811-2.   https://doi.org/10.1373/clinchem.2012.198176",https://intramural.nih.gov/search/searchview.taf?ipid=84116
531,BC011493-02,"October 01, 2013 -  September 30, 2014","Molecular Oncology of Pediatric, Adolescent and Young Adult Sarcomas",Fernanda  Arnaldez,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD,NULL,"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84135
532,BC011494-02,"October 01, 2013 -  September 30, 2014",Development of Therapeutic Approaches for Wild-Type GIST,Fernanda  Arnaldez,NULL,"Pediatric Oncology Branch, NCI",Lee Jay Helman; MD|Brigitte  Widemann; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84136
533,BC011495-02,"October 01, 2013 -  September 30, 2014",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Elise Dawn Bowman|Kristen Leigh Greathouse|Majda  Haznadar|Mohammed A. Khan; PhD|Hirokazu  Okayama; PhD|Emily Jean Place|Show all 11,"William J Blot|Ann  Schwartz (Karmanos Cancer Institute)|Ping  Yang; MD, PhD (Mayo Clinic)|Jun  Yokota (National Cancer Center Research Institute)","Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)",NULL,"1. Chang CM, Chia VM, Gunter MJ, Zanetti KA, Ryan BM, Goodman JE, Harris CC, Weissfeld J, Huang WY, Chanock S, Yeager M, Hayes RB, Berndt SI, Genetics and Epidemiology of Colorectal Cancer Consortium (2013). Innate immunity gene polymorphisms and the risk of colorectal neoplasia. Carcinogenesis  34, 2512-20.   https://doi.org/10.1093/carcin/bgt228|2. Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, Brenner H, Müller H, Harris CC, Duell EJ, Andrew AS, McLaughlin JR, Schwartz AG, Wenzlaff AS, Stucker I (2013). Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer  109, 1954-64.   https://doi.org/10.1038/bjc.2013.506|3. Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC (2014). Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer  134, 1399-407.   https://doi.org/10.1002/ijc.28457",https://intramural.nih.gov/search/searchview.taf?ipid=84117
534,BC011496-02,"October 01, 2013 -  September 30, 2014","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Tomer  Cooks|Izumi  Horikawa|Teruhide  Ishigame; PhD, MD|Elisa A Spillare|Casmir Elyse Turnquist-Held|Natalia  von Muhlinen; PhD",NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)",NULL,"1. Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N, Rozenfeld N, Harpaz N, Itzkowitz S, Harris CC, Rotter V, Gorgoulis VG, Oren M (2013). Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell  23, 634-46.   https://doi.org/10.1016/j.ccr.2013.03.022|2. Cui X, Witalison EE, Chumanevich AP, Chumanevich AA, Poudyal D, Subramanian V, Schetter AJ, Harris CC, Thompson PR, Hofseth LJ (2013). The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. PLoS One  8, e53791.   https://doi.org/10.1371/journal.pone.0053791|3. Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, Vera E, Mazur SJ, Appella E, Vojtesek B, Blasco MA, Lane DP, Harris CC (2013). p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J Clin Invest  123, 5247-57.   https://doi.org/10.1172/JCI70355|4. Nguyen GH, Dexheimer TS, Rosenthal AS, Chu WK, Singh DK, Mosedale G, Bachrati CZ, Schultz L, Sakurai M, Savitsky P, Abu M, McHugh PJ, Bohr VA, Harris CC, Jadhav A, Gileadi O, Maloney DJ, Simeonov A, Hickson ID (2013). A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells. Chem Biol  20, 55-62.   https://doi.org/10.1016/j.chembiol.2012.10.016|5. Nguyen GH, Tang W, Robles AI, Beyer RP, Gray LT, Welsh JA, Schetter AJ, Kumamoto K, Wang XW, Hickson ID, Maizels N, Monnat RJ, Harris CC (2014). Regulation of gene expression by the BLM helicase correlates with the presence of G-quadruplex DNA motifs. Proc Natl Acad Sci U S A  111, 9905-10.   https://doi.org/10.1073/pnas.1404807111",https://intramural.nih.gov/search/searchview.taf?ipid=84118
535,BC011498-02,"October 01, 2013 -  September 30, 2014",Clinical Trials of Immunotherapies for Childhood Cancer,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",Donna B Bernstein|Cynthia P Love|Kelly D Richards|Hua  Zhang|Rosandra N Kaplan,"Malcolm  Brenner (Baylor College of Medicine)|NaiKong  Cheung (Memorial Sloan Kettering Cancer Center)|Steven  Grupp (Children's Hospital of Philadelphia)|Carl  June (University of Pennsylvania)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Nabil F Ahmed (Information Resource & Technology Management Branch)|Show all 8","Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",David F Stroncek; MD (CC),"1. Tumaini B, Lee DW, Lin T, Castiello L, Stroncek DF, Mackall C, Wayne A, Sabatino M (2013). Simplified process for the production of anti-CD19-CAR-engineered T cells. Cytotherapy  15, 1406-15.   https://doi.org/10.1016/j.jcyt.2013.06.003|2. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL (2013). Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood  122, 1105-13.   https://doi.org/10.1182/blood-2012-08-449413",https://intramural.nih.gov/search/searchview.taf?ipid=84115
536,BC011500-02,"October 01, 2013 -  September 30, 2014",Pathogenesis and therapy of KSHV-associated Malignancies,Mark Niccolo Polizzotto; MD,NULL,"HIV and AIDS Malignancy Branch, NCI",Joseph M Ziegelbauer,Christina  Chang (Alfred Hospital)|Vikram  Khetani (Celgene Corporation)|Peter  Medveczky (University of South Florida)|Harold  Tjalsma (Radboud University Nijmegen Medical Center)|Ian  Woolley (Alfred Hospital)|Jerome  Zeldis (Celgene Corporation)|Show all 7,"Frank  Maldarelli (Host Virus Interaction Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Denise  Whitby (Office Of The Director)|Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|William D Figg; PharmD (Genitourinary Malignancies Branch)","Amir Hossein Gandjbakhche; PhD (NICHD) |Peter  Herscovitch; MD (CC) |Vojtech  Huser; MD, PhD (CC) |Corina M Millo; MD (CC) |Irini  Sereti; MD (NIAID)","1. Kainerstorfer JM, Polizzotto MN, Uldrick TS, Rahman R, Hassan M, Najafizadeh L, Ardeshirpour Y, Wyvill KM, Aleman K, Smith PD, Yarchoan R, Gandjbakhche AH (2013). Evaluation of non-invasive multispectral imaging as a tool for measuring the effect of systemic therapy in Kaposi sarcoma. PLoS One  8, e83887.   https://doi.org/10.1371/journal.pone.0083887|2. Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, Pittaluga S, O'Mahony D, Whitby D, Tosato G, Steinberg SM, Little RF, Yarchoan R (2013). Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood  122, 4189-98.   https://doi.org/10.1182/blood-2013-08-519959|3. Shahbazi S, Peer CJ, Polizzotto MN, Uldrick TS, Roth J, Wyvill KM, Aleman K, Zeldis JB, Yarchoan R, Figg WD (2014). A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analyses. J Pharm Biomed Anal  92, 63-8.   https://doi.org/10.1016/j.jpba.2014.01.001",https://intramural.nih.gov/search/searchview.taf?ipid=84141
537,BC011501-02,"October 01, 2013 -  September 30, 2014",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Sarah Faith Clatterbuck Soper; PhD|Rachel Michelle Gilbert|Susan Mary Hamilla|Tianhong  Wang|Kyota  Yasuda; PhD,Helim  Aranda-Espinoza (University of Maryland)|Wolfgang  Losert (University of Maryland),NULL,NULL,"1. Yasuda K, Zhang H, Loiselle D, Haystead T, Macara IG, Mili S (2013). The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J Cell Biol  203, 737-46.   https://doi.org/10.1083/jcb.201306058",https://intramural.nih.gov/search/searchview.taf?ipid=84154
538,BC011502-02,"October 01, 2013 -  September 30, 2014",Development and use of nanoFACS for analysis and sorting of nanoparticles,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Ife  Balogun|Jay Arthur Berzofsky; MD, PhD|Marjorie  Robert-Guroff; PhD|Katherine M McKinnon","Marty  Bigos (Stanford)|Sally Penny  Chisholm (MIT)|Tigges  John (BIDMC)|Susan  Knox (Stanford)|Roy  Overton (Partec, North America)|David  Park (Stanford)|Show all 9",Kevin A Camphausen; MD (Radiation Oncology Branch)|Norman Norman Coleman; MD (Radiation Research Program)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Anu  Puri; PhD (Basic Research Laboratory)|William G Telford (Experimental Transplantation and Immunology Branch)|Jane Beth Trepel (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84155
539,BC011503-02,"October 01, 2013 -  September 30, 2014",Novel Combinations of Radiation and Immunotherapy,"Jennifer Clare Jones; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Ife  Balogun|Jay Arthur Berzofsky; MD, PhD|George N Pavlakis; MD, PhD",Susan  Knox (Stanford)|Dale  Umetsu (Children's Hospital Boston)|Rosemarie  DeKruyff (Children's Hospital Boston)|Gordon  Freeman (Harvard),Kevin A Camphausen; MD (Radiation Oncology Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology),Darrell  Hurt (NIAID),"1. Jones JC, Freeman GJ (2013). Costimulatory genes: hotspots of conflict between host defense and autoimmunity. Immunity  38, 1083-5.   https://doi.org/10.1016/j.immuni.2013.06.008|2. Parker JJ, Jones JC, Strober S, Knox SJ (2013). Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line. Clin Immunol  148, 44-55.   https://doi.org/10.1016/j.clim.2013.03.008",https://intramural.nih.gov/search/searchview.taf?ipid=84156
540,BC011504-02,"October 01, 2013 -  September 30, 2014",Study the roles of p53 and p53 mutants in mesenchymal stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Glenn  Merlino; PhD,NULL,Chand  Khanna; MD (Pediatric Oncology Branch)|Jianxin  Shi (Biostatistics Branch)|Maxwell P Lee; PhD (Basic Research Laboratory),Pamela Gehron Robey; PhD (NIDCR),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84137
541,BC011505-02,"October 01, 2013 -  September 30, 2014",Characterization of the hematopoietic stem cell lineage,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder,NULL,Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Domyan ET, Branchfield K, Gibson DA, Naiche LA, Lewandoski M, Tessier-Lavigne M, Ma L, Sun X (2013). Roundabout receptors are critical for foregut separation from the body wall. Dev Cell  24, 52-63.   https://doi.org/10.1016/j.devcel.2012.11.018",https://intramural.nih.gov/search/searchview.taf?ipid=84113
542,BC011506-02,"October 01, 2013 -  September 30, 2014",New Synthetic Approaches to Small Molecules for Imaging,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Alexander Patrick Gorka|Roger Rauhauser Nani|James Blaine Shaum,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|David Anderson Wink (Radiation Biology Branch)|Hisataka  Kobayashi (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84153
543,BC011511-02,"October 01, 2013 -  September 30, 2014",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Amanda Lee Whiting,NULL,Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Staudt L, Bernal F, Yang Y (submitted in 2013) Inhibitors Of The Linear Ubiquitin Chain Assembly Complex (lubac) And Related Methods. Patent issued: 9,783,586 (US in 2018). Patent pending: PCT/US2014/023006 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=84143
544,BC011512-02,"October 01, 2013 -  September 30, 2014",Activatable molecular cancer imaging probe,Hisataka  Kobayashi,Peter L Choyke; MD,"Molecular Imaging Program, NCI",Hirofumi  Hanaoka|Chia Pin  Liang|Takahito  Nakajima; PhD|Rira  Watanabe; PhD,Neil  Bander (Cornell Univ)|Derek  Bartlett (ImaginAb)|Yu  Chen (Univ of Maryland)|Marcin  Ptaszek (UMBC)|Yasuteru  Urano,Terry Anne Van Dyke (Mouse Cancer Genetics Program)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Matthew R Young; PhD (Basic Research Laboratory),NULL,"1. Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H (2014). Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites. Cancer Sci  105, 308-14.   https://doi.org/10.1111/cas.12343|2. Sano K, Nakajima T, Ali T, Bartlett DW, Wu AM, Kim I, Paik CH, Choyke PL, Kobayashi H (2013). Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. J Biomed Opt  18, 101304.   https://doi.org/10.1117/1.JBO.18.10.101304|3. Sano K, Nakajima T, Miyazaki K, Ohuchi Y, Ikegami T, Choyke PL, Kobayashi H (2013). Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes. Bioconjug Chem  24, 811-6.   https://doi.org/10.1021/bc400050k",https://intramural.nih.gov/search/searchview.taf?ipid=84128
545,BC011513-02,"October 01, 2013 -  September 30, 2014",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi,Peter L Choyke; MD,"Molecular Imaging Program, NCI",NULL,Zaver  Bhujwalla (Johns Hopkins)|Yu  Chen (Univ of Maryland)|Toshiyoshi  Fujiwara (Okayama Univ)|Peter  Marinkovich (Stnford Univ)|Mikako  Ogawa,"Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Kobayashi H, Watanabe R, Choyke PL (2013). Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics  4, 81-9.   https://doi.org/10.7150/thno.7193|2. Nakajima T, Sano K, Choyke PL, Kobayashi H (2013). Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model. Theranostics  3, 357-65.   https://doi.org/10.7150/thno.5908|3. Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2013). Acute cytotoxic effects of photoimmunotherapy assessed by 18F-FDG PET. J Nucl Med  54, 770-5.   https://doi.org/10.2967/jnumed.112.112110",https://intramural.nih.gov/search/searchview.taf?ipid=84129
546,BC011514-02,"October 01, 2013 -  September 30, 2014",Investigating Pediatric CNS tumor biology,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Javad  Nazarian (Children's National Medical Center)|Eric H Raabe|Nada  Jabado (McGill University)|Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Fausto  Rodriguez (Johns Hopkins University)","Leomar Y Ballester; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Jonathan Keith Killian (Cancer Genetics Branch)",NULL,"1. Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, Quezado MM (2013). Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol  37, 1357-64.   https://doi.org/10.1097/PAS.0b013e318294e817",https://intramural.nih.gov/search/searchview.taf?ipid=84127
547,BC011518-02,"October 01, 2013 -  September 30, 2014",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Tae Sung  Kim|Jung Eun  Park|Suk-Youl  Park,Jeong Kyu Bang|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Kunsoo  Rhee (Seoul National University),Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling),Wei  Yang; PhD (NIDDK),"1. Kim TS, Park JE, Shukla A, Choi S, Murugan RN, Lee JH, Ahn M, Rhee K, Bang JK, Kim BY, Loncarek J, Erikson RL, Lee KS (2013). Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152. Proc Natl Acad Sci U S A  110, E4849-57.   https://doi.org/10.1073/pnas.1319656110|2. Park SY, Park JE, Kim TS, Kim JH, Kwak MJ, Ku B, Tian L, Murugan RN, Ahn M, Komiya S, Hojo H, Kim NH, Kim BY, Bang JK, Erikson RL, Lee KW, Kim SJ, Oh BH, Yang W, Lee KS (2014) Molecular basis for unidirectional scaffold switching of Plk4 in centriole biogenesis. Nat Struct Mol Biol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=84119
548,BC011519-02,"October 01, 2013 -  September 30, 2014",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hani  Ebrahimi|Alexander Charles George Eyles Fennell|Alfonso  Fernandez Alvarez|Haitong  Hou|Nadeem  Shaikh|Sophie  Zaaijer,NULL,NULL,NULL,"1. Tomita K, Bez C, Fennell A, Cooper JP (2013). A single internal telomere tract ensures meiotic spindle formation. EMBO Rep  14, 252-60.   https://doi.org/10.1038/embor.2012.218|2. Valente LP, Dehé PM, Klutstein M, Aligianni S, Watt S, Bähler J, Cooper JP (2013). Myb-domain protein Teb1 controls histone levels and centromere assembly in fission yeast. EMBO J  32, 450-60.",https://intramural.nih.gov/search/searchview.taf?ipid=84160
549,BC011522-02,"October 01, 2013 -  September 30, 2014",Discovery of kinase targets in chromosome 10 deleted glioma cells,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Diane Marie Kambach|Kevin A Camphausen; MD|Philip Jeffrey Tofilon,NULL,Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84144
550,BC011524-02,"October 01, 2013 -  September 30, 2014",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Anna  Afasizheva|Yorihisa  Kotobuki; MD, PhD|Stewart  Durell|Yinon  Shafrir",Emily  Chen|Hermann  Frieboes (University of Louisville),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84152
551,BC011525-02,"October 01, 2013 -  September 30, 2014",Targeting DNA damage repair and related pathways in HRD-womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Irene B Ekwede|Nicolas M Gordon|Nicole Dupas Houston|Minshu R Yu|Victoria Lauren Chiou; MD|Takuhei  Yokoyama|Show all 8,"Ursula  Matulonis (DFCI)|Angeles  Secord (Duke Cancer Center, Duke University)|Elizabeth  Swisher (Fred Hutchinson Cancer Center, University of Washington)","Peter L Choyke; MD (Molecular Imaging Program)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Daniel C Edelman (Cancer Genetics Branch)|Jeffrey E Green; MD (Laboratory of Cancer Biology and Genetics)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Bradford J Wood; MD (CC),"1. Baird JH, Minniti CP, Lee JM, Tian X, Wu C, Jackson M, Alam S, Taylor JG, Kato GJ (2015). Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide. Br J Haematol  168, 737-46.   https://doi.org/10.1111/bjh.13203|2. Kohn EC, Romano S, Lee JM (2013). Clinical implications of using molecular diagnostics for ovarian cancers. Ann Oncol  24 Suppl 10, x22-26.   https://doi.org/10.1093/annonc/mdt464|3. Moon DH, Lee JM, Noonan AM, Annunziata CM, Minasian L, Houston N, Hays JL, Kohn EC (2013). Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. Br J Cancer  109, 1072-8.   https://doi.org/10.1038/bjc.2013.389",https://intramural.nih.gov/search/searchview.taf?ipid=84140
552,BC011526-02,"October 01, 2013 -  September 30, 2014",Therapeutic evaluation in GEM pancreatic model,Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Maureen Baran Gearheart|Theresa Mae Guerin|Muhaymin Ahmed Kamal; MSc|Serguei V Kozlov|Philip L Martin|Jerome  Schlomer|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84132
553,BC011527-02,"October 01, 2013 -  September 30, 2014",Androgen Receptor in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Iawen  Hsu,NULL,Jane Beth Trepel (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84149
554,BC011528-02,"October 01, 2013 -  September 30, 2014","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84150
555,BC011529-02,"October 01, 2013 -  September 30, 2014",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Javed  Khan; MD (Pediatric Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84147
556,BC011530-02,"October 01, 2013 -  September 30, 2014",Investigate the role of EGFR and PDGFR regulated pathways in GBM tumorigenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Nailing  Zhang|Xiuyun  Lu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84131
557,BC011547-01,"-  September 30, 2014",Cancer Immunotherapy Clinical Trials,Christopher Ryan Heery; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Bonnie L Casey|Israel O Oyelakin|Chrisa Amanda Bynoe Thomas|Benedetto Paolo Farsaci; PhD|John  Greiner; PhD|James W Hodge; PhD|Show all 8,"Richard  Alexander (University of Maryland Medical Center)|James  Breitmeyer (BN ImmunoTherapeutics)|Corey Allan Carter|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Nuhad  Ibrahim (MD Anderson Cancer Center)|H  Lyerly (Office of the Director, Duke Comprehensive Cancer Center)|Show all 12","Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Susan  Bates; MD (Developmental Therapeutics Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87912
558,BC011548-01,"-  September 30, 2014",Probiotics as vehicles for vaccine administration,Howard A Young; PhD|IRP Faculty Profile,NULL,"Laboratory of Experimental Immunology, NCI",Michael E Sanford|Robert  Wiltrout; PhD,NULL,Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)|Terry Anne Van Dyke (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87911
559,BC011549-01,"-  September 30, 2014",Chronic graft-versus-host disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Francesco  DelGaldo (University of Leeds)|Stefanie  Sarantopolous (Duke University),"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87908
560,BC011550-01,"-  September 30, 2014",Anakinra for neutrophilic pustular skin disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Haley Bharat Naik,NULL,NULL,"Raphaela  Goldbach-Mansky; MD, MHS (NIAMS) |Alison Anne McBride; PhD (NIAID) |Nehal N Mehta (NHLBI) |Maria Irene Morasso; PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87909
561,BC011551-01,"-  September 30, 2014",Structural studies of molecular targets for drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",George T Lountos|Danielle  Needle,"Kamal  Saikh (USAMRIID)|Christopher  Self (Provide Pharma)|Robert  Ulrich (Molecular Immunology, USAMRIID)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|John Stephen Schneekloth (Chemical Biology Laboratory)|Robert  Shoemaker (Chemopreventive Agent Development Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87910
562,BC011552-01,"-  September 30, 2014",Targeting mechanisms of radiation resistance,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Grace B McKay-Corkum|Bradley T Scroggins|Ayla Oksuz White,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87907
563,BC011553-01,"-  September 30, 2014",The impact of malignant transformation on DNA double-strand break repair.,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jeongkyu  Kim; PhD|Andy Dong-Anh Tran; PhD|David  Sturgill,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87906
564,BC011554-01,"-  September 30, 2014",Understanding the Science Behind Racial Disparities in Lung Cancer Incidence,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Khadijah A Mitchell|Adriana  Zingone; MD,Sharon R Pine|Ann  Schwartz (Wayne State University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87904
565,BC011555-01,"-  September 30, 2014",Examining the Inverse Relationship Between Parkinsons Disease and Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Derek William Brown|Amy Lynn Flis|Khadijah A Mitchell|Adriana  Zingone; MD,"Jin  Jen|Ann  Schwartz (Wayne State University)|Linda  Sharp (National Cancer Registry of Ireland)|Kirsi  Vhkangas (University of Eastern Finland)|Ping  Yang; MD, PhD (Mayo Clinic)",Rachael Zoe Solomon (Nutritional Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87905
566,BC011556-01,"-  September 30, 2014",Examining novel roles of nicotine and tobacco smoke on RNA biology,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Derek William Brown|Adriana  Zingone; MD,"Christopher  Mason; PhD (Department of Physiology and Biophysics and the In, Cornell University)|Lars  Steinmetz (EMBL)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87901
567,BC011557-01,"-  September 30, 2014",Inflammation Biomarkers for Diagnosis and Prognosis of Early Stage Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,"Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)",NULL,"1. Ryan B, Pine S, Chaturvedi A, Caporoso N, Harris C (2014) A combined IL-6-IL-8 classifier is associated with outcome of stage I lung cancer. J Thoracic Oncol, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=87902
568,BC011558-01,"-  September 30, 2014",Effects of systemic and topical perturbations on human microbes,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Martin  Glatz; MD|Amanda Keli Johnson|Sharon M Osgood|Sheila E Phang|Amynah  Pradhan,Keisuke  Nagao (Keio University)|Eric  Simpson (Oregon Health and Sciences University),Dennis D Hickstein (Experimental Transplantation and Immunology Branch),"Yasmine  Belkaid; PhD (NIAID) |Steven M Holland; MD (NIAID) |Michail S Lionakis (NIAID) |Joshua David Milner; MD (NIAID) |Niki  Moutsopoulos; DDS, PhD (NIDCR) |Julia A Segre; PhD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87903
569,BC011559-01,"-  September 30, 2014",The role of the tumor biofilm in determining tissue tropism,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Anna  Afasizheva|Alexus Seniqua Eunique Devine|Nancy Ziyan Jiang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87900
570,BC011561-01,"-  September 30, 2014",Exploring mechanisms that govern immune homeostasis in skin,Keisuke  Nagao|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",Heidi H Kong,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87898
571,BC011564-01,"-  September 30, 2014",Near-IR Photorelease Chemistry: Discovery and Applications,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Alexander Patrick Gorka|Rohini B Nambiar|Roger Rauhauser Nani|Luxi  Qiao,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Anu  Puri; PhD (Basic Research Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87899
572,BC011565-01,"-  September 30, 2014",Adoptive T cell Therapy for Pediatric Leukemia,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Waleed M Haso|Haiying  Qin|Crystal L. Mackall; MD,"Janetta  Bijl (HÃ´pital Maisonneuve-Rosemont)|Stephen  Grupp (University of Pennsylvania Cancer Center,)",James N Kochenderfer (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87897
573,BC011566-01,"-  September 30, 2014",Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer,Shuo  Gu|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Lisheng  Dai|Julia Nicole Kulina|Acong  Yang|Zhi Ming  Zheng; MD, PhD",NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Carl E Mcintosh (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87894
574,BC011568-01,"-  September 30, 2014",Natural Products Discovery and Characterization Through Network Collaborations,Kirk R Gustafson; PhD|IRP Faculty Profile,James  McMahon; PhD,"Molecular Targets Laboratory, NCI",Brittany Nicole Beall|Heidi  Bokesch|Laura  Cartner|Susanna Tsz Shan Chan|Ana Sofia de Castro Valdeira; MSC|Richard W Fuller|Show all 9,NULL,Susan  Bates; MD (Developmental Therapeutics Branch)|Nancy H Colburn; PhD (Basic Research Laboratory)|William Marston Linehan; MD (Urologic Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Thomas Joseph Sayers; PhD (Laboratory of Experimental Immunology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87896
575,BC011575-01,"-  September 30, 2014",Modulation of Radiation Response,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,"Jennifer Clare Jones; MD, PhD (Vaccine Branch)|James B Mitchell; PhD (Radiation Biology Branch)|David Anderson Wink (Radiation Biology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87888
576,BC011577-01,"-  September 30, 2014",Novel Imaging Approaches to Solid Tumors,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87889
577,BC011579-01,"-  September 30, 2014",Fas-signaling in memory CD8+ T cell differentiation,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",Tori Nicolle Yamamoto,NULL,Luca  Gattinoni (Experimental Transplantation and Immunology Branch),"Francesco M. Marincola; MD (CC) |Richard M Siegel; MD, PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87892
578,BC011583-01,"-  September 30, 2014",CD62L+-Derived T cells Transduced With a TCR against NY-ESO-1,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",Tori Nicolle Yamamoto,NULL,Luca  Gattinoni (Experimental Transplantation and Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87886
579,BC011584-01,"-  September 30, 2014",Clinical trials in womens cancers,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Philip Stephen Culbertson|Irene B Ekwede|Nicole Dupas Houston|Stanley  Lipkowitz; MD, PhD",NULL,Jinqiu  Chen (Pigment Cell Biology Section)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Elise C Kohn; MD (Clinical Investigations Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87884
580,BC011585-01,"-  September 30, 2014",Identification of Nucleic Acid Binding Small Molecules,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Lindsey Blair Saunders,NULL,Barry R O'Keefe (Molecular Targets Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87885
581,BC011586-01,"-  September 30, 2014",T-T interactions between naive and memory CD8+ T cells,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",NULL,NULL,Luca  Gattinoni (Experimental Transplantation and Immunology Branch),"Francesco M. Marincola; MD (CC) |Richard M Siegel; MD, PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87882
582,BC011589-01,"-  September 30, 2014",Systems biology study of astrocytomagenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Yaroslava  Ruzankina|Chunhui  Wang,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87883
583,BC011590-01,"-  September 30, 2014",Analysis of genetic changes associated with astrocytomagenesis,Terry Anne Van Dyke,NULL,"Mouse Cancer Genetics Program, NCI",Amit Shrikant Adhikari; PhD|Debra J Gilbert|Theresa N O'Sullivan|Yurong  Song; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87878
584,BC011591-01,"-  September 30, 2014",Contribution of Y-specific Genes to Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Iawen  Hsu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87879
585,BC011592-01,"-  September 30, 2014",Evaluation of Protein Kinase D1 in Bladder Cancer as a Novel Tumor Suppressor,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Iawen  Hsu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87880
586,BC011593-01,"-  September 30, 2014",Investigation of Epigentic Modifiers in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87881
587,BC011594-01,"-  September 30, 2014",Targeting the MET pathway in urothelial carcinoma,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Kattie  Sankoh|Tiffany Karen Wong,NULL,Donald P Bottaro; PhD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87877
588,CO020003-06,"October 01, 2013 -  September 30, 2014",Office of Cancer Genomics,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Daniela S Gerhard,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84165
589,CP000101-10,"October 01, 2013 -  September 30, 2014",Human Studies of Diet and Nutrition,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch)|Blossom  Patterson (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84207
590,CP000112-10,"October 01, 2013 -  September 30, 2014",Nutrition Intervention Trials in Linxian China,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  |Philip  Taylor; MD, ScD",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Guo-Qing  Wang (CICAMS)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",NULL,NULL,"1. Fan JH, Wang JB, Qu CX, Zhang YQ, Taylor PR, Abnet CC, Dawsey SM, Qiao YL (2014). Association between oral leukoplakia and upper gastrointestinal cancers: a 28-year follow-up study in the Linxian General Population Trial. Oral Oncol  50, 971-5.   https://doi.org/10.1016/j.oraloncology.2014.07.009|2. Golozar A, Beaty TH, Gravitt PE, Ruczinski I, Qiao YL, Fan JH, Ding T, Tang ZZ, Etemadi A, Hu N, Hyland PL, Wang L, Wang C, Dawsey SM, Freedman ND, Abnet CC, Goldstein AM, Taylor PR (2014) Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A. Eur J Cancer 50:2855-65|3. Wu C, Wang Z, Song X, Feng XS, Abnet CC, He J, Hu N, Zuo XB, Tan W, Zhan Q, Hu Z, He Z, Jia W, Zhou Y, Yu K, Shu XO, Yuan JM, Zheng W, Zhao XK, Gao SG, Yuan ZQ, Zhou FY, Fan ZM, Cui JL, Lin HL, et al. [123 more authors] (2014). Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations. Nat Genet  46, 1001-1006.   https://doi.org/10.1038/ng.3064",https://intramural.nih.gov/search/searchview.taf?ipid=84206
591,CP000176-10,"October 01, 2013 -  September 30, 2014",Biologic Specimen Bank for Early Lung Cancer Markers in Chinese Tin Miners,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",NULL,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wendy  Wang (NCI/DCP),Ping  Hu; MS (Biometry Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84208
592,CP000185-10,"October 01, 2013 -  September 30, 2014",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Ning  Lu (Cancer Institute, Chinese Academy of Medical Sciences)|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|Show all 12",NULL,NULL,"1. Etemadi A, Abnet CC, Kamangar F, Islami F, Khademi H, Pourshams A, Poustchi H, Bagheri M, Sohrabpour AA, Aliasgar A, Khoshnia M, Wacholder S, Matthews CC, Pharoah PD, Brennan P, Boffetta P, Malekzadeh R, Dawsey SM (2014). Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol  29, 95-109.   https://doi.org/10.1007/s10654-014-9883-6|2. Hakami R, Etemadi A, Kamangar F, Pourshams A, Mohtadinia J, Firoozi MS, Birkett N, Boffetta P, Dawsey SM, Malekzadeh R (2014). Cooking methods and esophageal squamous cell carcinoma in high-risk areas of Iran. Nutr Cancer  66, 500-5.   https://doi.org/10.1080/01635581.2013.779384|3. Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Malekzadeh R (2014). Determinants of gastroesophageal reflux disease, including hookah smoking and opium use- a cross-sectional analysis of 50,000 individuals. PLoS One  9, e89256.   https://doi.org/10.1371/journal.pone.0089256|4. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014). Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev  23, 700-13.   https://doi.org/10.1158/1055-9965.EPI-13-1057|5. Roshandel G, Khoshnia M, Sotoudeh M, Merat S, Etemadi A, Nickmanesh A, Norouzi A, Pourshams A, Poustchi H, Semnani S, Ghasemi-Kebria F, Noorbakhsh R, Abnet C, Dawsey SM, Malekzadeh R (2014). Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran. Arch Iran Med  17, 246-52.   https://doi.org/014174/AIM.006|6. Yu G, Dye BA, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Freedman ND, Abnet CC (2014). The association between the upper digestive tract microbiota by HOMIM and oral health in a population-based study in Linxian, China. BMC Public Health  14, 1110.   https://doi.org/10.1186/1471-2458-14-1110|7. Yu G, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Freedman ND, Abnet CC (2014). Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev  23, 735-41.   https://doi.org/10.1158/1055-9965.EPI-13-0855",https://intramural.nih.gov/search/searchview.taf?ipid=84209
593,CP004410-38,"October 01, 2013 -  September 30, 2014",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,"Gladys M. Glenn; MD, PhD (Clinical Genetics Branch)|June  Peters (Clinical Genetics Branch)|Kenneth H Kraemer; MD (Dermatology Branch)","Jeffery P Struewing; MS, MD (NHGRI)","1. Hill VK, Gartner JJ, Samuels Y, Goldstein AM (2013). The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet  14, 257-79.   https://doi.org/10.1146/annurev-genom-091212-153429|2. Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V (2014). Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res  24, 480-7.   https://doi.org/10.1097/CMR.0000000000000112|3. Rotunno M, Sun X, Figueroa J, Sherman ME, Garcia-Closas M, Meltzer P, Williams T, Schneider SS, Jerry DJ, Yang XR, Troester MA (2014). Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res  16, R74.   https://doi.org/10.1186/bcr3689|4. Shi J, Yang XR, Ballew B, Rotunno M, Calista D, Fargnoli MC, Ghiorzo P, Bressac-de Paillerets B, Nagore E, Avril MF, Caporaso NE, McMaster ML, Cullen M, Wang Z, Zhang X, NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, French Familial Melanoma Study Group, Bruno W, Pastorino L, Queirolo P, Banuls-Roca J, Garcia-Casado Z, Vaysse A, Mohamdi H, Riazalhosseini Y, Foglio M, Jouenne F, et al. [24 more authors] (2014). Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nat Genet  46, 482-6.   https://doi.org/10.1038/ng.2941|5. Slager SL, Caporaso NE, de Sanjose S, Goldin LR (2013). Genetic susceptibility to chronic lymphocytic leukemia. Semin Hematol  50, 296-302.   https://doi.org/10.1053/j.seminhematol.2013.09.007",https://intramural.nih.gov/search/searchview.taf?ipid=84181
594,CP005782-20,"October 01, 2013 -  September 30, 2014",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Nutritional Epidemiology Branch),Barbara  Rehermann; MD (NIDDK) |Raymond  Donnelly (OD),"1. Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, O'Brien TR (2014). Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. J Infect Dis  209, 350-4.   https://doi.org/10.1093/infdis/jit433|2. O'Brien TR, Lang Kuhs KA, Pfeiffer RM (2014). Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C. Open Forum Infect Dis  1, ofu110.   https://doi.org/10.1093/ofid/ofu110|3. O'Brien TR, Prokunina-Olsson L, Donnelly RP (2014). IFN-λ4: the paradoxical new member of the interferon lambda family. J Interferon Cytokine Res  34, 829-38.   https://doi.org/10.1089/jir.2013.0136|4. Wang AS, Pfeiffer RM, Morgan TR, O'Brien TR (2014). Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor. Hepatology  59, 2423-4.   https://doi.org/10.1002/hep.26771",https://intramural.nih.gov/search/searchview.taf?ipid=84180
595,CP005803-20,"October 01, 2013 -  September 30, 2014",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI",NULL,NULL,NULL,NULL,"1. Slager SL, Caporaso NE, de Sanjose S, Goldin LR (2013). Genetic susceptibility to chronic lymphocytic leukemia. Semin Hematol  50, 296-302.   https://doi.org/10.1053/j.seminhematol.2013.09.007",https://intramural.nih.gov/search/searchview.taf?ipid=84179
596,CP005804-20,"October 01, 2013 -  September 30, 2014",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Andrea  Baccarelli|Alisa  Goldstein; PhD|Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Office of the Director)|Margaret Anne Tucker (Human Genetics Program),NULL,"1. Lam TK, Rotunno M, Ryan BM, Pesatori AC, Bertazzi PA, Spitz M, Caporaso NE, Landi MT (2014). Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog  53, 548-56.   https://doi.org/10.1002/mc.22006",https://intramural.nih.gov/search/searchview.taf?ipid=84178
597,CP010119-19,"October 01, 2013 -  September 30, 2014",Studies of Occupational Cancer (Pesticides),"Laura Elizabeth Beane Freeman|IRP Faculty Profile  |Jay  Lubin; PhD| | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  |Michael  Alavanja; PhD",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI","Gabriella  Andreotti|Stella  Koutros|Jonathan Nicholas Hofmann|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Dalsu  Baris|Show all 7",Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Jane  Hoppin (North Carolina State University)|Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Dale  Sandler; PhD (NIEHS),"Ola Anders Landgren (Lymphoid Malignancies Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)",NULL,"1. Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F (2015). Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. Environ Int  75, 144-50.   https://doi.org/10.1016/j.envint.2014.11.002|2. Hoppin JA, Umbach DM, Long S, Rinsky JL, Henneberger PK, Salo PM, Zeldin DC, London SJ, Alavanja MC, Blair A, Beane Freeman LE, Sandler DP (2014). Respiratory disease in United States farmers. Occup Environ Med  71, 484-91.   https://doi.org/10.1136/oemed-2013-101983|3. Rinsky JL, Hoppin JA, Blair A, He K, Beane Freeman LE, Chen H (2013). Agricultural exposures and stroke mortality in the Agricultural Health Study. J Toxicol Environ Health A  76, 798-814.   https://doi.org/10.1080/15287394.2013.819308|4. Weichenthal S, Villeneuve PJ, Burnett RT, van Donkelaar A, Martin RV, Jones RR, DellaValle CT, Sandler DP, Ward MH, Hoppin JA (2014). Long-term exposure to fine particulate matter: association with nonaccidental and cardiovascular mortality in the agricultural health study cohort. Environ Health Perspect  122, 609-15.   https://doi.org/10.1289/ehp.1307277",https://intramural.nih.gov/search/searchview.taf?ipid=84173
598,CP010120-19,"October 01, 2013 -  September 30, 2014",Studies of Occupational Cancer,"Michael  Alavanja; PhD| | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Show all 13",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Montserrat  Garcia-Closas; MD, PhD (Office of the Director)","Dale  Sandler; PhD (NIEHS) |Jane  Hoppin; ScD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Daniels RD, Kubale TL, Yiin JH, Dahm MM, Hales TR, Baris D, Zahm SH, Beaumont JJ, Waters KM, Pinkerton LE (2014). Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950-2009). Occup Environ Med  71, 388-97.   https://doi.org/10.1136/oemed-2013-101662|2. Vermeulen R, Silverman DT, Garshick E, Vlaanderen J, Portengen L, Steenland K (2014). Exposure-response estimates for diesel engine exhaust and lung cancer mortality based on data from three occupational cohorts. Environ Health Perspect  122, 172-7.   https://doi.org/10.1289/ehp.1306880",https://intramural.nih.gov/search/searchview.taf?ipid=84175
599,CP010121-19,"October 01, 2013 -  September 30, 2014",Molecular Epidemiology Studies of Occupational and Environmental Exposures,Nathaniel C Rothman; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Mustafa  Dosemeci; PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Show all 14","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13",Patricia  Hartge; ScD (Epidemiology and Biostatistics Program),NULL,"1. Bassig BA, Zhang L, Cawthon RM, Smith MT, Yin S, Li G, Hu W, Shen M, Rappaport S, Barone-Adesi F, Rothman N, Vermeulen R, Lan Q (2014). Alterations in leukocyte telomere length in workers occupationally exposed to benzene. Environ Mol Mutagen  55, 673-8.   https://doi.org/10.1002/em.21880|2. Kim C, Chapman RS, Hu W, He X, Hosgood HD, Liu LZ, Lai H, Chen W, Silverman DT, Vermeulen R, Tian L, Bassig B, Shen M, Zhang Y, Ma S, Rothman N, Lan Q (2014). Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China. Lung Cancer  84, 31-5.   https://doi.org/10.1016/j.lungcan.2014.01.004|3. Thomas R, Hubbard AE, McHale CM, Zhang L, Rappaport SM, Lan Q, Rothman N, Vermeulen R, Guyton KZ, Jinot J, Sonawane BR, Smith MT (2014). Characterization of changes in gene expression and biochemical pathways at low levels of benzene exposure. PLoS One  9, e91828.   https://doi.org/10.1371/journal.pone.0091828|4. Thomas R, McHale CM, Lan Q, Hubbard AE, Zhang L, Vermeulen R, Li G, Rappaport SM, Yin S, Rothman N, Smith MT (2013). Global gene expression response of a population exposed to benzene: a pilot study exploring the use of RNA-sequencing technology. Environ Mol Mutagen  54, 566-73.   https://doi.org/10.1002/em.21801",https://intramural.nih.gov/search/searchview.taf?ipid=84176
600,CP010122-19,"October 01, 2013 -  September 30, 2014",Occupational Exposure Assessment,Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Mary Helen Ward; MS, PhD|Mustafa  Dosemeci; PhD|Michael  Alavanja; PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Show all 13",Tye  Arbuckle (Health Canada)|Susan  Shortreed (McGill University)|Berit  Bakke (National Institute of Occupational Health)|Igor  Burstyn (Drexel University)|Jerome  Lavoue (University of Montreal)|Robert  Branch (University of Pittsburgh)|Show all 59,Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Ligia  Pinto (Infection & Immunoepidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84174
601,CP010123-19,"October 01, 2013 -  September 30, 2014",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Michael  Alavanja; PhD| | |Melissa Charmaine Friesen|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt",NULL,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Engel LS, Buckley JP, Yang G, Liao LM, Satagopan J, Calafat AM, Matthews CE, Cai Q, Ji BT, Cai H, Engel SM, Wolff MS, Rothman N, Zheng W, Xiang YB, Shu XO, Gao YT, Chow WH (2014). Predictors and variability of repeat measurements of urinary phenols and parabens in a cohort of Shanghai women and men. Environ Health Perspect  122, 733-40.   https://doi.org/10.1289/ehp.1306830|2. Hofmann JN, Liao LM, Strickland PT, Shu XO, Yang G, Ji BT, Li HL, Rothman N, Kamangar F, Gao YT, Zheng W, Chow WH (2013). Polycyclic aromatic hydrocarbons: determinants of urinary 1-hydroxypyrene glucuronide concentration and risk of colorectal cancer in the Shanghai Women's Health Study. BMC Cancer  13, 282.   https://doi.org/10.1186/1471-2407-13-282|3. Liao LM, Friesen MC, Xiang YB, Cai H, Koh DH, Ji BT, Yang G, Li HL, Locke SJ, Rothman N, Zheng W, Gao YT, Shu XO, Purdue MP (2014). 0346Occupational exposure to lead and cancer in two cohort studies of men and women in shanghai, china. Occup Environ Med  71 Suppl 1, A42.|4. Shi J, Sung H, Zhang B, Lu W, Choi JY, Xiang YB, Kim MK, Iwasaki M, Long J, Ji BT, Park SK, Zheng Y, Tsugane S, Yoo KY, Wang W, Noh DY, Han W, Kim SW, Lee MH, Lee JW, Lee JY, Shen CY, Matsuo K, Ahn SH, Gao YT, et al. [4 more authors] (2013). New breast cancer risk variant discovered at 10q25 in East Asian women. Cancer Epidemiol Biomarkers Prev  22, 1297-303.   https://doi.org/10.1158/1055-9965.EPI-12-1393|5. Vogtmann E, Shu XO, Li HL, Chow WH, Yang G, Ji BT, Cai H, Yu C, Gao YT, Zheng W, Xiang YB (2014). Cholelithiasis and the risk of liver cancer: results from cohort studies of 134,546 Chinese men and women. J Epidemiol Community Health  68, 565-70.   https://doi.org/10.1136/jech-2013-203503|6. Wu SH, Shu XO, Chow WH, Xiang YB, Zhang X, Li HL, Cai Q, Milne G, Ji BT, Cai H, Rothman N, Gao YT, Zheng W, Yang G (2014). Nonexercise physical activity and inflammatory and oxidative stress markers in women. J Womens Health (Larchmt)  23, 159-67.   https://doi.org/10.1089/jwh.2013.4456|7. Yang WS, Shu XO, Gao J, Li HL, Cai H, Yang G, Ji BT, Rothman N, Gao YT, Zheng W, Xiang YB (2013). Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women. Ann Oncol  24, 1679-85.   https://doi.org/10.1093/annonc/mdt017",https://intramural.nih.gov/search/searchview.taf?ipid=84177
602,CP010124-19,"October 01, 2013 -  September 30, 2014",Cervical cancer and human papillomavirus (HPV) infection,Joshua Neil Sampson|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",Julia  Gage|Hormuzdiar Aspandiar Katki; MS|Vikrant Vasant Sahasrabuddhe|Hannah  Yang|Clara  Bodelon,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Diane  Solomon; PhD (Breast and Gynecologic Cancer Research Group),NULL,"1. De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP (2013). The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine  31 Suppl 5, F32-46.   https://doi.org/10.1016/j.vaccine.2012.07.092|2. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014). Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol  52, 187-92.   https://doi.org/10.1128/JCM.01623-13|3. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014). Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol  60, 414-7.   https://doi.org/10.1016/j.jcv.2014.04.016|4. Schwartz LM, Castle PE, Follansbee S, Borgonovo S, Fetterman B, Tokugawa D, Lorey TS, Sahasrabuddhe VV, Luhn P, Gage JC, Darragh TM, Wentzensen N (2013). Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis  208, 1768-75.   https://doi.org/10.1093/infdis/jit374|5. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE (2014). Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. J Clin Microbiol  52, 2892-7.   https://doi.org/10.1128/JCM.03517-13|6. Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM, New Mexico HPV Pap Registry Steering Committee (2014). No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. J Infect Dis  209, 855-64.   https://doi.org/10.1093/infdis/jit577|7. Wentzensen N, Schiffman M (2014). Filling a gap in cervical cancer screening programmes. Lancet Oncol  15, 249-51.   https://doi.org/10.1016/S1470-2045(14)70073-7|8. Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N (2014). Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. J Infect Dis  210, 448-55.   https://doi.org/10.1093/infdis/jiu104",https://intramural.nih.gov/search/searchview.taf?ipid=84169
603,CP010125-19,"October 01, 2013 -  September 30, 2014",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris|Joanne S Colt|Debra  Silverman; ScD, ScM|Michael  Alavanja; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Show all 13","James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John W Brock (CDC)|Alexander  Parker (Mayo Clinic, Rochestor, NM)|Show all 25",Jay  Lubin; PhD (Biostatistics Branch),Lawrence Stuart Engel; PhD (NIEHS),"1. Colt JS, Friesen MC, Stewart PA, Donguk P, Johnson A, Schwenn M, Karagas MR, Armenti K, Waddell R, Verrill C, Ward MH, Freeman LE, Moore LE, Koutros S, Baris D, Silverman DT (2014). A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men. Occup Environ Med  71, 667-74.   https://doi.org/10.1136/oemed-2013-102056|2. Friesen MC, Park DU, Colt JS, Baris D, Schwenn M, Karagas MR, Armenti KR, Johnson A, Silverman DT, Stewart PA (2014). Developing estimates of frequency and intensity of exposure to three types of metalworking fluids in a population-based case-control study of bladder cancer. Am J Ind Med  57, 915-27.   https://doi.org/10.1002/ajim.22328|3. Jones RR, Yu CL, Nuckols JR, Cerhan JR, Airola M, Ross JA, Robien K, Ward MH (2014). Farm residence and lymphohematopoietic cancers in the Iowa Women's Health Study. Environ Res  133, 353-61.   https://doi.org/10.1016/j.envres.2014.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=84182
604,CP010126-19,"October 01, 2013 -  September 30, 2014",Hormone-Related Cancers,Michael Blaise Cook|IRP Faculty Profile  |Jonine Danya Figueroa| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Roni T Falk|Britton Lindsay Trabert|Hannah  Yang|Barbara J Fuhrman|Sarah Jane Nyante,David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, Meyer KB, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H, Kondo N, kConFab Investigators, Australian Ovarian Cancer Study Group, GENICA Network, TNBCC, et al. [153 more authors] (2014). FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer  110, 1088-100.|2. Ali AM, Schmidt MK, Bolla MK, Wang Q, Gago-Dominguez M, Castelao JE, Carracedo A, Garzón VM, Bojesen SE, Nordestgaard BG, Flyger H, Chang-Claude J, Vrieling A, Rudolph A, Seibold P, Nevanlinna H, Muranen TA, Aaltonen K, Blomqvist C, Matsuo K, Ito H, Iwata H, Horio A, John EM, Sherman M, et al. [27 more authors] (2014). Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases. Cancer Epidemiol Biomarkers Prev  23, 934-45.   https://doi.org/10.1158/1055-9965.EPI-13-0901|3. Benson G, Yang X, Figueroa J, Sherman M (2013) Emerging concepts in breast cancer risk prediction. Curr Obstet Gynecol Rep 2:43-52|4. Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Georgia Chenevix-Trench, for AOCS, /ACS Group, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, Levine DA, Gronwald J, Culver HA, Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk J, Chang-Claude J, Bandera EV, Hogdall E, Heitz F, Kaye SB, et al. [66 more authors] (2014). Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev  23, 1421-7.   https://doi.org/10.1158/1055-9965.EPI-13-0962|5. Brinton LA, Figueroa JD, Awuah B, Yarney J, Wiafe S, Wood SN, Ansong D, Nyarko K, Wiafe-Addai B, Clegg-Lamptey JN (2014). Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat  144, 467-78.   https://doi.org/10.1007/s10549-014-2868-z|6. Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, Severi G, Trabert B, Wentzensen N, Chenevix-Trench G, for AOCS/ACS group, Whittemore AS, Sieh W, Chang-Claude J, Bandera EV, Orlow I, Terry K, et al. [104 more authors] (2014). Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res  74, 852-61.   https://doi.org/10.1158/0008-5472.CAN-13-1051|7. Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, Henderson BE, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Lu L, Orlow I, Petruzella S, Polidoro S, Pooler L, et al. [15 more authors] (2014). Exome-wide association study of endometrial cancer in a multiethnic population. PLoS One  9, e97045.   https://doi.org/10.1371/journal.pone.0097045|8. De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, Australian National Endometrial Cancer Study Group, Attia J, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Dunning AM, Easton DF, Friedenreich CM, Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE, Holliday E, Horn-Ross PL, Hunter DJ, et al. [30 more authors] (2014). Genome-wide association study of endometrial cancer in E2C2. Hum Genet  133, 211-24.   https://doi.org/10.1007/s00439-013-1369-1|9. Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Australian Cancer Study, et al. [1 more author] (2014) Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 133:481-97|10. Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, Fortner RT, Hankinson SE, Helzlsouer KJ, Hoff man-Bolton J, Comstock GW, Kaaks R, Kahle LL, Muti P, Overvad K, Peeters PH, Riboli E, et al. [6 more authors] (2013). Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol  14, 1009-19.   https://doi.org/10.1016/S1470-2045(13)70301-2|11. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME (2014). Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju286|12. Horne HN, Sherman ME, Garcia-Closas M, Pharoah PD, Blows FM, Yang XR, Hewitt SM, Conway CM, Lissowska J, Brinton LA, Prokunina-Olsson L, Dawson SJ, Caldas C, Easton DF, Chanock SJ, Figueroa JD (2014). Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. Breast Cancer Res Treat  143, 181-7.   https://doi.org/10.1007/s10549-013-2771-z|13. Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP, Hopper JL, Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van't Veer LJ, Atsma F, Muir K, Lophatananon A, Fasching PA, Beckmann MW, Ekici AB, Renner SP, Sawyer E, Tomlinson I, Kerin M, GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, kConFab Investigators, Australian Ovarian Cancer Study Group, et al. [157 more authors] (2014). Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Res  16, R51.   https://doi.org/10.1186/bcr3662|14. Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U, GENICA Network, Andrulis IL, Knight JA, Glendon G, Tchatchou S, kConFab Investigators, Australian Ovarian Cancer Study Group, TNBCC, et al. [152 more authors] (2014). Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum Mol Genet  23, 6096-111.   https://doi.org/10.1093/hmg/ddu311|15. Perry JR, Hsu YH, Chasman DI, Johnson AD, Elks C, Albrecht E, Andrulis IL, Beesley J, Berenson GS, Bergmann S, Bojesen SE, Bolla MK, Brown J, Buring JE, Campbell H, Chang-Claude J, Chenevix-Trench G, Corre T, Couch FJ, Cox A, Czene K, D'adamo AP, Davies G, Deary IJ, Dennis J, kConFab investigators, ReproGen Consortium, et al. [56 more authors] (2014). DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet  23, 2490-7.   https://doi.org/10.1093/hmg/ddt620|16. Razzaghi H, Troester MA, Gierach GL, Olshan AF, Yankaskas BC, Millikan RC (2013) Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res 15:R76|17. Rusner C, Streller B, Stegmaier C, Trocchi P, Kuss O, McGlynn KA, Trabert B, Stang A (2014). Risk of second primary cancers after testicular cancer in East and West Germany: a focus on contralateral testicular cancers. Asian J Androl  16, 285-9.   https://doi.org/10.4103/1008-682X.122069|18. Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, Swann R, Dwek M, Perkins KA, Gillett C, Houlston R, Ross G, De Ieso P, Southey MC, Hopper JL, Provenzano E, GENICA Network, et al. [128 more authors] (2014). Genetic predisposition to in situ and invasive lobular carcinoma of the breast. PLoS Genet  10, e1004285.   https://doi.org/10.1371/journal.pgen.1004285|19. Schoeps A, Rudolph A, Seibold P, Dunning AM, Milne RL, Bojesen SE, Swerdlow A, Andrulis I, Brenner H, Behrens S, Orr N, Jones M, Ashworth A, Li J, Cramp H, Connley D, Czene K, Darabi H, Chanock SJ, Lissowska J, Figueroa JD, Knight J, Glendon G, Mulligan AM, Dumont M, et al. [56 more authors] (2014). Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol  38, 84-93.   https://doi.org/10.1002/gepi.21771|20. Sherman ME, Mies C, Gierach GL (2014). Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches. Breast Dis  34, 105-16.   https://doi.org/10.3233/BD-130359|21. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, Wesolowska E, Boyd NF, Johnson NB, Figueroa JD, Sherman ME, Troester MA (2013). Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res  19, 4972-4982.   https://doi.org/10.1158/1078-0432.CCR-13-0029|22. Trabert B, Chodick G, Shalev V, Sella T, Longnecker MP, McGlynn KA (2014). Gestational diabetes and the risk of cryptorchidism and hypospadias. Epidemiology  25, 152-3.   https://doi.org/10.1097/EDE.0000000000000014|23. Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Ovarian Cancer Association Consortium, et al. [12 more authors] (2014). Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst  106, djt431.   https://doi.org/10.1093/jnci/djt431|24. Tsilidis KK, Rohrmann S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin G, Feinleib M, Joshu CE, Kanarek N, Nelson WG, Selvin E, Platz EA (2013). Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology  1, 919-28.   https://doi.org/10.1111/j.2047-2927.2013.00129.x|25. Wang J, Barker K, Steel J, Park J, Saul J, Festa F, Wallstrom G, Yu X, Bian X, Anderson KS, Figueroa JD, LaBaer J, Qiu J (2013). A versatile protein microarray platform enabling antibody profiling against denatured proteins. Proteomics Clin Appl  7, 378-83.   https://doi.org/10.1002/prca.201200062|26. Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA (2014). Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol  24, 376-82.   https://doi.org/10.1016/j.annepidem.2014.02.007|27. Wimberly H, Han G, Pinnaduwage D, Murphy LC, Yang XR, Andrulis IL, Sherman M, Figueroa J, Rimm DL (2014). ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Res Treat  146, 657-67.   https://doi.org/10.1007/s10549-014-3050-3",https://intramural.nih.gov/search/searchview.taf?ipid=84183
605,CP010127-19,"October 01, 2013 -  September 30, 2014",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84201
606,CP010128-19,"October 01, 2013 -  September 30, 2014",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Vikrant Vasant Sahasrabuddhe|Britton Lindsay Trabert,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Carolyn  Westhoff (Columbia University School of Public Health)|Show all 8,"Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Catherine G Schairer (Biostatistics Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Jay  Lubin; PhD (Biostatistics Branch)",NULL,"1. Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, Trabert B, Lamb EJ (2014). Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarkers Prev  23, 584-93.   https://doi.org/10.1158/1055-9965.EPI-13-0996|2. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS (2013). Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod  28, 2813-21.   https://doi.org/10.1093/humrep/det323|3. Dallal CM, Tice JA, Buist DS, Bauer DC, Lacey JV, Cauley JA, Hue TF, Lacroix A, Falk RT, Pfeiffer RM, Fuhrman BJ, Veenstra TD, Xu X, Brinton LA, B~FIT Research Group (2014). Estrogen metabolism and breast cancer risk among postmenopausal women: a case-cohort study within B~FIT. Carcinogenesis  35, 346-55.   https://doi.org/10.1093/carcin/bgt367|4. Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, Vangen S, Brinton LA, Storeng R (2015). Risk of breast cancer following fertility treatment--a registry based cohort study of parous women in Norway. Int J Cancer  136, 1140-8.   https://doi.org/10.1002/ijc.29069|5. Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA (2013). Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertil Steril  100, 1660-6.   https://doi.org/10.1016/j.fertnstert.2013.08.008",https://intramural.nih.gov/search/searchview.taf?ipid=84184
607,CP010131-19,"October 01, 2013 -  September 30, 2014",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 13",David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF, Aleman BM, Morton LM, Gilbert ES (2014). Pancreatic cancer risk after treatment of Hodgkin lymphoma. Ann Oncol  25, 2073-9.   https://doi.org/10.1093/annonc/mdu287|2. Freedman DM, Wu J, Daugherty SE, Kuncl RW, Enewold LR, Pfeiffer RM (2014). The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study. Int J Cancer  135, 1745-50.   https://doi.org/10.1002/ijc.28795|3. Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM (2013). Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers. Leuk Lymphoma  54, 1691-7.   https://doi.org/10.3109/10428194.2012.753543|4. Lamart S, Imran R, Simon S, Doi K, Morton L, Curtis R, Drozdovitch V, Maass Moreno R, Chen C, Whatley M, Miller D, Pacak K, Lee C (2013) Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy. Physics in Medicine and Biology 58:8739-53|5. Lamart S, Imran R, Simon SL, Doi K, Morton LM, Curtis RE, Lee C, Drozdovitch V, Maass-Moreno R, Chen CC, Whatley M, Miller DL, Pacak K, Lee C (2013). Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy. Phys Med Biol  58, 8739-53.   https://doi.org/10.1088/0031-9155/58/24/8739|6. Little MP, Schaeffer ML, Reulen RC, Abramson DH, Stovall M, Weathers R, de Vathaire F, Diallo I, Seddon JM, Hawkins MM, Tucker MA, Kleinerman RA (2014). Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study. Br J Cancer  110, 2623-32.   https://doi.org/10.1038/bjc.2014.193|7. Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF, Travis LB, et al. [2 more authors] (2013). Stomach cancer risk after treatment for hodgkin lymphoma. J Clin Oncol  31, 3369-77.   https://doi.org/10.1200/JCO.2013.50.6832|8. Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF, Curtis RE (2013). Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood  121, 2996-3004.   https://doi.org/10.1182/blood-2012-08-448068|9. Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF, et al. [2 more authors] (2014). Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma. Haematologica  99, e193-6.   https://doi.org/10.3324/haematol.2014.108258|10. Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT (2014). The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book   e57-67  https://doi.org/10.14694/EdBook_AM.2014.34.e57|11. Schonfeld SJ, Berrington de Gonzalez A, Visvanathan K, Pfeiffer RM, Anderson WF (2013). Declining second primary ovarian cancer after first primary breast cancer. J Clin Oncol  31, 738-43.   https://doi.org/10.1200/JCO.2012.43.2757",https://intramural.nih.gov/search/searchview.taf?ipid=84185
608,CP010132-19,"October 01, 2013 -  September 30, 2014",Studies of Populations Exposed to Environmental Sources of Radiation,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI

Office of the Director, NCI",Steven L Simon|Alina V Brenner|Maureen Cusack Hatch; MD|Vladimir  Drozdovitch|Daryl  Freedman|Alice  Sigurdson; PhD|Show all 7,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Abend M, Pfeiffer RM, Ruf C, Hatch M, Bogdanova TI, Tronko MD, Hartmann J, Meineke V, Mabuchi K, Brenner AV (2013). Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers. Br J Cancer  109, 2286-94.   https://doi.org/10.1038/bjc.2013.574|2. Doss M, Little MP, Orton CG (2014). Point/Counterpoint: low-dose radiation is beneficial, not harmful. Med Phys  41, 070601.   https://doi.org/10.1118/1.4881095|3. Drozdovitch V, Minenko V, Khrouch V, Leshcheva S, Gavrilin Y, Khrutchinsky A, Kukhta T, Kutsen S, Luckyanov N, Shinkarev S, Tretyakevich S, Trofimik S, Voillequé P, Bouville A (2013). Thyroid dose estimates for a cohort of Belarusian children exposed to radiation from the Chernobyl accident. Radiat Res  179, 597-609.   https://doi.org/10.1667/RR3153.1|4. Drozdovitch V, Zhukova O, Germenchuk M, Khrutchinsky A, Kukhta T, Luckyanov N, Minenko V, Podgaiskaya M, Savkin M, Vakulovsky S, Voillequé P, Bouville A (2013). Database of meteorological and radiation measurements made in Belarus during the first three months following the Chernobyl accident. J Environ Radioact  116, 84-92.   https://doi.org/10.1016/j.jenvrad.2012.09.010|5. Kitahara CM, Linet MS, Brenner AV, Wang SS, Melin BS, Wang Z, Inskip PD, Freeman LE, Braganza MZ, Carreón T, Feychting M, Gaziano JM, Peters U, Purdue MP, Ruder AM, Sesso HD, Shu XO, Waters MA, White E, Zheng W, Hoover RN, Fraumeni JF, Chatterjee N, Yeager M, Chanock SJ, et al. [2 more authors] (2014). Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies. Cancer Epidemiol Biomarkers Prev  23, 47-54.   https://doi.org/10.1158/1055-9965.EPI-13-0913|6. Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY, Nikiforova MN, Yue NJ, Zhang M, Mabuchi K, Tronko MD, Nikiforov YE (2014). ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer  120, 799-807.   https://doi.org/10.1002/cncr.28484|7. Likhtarov I, Kovgan L, Masiuk S, Talerko M, Chepurny M, Ivanova O, Gerasymenko V, Boyko Z, Voillequé P, Drozdovitch V, Bouville A (2014). Thyroid cancer study among Ukrainian children exposed to radiation after the Chornobyl accident: improved estimates of the thyroid doses to the cohort members. Health Phys  106, 370-96.   https://doi.org/10.1097/HP.0b013e31829f3096|8. McDonald E, Freedman DM, Alexander BH, Doody MM, Tucker MA, Linet MS, Cahoon EK (2014). Prescription diuretic use and risk of basal cell carcinoma in the nationwide U.S. radiologic technologists cohort. Cancer Epidemiol Biomarkers Prev  23, 1539-45.   https://doi.org/10.1158/1055-9965.EPI-14-0251|9. Neta G, Hatch M, Meinhold C, Ostroumova E, Bolshova E, Tereschenko V, Tronko M, Brenner A (2014) In utero exposure to iodine-131 from Chernobyl fallout and anthropometric characteristics in adolescence. Radiation Research 181:293-301|10. Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, Nadyrov E, Petrenko S, Romanov G, Yauseyenka V, Drozdovitch V, Minenko V, Prokopovich A, Savasteeva I, Zablotska LB, Mabuchi K, Brenner AV (2014). Iodine-131 and thyroid function: Ostroumova et al. respond. Environ Health Perspect  122, A40-1.   https://doi.org/10.1289/ehp.1307737R|11. Schonfeld S (2013) Solid cancer mortality in the Techa River Cohort (1950-2007). Radiation Research 179:183-9",https://intramural.nih.gov/search/searchview.taf?ipid=84170
609,CP010133-19,"October 01, 2013 -  September 30, 2014",Studies of Populations Exposed to Occupational Sources of Radiation,"Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Peter D Inskip; ScD|Alice  Sigurdson; PhD|Steven L Simon|Show all 8,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Bouville A, Linet MS, Hatch M, Mabuchi K, Simon SL (2014). Guidelines for exposure assessment in health risk studies following a nuclear reactor accident. Environ Health Perspect  122, 1-5.   https://doi.org/10.1289/ehp.1307120|2. Drozdovitch V, Brill AB, Mettler FA, Beckner WM, Goldsmith SJ, Gross MD, Hays MT, Kirchner PT, Langan JK, Reba RC, Smith GT, Bouville A, Linet MS, Melo DR, Lee C, Simon SL (2014). Nuclear medicine practices in the 1950s through the mid-1970s and occupational radiation doses to technologists from diagnostic radioisotope procedures. Health Phys  107, 300-10.   https://doi.org/10.1097/HP.0000000000000107|3. Little MP, Kwon D, Doi K, Simon SL, Preston DL, Doody MM, Lee T, Miller JS, Kampa DM, Bhatti P, Tucker JD, Linet MS, Sigurdson AJ (2014). Association of chromosome translocation rate with low dose occupational radiation exposures in U.S. radiologic technologists. Radiat Res  182, 1-17.   https://doi.org/10.1667/RR13413.1|4. Simon SL, Preston DL, Linet MS, Miller JS, Sigurdson AJ, Alexander BH, Kwon D, Yoder RC, Bhatti P, Little MP, Rajaraman P, Melo D, Drozdovitch V, Weinstock RM, Doody MM (2014). Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings. Radiat Res  182, 507-28.   https://doi.org/10.1667/RR13542.1",https://intramural.nih.gov/search/searchview.taf?ipid=84186
610,CP010134-19,"October 01, 2013 -  September 30, 2014",Studies of Atomic Bomb Survivors,"Amy  de Gonzalez|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner,"Dale  Preston (Hirosoft)|Kazunori  Kodama (Radiation Effects Research Foundation, Japan)|Kyoji  Furukawa; PhD|Kotaro  Ozasa (Radiation Effects Research Foundation)|Yuko  Hirai (Genetics, Radiation Effects Research Foundation)|Nori  Nakamwa (Radiation Effects Research Foundation)|Show all 9",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84211
611,CP010135-19,"October 01, 2013 -  September 30, 2014",Studies of Non-Ionizing Radiation-Related Cancer,Martha S Linet; PhD|IRP Faculty Profile  |Peter D Inskip; ScD,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Daryl  Freedman|Alice  Sigurdson; PhD|Mark Peter Little|Rochelle E Curtis,"Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Robert  Selker (Division of Neurosurgery, Western Pennsylvania Hospital)|Show all 13",Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Preetha  Rajaraman (Center For Global Health)|Gila I Neta (Office of the Director)|Susan Shaw Devesa (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84187
612,CP010136-19,"October 01, 2013 -  September 30, 2014",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Dalsu  Baris|Joanne S Colt|Mary Helen Ward; MS, PhD|Joseph B Coble|Claudine M Samanic|Show all 11",NULL,"Linda M Brown; MPH, DPhil (Office Of Science Planning and Assessment)|Mark  Schiffman; MD (Clinical Genetics Branch)",NULL,"1. Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O (2014). Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial. Leukemia  28, 413-6.   https://doi.org/10.1038/leu.2013.268|2. Dellavalle CT, Xiao Q, Yang G, Shu XO, Aschebrook-Kilfoy B, Zheng W, Lan Li H, Ji BT, Rothman N, Chow WH, Gao YT, Ward MH (2014). Dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study. Int J Cancer  134, 2917-26.   https://doi.org/10.1002/ijc.28612|3. Filson CP, Schwartz K, Colt JS, Ruterbusch J, Linehan WM, Chow WH, Miller DC (2014). Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension. Urol Oncol  32, 27.e15-21.   https://doi.org/10.1016/j.urolonc.2012.09.014|4. Hofmann JN, Hutchinson AA, Cawthon R, Liu CS, Lynch SM, Lan Q, Rothman N, Stolzenberg-Solomon R, Purdue MP (2014). Telomere length varies by DNA extraction method: implications for epidemiologic research-letter. Cancer Epidemiol Biomarkers Prev  23, 1129-30.   https://doi.org/10.1158/1055-9965.EPI-14-0145",https://intramural.nih.gov/search/searchview.taf?ipid=84188
613,CP010142-16,"October 01, 2013 -  September 30, 2014",Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI",Phuong L Mai|Jennifer T Loud|Anand  Pathak|Rebecca  Troisi|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Chester  Douglass (Harvard School of Dentistry),NULL,NULL,"1. Basavaraju U, Shebl FM, Palmer AJ, Berry S, Hold GL, El-Omar EM, Rabkin CS (2015). Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland. Eur J Cancer Prev  24, 296-304.   https://doi.org/10.1097/CEJ.0000000000000087|2. Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, et al. [7 more authors] (2014). Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res  20, 4200-9.   https://doi.org/10.1158/1078-0432.CCR-13-2574|3. Savage SA (2014). Genomic clues to ethnic differences in ALL. Blood  123, 2440-2.   https://doi.org/10.1182/blood-2014-02-557330",https://intramural.nih.gov/search/searchview.taf?ipid=84189
614,CP010144-16,"October 01, 2013 -  September 30, 2014",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI","Mitchell Henry Gail; PhD, MD|Shahinaz M Gadalla|Neelam K Giri; MD|Sholom  Wacholder; PhD|Phuong L Mai|Renee C Bremer|Show all 15",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|Lawrence  Einhorn (Indiana University Medical Center)|Show all 53,"Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Margaret Anne Tucker (Human Genetics Program)|Stephen J Chanock; MD, PhD (Office of the Director)","Jeffery P Struewing; MS, MD (NHGRI) |Pamela  Stratton; MD (NICHD)","1. Kratz C, Greene M (2014) Chapter 45: Familial Testicular Cancer, in Clinical Genomics: Practical Applications in Adult Patient Care., pp. 228-230.|2. Alter BP, Giri N, Pan Y, Savage SA, Pinto LA (2014). Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromes. Vaccine  32, 1169-73.   https://doi.org/10.1016/j.vaccine.2013.11.048|3. Gadalla S, Pfeiffer R, Kristinsson S, Bjrkholm M, Hilbert J, Moxley III R, Landgren O, Greene M (2013) Mortality and Cancer Burden in Patients with Myotonic Dystrophy: A Population-Based Study. PloS ONE 2013; 8(11):e79851, Epub 8:e79851|4. Greene M, Savage S (2013) Common genetic variants in the 9p21 region and their associations with multiple tumours. Brit J Cancer 108:1378-1386|5. Kratz CP, Edelman DC, Wang Y, Meltzer PS, Greene MH (2014). Genetic and epigenetic analysis of monozygotic twins discordant for testicular cancer. Int J Mol Epidemiol Genet  5, 135-9.|6. Mirabello L, Macari ER, Jessop L, Ellis SR, Myers T, Giri N, Taylor AM, McGrath KE, Humphries JM, Ballew BJ, Yeager M, Boland JF, He J, Hicks BD, Burdett L, Alter BP, Zon L, Savage SA (2014). Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. Blood  124, 24-32.   https://doi.org/10.1182/blood-2013-11-540278|7. Mueller CM, Korde LA, McMaster ML, Peters JA, Bratslavsky G, Watkins RJ, Ling A, Kratz CP, Wulfsberg EA, Rosenberg PS, Greene MH (2014). Familial testicular germ cell tumor: no associated syndromic pattern identified. Hered Cancer Clin Pract  12, 3.   https://doi.org/10.1186/1897-4287-12-3|8. Pemov A, Sung H, Hyland PL, Sloan JL, Ruppert SL, Baldwin AM, Boland JF, Bass SE, Lee HJ, Jones KM, Zhang X, NISC Comparative Sequencing Program, Mullikin JC, Widemann BC, Wilson AF, Stewart DR (2014). Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis. PLoS Genet  10, e1004575.   https://doi.org/10.1371/journal.pgen.1004575|9. Sklavos MM, Giri N, Stratton P, Alter BP, Pinto LA (2014). Anti-Müllerian hormone deficiency in females with Fanconi anemia. J Clin Endocrinol Metab  99, 1608-14.   https://doi.org/10.1210/jc.2013-3559|10. Stewart DR, Pemov A, Johnston JJ, Sapp JC, Yeager M, He J, Boland JF, Burdett L, Brown C, Gatti RA, Alter BP, Biesecker LG, Savage SA (2014). Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders. PLoS One  9, e98686.   https://doi.org/10.1371/journal.pone.0098686",https://intramural.nih.gov/search/searchview.taf?ipid=84190
615,CP010145-15,"October 01, 2013 -  September 30, 2014",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Breast and Gynecologic Cancer Research Group, NCI",Phuong L Mai|June  Peters|Jennifer T Loud,David  Alberts (University of Arizona Cancer Center)|Steven  Skates (Massachusetts General Hospital)|Martee  Hensley (Memorial Sloan-Kettering Cancer Center)|Karen  Lu (MD Anderson Cancer Center)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Show all 16,Margaret Anne Tucker (Human Genetics Program)|Lori M Minasian (Office of the Director)|Richard P Moser (Science Of Research & Technology Branch),Paul Kj Han (NHGRI) |Gustavo Javier Rodriguez (OD),"1. Hoskins L, WernerLin A, Greene M (2014) In Their Own Words: Treating very young BRCA12 mutation-positive women with care and caution. PLoS One 9:e87696|2. Loud JT, Gierach GL, Veenstra TD, Falk RT, Nichols K, Guttmann A, Xu X, Greene MH, Gail MH (2014). Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers. Breast Cancer Res Treat  143, 517-29.   https://doi.org/10.1007/s10549-013-2821-6",https://intramural.nih.gov/search/searchview.taf?ipid=84191
616,CP010150-15,"October 01, 2013 -  September 30, 2014","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Anil Kumar Chaturvedi|Jill Elizabeth Koshiol|James Jerome Goedert; MD,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Neal David Freedman (Nutritional Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Adebamowo CA, Casper C, Bhatia K, Mbulaiteye SM, Sasco AJ, Phipps W, Vermund SH, Krown SE (2014) Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa. J Acquir Immune Defic Syndr 67 Suppl 1:S17-26|2. Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, Parkin DM, Rebbeck TR, Ross H, Santini LA, Torode J, Trimble EL, Wild CP, Young AM, Kerr DJ (2014). Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol  11, 251-9.   https://doi.org/10.1038/nrclinonc.2014.37|3. Basavaraju U, Shebl FM, Palmer AJ, Berry S, Hold GL, El-Omar EM, Rabkin CS (2015). Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland. Eur J Cancer Prev  24, 296-304.   https://doi.org/10.1097/CEJ.0000000000000087|4. Chang CM, Stapleton JT, Klinzman D, McLinden JH, Purdue MP, Katki HA, Engels EA (2014). GBV-C infection and risk of NHL among U.S. adults. Cancer Res  74, 5553-60.   https://doi.org/10.1158/0008-5472.CAN-14-0209|5. Engels EA, Wacholder S, Katki HA, Chaturvedi AK (2014). Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology. Cancer Epidemiol Biomarkers Prev  23, 1959-64.   https://doi.org/10.1158/1055-9965.EPI-14-0282|6. Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA (2014). Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS  28, 2313-8.   https://doi.org/10.1097/QAD.0000000000000428|7. Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA (2014). Moving forward in HIV-associated cancer. J Clin Oncol  32, 876-80.   https://doi.org/10.1200/JCO.2013.53.1376|8. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA (2014). Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol  12, 1541-9.e3.   https://doi.org/10.1016/j.cgh.2013.12.018|9. Marks MA, Engels EA (2014). Venous thromboembolism and cancer risk among elderly adults in the United States. Cancer Epidemiol Biomarkers Prev  23, 774-83.   https://doi.org/10.1158/1055-9965.EPI-13-1138|10. McShane CM, Murray LJ, Engels EA, Anderson LA (2014). Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia. Br J Haematol  164, 653-8.   https://doi.org/10.1111/bjh.12671|11. McShane CM, Murray LJ, Engels EA, Landgren O, Anderson LA (2014). Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study. Int J Cancer  134, 1734-40.   https://doi.org/10.1002/ijc.28479|12. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA (2014). Risk of myeloid neoplasms after solid organ transplantation. Leukemia  28, 2317-23.   https://doi.org/10.1038/leu.2014.132|13. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA (2014). Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica  99, 70-3.   https://doi.org/10.3324/haematol.2013.101600|14. Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DA, van Boerdonk RA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, et al. [15 more authors] (2014). HPV-associated lung cancers: an international pooled analysis. Carcinogenesis  35, 1267-75.   https://doi.org/10.1093/carcin/bgu038|15. Robbins HA, Shiels MS, Pfeiffer RM, Engels EA (2014). Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS  28, 881-90.   https://doi.org/10.1097/QAD.0000000000000163|16. Ryan BM, Pine SR, Chaturvedi AK, Caporaso N, Harris CC (2014). A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Thorac Oncol  9, 1494-503.   https://doi.org/10.1097/JTO.0000000000000278|17. Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK (2014). Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju294|18. Shiels MS, Koritzinsky EH, Clarke CA, Suneja G, Morton LM, Engels EA (2014). Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases. Cancer Epidemiol Biomarkers Prev  23, 274-81.   https://doi.org/10.1158/1055-9965.EPI-13-0865|19. Suneja G, Shiels MS, Angulo R, Copeland GE, Gonsalves L, Hakenewerth AM, Macomber KE, Melville SK, Engels EA (2014). Cancer treatment disparities in HIV-infected individuals in the United States. J Clin Oncol  32, 2344-50.   https://doi.org/10.1200/JCO.2013.54.8644|20. Titmarsh GJ, McMullin MF, McShane CM, Clarke M, Engels EA, Anderson LA (2014). Community-acquired infections and their association with myeloid malignancies. Cancer Epidemiol  38, 56-61.   https://doi.org/10.1016/j.canep.2013.10.009|21. Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA (2014). Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol  25, 2335-41.   https://doi.org/10.1681/ASN.2013101122",https://intramural.nih.gov/search/searchview.taf?ipid=84192
617,CP010152-15,"October 01, 2013 -  September 30, 2014",PLCO Trial Etiologic and Early Marker Study,"Mark  Purdue|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Wen-Yi  Huang|Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Christine Dorothy Berg (Early Detection Research Group),NULL,"1. Barry KH, Moore LE, Liao LM, Huang WY, Andreotti G, Poulin M, Berndt SI (2015). Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer. Prostate  75, 1718-25.   https://doi.org/10.1002/pros.23053|2. Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J (2013). Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. Br J Cancer  109, 1352-9.   https://doi.org/10.1038/bjc.2013.434|3. Hofmann JN, Hosgood HD, Liu CS, Chow WH, Shuch B, Cheng WL, Lin TT, Moore LE, Lan Q, Rothman N, Purdue MP (2014). A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis  35, 1028-31.   https://doi.org/10.1093/carcin/bgt495|4. Karami S, Andreotti G, Liao LM, Pfeiffer RM, Weinstein SJ, Purdue MP, Hofmann JN, Albanes D, Mannisto S, Moore LE (2015). LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. Epigenetics  10, 282-92.   https://doi.org/10.1080/15592294.2015.1006505|5. Karami S, Daugherty SE, Purdue MP (2015). A prospective study of alcohol consumption and renal cell carcinoma risk. Int J Cancer  137, 238-42.   https://doi.org/10.1002/ijc.29359|6. Kim C, Bassig BA, Seow WJ, Hu W, Purdue MP, Huang WY, Liu CS, Cheng WL, Männistö S, Vermeulen R, Weinstein SJ, Lim U, Hosgood HD, Bonner MR, Caporaso NE, Albanes D, Lan Q, Rothman N (2015). Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. Cancer Epidemiol Biomarkers Prev  24, 148-53.   https://doi.org/10.1158/1055-9965.EPI-14-0753|7. Kunzmann AT, Coleman HG, Huang WY, Kitahara CM, Cantwell MM, Berndt SI (2015). Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr  102, 881-90.   https://doi.org/10.3945/ajcn.115.113282|8. Murphy N, Cross AJ, Huang WY, Rajabzadeh-Heshejin V, Stanczyk F, Hayes R, Gunter MJ (2015). A prospective evaluation of C-peptide levels and colorectal adenoma incidence. Cancer Epidemiol  39, 160-5.   https://doi.org/10.1016/j.canep.2014.12.011|9. Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC (2014). Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer  134, 1399-407.   https://doi.org/10.1002/ijc.28457|10. Wu SP, Costello R, Hofmann JN, Korde N, Mailankody S, Purdue M, Landgren O (2013). MGUS prevalence in a cohort of AML patients. Blood  122, 294-5.   https://doi.org/10.1182/blood-2013-04-497859",https://intramural.nih.gov/search/searchview.taf?ipid=84193
618,CP010158-14,"October 01, 2013 -  September 30, 2014",Studies of Rare Cancers,Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  |Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Elna Christina Marianne Persson|Vikrant Vasant Sahasrabuddhe,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",Kelly Jen-Yi Yu (Early Detection Research Group),NULL,"1. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA (2014). Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol  109, 542-53.   https://doi.org/10.1038/ajg.2014.11|2. Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, European Rare Cancer Study Group, et al. [11 more authors] (2014). Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst  106, djt465.   https://doi.org/10.1093/jnci/djt465|3. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF (2013). Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J  1, 351-7.   https://doi.org/10.1177/2050640613501507|4. Enewold LR, McGlynn KA, Zahm SH, Poudrier J, Anderson WF, Shriver CD, Zhu K (2014). Breast reconstruction after mastectomy among Department of Defense beneficiaries by race. Cancer  120, 3033-9.   https://doi.org/10.1002/cncr.28806|5. Gill AA, Zahm SH, Shriver CD, Stojadinovic A, McGlynn KA, Zhu K (2015). Colon cancer lymph node evaluation among military health system beneficiaries: an analysis by race/ethnicity. Ann Surg Oncol  22, 195-202.   https://doi.org/10.1245/s10434-014-3939-4|6. Major JM, Sargent JD, Graubard BI, Carlos HA, Hollenbeck AR, Altekruse SF, Freedman ND, McGlynn KA (2014). Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle. Ann Epidemiol  24, 104-10.   https://doi.org/10.1016/j.annepidem.2013.11.006|7. Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K (2014). Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Cancer Causes Control  25, 959-68.   https://doi.org/10.1007/s10552-014-0395-1|8. Schwartz LM, Persson EC, Weinstein SJ, Graubard BI, Freedman ND, Männistö S, Albanes D, McGlynn KA (2013). Alcohol consumption, one-carbon metabolites, liver cancer and liver disease mortality. PLoS One  8, e78156.   https://doi.org/10.1371/journal.pone.0078156",https://intramural.nih.gov/search/searchview.taf?ipid=84194
619,CP010167-14,"October 01, 2013 -  September 30, 2014",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi|Patricia  Hartge; ScD,NULL,Sharon Ann Savage (Clinical Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84195
620,CP010168-14,"October 01, 2013 -  September 30, 2014",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 12",NULL,NULL,"1. Houghton LC, Cooper GD, Bentley GR, Booth M, Chowdhury OA, Troisi R, Ziegler RG, Hoover RN, Katki HA (2014). A migrant study of pubertal timing and tempo in British-Bangladeshi girls at varying risk for breast cancer. Breast Cancer Res  16, 469.   https://doi.org/10.1186/s13058-014-0469-8",https://intramural.nih.gov/search/searchview.taf?ipid=84196
621,CP010169-13,"October 01, 2013 -  September 30, 2014","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Mitchell Henry Gail; PhD, MD|Gloria L Gridley|Patricia  Hartge; ScD|Hormuzdiar Aspandiar Katki; MS|Catherine G Schairer","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)|Peter D Inskip; ScD (Radiation Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch),NULL,"1. Fortner RT, Oh H, Daugherty SE, Xu X, Hankinson SE, Ziegler RG, Eliassen AH (2014). Analgesic use and patterns of estrogen metabolism in premenopausal women. Horm Cancer  5, 104-12.   https://doi.org/10.1007/s12672-013-0167-5",https://intramural.nih.gov/search/searchview.taf?ipid=84199
622,CP010170-14,"October 01, 2013 -  September 30, 2014",Multidisciplinary Studies of Hematopoietic Malignancies,Patricia  Hartge; ScD| | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Martha S Linet; PhD,"Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)","Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)|Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Sophia S Wang; PhD (Infection & Immunoepidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",NULL,"1. DellaValle CT, Wheeler DC, Deziel NC, De Roos AJ, Cerhan JR, Cozen W, Severson RK, Flory AR, Locke SJ, Colt JS, Hartge P, Ward MH (2013). Environmental determinants of polychlorinated biphenyl concentrations in residential carpet dust. Environ Sci Technol  47, 10405-14.   https://doi.org/10.1021/es401447w|2. Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM (2014). Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol  165, 67-77.   https://doi.org/10.1111/bjh.12730|3. Morton LM, Freedman DM (2013). Shedding light on UVR and Hodgkin lymphoma. Blood  122, 3395-7.   https://doi.org/10.1182/blood-2013-09-527648|4. Skibola CF, Slager SL, Berndt SI, Lightfoot T, Sampson JN, Morton LM, Weisenburger DD (2014). Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr  2014, 125-9.   https://doi.org/10.1093/jncimonographs/lgu009|5. Wang J, Cozen W, Thorne PS, Berhane K, Cerhan JR, Hartge P, Ward MH, De Roos AJ, Severson RK, Morton LM, Bernstein L, Linet MS, Colt JS (2013). Household endotoxin levels and the risk of non-Hodgkin lymphoma. Cancer Causes Control  24, 357-64.   https://doi.org/10.1007/s10552-012-0121-9",https://intramural.nih.gov/search/searchview.taf?ipid=84197
623,CP010176-14,"October 01, 2013 -  September 30, 2014",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI",Charles  Rabkin|Anil Kumar Chaturvedi,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Stephen J Chanock; MD, PhD (Office of the Director)|Denise  Whitby (Office Of The Director)",NULL,"1. Adewole I, Martin DN, Williams MJ, Adebamowo C, Bhatia K, Berling C, Casper C, Elshamy K, Elzawawy A, Lawlor RT, Legood R, Mbulaiteye SM, Odedina FT, Olopade OI, Olopade CO, Parkin DM, Rebbeck TR, Ross H, Santini LA, Torode J, Trimble EL, Wild CP, Young AM, Kerr DJ (2014). Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol  11, 251-9.   https://doi.org/10.1038/nrclinonc.2014.37|2. Akarolo-Anthony SN, Maso LD, Igbinoba F, Mbulaiteye SM, Adebamowo CA (2014). Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study. Infect Agent Cancer  9, 1.   https://doi.org/10.1186/1750-9378-9-1|3. Mbulaiteye SM, Buonaguro FM (2013). Infections and cancer: debate about using vaccines as a cancer control tool. Infect Agent Cancer  8, 16.   https://doi.org/10.1186/1750-9378-8-16|4. Mbulaiteye SM, Pullarkat ST, Nathwani BN, Weiss LM, Rao N, Emmanuel B, Lynch CF, Hernandez B, Neppalli V, Hawes D, Cockburn MG, Kim A, Williams M, Altekruse S, Bhatia K, Goodman MT, Cozen W (2014). Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009. APMIS  122, 5-15.   https://doi.org/10.1111/apm.12078|5. Rohner E, Wyss N, Trelle S, Mbulaiteye SM, Egger M, Novak U, Zwahlen M, Bohlius J (2014). HHV-8 seroprevalence: a global view. Syst Rev  3, 11.   https://doi.org/10.1186/2046-4053-3-11|6. Williams CK, Cristina Stefan D, Rawlinson F, Simbiri K, Mbulaiteye SM (2014). The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21-24 November 2013. Ecancermedicalscience  8, 396.   https://doi.org/10.3332/ecancer.2014.396",https://intramural.nih.gov/search/searchview.taf?ipid=84198
624,CP010180-13,"October 01, 2013 -  September 30, 2014",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Sabah  Quraishi|Lisa Wey-Lan Chu,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch),NULL,"1. Cook MB, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chung CC, Chokkalingam AP, Chu LW, Yeager M, Hutchinson A, Yu K, Rand KA, Haiman CA, African Ancestry Prostate Cancer GWAS Consortium, Hoover RN, Hsing AW, Chanock SJ (2014). A genome-wide association study of prostate cancer in West African men. Hum Genet  133, 509-21.   https://doi.org/10.1007/s00439-013-1387-z|2. Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, Netto GJ, Yu K, Li Y, Chokkalingam AP, Chu LW, Chia D, Partin A, Thompson IM, Quraishi SM, Niwa S, Tarone R, Hoover RN (2014). High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer. J Urol  192, 730-5.   https://doi.org/10.1016/j.juro.2014.04.017",https://intramural.nih.gov/search/searchview.taf?ipid=84212
625,CP010181-12,"October 01, 2013 -  September 30, 2014",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  |Nilanjan  Chatterjee",NULL,"Biostatistics Branch, NCI",Junmo  Nam,"Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Laure  El Ghormli (GW Biostat)|Show all 13","Patricia  Hartge; ScD (Epidemiology and Biostatistics Program)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)",NULL,"1. Anderson WF, Rosenberg PS, Katki HA (2014). Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer. J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju093|2. Boca SM, Sinha R, Cross AJ, Moore SC, Sampson JN (2014). Testing multiple biological mediators simultaneously. Bioinformatics  30, 214-20.   https://doi.org/10.1093/bioinformatics/btt633|3. Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park JH (2013). Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet  45, 400-5, 405e1-3.   https://doi.org/10.1038/ng.2579|4. Chen H, Pfeiffer R, Shunpu Zhang (2013) A powerful method for combining p-values in genomic studies. GENET EPIDEMIOL 37:814-819|5. Flegal KM, Kit BK, Graubard BI (2014). Body mass index categories in observational studies of weight and risk of death. Am J Epidemiol  180, 288-96.   https://doi.org/10.1093/aje/kwu111|6. Gail MH (2014). Using absolute risks to assess the risks and benefits of treatment. Thorax  69, 604-5.   https://doi.org/10.1136/thoraxjnl-2014-205175|7. Gail MH, You WC, Li WQ (2014). RE: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Response. J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju348|8. Garcia-Closas M, Gunsoy NB, Chatterjee N (2014). Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju305|9. Ghosh A, Hartge P, Kraft P, Joshi AD, Ziegler RG, Barrdahl M, Chanock SJ, Wacholder S, Chatterjee N (2014). Leveraging family history in population-based case-control association studies. Genet Epidemiol  38, 114-22.   https://doi.org/10.1002/gepi.21785|10. Hutter CM, Mechanic LE, Chatterjee N, Kraft P, Gillanders EM, NCI Gene-Environment Think Tank (2013). Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report. Genet Epidemiol  37, 643-57.   https://doi.org/10.1002/gepi.21756|11. Ke L, Graubard BI, Albanes D, Fraser DR, Weinstein SJ, Virtamo J, Brock KE (2013). Hypertension, pulse, and other cardiovascular risk factors and vitamin D status in Finnish men. Am J Hypertens  26, 951-6.   https://doi.org/10.1093/ajh/hpt051|12. Kovalchik S, Martin Tammemagi , Christine D Berg , Caporaso N, Riley T, Mary Korch , Gerard A Silvestri , Denise R Aberle , Constantine Gatsonis , Fagerstrom R, Chaturvedi A, Katki H (2013) Variability In The Efficacy Of Low-Dose Computed Tomography Screening With Risk Of Lung Cancer Mortality: Results From The National Lung Screening Trial. NEW ENGL J MED 369:245-254|13. Kovalchik SA, Varadhan R, Fetterman B, Poitras NE, Wacholder S, Katki HA (2013). A general binomial regression model to estimate standardized risk differences from binary response data. Stat Med  32, 808-21.   https://doi.org/10.1002/sim.5553|14. Lubin JH, De Stefani E, Abnet CC, Acosta G, Boffetta P, Victora C, Graubard BI, Muñoz N, Deneo-Pellegrini H, Franceschi S, Castellsagué X, Ronco AL, Dawsey SM (2014). Maté drinking and esophageal squamous cell carcinoma in South America: pooled results from two large multicenter case-control studies. Cancer Epidemiol Biomarkers Prev  23, 107-16.   https://doi.org/10.1158/1055-9965.EPI-13-0796|15. Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V (2014). Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res  24, 480-7.   https://doi.org/10.1097/CMR.0000000000000112|16. Rosenberg PS, Check DP, Anderson WF (2014). A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev  23, 2296-302.   https://doi.org/10.1158/1055-9965.EPI-14-0300|17. Sampson JN, Wheeler B, Li P, Shi J (2014). LEVERAGING LOCAL IDENTITY-BY-DESCENT INCREASES THE POWER OF CASE/CONTROL GWAS WITH RELATED INDIVIDUALS. Ann Appl Stat  8, 974-998.   https://doi.org/10.1214/14-aoas715|18. Shi J, Li P (2013) Testing associations of copy number variations in genome-wide association studies. STAT SINICA 23:1463-1477|19. Shi J, Yang XR, Caporaso NE, Landi MT, Li P (2014). VTET: a variable threshold exact test for identifying disease-associated copy number variations enriched in short genomic regions. Front Genet  5, 53.   https://doi.org/10.3389/fgene.2014.00053|20. Tang M, Slud EV, Pfeiffer RM (2014). Goodness of Fit Tests for Linear Mixed Models. J Multivar Anal  130, 176-193.   https://doi.org/10.1016/j.jmva.2014.03.012|21. Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, Landgren O (2014). Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood  123, 338-45.   https://doi.org/10.1182/blood-2013-05-505487|22. Yao W, Li Z, Graubard BI (2015). Estimation of ROC curve with complex survey data. Stat Med  34, 1293-303.   https://doi.org/10.1002/sim.6405|23. Zhang H, Shi J, Liang F, Wheeler W, Stolzenberg-Solomon R, Yu K (2014). A fast multilocus test with adaptive SNP selection for large-scale genetic-association studies. Eur J Hum Genet  22, 696-702.   https://doi.org/10.1038/ejhg.2013.201|24. Zhang H, Wheeler W, Wang Z, Taylor PR, Yu K (2014). A fast and powerful tree-based association test for detecting complex joint effects in case-control studies. Bioinformatics  30, 2171-8.   https://doi.org/10.1093/bioinformatics/btu186",https://intramural.nih.gov/search/searchview.taf?ipid=84172
626,CP010182-12,"October 01, 2013 -  September 30, 2014",Epidemiologic Field Studies,"Nilanjan  Chatterjee| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",Catherine G Schairer,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84202
627,CP010183-12,"October 01, 2013 -  September 30, 2014",Descriptive Studies and Record Linkage,William Frederick Anderson,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD|Catherine G Schairer|Sholom  Wacholder; PhD",F  Bray (International Agency for Research on Cancer)|Susan Shaw Devesa (NCI)|Ismail  Jatoi (US Army)|Ahmedin  Jemal (American Cancer Society)|MajBritt  Jensen (Danish Breast Cancer Group)|Niels  Kroman (Danish Breast Cancer Group)|Show all 11,"Dalsu  Baris (Occupational and Environmental Epidemiology Branch)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Anil Kumar Chaturvedi (Infection & Immunoepidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)",NULL,"1. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME (2014). How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst  106.   https://doi.org/10.1093/jnci/dju165|2. Banegas MP, Tao L, Altekruse S, Anderson WF, John EM, Clarke CA, Gomez SL (2014). Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Breast Cancer Res Treat  144, 625-34.   https://doi.org/10.1007/s10549-014-2882-1|3. Kovalchik SA, De Matteis S, Landi MT, Caporaso NE, Varadhan R, Consonni D, Bergen AW, Katki HA, Wacholder S (2013). A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers. BMC Med Res Methodol  13, 143.   https://doi.org/10.1186/1471-2288-13-143|4. Murphy RA, Schairer C, Gierach GL, Byrne C, Sherman ME, Register TC, Ding J, Kritchevsky SB, Harris TB (2013). Beyond breast cancer: mammographic features and mortality risk in a population of healthy women. PLoS One  8, e78722.   https://doi.org/10.1371/journal.pone.0078722|5. Wacholder S (2013). Precursors in cancer epidemiology: aligning definition and function. Cancer Epidemiol Biomarkers Prev  22, 521-7.   https://doi.org/10.1158/1055-9965.EPI-13-0084",https://intramural.nih.gov/search/searchview.taf?ipid=84171
628,CP010184-12,"October 01, 2013 -  September 30, 2014",Consultation and Collaboration,Sholom  Wacholder; PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Nilanjan  Chatterjee|Junmo  Nam|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD",David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Scott R Diehl; PhD (NIDCR)|Show all 81,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)|Wen-Yi  Huang (Occupational and Environmental Epidemiology Branch)",Harvey J Alter; MD (CC) |Jane  Hoppin; ScD (NIEHS) |Joni L Rutter (NIDA) |Dale  Sandler; PhD (NIEHS) |Clarice  Weinberg; PhD (NIEHS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84204
629,CP010185-12,"October 01, 2013 -  September 30, 2014",Biodefense Project,Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alice  Sigurdson; PhD|Vladimir  Drozdovitch|Choonsik  Lee|Amy  de Gonzalez|Andre  Bouville,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84203
630,CP010187-10,"October 01, 2013 -  September 30, 2014",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,"1. Figueroa JD, Han SS, Garcia-Closas M, Baris D, Jacobs EJ, Kogevinas M, Schwenn M, Malats N, Johnson A, Purdue MP, Caporaso N, Landi MT, Prokunina-Olsson L, Wang Z, Hutchinson A, Burdette L, Wheeler W, Vineis P, Siddiq A, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, et al. [43 more authors] (2014). Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis  35, 1737-44.   https://doi.org/10.1093/carcin/bgu064|2. Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, Purdue M, Jacobs EJ, Albanes D, Wang Z, Deng X, Chung CC, Tang W, Bas Bueno-de-Mesquita H, Trichopoulos D, Ljungberg B, et al. [67 more authors] (2014). Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet  23, 1387-98.   https://doi.org/10.1093/hmg/ddt519",https://intramural.nih.gov/search/searchview.taf?ipid=84210
631,CP010188-10,"October 01, 2013 -  September 30, 2014",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Catherine G Schairer|Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington)|Stephanie Ann Kovalchik|Ju-Hyun  Park,"Demetrius  Albanes; MD (Nutritional Epidemiology Branch)|Yikyung  Park (Nutritional Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84205
632,CP010190-09,"October 01, 2013 -  September 30, 2014",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Mark H Greene; MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Shahinaz M Gadalla|Bari Jane Ballew,"Immaculata  DeVivo (Harvard Medical School)|David  Hunter (Harvard School of Public Health)|Richard  Cawthon (University of Utah)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Show all 10",Lisa  Mirabello (Genetic Epidemiology Branch),NULL,"1. Ballew BJ, Joseph V, De S, Sarek G, Vannier JB, Stracker T, Schrader KA, Small TN, O'Reilly R, Manschreck C, Harlan Fleischut MM, Zhang L, Sullivan J, Stratton K, Yeager M, Jacobs K, Giri N, Alter BP, Boland J, Burdett L, Offit K, Boulton SJ, Savage SA, Petrini JH (2013). A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet  9, e1003695.   https://doi.org/10.1371/journal.pgen.1003695|2. Bodelon C, Savage SA, Gadalla SM (2014). Telomeres in molecular epidemiology studies. Prog Mol Biol Transl Sci  125, 113-31.   https://doi.org/10.1016/B978-0-12-397898-1.00005-0|3. Khincha PP, Wentzensen IM, Giri N, Alter BP, Savage SA (2014). Response to androgen therapy in patients with dyskeratosis congenita. Br J Haematol  165, 349-57.   https://doi.org/10.1111/bjh.12748|4. Kocak H, Ballew BJ, Bisht K, Eggebeen R, Hicks BD, Suman S, O'Neil A, Giri N, NCI DCEG Cancer Genomics Research Laboratory, NCI DCEG Cancer Sequencing Working Group, Maillard I, Alter BP, Keegan CE, Nandakumar J, Savage SA (2014). Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev  28, 2090-102.   https://doi.org/10.1101/gad.248567.114",https://intramural.nih.gov/search/searchview.taf?ipid=84213
633,CP010192-07,"October 01, 2013 -  September 30, 2014","Biorepository Processing, Storage, and Research","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,Karen E Berliner (Human Genetics Program)|Marianne  Henderson (Office of Division Operations and Analysis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84220
634,CP010193-08,"October 01, 2013 -  September 30, 2014",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Patricia  Hartge; ScD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI

Office of the Director, NCI",Julie  Mendelsohn|Amy  Hutchinson,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Kathy  Helzlsouer; MD (Epidemiology, Johns Hopkins University)|Show all 17",Geoffrey Scott Tobias (Human Genetics Program)|Kai  Yu (Biostatistics Branch),NULL,"1. Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F, Cao G, Duell EJ, Elena JW, Gaziano JM, Giovannucci EL, et al. [31 more authors] (2014). Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut  63, 152-60.   https://doi.org/10.1136/gutjnl-2012-303477|2. Wu L, Goldstein AM, Yu K, Yang XR, Rabe KG, Arslan AA, Canzian F, Wolpin BM, Stolzenberg-Solomon R, Amundadottir LT, Petersen GM (2014). Variants associated with susceptibility to pancreatic cancer and melanoma do not reciprocally affect risk. Cancer Epidemiol Biomarkers Prev  23, 1121-4.   https://doi.org/10.1158/1055-9965.EPI-13-0627",https://intramural.nih.gov/search/searchview.taf?ipid=84214
635,CP010195-08,"October 01, 2013 -  September 30, 2014","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI",Stephanie Joan Weinstein|Alison Marian Mondul|Jacqueline M Major; MS,David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Genetic Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Anic GM, Weinstein SJ, Mondul AM, Männistö S, Albanes D (2014). Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer. PLoS One  9, e102966.   https://doi.org/10.1371/journal.pone.0102966|2. Freedman DM, Kuncl RW, Weinstein SJ, Albanes D (2013). Comment on ""Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies"". Ann Neurol  74, 307.   https://doi.org/10.1002/ana.23952|3. Jacobs EJ, Newton CC, Silverman DT, Nogueira LM, Albanes D, Männistö S, Pollak M, Stolzenberg-Solomon RZ (2014). Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Cancer Causes Control  25, 1083-91.   https://doi.org/10.1007/s10552-014-0409-z|4. Mondul AM, Moore SC, Weinstein SJ, Männistö S, Sampson JN, Albanes D (2014). 1-stearoylglycerol is associated with risk of prostate cancer: results from serum metabolomic profiling. Metabolomics  10, 1036-1041.   https://doi.org/10.1007/s11306-014-0643-0|5. Mondul AM, Weinstein SJ, Moy KA, Männistö S, Albanes D (2014). Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. Int J Cancer  134, 2699-706.   https://doi.org/10.1002/ijc.28596|6. Moy KA, Mondul AM, Zhang H, Weinstein SJ, Wheeler W, Chung CC, Männistö S, Yu K, Chanock SJ, Albanes D (2014). Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr  99, 1424-31.   https://doi.org/10.3945/ajcn.113.080309|7. Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, Huttunen J, Albanes D (2014). Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer  135, 178-85.   https://doi.org/10.1002/ijc.28641",https://intramural.nih.gov/search/searchview.taf?ipid=84216
636,CP010196-08,"October 01, 2013 -  September 30, 2014",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI","Yikyung  Park|Rachael Zoe Solomon|Neal David Freedman|Steven  Moore|Christian Cormac Abnet; PhD, MPH",NULL,Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Arem H, Moore SC, Park Y, Ballard-Barbash R, Hollenbeck A, Leitzmann M, Matthews CE (2014). Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort. Int J Cancer  135, 423-31.   https://doi.org/10.1002/ijc.28659|2. Brinton LA, Smith L, Gierach GL, Pfeiffer RM, Nyante SJ, Sherman ME, Park Y, Hollenbeck AR, Dallal CM (2014). Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study. Cancer Causes Control  25, 843-57.   https://doi.org/10.1007/s10552-014-0385-3|3. Chau JY, Grunseit AC, Chey T, Stamatakis E, Brown WJ, Matthews CE, Bauman AE, van der Ploeg HP (2013). Daily sitting time and all-cause mortality: a meta-analysis. PLoS One  8, e80000.   https://doi.org/10.1371/journal.pone.0080000|4. Cohen SS, Park Y, Signorello LB, Patel AV, Boggs DA, Kolonel LN, Kitahara CM, Knutsen SF, Gillanders E, Monroe KR, Berrington de Gonzalez A, Bethea TN, Black A, Fraser G, Gapstur S, Hartge P, Matthews CE, Park SY, Purdue MP, Singh P, Harvey C, Blot WJ, Palmer JR (2014). A pooled analysis of body mass index and mortality among African Americans. PLoS One  9, e111980.   https://doi.org/10.1371/journal.pone.0111980|5. Cook MB, Matthews CE, Gunja MZ, Abid Z, Freedman ND, Abnet CC (2013). Physical activity and sedentary behavior in relation to esophageal and gastric cancers in the NIH-AARP cohort. PLoS One  8, e84805.   https://doi.org/10.1371/journal.pone.0084805|6. Felix AS, Yang HP, Gierach GL, Park Y, Brinton LA (2014). Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control  25, 479-89.   https://doi.org/10.1007/s10552-014-0350-1|7. Guo X, Park Y, Freedman ND, Sinha R, Hollenbeck AR, Blair A, Chen H (2014). Sweetened beverages, coffee, and tea and depression risk among older US adults. PLoS One  9, e94715.   https://doi.org/10.1371/journal.pone.0094715|8. Jankovic N, Geelen A, Streppel MT, de Groot LC, Orfanos P, van den Hooven EH, Pikhart H, Boffetta P, Trichopoulou A, Bobak M, Bueno-de-Mesquita HB, Kee F, Franco OH, Park Y, Hallmans G, Tjønneland A, May AM, Pajak A, Malyutina S, Kubinova R, Amiano P, Kampman E, Feskens EJ (2014). Adherence to a healthy diet according to the World Health Organization guidelines and all-cause mortality in elderly adults from Europe and the United States. Am J Epidemiol  180, 978-88.   https://doi.org/10.1093/aje/kwu229|9. Liu R, Baird D, Park Y, Freedman ND, Huang X, Hollenbeck A, Blair A, Chen H (2014). Female reproductive factors, menopausal hormone use, and Parkinson's disease. Mov Disord  29, 889-96.   https://doi.org/10.1002/mds.25771|10. Lynch BM, Friedenreich CM, Kopciuk KA, Hollenbeck AR, Moore SC, Matthews CE (2014). Sedentary behavior and prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Epidemiol Biomarkers Prev  23, 882-9.   https://doi.org/10.1158/1055-9965.EPI-13-0808|11. Mitchell JA, Bottai M, Park Y, Marshall SJ, Moore SC, Matthews CE (2014). A prospective study of sedentary behavior and changes in the body mass index distribution. Med Sci Sports Exerc  46, 2244-52.   https://doi.org/10.1249/MSS.0000000000000366|12. Nyante SJ, Dallal CM, Gierach GL, Park Y, Hollenbeck AR, Brinton LA (2013). Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol  178, 359-71.   https://doi.org/10.1093/aje/kws471|13. Nyante SJ, Gierach GL, Dallal CM, Freedman ND, Park Y, Danforth KN, Hollenbeck AR, Brinton LA (2014). Cigarette smoking and postmenopausal breast cancer risk in a prospective cohort. Br J Cancer  110, 2339-47.   https://doi.org/10.1038/bjc.2014.132|14. Park Y, Wang S, Kitahara CM, Moore SC, Berrington de Gonzalez A, Bernstein L, Chang ET, Flint AJ, Freedman DM, Gaziano JM, Hoover RN, Linet MS, Purdue M, Robien K, Schairer C, Sesso HD, White E, Willcox BJ, Thun MJ, Hartge P, Willett WC (2014). Body mass index and risk of death in Asian Americans. Am J Public Health  104, 520-5.   https://doi.org/10.2105/AJPH.2013.301573|15. Pelser C, Arem H, Pfeiffer RM, Elena JW, Alfano CM, Hollenbeck AR, Park Y (2014). Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer  120, 1540-7.   https://doi.org/10.1002/cncr.28573|16. Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, Park Y, Subar AF (2014). Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J Nutr  144, 881-9.   https://doi.org/10.3945/jn.113.189407|17. Tasevska N, Park Y, Jiao L, Hollenbeck A, Subar AF, Potischman N (2014). Sugars and risk of mortality in the NIH-AARP Diet and Health Study. Am J Clin Nutr  99, 1077-88.   https://doi.org/10.3945/ajcn.113.069369|18. Xiao Q, Freedman ND, Ren J, Hollenbeck AR, Abnet CC, Park Y (2014). Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study. Br J Cancer  110, 1328-33.   https://doi.org/10.1038/bjc.2014.17|19. Xiao Q, Park Y, Hollenbeck AR, Kitahara CM (2014). Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev  23, 1102-8.   https://doi.org/10.1158/1055-9965.EPI-13-1150",https://intramural.nih.gov/search/searchview.taf?ipid=84222
637,CP010197-08,"October 01, 2013 -  September 30, 2014","Physical Activity, Energy Balance, and Cancer",Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Behrens G, Matthews CE, Moore SC, Hollenbeck AR, Leitzmann MF (2014). Body size and physical activity in relation to incidence of chronic obstructive pulmonary disease. CMAJ  186, E457-69.   https://doi.org/10.1503/cmaj.140025|2. George SM, Alfano CM, Groves J, Karabulut Z, Haman KL, Murphy BA, Matthews CE (2014). Objectively measured sedentary time is related to quality of life among cancer survivors. PLoS One  9, e87937.   https://doi.org/10.1371/journal.pone.0087937|3. Kozey Keadle S, Lyden K, Hickey A, Ray EL, Fowke JH, Freedson PS, Matthews CE (2014). Validation of a previous day recall for measuring the location and purpose of active and sedentary behaviors compared to direct observation. Int J Behav Nutr Phys Act  11, 12.   https://doi.org/10.1186/1479-5868-11-12|4. Matthews CE, Cohen SS, Fowke JH, Han X, Xiao Q, Buchowski MS, Hargreaves MK, Signorello LB, Blot WJ (2014). Physical activity, sedentary behavior, and cause-specific mortality in black and white adults in the Southern Community Cohort Study. Am J Epidemiol  180, 394-405.   https://doi.org/10.1093/aje/kwu142|5. Su LJ, Fiehn O, Maruvada P, Moore SC, O'Keefe SJ, Wishart DS, Zanetti KA (2014). The use of metabolomics in population-based research. Adv Nutr  5, 785-8.   https://doi.org/10.3945/an.114.006494",https://intramural.nih.gov/search/searchview.taf?ipid=84217
638,CP010198-08,"October 01, 2013 -  September 30, 2014",Lower Gastrointestinal Cancer Studies,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Gwen  Murphy,NULL,NULL,NULL,"1. Xiao Q, Moore SC, Boca SM, Matthews CE, Rothman N, Stolzenberg-Solomon RZ, Sinha R, Cross AJ, Sampson JN (2014). Sources of variability in metabolite measurements from urinary samples. PLoS One  9, e95749.   https://doi.org/10.1371/journal.pone.0095749",https://intramural.nih.gov/search/searchview.taf?ipid=84218
639,CP010199-08,"October 01, 2013 -  September 30, 2014",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",Charles E Matthews,NULL,Amy F Subar (Risk Factor Monitoring and Methods Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Monitoring and Methods Branch)|Douglas N Midthune (Biometry Research Group)|Laurence  Freedman (Biometry Research Group)|Richard P Troiano (Risk Factor Monitoring and Methods Branch),NULL,"1. Cross AJ, Major JM, Rothman N, Sinha R (2014). Urinary 1-methylhistidine and 3-methylhistidine, meat intake, and colorectal adenoma risk. Eur J Cancer Prev  23, 385-90.   https://doi.org/10.1097/CEJ.0000000000000027",https://intramural.nih.gov/search/searchview.taf?ipid=84219
640,CP010200-07,"October 01, 2013 -  September 30, 2014",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84221
641,CP010201-05,"October 01, 2013 -  September 30, 2014",Laboratory of Translational Genomics,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Human Genetics Program, NCI",NULL,NULL,"Stephen J Chanock; MD, PhD (Office of the Director)|Laufey Thora Amundadottir (Laboratory Translational Genomics)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Kevin Michael Brown (Laboratory Translational Genomics)",NULL,"1. Bhatia G, Tandon A, Patterson N, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Caporaso N, Casey G, Deming SL, Diver WR, Gapstur SM, Gillanders EM, Harris CC, Henderson BE, Ingles SA, Isaacs W, De Jager PL, John EM, Kittles RA, Larkin E, et al. [24 more authors] (2014). Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. Am J Hum Genet  95, 437-44.   https://doi.org/10.1016/j.ajhg.2014.08.011|2. Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD, Chen K, Wang JC, Wen W, Cawthon R, Chatterjee N, Hu W, Caporaso NE, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, et al. [107 more authors] (2015). Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: a report from the female lung cancer consortium in Asia. Int J Cancer  137, 311-9.   https://doi.org/10.1002/ijc.29393",https://intramural.nih.gov/search/searchview.taf?ipid=84226
642,CP010202-06,"October 01, 2013 -  September 30, 2014","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Nutritional Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)|Richard  Hayes; PhD (Occupational and Environmental Epidemiology Branch)",NULL,"1. Jacobs EJ, Newton CC, Silverman DT, Nogueira LM, Albanes D, Männistö S, Pollak M, Stolzenberg-Solomon RZ (2014). Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Cancer Causes Control  25, 1083-91.   https://doi.org/10.1007/s10552-014-0409-z|2. Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ (2014). Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev  23, 1414-20.   https://doi.org/10.1158/1055-9965.EPI-13-1359",https://intramural.nih.gov/search/searchview.taf?ipid=84168
643,CP010206-05,"October 01, 2013 -  September 30, 2014","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Julia  Gage,"Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Walter  Kinney (Kaiser Permanente Northern California)|Cosette  Wheeler (University of New Mexico)|Philip E Castle; PhD, MPH (NCI)|Show all 11",Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Lisa  Mirabello (Genetic Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84227
644,CP010207-05,"October 01, 2013 -  September 30, 2014",PLCO EEMS and Extended Follow Up,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Mark  Purdue (Occupational and Environmental Epidemiology Branch)|Christine Dorothy Berg (Early Detection Research Group)|Philip  Prorok (Office of the Director),NULL,"1. Black A, Gibson TM, Shiels MS, Park Y, Robien K, Albanes D, Weinstein SJ, Freeman LE, Andreotti G, Purdue MP, Fraumeni JF, Hartge P, Tucker MA, Hoover RN, Cerhan JR, Zeleniuch-Jacquotte A, Curtis RE, Elena J, Sampson JN, Berrington de Gonzalez A, Morton LM (2014). Pooling prospective studies to investigate the etiology of second cancers. Cancer Epidemiol Biomarkers Prev  23, 1598-608.   https://doi.org/10.1158/1055-9965.EPI-14-0191",https://intramural.nih.gov/search/searchview.taf?ipid=84228
645,CP010209-05,"October 01, 2013 -  September 30, 2014",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kreimer AR, Johansson M, Hildesheim A, Pawlita M, Brennan P (2014). Reply to P.E. Castle. J Clin Oncol  32, 361-2.   https://doi.org/10.1200/JCO.2013.53.2697",https://intramural.nih.gov/search/searchview.taf?ipid=84230
646,CP010210-05,"October 01, 2013 -  September 30, 2014","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Sholom  Wacholder; PhD (Biostatistics Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,"1. Kreimer AR, Safaeian M, Hildesheim A (2014). Number of human papillomavirus vaccine doses and condyloma. JAMA  311, 2439.   https://doi.org/10.1001/jama.2014.5009",https://intramural.nih.gov/search/searchview.taf?ipid=84231
647,CP010211-05,"October 01, 2013 -  September 30, 2014",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Cindy M Chang,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Kelly Jen-Yi Yu (Early Detection Research Group)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84232
648,CP010212-05,"October 01, 2013 -  September 30, 2014",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Camargo MC, Freedman ND, Hollenbeck AR, Abnet CC, Rabkin CS (2014). Height, weight, and body mass index associations with gastric cancer subsites. Gastric Cancer  17, 463-8.   https://doi.org/10.1007/s10120-013-0312-4|2. Camargo MC, García A, Riquelme A, Otero W, Camargo CA, Hernandez-García T, Candia R, Bruce MG, Rabkin CS (2014). The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol  109, 485-95.   https://doi.org/10.1038/ajg.2014.24|3. Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, Eurgast-EPIC Group, Yu J, Carrasquilla G, Sung JJ, Alvarado-Cabrero I, Lissowska J, Meneses-Gonzalez F, Yatabe Y, Ding T, Hu N, Taylor PR, Morgan DR, Gulley ML, Torres J, Akiba S, Rabkin CS (2014). Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer  134, 948-53.   https://doi.org/10.1002/ijc.28402",https://intramural.nih.gov/search/searchview.taf?ipid=84233
649,CP010213-05,"October 01, 2013 -  September 30, 2014",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Chaturvedi AK, Graubard BI, Pickard RK, Xiao W, Gillison ML (2014). High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010. J Infect Dis  210, 441-7.   https://doi.org/10.1093/infdis/jiu116",https://intramural.nih.gov/search/searchview.taf?ipid=84234
650,CP010214-05,"October 01, 2013 -  September 30, 2014",Microbes and Human Malignancies,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Barbara J Fuhrman (Hormonal and Reproductive Epidemiology Branch)|Roberto  Flores (Nutritional Science Research Group),NULL,"1. An P, Goedert JJ, Donfield S, Buchbinder S, Kirk GD, Detels R, Winkler CA (2014). Regulatory variation in HIV-1 dependency factor ZNRD1 associates with host resistance to HIV-1 acquisition. J Infect Dis  210, 1539-48.   https://doi.org/10.1093/infdis/jiu291|2. Feigelson HS, Bischoff K, Ardini MA, Ravel J, Gail MH, Flores R, Goedert JJ (2014). Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome. BMC Res Notes  7, 204.   https://doi.org/10.1186/1756-0500-7-204|3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R (2014). Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis  35, 2089-96.   https://doi.org/10.1093/carcin/bgu131|4. Wojcik G, Latanich R, Mosbruger T, Astemborski J, Kirk GD, Mehta SH, Goedert JJ, Kim AY, Seaberg EC, Busch M, Thomas DL, Duggal P, Thio CL (2014). Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. J Infect Dis  209, 355-9.   https://doi.org/10.1093/infdis/jit444",https://intramural.nih.gov/search/searchview.taf?ipid=84235
651,CP010215-05,"October 01, 2013 -  September 30, 2014",Human microbiome and cancer,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84236
652,CP010216-05,"October 01, 2013 -  September 30, 2014",Immune responses to HPV infection and HPV vaccination,Mahboobeh  Safaeian,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Castellsagué X, Naud P, Chow SN, Wheeler CM, Germar MJ, Lehtinen M, Paavonen J, Jaisamrarn U, Garland SM, Salmerón J, Apter D, Kitchener H, Teixeira JC, Skinner SR, Limson G, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Peters K, Tjalma WA, Safaeian M, et al. [6 more authors] (2014). Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA. J Infect Dis  210, 517-34.   https://doi.org/10.1093/infdis/jiu139|2. Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM (2014). Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol  4, 119.   https://doi.org/10.3389/fonc.2014.00119|3. Safaeian M, Sherman ME (2013). From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. J Natl Cancer Inst  105, 1524-6.   https://doi.org/10.1093/jnci/djt267",https://intramural.nih.gov/search/searchview.taf?ipid=84237
653,CP010217-04,"October 01, 2013 -  September 30, 2014",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Sholom  Wacholder; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Anil Kumar Chaturvedi|Felipe A Castro,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Hildesheim A, Wacholder S, Catteau G, Struyf F, Dubin G, Herrero R, CVT Group (2014). Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial. Vaccine  32, 5087-97.   https://doi.org/10.1016/j.vaccine.2014.06.038|2. Robbins HA, Waterboer T, Porras C, Kemp TJ, Pawlita M, Rodriguez AC, Wacholder S, Gonzalez P, Schiller JT, Lowy DR, Esser M, Matys K, Poncelet S, Herrero R, Hildesheim A, Pinto LA, Safaeian M (2014). Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Hum Vaccin Immunother  10, 2965-74.   https://doi.org/10.4161/21645515.2014.972811",https://intramural.nih.gov/search/searchview.taf?ipid=84238
654,CP010218-04,"October 01, 2013 -  September 30, 2014",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Felipe A Castro,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Xu HL, Hsing AW, Koshiol J, Chu LW, Cheng JR, Gao J, Tan YT, Wang BS, Shen MC, Gao YT (2014). Variants in motilin, somatostatin and their receptor genes and risk of biliary tract cancers and stones in Shanghai, China. Meta Gene  2, 418-426.   https://doi.org/10.1016/j.mgene.2014.04.012",https://intramural.nih.gov/search/searchview.taf?ipid=84239
655,CP010219-04,"October 01, 2013 -  September 30, 2014",Studies of other risk factors for radiosensitive tumors,Martha S Linet; PhD|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, Moore SC, Robien K, Rosenberg PS, Singh PN, Weiderpass E, Adami HO, Anton-Culver H, Ballard-Barbash R, Buring JE, Freedman DM, Fraser GE, Beane Freeman LE, Gapstur SM, Gaziano JM, Giles GG, Håkansson N, Hoppin JA, Hu FB, Koenig K, et al. [11 more authors] (2014). Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med  11, e1001673.   https://doi.org/10.1371/journal.pmed.1001673|2. Kitahara CM, Gamborg M, Berrington de González A, Sørensen TI, Baker JL (2014). Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res  74, 235-42.   https://doi.org/10.1158/0008-5472.CAN-13-2228|3. Meinhold C, Gamborg M, Rajaraman P, Srensen T, Baker J (2014) Height and body mass index in childhood, birth weight, and the risk of adult glioma. Cancer Research 74:235-42",https://intramural.nih.gov/search/searchview.taf?ipid=84240
656,CP010220-04,"October 01, 2013 -  September 30, 2014",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Nutritional Epidemiology Branch, NCI

Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA, Casson AG, Freedman ND, Chow WH, Wu AH, Bernstein L, Nyrén O, Pandeya N, Whiteman DC, Vaughan TL (2014). Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One  9, e103508.   https://doi.org/10.1371/journal.pone.0103508|2. Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, Shaheen NJ, Corley DA (2014). Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol  109, 1586-94.   https://doi.org/10.1038/ajg.2014.206",https://intramural.nih.gov/search/searchview.taf?ipid=84241
657,CP010221-04,"October 01, 2013 -  September 30, 2014",Etiologic Studies of Prostate Cancer,"Sonja  Berndt|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Nutritional Epidemiology Branch, NCI

Office of the Director, NCI",Alison Marian Mondul|Stephanie Joan Weinstein|Jacqueline M Major; MS|Mark  Purdue|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Kevin  Jacobs (Laboratory Translational Genomics)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)",NULL,"1. Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC (2014). Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. PLoS One  9, e110569.   https://doi.org/10.1371/journal.pone.0110569",https://intramural.nih.gov/search/searchview.taf?ipid=84242
658,CP010222-04,"October 01, 2013 -  September 30, 2014",Studies of Populations Exposed to Diagnostic Medical Radiation,Peter D Inskip; ScD| | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Steven L Simon|Kiyohiko  Mabuchi; MD, DPhil|Show all 13",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Cantley JL, Hanlon J, Chell E, Lee C, Smith WC, Bolch WE (2013). Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD. Phys Med Biol  58, 6887-96.   https://doi.org/10.1088/0031-9155/58/19/6887|2. Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA, Sigurdson AJ, Nikiforov YE (2014). The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab  99, E276-85.   https://doi.org/10.1210/jc.2013-2503",https://intramural.nih.gov/search/searchview.taf?ipid=84243
659,CP010224-03,"October 01, 2013 -  September 30, 2014",Esophageal cancer genetic project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Chaoyu C Wang|Alisa  Goldstein; PhD,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|LiDong  Wang (Zhengzhou Medical University)|DongXin  Lin (CICAMS)|Wei  Zheng (Vanderbilt University)|XiaoOu  Shu (Vanderbilt University)|JianMin  Yuan (University of Pittsburgh)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84245
660,CP010225-03,"October 01, 2013 -  September 30, 2014",Barretts esophagus early detection project,"Philip  Taylor; MD, ScD",NULL,"Genetic Epidemiology Branch, NCI",Nan  Hu|Paula L Hyland|Melissa  Rotunno,NULL,"Ruth  Pfeiffer; PhD (Biostatistics Branch)|Sanford Martin Dawsey; MD (Nutritional Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Nutritional Epidemiology Branch)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84246
661,SC000167-23,"October 01, 2013 -  September 30, 2014",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84257
662,SC000550-34,"October 01, 2013 -  September 30, 2014",Lymphoma Disease Discovery and Definition,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Theresa M Davies Hill|Alina  Nicolae|Stefania  Pittaluga|Shahed  Abdullah|Mark  Raffeld; MD|Stephen M Hewitt; MD, PhD|Show all 7","Wing  Chan (Pathology, University of Nebraska)|Elias  Campo (University of Barcelona)|Bertrand  Nadel (CNRS-INSERM-UniversitÃ© de la MÃ©diterranÃ©e)|Andrew  Feldman (Mayo Clinic)",NULL,NULL,"1. Bajor-Dattilo EB, Pittaluga S, Jaffe ES (2013). Pathobiology of T-cell and NK-cell lymphomas. Best Pract Res Clin Haematol  26, 75-87.   https://doi.org/10.1016/j.beha.2013.04.007|2. Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM (2013). Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma. Proc Natl Acad Sci U S A  110, 3943-8.   https://doi.org/10.1073/pnas.1217271110|3. Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH (2013). Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med  368, 1408-16.   https://doi.org/10.1056/NEJMoa1214561|4. Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH (2013). Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med  369, 1915-25.   https://doi.org/10.1056/NEJMoa1308392|5. Enjuanes A, Albero R, Clot G, Navarro A, Beà S, Pinyol M, Martín-Subero JI, Klapper W, Staudt LM, Jaffe ES, Rimsza L, Braziel RM, Delabie J, Cook JR, Tubbs RR, Gascoyne R, Connors JM, Weisenburger DD, Greiner TC, Chan WC, López-Guillermo A, Rosenwald A, Ott G, Campo E, Jares P (2013). Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features. Int J Cancer  133, 2852-63.   https://doi.org/10.1002/ijc.28321|6. Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N, Vose JM (2013). Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol  31, 240-6.   https://doi.org/10.1200/JCO.2011.37.3647|7. Goldenberg DM, Gold DV, Loo M, Liu D, Chang CH, Jaffe ES (2013). Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One  8, e55324.   https://doi.org/10.1371/journal.pone.0055324|8. Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Gascoyne RD, Cook JR, Tubbs RR, Jaffe ES, Armitage JO, Vose JM, Staudt LM, McKeithan TW, et al. [3 more authors] (2013). Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol  31, 4520-8.   https://doi.org/10.1200/JCO.2012.45.6004|9. Huppmann AR, Roullet MR, Raffeld M, Jaffe ES (2013). Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol  31, e28-30.   https://doi.org/10.1200/JCO.2012.43.3797|10. Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES (2013). Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer  60, 1165-70.   https://doi.org/10.1002/pbc.24462|11. Jaffe ES (2013). Follicular lymphomas: a tapestry of common and contrasting threads. Haematologica  98, 1163-5.   https://doi.org/10.3324/haematol.2013.086678|12. Jaffe ES, Nicolae A, Pittaluga S (2013). Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls. Mod Pathol  26 Suppl 1, S71-87.   https://doi.org/10.1038/modpathol.2012.181|13. Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES (2013). Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall. Histopathology  63, 877-80.   https://doi.org/10.1111/his.12213|14. Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S (2014). A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology  64, 455-9.   https://doi.org/10.1111/his.12274|15. Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA (2013). Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma. J Clin Oncol  31, e53-6.   https://doi.org/10.1200/JCO.2012.43.2377|16. Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES (2013). Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol  37, 816-26.   https://doi.org/10.1097/PAS.0b013e3182785610|17. Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, Chan WC (2013). Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood  122, 3599-606.   https://doi.org/10.1182/blood-2013-07-512830|18. Salaverria I, Royo C, Carvajal-Cuenca A, Clot G, Navarro A, Valera A, Song JY, Woroniecka R, Rymkiewicz G, Klapper W, Hartmann EM, Sujobert P, Wlodarska I, Ferry JA, Gaulard P, Ott G, Rosenwald A, Lopez-Guillermo A, Quintanilla-Martinez L, Harris NL, Jaffe ES, Siebert R, Campo E, Beà S (2013). CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood  121, 1394-402.   https://doi.org/10.1182/blood-2012-08-452284|19. Song JY, Jaffe ES (2013). HHV-8-positive but EBV-negative primary effusion lymphoma. Blood  122, 3712.   https://doi.org/10.1182/blood-2013-07-515882|20. Valera A, Colomo L, Martínez A, de Jong D, Balagué O, Matheu G, Martínez M, Taddesse-Heath L, Jaffe ES, Bacchi CE, Campo E (2013). ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol  26, 1329-37.   https://doi.org/10.1038/modpathol.2013.73|21. Venkataraman G, Song JY, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Traverse-Glehen A, Eberle FC, Hanson JC, Raffeld MA, Pittaluga S, Jaffe ES (2013). Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood  121, 1795-804.   https://doi.org/10.1182/blood-2012-06-439455|22. Vo P, Jaffe ES, Cook L, Ramos C, Childs R (2013). Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon. Clin Lymphoma Myeloma Leuk  13, e1-5.   https://doi.org/10.1016/j.clml.2013.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=84258
663,SC000892-31,"October 01, 2013 -  September 30, 2014",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",NULL,George  Sledge Jr (Indiana University)|Fernando  Vidal-Vanaclocha,Maria  Merino; PhD (Laboratory of Pathology)|Natasha  Caplen (Cancer Genetics Branch),NULL,"1. Brabletz T, Lyden D, Steeg PS, Werb Z (2013). Roadblocks to translational advances on metastasis research. Nat Med  19, 1104-9.   https://doi.org/10.1038/nm.3327|2. Marino N, Marshall JC, Collins JW, Zhou M, Qian Y, Veenstra T, Steeg PS (2013). Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Cancer Res  73, 5949-62.   https://doi.org/10.1158/0008-5472.CAN-13-0368|3. Marino N, Woditschka S, Reed LT, Nakayama J, Mayer M, Wetzel M, Steeg PS (2013). Breast cancer metastasis: issues for the personalization of its prevention and treatment. Am J Pathol  183, 1084-1095.   https://doi.org/10.1016/j.ajpath.2013.06.012",https://intramural.nih.gov/search/searchview.taf?ipid=84260
664,SC003657-40,"October 01, 2013 -  September 30, 2014",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Dermatology Branch, NCI",NULL,NULL,Howard A Young; PhD (Laboratory of Experimental Immunology),John J O'Shea; MD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84261
665,SC003669-25,"October 01, 2013 -  September 30, 2014",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Dermatology Branch, NCI",Michael C Lu|Gaku  Nakato|Yoichi  Ogawa|Takeshi  Ouchi; MD,Keisuke  Nagao (Keio University Schiool of Medicine)|Adam  Glick; PhD (NCI),NULL,Maria Irene Morasso; PhD (NIAMS) |Ulrich K Siebenlist; PhD (NIAID),"1. Hai H, Wang H, Pisitkuni P, Kim J, Tassi I, Tang W, Morasso M, Udey M, Siebenlist U (2014) IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci USA, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=84262
666,SC004002-45,"October 01, 2013 -  September 30, 2014",IL-2IL-15 cytokine receptor: implications for cancer therapy and vaccine,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Nicole  Urquhart (Dept of, University of the West Indies)|Sandor  Damjanovich MD (University of Debrecen)|Bana  Jabri (University of Chicago)|Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)",Elaine S Jaffe; MD (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology),Steven J Jacobson; PhD (NINDS),"1. Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas CJ, Discepolo V, Jabri B, Waldmann TA (2013). Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc Natl Acad Sci U S A  110, 13534-9.   https://doi.org/10.1073/pnas.1312911110|2. Merkel TJ, Perera PY, Lee GM, Verma A, Hiroi T, Yokote H, Waldmann TA, Perera LP (2013). Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection. Hum Vaccin Immunother  9, 1841-8.   https://doi.org/10.4161/hv.25337|3. Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC (2013). Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood  121, 476-84.   https://doi.org/10.1182/blood-2012-08-450585",https://intramural.nih.gov/search/searchview.taf?ipid=84264
667,SC004020-37,"October 01, 2013 -  September 30, 2014","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Rolf  Billeskov|Andrew G Brandmaier|Blake Francis Frey|Shingo  Kato; MD, PhD|Laurel  Lagenaur; PhD|Aizea  Morales Kastresana|Show all 19","Charles  Delisi|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Mark  Smyth (University of Melbourne)|Show all 33","William Marston Linehan; MD (Urologic Oncology Branch)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Dennis M Klinman; MD, PhD (Laboratory of Experimental Immunology)","Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Raj K Puri (OD) |Warren J Leonard; MD (NHLBI)","1. Ben-Sasson SZ, Hogg A, Hu-Li J, Wingfield P, Chen X, Crank M, Caucheteux S, Ratner-Hurevich M, Berzofsky JA, Nir-Paz R, Paul WE (2013). IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J Exp Med  210, 491-502.   https://doi.org/10.1084/jem.20122006|2. Berzofsky JA, Wood LV, Terabe M (2013). Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer. Expert Rev Vaccines  12, 1115-8.   https://doi.org/10.1586/14760584.2013.836906|3. Huang YH, Terabe M, Pendleton CD, Stewart Khursigara D, Bera TK, Pastan I, Berzofsky JA (2013). Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE. PLoS One  8, e64365.   https://doi.org/10.1371/journal.pone.0064365|4. Izhak L, Ambrosino E, Kato S, Parish ST, O'Konek JJ, Weber H, Xia Z, Venzon D, Berzofsky JA, Terabe M (2013). Delicate balance among three types of T cells in concurrent regulation of tumor immunity. Cancer Res  73, 1514-23.   https://doi.org/10.1158/0008-5472.CAN-12-2567|5. Izhak L, Berzofsky JA, Terabe M (2013). Balance is a key for happiness. Oncoimmunology  2, e24211.   https://doi.org/10.4161/onci.24211|6. O'Konek JJ, Kato S, Takao S, Izhak L, Xia Z, Illarionov P, Besra GS, Terabe M, Berzofsky JA (2013). β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy. Clin Cancer Res  19, 4404-11.   https://doi.org/10.1158/1078-0432.CCR-12-2169|7. Sui Y, Gordon S, Franchini G, Berzofsky JA (2013). Nonhuman primate models for HIV/AIDS vaccine development. Curr Protoc Immunol  102, Unit 12.14.   https://doi.org/10.1002/0471142735.im1214s102|8. Vargas-Inchaustegui DA, Xiao P, Hogg AE, Demberg T, McKinnon K, Venzon D, Brocca-Cofano E, Dipasquale J, Lee EM, Hudacik L, Pal R, Sui Y, Berzofsky JA, Liu L, Langermann S, Robert-Guroff M (2013). Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques. Virology  447, 274-84.   https://doi.org/10.1016/j.virol.2013.09.015|9. Zhu Q, Berzofsky JA (2013). Oral vaccines: directed safe passage to the front line of defense. Gut Microbes  4, 246-52.   https://doi.org/10.4161/gmic.24197",https://intramural.nih.gov/search/searchview.taf?ipid=84265
668,SC006321-35,"October 01, 2013 -  September 30, 2014",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Janet W Gamson|Askale Y Mathias|Anastasia L Sowers|Show all 8,NULL,Deborah E Citrin (Radiation Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD)","1. Friedman JA, Wise SC, Hu M, Gouveia C, Vander Broek R, Freudlsperger C, Kannabiran VR, Arun P, Mitchell JB, Chen Z, Van Waes C (2013). HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma. Transl Oncol  6, 429-41.   https://doi.org/10.1593/tlo.13292|2. Han G, Bian L, Li F, Cotrim A, Wang D, Lu J, Deng Y, Bird G, Sowers A, Mitchell JB, Gutkind JS, Zhao R, Raben D, ten Dijke P, Refaeli Y, Zhang Q, Wang XJ (2013). Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis. Nat Med  19, 421-8.   https://doi.org/10.1038/nm.3118|3. Herzog A, Bian Y, Vander Broek R, Hall B, Coupar J, Cheng H, Sowers AL, Cook JD, Mitchell JB, Chen Z, Kulkarni AB, Van Waes C (2013). PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin Cancer Res  19, 3808-19.   https://doi.org/10.1158/1078-0432.CCR-12-2716|4. Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, Simone NL (2013). Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle  12, 1955-63.   https://doi.org/10.4161/cc.25016",https://intramural.nih.gov/search/searchview.taf?ipid=84266
669,SC006330-34,"October 01, 2013 -  September 30, 2014",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|Hu-Chen  Xie|Ying  Zhuge,"Thomas  Fearon (Radiology, Children's National Medical Center)|Chang-Ming  Ma (Radiation Oncology Department, Fox Chase Cancer Center)",NULL,NULL,"1. Zhuge Y, Ciesielski KC, Udupa JK, Miller RW (2013). GPU-based relative fuzzy connectedness image segmentation. Med Phys  40, 011903.   https://doi.org/10.1118/1.4769418",https://intramural.nih.gov/search/searchview.taf?ipid=84252
670,SC006353-32,"October 01, 2013 -  September 30, 2014",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Janai Sinclaire Burrell|Young-Seung  Kim|Diane E Milenic|Nebiat  Sisay Ashenafi|Kwon Joong  Yong|Show all 8,"Andrew  Scott (Ludwig Institute for Cancer Research)|Ruby  Meredith (UAB)|Silvia  Jurisson (University of Missouri, Columbia)|Tom  Quinn (U. Missouri, Co.)|Marty  Pomper (Johns Hopkins)","James B Mitchell; PhD (Radiation Biology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)",Peter  Herscovitch; MD (CC),"1. Baidoo KE, Milenic DE, Brechbiel MW (2013). Methodology for labeling proteins and peptides with lead-212 (212Pb). Nucl Med Biol  40, 592-9.   https://doi.org/10.1016/j.nucmedbio.2013.01.010|2. Guérard F, Gestin JF, Brechbiel MW (2013). Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapy. Cancer Biother Radiopharm  28, 1-20.   https://doi.org/10.1089/cbr.2012.1292|3. Kang CS, Song HA, Milenic DE, Baidoo KE, Brechbiel MW, Chong HS (2013). Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies. Nucl Med Biol  40, 600-5.   https://doi.org/10.1016/j.nucmedbio.2013.01.012|4. Milenic DE, Baidoo KE, Shih JH, Wong KJ, Brechbiel MW (2013). Evaluation of platinum chemotherapy in combination with HER2-targeted α-particle radiation. Cancer Biother Radiopharm  28, 441-9.   https://doi.org/10.1089/cbr.2012.1423|5. Nayak TK, Bernardo M, Milenic DE, Choyke PL, Brechbiel MW (2013). Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies. Radiology  267, 173-82.   https://doi.org/10.1148/radiol.12121021|6. Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW (2013). 212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint. Br J Cancer  108, 2013-20.   https://doi.org/10.1038/bjc.2013.189|7. Yong KJ, Milenic DE, Baidoo KE, Kim YS, Brechbiel MW (2013). Gene expression profiling upon (212) Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model. Cancer Med  2, 646-53.   https://doi.org/10.1002/cam4.132",https://intramural.nih.gov/search/searchview.taf?ipid=84267
671,SC006387-27,"October 01, 2013 -  September 30, 2014",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|William  Degraff|Janet W Gamson|Askale Y Mathias|Hope Laura Miller|Show all 9,NULL,Frank Jess Gonzalez; PhD (Nucleic Acids Section)|Miriam Christine Poirier; PhD (Laboratory of Cancer Biology and Genetics),Tracey Ann Rouault; MD (NICHD),"1. Han G, Bian L, Li F, Cotrim A, Wang D, Lu J, Deng Y, Bird G, Sowers A, Mitchell JB, Gutkind JS, Zhao R, Raben D, ten Dijke P, Refaeli Y, Zhang Q, Wang XJ (2013). Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis. Nat Med  19, 421-8.   https://doi.org/10.1038/nm.3118|2. Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ (2013). Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun  4, 2384.   https://doi.org/10.1038/ncomms3384|3. Li F, Pang X, Krausz KW, Jiang C, Chen C, Cook JA, Krishna MC, Mitchell JB, Gonzalez FJ, Patterson AD (2013). Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology. J Proteome Res  12, 1369-76.   https://doi.org/10.1021/pr301023x|4. Li F, Patterson AD, Krausz KW, Jiang C, Bi H, Sowers AL, Cook JA, Mitchell JB, Gonzalez FJ (2013). Metabolomics reveals that tumor xenografts induce liver dysfunction. Mol Cell Proteomics  12, 2126-35.   https://doi.org/10.1074/mcp.M113.028324",https://intramural.nih.gov/search/searchview.taf?ipid=84268
672,SC006538-21,"October 01, 2013 -  September 30, 2014",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Cindy Huong-Bich Chau|Elena Valerie Fernandez|Douglas K Price|Kelie M Reece; PhD|Andrea Borghese Apolo|Ravi  Madan,Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford),"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)",NULL,"1. Dahut WL, Madan RA, Karakunnel JJ, Adelberg D, Gulley JL, Turkbey IB, Chau CH, Spencer SD, Mulquin M, Wright J, Parnes HL, Steinberg SM, Choyke PL, Figg WD (2013). Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU Int  111, 1269-80.   https://doi.org/10.1111/j.1464-410X.2012.11667.x|2. Keevan J, Figg WD (2014). New mechanism of lenalidomide activity. Cancer Biol Ther  15, 968-9.   https://doi.org/10.4161/cbt.29189|3. Mahony C, Erskine L, Niven J, Greig NH, Figg WD, Vargesson N (2013). Pomalidomide is nonteratogenic in chicken and zebrafish embryos and nonneurotoxic in vitro. Proc Natl Acad Sci U S A  110, 12703-8.   https://doi.org/10.1073/pnas.1307684110|4. Vaishampayan UN, Fontana J, Heilbrun LK, Smith D, Heath E, Dickow B, Figg WD (2014). Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer. Urol Oncol  32, 31.e25-33.   https://doi.org/10.1016/j.urolonc.2012.11.017|5. Vargesson N, Mahony C, Erskine L, Niven J, Greig NH, Figg WD (2013). Reply to D’Amato et al. and Zeldis et al.: Screening of thalidomide derivatives in chicken and zebrafish embryos. Proc Natl Acad Sci U S A  110, E4820.   https://doi.org/10.1073/pnas.1318475110",https://intramural.nih.gov/search/searchview.taf?ipid=84269
673,SC006581-31,"October 01, 2013 -  September 30, 2014",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Wei-Dong  Chen|Yulia  Demchenko,"P.  Bergsagel (Divison of Hematology, Mayo Clinic)|Rafael  Fonseca (Division of Hematology, Mayo Clinic)|Bart  Barlogie (Univ. of Arkansas for Medical Sciences)|Jonathan  Keats (TGen (Translational Genomics Research Institute))",Louis  Staudt; MD (Lymphoid Malignancies Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics),NULL,"1. Bergsagel PL, Kuehl WM (2013). Degree of focal immunoglobulin heavy chain locus deletion as a measure of B-cell tumor purity. Leukemia  27, 2067-8.   https://doi.org/10.1038/leu.2013.139",https://intramural.nih.gov/search/searchview.taf?ipid=84270
674,SC006663-25,"October 01, 2013 -  September 30, 2014",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Sheila Ann Prindiville (Office Of The Director)",NULL,1. Danforth Jr DN (2013) Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res 15:208,https://intramural.nih.gov/search/searchview.taf?ipid=84271
675,SC006732-26,"October 01, 2013 -  September 30, 2014","Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance","Antonio  Fojo; MD, PhD",NULL,"Genitourinary Malignancies Branch, NCI","Douglas K Price|William D Figg; PharmD|James L Gulley; MD, PhD",NULL,"Susan  Bates; MD (Developmental Therapeutics Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)",Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84272
676,SC006737-23,"October 01, 2013 -  September 30, 2014",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Hiroaki  Mitsuya,NULL,"George N Pavlakis; MD, PhD (Vaccine Branch)|Eric O Freed; PhD (Retroviral Replication Laboratory)|Frank  Maldarelli (Host Virus Interaction Branch)",Paul T Wingfield; PhD (NIAMS) |John Grant Bernbaum (NIAID) |Stephen J Stahl; PhD (NIAMS),"1. Yarchoan R, Mitsuya H (2013) Development of the first AIDS drugs: AZT and other dideoxynucleosides, in Human Immunodeficiency Virus Reverse Transcriptase: A Bench-to-Bedside Success. LeGrice S, Gotte M, eds., pp. 1-22.|2. Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, Wang V, Pittaluga S, O'Mahony D, Steinberg SM, Little RF, Yarchoan R (2014). Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood  124, 3544-52.   https://doi.org/10.1182/blood-2014-07-586800",https://intramural.nih.gov/search/searchview.taf?ipid=84273
677,SC006738-23,"October 01, 2013 -  September 30, 2014",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD|Nicole  Delino|Garimella  Harisha|Kenji  Maeda|Shota  Ono|Yuki  Takamatsu; MD|Show all 8,"Arun  Ghosh|Masao 		  Matsuoka (Institute for Virus Research, Kyoto University)|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Hiroyuki  Hayakawa (Yamasa Corporation)|Eiichi  Kodama (Kyoto University)|Show all 11",NULL,Paul T Wingfield; PhD (NIAMS),"1. Amano M, Tojo Y, Salcedo-Gómez PM, Campbell JR, Das D, Aoki M, Xu CX, Rao KV, Ghosh AK, Mitsuya H (2013). GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro. Antimicrob Agents Chemother  57, 2036-46.   https://doi.org/10.1128/AAC.02189-12|2. Feng L, Sharma A, Slaughter A, Jena N, Koh Y, Shkriabai N, Larue RC, Patel PA, Mitsuya H, Kessl JJ, Engelman A, Fuchs JR, Kvaratskhelia M (2013). The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors. J Biol Chem  288, 15813-20.   https://doi.org/10.1074/jbc.M112.443390|3. Ghosh AK, Parham GL, Martyr CD, Nyalapatla PR, Osswald HL, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H (2013) Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies. J Med Chem 56:6792-802|4. Hachiya A, Reeve AB, Marchand B, Michailidis E, Ong YT, Kirby KA, Leslie MD, Oka S, Kodama EN, Rohan LC, Mitsuya H, Parniak MA, Sarafianos SG (2013). Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral Drugs. Antimicrob Agents Chemother  57, 4554-4558.   https://doi.org/10.1128/AAC.00283-13|5. Kirby KA, Michailidis E, Fetterly TL, Steinbach MA, Singh K, Marchand B, Leslie MD, Hagedorn AN, Kodama EN, Marquez VE, Hughes SH, Mitsuya H, Parniak MA, Sarafianos SG (2013). Effects of substitutions at the 4' and 2 positions on the bioactivity of 4'-ethynyl-2-fluoro-2'-deoxyadenosine. Antimicrob Agents Chemother  57, 6254-64.   https://doi.org/10.1128/AAC.01703-13|6. Michailidis E, Ryan EM, Hachiya A, Kirby KA, Marchand B, Leslie MD, Huber AD, Ong YT, Jackson JC, Singh K, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG (2013). Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. Retrovirology  10, 65.   https://doi.org/10.1186/1742-4690-10-65|7. Nishijima T, Gatanaga H, Shimbo T, Komatsu H, Endo T, Horiba M, Koga M, Naito T, Itoda I, Tei M, Fujii T, Takada K, Yamamoto M, Miyakawa T, Tanabe Y, Mitsuya H, Oka S, SPARE study team (2013). Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial. PLoS One  8, e73639.   https://doi.org/10.1371/journal.pone.0073639|8. Salcedo Gómez PM, Amano M, Yashchuk S, Mizuno A, Das D, Ghosh AK, Mitsuya H (2013). GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration. Antimicrob Agents Chemother  57, 6110-21.   https://doi.org/10.1128/AAC.01420-13|9. Yedidi RS, Maeda K, Fyvie WS, Steffey M, Davis DA, Palmer I, Aoki M, Kaufman JD, Stahl SJ, Garimella H, Das D, Wingfield PT, Ghosh AK, Mitsuya H (2013). P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety. Antimicrob Agents Chemother  57, 4920-7.   https://doi.org/10.1128/AAC.00868-13|10. Zhang W, Parniak MA, Mitsuya H, Sarafianos SG, Graebing PW, Rohan LC (2014). Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention. Drug Dev Ind Pharm  40, 1101-11.   https://doi.org/10.3109/03639045.2013.809535",https://intramural.nih.gov/search/searchview.taf?ipid=84253
678,SC006741-22,"October 01, 2013 -  September 30, 2014",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,NULL,"Louis  Staudt; MD (Lymphoid Malignancies Branch)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)","Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84254
679,SC006891-26,"October 01, 2013 -  September 30, 2014",Clinical Studies in Pediatric Solid Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sosipatros A Boikos|Crystal L. Mackall; MD|Brigitte  Widemann; MD|Chand  Khanna; MD,George  Demetri (Dana Farber Cancer Institute)|Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)","Constantine Argyrios Stratakis; MD, DSc (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84274
680,SC006892-26,"October 01, 2013 -  September 30, 2014",Molecular Biology of Pediatric Tumors,Lee Jay Helman; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Chand  Khanna; MD,Katherine  Janeway (Dana Farber Cancer Institute)|Alberto  Pappo (St Jude Children's Research Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)","Karel  Pacak; MD, PhD (NICHD) |Constantine Argyrios Stratakis; MD, DSc (NICHD)","1. Grohar PJ, Segars LE, Yeung C, Pommier Y, D'Incalci M, Mendoza A, Helman LJ (2014). Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth. Clin Cancer Res  20, 1190-203.   https://doi.org/10.1158/1078-0432.CCR-13-0901|2. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene  32, 5429-38.   https://doi.org/10.1038/onc.2012.590",https://intramural.nih.gov/search/searchview.taf?ipid=84275
681,SC007263-22,"October 01, 2013 -  September 30, 2014",TRAIL-induced Cell Death in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Jennifer Lynn Dine|Donna M Voeller|Christina M Annunziata,Mauricio A Cuello|Sandra M Swain; MD|David  Tice (MedImmune),"Natasha  Caplen (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",Scott E Martin (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84276
682,SC007281-21,"October 01, 2013 -  September 30, 2014",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Yuk Sing Robert Cheng|Xinyi  Li|Lisa Ann Ridnour|James B Mitchell; PhD,NULL,Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Larry K Keefer; PhD (Chemical Biology Laboratory)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84277
683,SC009144-30,"October 01, 2013 -  September 30, 2014",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Zuqin  Nie; PhD|Suzanne Laurie Sanford|Ying  Zheng,NULL,"Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program)",Keji  Zhao; PhD (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS) |Teresa M Przytycka (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84278
684,SC009172-26,"October 01, 2013 -  September 30, 2014",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|Michael L Pendrak|John M Sipes|David Ricardo Soto Pantoja; PhD|Erica  Stein,Jeff  Isenberg (University of Pittsburgh)|Katherine  Cook (Georgetown University Medical Center)|Elsa  Garcin (University of Maryland Baltimore County),David Anderson Wink (Radiation Biology Branch),Abdel G Elkahloun; PhD (NHGRI) |Chengyu  Liu; PhD (NHLBI),"1. Miller TW, Kaur S, Ivins-O'Keefe K, Roberts DD (2013). Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biol  32, 316-24.   https://doi.org/10.1016/j.matbio.2013.02.009",https://intramural.nih.gov/search/searchview.taf?ipid=84249
685,SC009173-26,"October 01, 2013 -  September 30, 2014",Host Colonization and Vascular Dissemination of Candida albicans,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Michael L Pendrak|John M Sipes|Erica  Stein,NULL,NULL,Martin J Lizak; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Michail S Lionakis (NIAID) |Dorian  McGavern (NINDS),"1. Navarathna DH, Munasinghe J, Lizak MJ, Nayak D, McGavern DB, Roberts DD (2013). MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis. NMR Biomed  26, 1125-34.   https://doi.org/10.1002/nbm.2926",https://intramural.nih.gov/search/searchview.taf?ipid=84250
686,SC009174-26,"October 01, 2013 -  September 30, 2014",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|John M Sipes|David Ricardo Soto Pantoja; PhD,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)|Robert  Clarke (Georgetown University Medical Center)|Katherine  Cook (Georgetown University Medical Center)|Elsa  Garcin (University of Maryland Baltimore County),David Anderson Wink (Radiation Biology Branch),NULL,"1. Navarathna DH, Munasinghe J, Lizak MJ, Nayak D, McGavern DB, Roberts DD (2013). MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis. NMR Biomed  26, 1125-34.   https://doi.org/10.1002/nbm.2926",https://intramural.nih.gov/search/searchview.taf?ipid=84248
687,SC009179-26,"October 01, 2013 -  September 30, 2014","The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Dimitra  Bourmpoulia; PhD|Ananda  Chowdhury; PhD|Huiying  Han|Sandra  Jensen-Taubman|Sarvesh  Kumar|Beiyang  Wei,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A (2013). Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene. PLoS One  8, e59367.   https://doi.org/10.1371/journal.pone.0059367|2. Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-Stevenson WG (2013). TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells. Oncotarget  4, 163-73.|3. Han H, Bourboulia D, Jensen-Taubman S, Isaac B, Wei B, Stetler-Stevenson WG (2014). An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells. Oncogene  33, 1198-206.   https://doi.org/10.1038/onc.2013.61|4. Stetler-Stevenson WG, Gavil NV (2014). Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic. Connect Tissue Res  55, 13-9.   https://doi.org/10.3109/03008207.2013.867339",https://intramural.nih.gov/search/searchview.taf?ipid=84280
688,SC009389-21,"October 01, 2013 -  September 30, 2014",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Heather  Sheppard,Massimo  Santoro|Ginesa  Garcia-Rostan (University of Valladolid),"Sheueyann  Cheng; PhD (Gene Regulation Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84283
689,SC010051-19,"October 01, 2013 -  September 30, 2014",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,Martin W Brechbiel; PhD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Kwamena  Baidoo|Young-Seung  Kim|Diane E Milenic|Yang  Zhou,NULL,NULL,Lacy Henry Bryant (CC) |Daniel  Appella; PhD (NIDDK),"1. Bumb A, Sarkar SK, Billington N, Brechbiel MW, Neuman KC (2013). Silica encapsulation of fluorescent nanodiamonds for colloidal stability and facile surface functionalization. J Am Chem Soc  135, 7815-8.   https://doi.org/10.1021/ja4016815|2. Lee SM, Tsai DH, Hackley VA, Brechbiel MW, Cook RF (2013). Surface-engineered nanomaterials as X-ray absorbing adjuvant agents for Auger-mediated chemo-radiation. Nanoscale  5, 5252-6.   https://doi.org/10.1039/c3nr00333g",https://intramural.nih.gov/search/searchview.taf?ipid=84284
690,SC010074-19,"October 01, 2013 -  September 30, 2014",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Toshiki  Kijima|Chengyuan  Li|Michael Anthony Moses|Thomas L Prince|Harvey Grant Schwartz|Show all 9,"YunJin  Jung (Pusan National University)|Brian  Blagg (Chemistry, University of Kansas)|David  Toft (Cell Biology, Mayo Clinic)|Larry  Karnitz (Mayo Clinic)|Robert  Cotter (Johns Hopkins University)|Neal  Rosen (Medicine, Memorial Sloan Kettering Cancer Center)|Show all 12",James G McNally; PhD (Laboratory of Receptor Biology and Gene Expression)|Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Jane Beth Trepel (Developmental Therapeutics Branch),NULL,"1. Barrott JJ, Hughes PF, Osada T, Yang XY, Hartman ZC, Loiselle DR, Spector NL, Neckers L, Rajaram N, Hu F, Ramanujam N, Vaidyanathan G, Zalutsky MR, Lyerly HK, Haystead TA (2013). Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells. Chem Biol  20, 1187-97.   https://doi.org/10.1016/j.chembiol.2013.08.004|2. Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-Stevenson WG (2013). TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells. Oncotarget  4, 166-76.   https://doi.org/10.18632/oncotarget.801|3. Giubellino A, Sourbier C, Lee MJ, Scroggins B, Bullova P, Landau M, Ying W, Neckers L, Trepel JB, Pacak K (2013). Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. PLoS One  8, e56083.   https://doi.org/10.1371/journal.pone.0056083|4. Mollapour M, Bourboulia D, Beebe K, Woodford MR, Polier S, Hoang A, Chelluri R, Li Y, Guo A, Lee MJ, Fotooh-Abadi E, Khan S, Prince T, Miyajima N, Yoshida S, Tsutsumi S, Xu W, Panaretou B, Stetler-Stevenson WG, Bratslavsky G, Trepel JB, Prodromou C, Neckers L (2014). Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors. Mol Cell  53, 317-29.   https://doi.org/10.1016/j.molcel.2013.12.007|5. Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S, Vartholomaiou E, Tatokoro M, Beebe K, Miyajima N, Mohney RP, Chen Y, Hasumi H, Xu W, Fukushima H, Nakamura K, Koga F, Kihara K, Trepel J, Picard D, Neckers L (2013). Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A  110, E1604-12.   https://doi.org/10.1073/pnas.1220659110",https://intramural.nih.gov/search/searchview.taf?ipid=84285
691,SC010093-18,"October 01, 2013 -  September 30, 2014",Targeting the Epigenome for Lung Cancer Therapy,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Julie A Hong|Mahadev  Rao|Mary R Zhang|Colleen Donahue Bond|Tricia M Frary|Deborah Ann Nielsen,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Reardon ES, Schrump DS (2014). Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified? Thorac Surg Clin  24, 457-64.   https://doi.org/10.1016/j.thorsurg.2014.07.012",https://intramural.nih.gov/search/searchview.taf?ipid=84256
692,SC010098-12,"October 01, 2013 -  September 30, 2014",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Guinevere Joy Ng Chun|Anna C Couvillon; NP|Nancy A Harold|Ravi  Madan,"Anthony  D'Amico (Radiation Oncology, Harvard Medical School)|Phil  Kantoff (DFCI)","William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Philip M Arlen; MD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84305
693,SC010282-17,"October 01, 2013 -  September 30, 2014",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Mohammed Zulfiqar Farooqui; DO (NHLBI)","1. Shaffer BC, Modric M, Stetler-Stevenson M, Arthur DC, Steinberg SM, Liewehr DJ, Fowler DH, Gale RP, Bishop MR, Pavletic SZ (2013). Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia. Exp Hematol  41, 772-8.   https://doi.org/10.1016/j.exphem.2013.04.015",https://intramural.nih.gov/search/searchview.taf?ipid=84286
694,SC010288-17,"October 01, 2013 -  September 30, 2014",Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI","Ronald E Gress; MD|Steven  Pavletic; MD, MS|Frances  Hakim; PhD","Carl  June (University of Penn)|Bruce  Levine (Abramson Family Cancer Research Center, University of Pennsylvania)|Robert  Korngold (Cancer Center, Hackensack University)","Ira H Pastan; MD (Molecular Biology Section)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)",David F Stroncek; MD (CC) |Hanh M Khuu; MD (CC),"1. Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA, Williams KM, Datiles MB, Bishop R, Bassim CW, Mays JW, Edwards D, Cole K, Avila DN, Taylor T, Urban A, Joe GO, Comis LE, Berger A, Stratton P, Zhang D, Shelhamer JH, Gea-Banacloche JC, Sportes C, Fowler DH, et al. [2 more authors] (2013). National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant  19, 632-9.   https://doi.org/10.1016/j.bbmt.2013.01.013|2. Bevans MF, Mitchell SA, Barrett JA, Bishop MR, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L, Yang L (2014). Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biol Blood Marrow Transplant  20, 387-95.   https://doi.org/10.1016/j.bbmt.2013.12.001|3. Castiello L, Mossoba M, Viterbo A, Sabatino M, Fellowes V, Foley JE, Winterton M, Halverson DC, Civini S, Jin P, Fowler DH, Stroncek DF (2013). Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells. Cytotherapy  15, 598-609.   https://doi.org/10.1016/j.jcyt.2012.12.008|4. Fisher V, Khuu H, David-Ocampo V, Byrne K, Pavletic S, Bishop M, Fowler DH, Barrett AJ, Stroncek DF (2014). Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation. Transfusion  54, 1088-92.   https://doi.org/10.1111/trf.12428|5. Foglietta M, Neelapu SS, Kwak LW, Jiang Y, Nattamai D, Lee ST, Fowler DH, Sportes C, Gress RE, Steinberg SM, Vence LM, Radvanyi L, Dwyer KC, Qazilbash MH, Bryant RN, Bishop MR (2013). Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplant  48, 269-77.   https://doi.org/10.1038/bmt.2012.132|6. Fowler DH (2014). Rapamycin-resistant effector T-cell therapy. Immunol Rev  257, 210-25.   https://doi.org/10.1111/imr.12127|7. Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood  121, 2864-74.   https://doi.org/10.1182/blood-2012-08-446872|8. Shaffer BC, Modric M, Stetler-Stevenson M, Arthur DC, Steinberg SM, Liewehr DJ, Fowler DH, Gale RP, Bishop MR, Pavletic SZ (2013). Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia. Exp Hematol  41, 772-8.   https://doi.org/10.1016/j.exphem.2013.04.015",https://intramural.nih.gov/search/searchview.taf?ipid=84287
695,SC010354-15,"October 01, 2013 -  September 30, 2014",Clinical Development of Novel Drugs for Children with Refractory Cancers,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Srivandana  Akshintala|Diane  Cole|Eva  Dombi|Nalini M Jayaprakash|Seungyeon  Jung|Robert F Murphy|Show all 14,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Elizabeth  Fox; MD (NCI)|AeRang  Kim (Children's National Medical Center)|Shivaani  Kummar (NCI)|Yang  Liu (Children's National Medical Center)|David  Loeb (Pediatric Hematology-Oncology, Johns Hopkins University)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Kieron Michael Dunleavy (Lymphoid Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Jonathan Keith Killian (Cancer Genetics Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)",Elizabeth C Jones (CC) |Aradhana M Venkatesan (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84289
696,SC010355-15,"October 01, 2013 -  September 30, 2014",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Ciara  Egan|Hyeong Il  Kwak|Hidetaka  Ohnuki|Ombretta  Salvucci|David  Sanchez Martin; PhD,Maria  Cid (Univ. of Barcelona Medical School)|Catherine  Porcher (Oxford Univ)|Anna C Berardi|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst)|Amparo  Acher-Palmer (University of Frankfurt),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Ira  Daar; PhD (Laboratory of Cell and Developmental Signaling),Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI) |Dragan  Maric; PhD (NINDS) |Jinfang  Zhu; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84290
697,SC010356-15,"October 01, 2013 -  September 30, 2014",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Hyeong Il  Kwak|Hidetaka  Ohnuki|Ombretta  Salvucci|David  Sanchez Martin; PhD,Frederick  Wang (Harvard Univ)|Stefan  Rose-John (Univ. of Kiel),Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Mark Niccolo Polizzotto; MD (HIV and AIDS Malignancy Branch),Joshua  Farber; MD (NIAID) |Manfred  Boehm; MD (NHLBI) |Dragan  Maric; PhD (NINDS),"1. Oksenhendler E, Boutboul D, Beldjord K, Meignin V, de Labarthe A, Fieschi C, Dossier A, Agbalika F, Parravicini C, Tosato G, Gérard L, Galicier L (2013). Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients. Eur J Haematol  91, 497-503.   https://doi.org/10.1111/ejh.12191",https://intramural.nih.gov/search/searchview.taf?ipid=84291
698,SC010357-15,"October 01, 2013 -  September 30, 2014",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)",Michael John Kruhlak; PhD (Experimental Immunology Branch),Chuxia  Deng; PhD (NIDDK) |Jun  Zhu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84292
699,SC010366-14,"October 01, 2013 -  September 30, 2014",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Carol J Thiele,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Andrew  Pearson (Paediatric Section, Institute of Cancer Research)|Peter  Ambros (Children’s Cancer Research Institute)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84293
700,SC010372-14,"October 01, 2013 -  September 30, 2014",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84294
701,SC010373-14,"October 01, 2013 -  September 30, 2014",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84295
702,SC010375-14,"October 01, 2013 -  September 30, 2014",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Molecular Regulation Section, NCI",NULL,NULL,NULL,NULL,"1. Gegonne A, Devaiah BN, Singer DS (2013). TAF7: traffic controller in transcription initiation. Transcription  4, 29-33.   https://doi.org/10.4161/trns.22842",https://intramural.nih.gov/search/searchview.taf?ipid=84296
703,SC010376-14,"October 01, 2013 -  September 30, 2014","TNF Signaling, Cell Death and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Anling  Zhang,Xuemin  Zhang|Anning  Lin (Shanghai Institute of Biochemistry and Cell Biology),NULL,Richard James Youle; PhD (NINDS),"1. Zhang T, Park KA, Li Y, Byun HS, Jeon J, Lee Y, Hong JH, Kim JM, Huang SM, Choi SW, Kim SH, Sohn KC, Ro H, Lee JH, Lu T, Stark GR, Shen HM, Liu ZG, Park J, Hur GM (2013). PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65. Nat Commun  4, 2062.   https://doi.org/10.1038/ncomms3062",https://intramural.nih.gov/search/searchview.taf?ipid=84297
704,SC010378-14,"October 01, 2013 -  September 30, 2014",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Liat Hava Goldberg-Cooks|Subhadip  Kundu|Masahiro  Onozawa|Eun Sil  Park|Rachel  Pierce|Show all 8,"Trang  Hoang (U. Montreal)|Adolfo  Ferrando (Genetics, Columbia U.)",David  Levens; PhD (Laboratory of Pathology)|Crystal L. Mackall; MD (Pediatric Oncology Branch),NULL,"1. Beachy SH, Onozawa M, Silverman D, Chung YJ, Rivera MM, Aplan PD (2013). Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia. Exp Hematol  41, 518-529.e5.   https://doi.org/10.1016/j.exphem.2013.02.006|2. Chung YJ, Robert C, Gough SM, Rassool FV, Aplan PD (2014). Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome. Leuk Res  38, 95-102.   https://doi.org/10.1016/j.leukres.2013.07.008|3. Goldberg L, Tijssen MR, Birger Y, Hannah RL, Kinston SJ, Schütte J, Beck D, Knezevic K, Schiby G, Jacob-Hirsch J, Biran A, Kloog Y, Marcucci G, Bloomfield CD, Aplan PD, Pimanda JE, Göttgens B, Izraeli S (2013). Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia. Blood  122, 2694-703.   https://doi.org/10.1182/blood-2013-01-477133|4. Levens D, Aplan PD (2013). Notching up MYC gives a LIC. Cell Stem Cell  13, 8-9.   https://doi.org/10.1016/j.stem.2013.06.008|5. Saw J, Curtis DJ, Hussey DJ, Dobrovic A, Aplan PD, Slape CI (2013). The fusion partner specifies the oncogenic potential of NUP98 fusion proteins. Leuk Res  37, 1668-73.   https://doi.org/10.1016/j.leukres.2013.09.013",https://intramural.nih.gov/search/searchview.taf?ipid=84298
705,SC010379-14,"October 01, 2013 -  September 30, 2014",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Liat Hava Goldberg-Cooks|Masahiro  Onozawa|Zhenhua  Zhang|Walter M Kuehl; MD, PhD",NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84299
706,SC010384-14,"October 01, 2013 -  September 30, 2014",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer|Laura M Tuschong,David  Russell (University of Washington)|Derek  Persons (St. Jude's Cancer Research Center)|Punam  Malik,NULL,Harry Lewis Malech; MD (NIAID),"1. Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD (2013). Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency. Mol Ther  21, 964-72.   https://doi.org/10.1038/mt.2013.34",https://intramural.nih.gov/search/searchview.taf?ipid=84300
707,SC010437-14,"October 01, 2013 -  September 30, 2014",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",Maria  Merino; PhD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84301
708,BC010906-07,"October 01, 2013 -  September 30, 2014",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Bonita R Bryant|Liyanage P Perera; PhD|Arlethia J Spencer|Tatyana  Worthy,NULL,"Jason L Yovandich (Biological Resources Branch)|Stephen  Creekmore; PhD (Biological Resources Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,"1. Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas CJ, Discepolo V, Jabri B, Waldmann TA (2013). Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα. Proc Natl Acad Sci U S A  110, 13534-9.   https://doi.org/10.1073/pnas.1312911110|2. Merkel TJ, Perera PY, Lee GM, Verma A, Hiroi T, Yokote H, Waldmann TA, Perera LP (2013). Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection. Hum Vaccin Immunother  9, 1841-8.   https://doi.org/10.4161/hv.25337|3. Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC (2013). Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood  121, 476-84.   https://doi.org/10.1182/blood-2012-08-450585",https://intramural.nih.gov/search/searchview.taf?ipid=83832
709,BC009255-40,"October 01, 2013 -  September 30, 2014",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,"1. Bowen S, Sun P, Livak F, Sharrow S, Hodes RJ (2014). A novel T cell subset with trans-rearranged Vγ-Cβ TCRs shows Vβ expression is dispensable for lineage choice and MHC restriction. J Immunol  192, 169-77.   https://doi.org/10.4049/jimmunol.1302398|2. Callen E, Di Virgilio M, Kruhlak MJ, Nieto-Soler M, Wong N, Chen HT, Faryabi RB, Polato F, Santos M, Starnes LM, Wesemann DR, Lee JE, Tubbs A, Sleckman BP, Daniel JA, Ge K, Alt FW, Fernandez-Capetillo O, Nussenzweig MC, Nussenzweig A (2013). 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell  153, 1266-80.   https://doi.org/10.1016/j.cell.2013.05.023|3. Hathcock KS, Bowen S, Livak F, Hodes RJ (2013). ATM influences the efficiency of TCRβ rearrangement, subsequent TCRβ-dependent T cell development, and generation of the pre-selection TCRβ CDR3 repertoire. PLoS One  8, e62188.   https://doi.org/10.1371/journal.pone.0062188|4. Jenkinson SR, Williams JA, Jeon H, Zhang J, Nitta T, Ohigashi I, Kruhlak M, Zuklys S, Sharrow S, Adams A, Granger L, Choi Y, Siebenlist U, Bishop GA, Hollander GA, Takahama Y, Hodes RJ (2013). TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development. Proc Natl Acad Sci U S A  110, 21107-12.   https://doi.org/10.1073/pnas.1314859111",https://intramural.nih.gov/search/searchview.taf?ipid=83456
710,BC010469-12,"October 01, 2013 -  September 30, 2014",Molecular Targets Laboratory,James  McMahon; PhD,NULL,"Molecular Targets Laboratory, NCI",Emad  Darvishi|Curtis  Henrich|Tanya R Johnson|Emily Ann Smith|Anthony  Wamiru|Jennifer A Wilson|Show all 7,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Patrick  Cummings (Masters Program development, Johns Hopkins University)|Ihsan  Calis (Natural product diversity librarires, Hacteppe University)|Johnny  Easmon (HDAC Inhibitors, University of Innsbruck)|Yutaka  Takebe (National Institute of Infectious Diseases)|Show all 9",Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|William Marston Linehan; MD (Urologic Oncology Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Alexander  Wlodawer; PhD (Protein Structure Section)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Jonathan S Wiest; PhD (Laboratory of Cancer Biology and Genetics),Michael P Bray (NIAID),"1. Beutler J (2013) Natural Products as Tools for Discovering New Cancer Targets, in Natural Products and Cancer Drug Discovery. Koehn F, ed., pp. 213-237.|2. Alexandre KB, Moore PL, Nonyane M, Gray ES, Ranchobe N, Chakauya E, McMahon JB, O'Keefe BR, Chikwamba R, Morris L (2013). Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN. Virology  446, 66-76.   https://doi.org/10.1016/j.virol.2013.07.019|3. Devkota KP, Covell D, Ransom T, McMahon JB, Beutler JA (2013). Growth inhibition of human colon carcinoma cells by sesquiterpenoids and tetralones of Zygogynum calothyrsum. J Nat Prod  76, 710-4.   https://doi.org/10.1021/np400042q|4. Dossou KS, Devkota KP, Kavanagh PV, Beutler JA, Egan JM, Moaddel R (2013). Development and preliminary validation of a plate-based CB1/CB2 receptor functional assay. Anal Biochem  437, 138-43.   https://doi.org/10.1016/j.ab.2013.02.025|5. Jayatunga MK, Thompson S, McKee TC, Chan MC, Reece KM, Hardy AP, Sekirnik R, Seden PT, Cook KM, McMahon JB, Figg WD, Schofield CJ, Hamilton AD (2015). Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II). Eur J Med Chem  94, 509-16.   https://doi.org/10.1016/j.ejmech.2014.06.006|6. Masaoka T, Chung S, Caboni P, Rausch JW, Wilson JA, Taskent-Sezgin H, Beutler JA, Tocco G, Le Grice SF (2013). Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. J Med Chem  56, 5436-45.   https://doi.org/10.1021/jm400405z|7. Takebe Y, Saucedo CJ, Lund G, Uenishi R, Hase S, Tsuchiura T, Kneteman N, Ramessar K, Tyrrell DL, Shirakura M, Wakita T, McMahon JB, O'Keefe BR (2013). Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus. PLoS One  8, e64449.   https://doi.org/10.1371/journal.pone.0064449",https://intramural.nih.gov/search/searchview.taf?ipid=83604
711,BC010517-12,"October 01, 2013 -  September 30, 2014",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Alexey Vladimirovich Zakharov; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 15,NULL,"Christopher P Austin; AB, MD (NCATS) |Evan  Bolton; PhD (NLM) |Tyler Andrew Peryea (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83607
712,BC010548-12,"October 01, 2013 -  September 30, 2014",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kathryn  Compton|Cody John Peer,"Alex  Sparreboom|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)|Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)",Heidi H Kong (Dermatology Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83724
713,BC010639-11,"October 01, 2013 -  September 30, 2014",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Laura  Guasch Pamies|Megan L Peach|John Stephen Schneekloth|Terrence R Burke; PhD|Jordan Leslie Meier; PhD,Julieta  Comin (University of Buenos Aires)|Iwona Elzbieta Weidlich,Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|David D Roberts; PhD (Laboratory of Pathology)|Sergey G Tarasov (Structural Biophysics Laboratory)|John A Beutler (Molecular Targets Laboratory),"Paul P. Liu; MD, PhD (NHGRI)","1. Weidlich IE, Filippov IV, Brown J, Kaushik-Basu N, Krishnan R, Nicklaus MC, Thorpe IF (2013). Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods. Bioorg Med Chem  21, 3127-37.   https://doi.org/10.1016/j.bmc.2013.03.032|2. Zakharov AV, Peach ML, Sitzmann M, Nicklaus MC (2014). A new approach to radial basis function approximation and its application to QSAR. J Chem Inf Model  54, 713-9.   https://doi.org/10.1021/ci400704f|3. Zakharov AV, Peach ML, Sitzmann M, Nicklaus MC (2014). QSAR modeling of imbalanced high-throughput screening data in PubChem. J Chem Inf Model  54, 705-12.   https://doi.org/10.1021/ci400737s",https://intramural.nih.gov/search/searchview.taf?ipid=83629
714,BC010685-10,"October 01, 2013 -  September 30, 2014",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Jeannette Marie McNulty|Michael Kanwolo Newford|Sarah Paige Young|Willie J Young,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NHLBI)","1. Oppenheimer AP, Koh C, McLaughlin M, Williamson JC, Norton TD, Laudadio J, Heller T, Kleiner DE, High KP, Morse CG (2013). Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases. World J Gastroenterol  19, 115-21.   https://doi.org/10.3748/wjg.v19.i1.115",https://intramural.nih.gov/search/searchview.taf?ipid=83648
715,BC010687-10,"October 01, 2013 -  September 30, 2014",Histology Core Laboratory,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Helen G Lynch|Jeannette Marie McNulty|Sereen Georgia Morgan-Murray|Catherine R Neely|Michael Kanwolo Newford|Claire D Roque|Show all 8,"Elizabeth  Brunt (Pathology, St. Louis University)|Arthur  Mccullough (Gastroenterology/Hepatology, Cleveland Clinic Foundation)|Joel  Lavine (Pediatrics, University of California San Diego Medical Center)|Arun  Sanyal (Hepatology, Virginia Commonwealth University Medical Center)|James  Tonascia (n/a, Johns Hopkins Center for Clinical Trials)|Paul B. Watkins; MD (General Clinical Research Ctr, UNC HC University Hospital)|Show all 11","Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Austin Gerard Duffy (Thoracic & Oncologic Surgery Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)","Jay  Hoofnagle; MD (NIDDK) |Marc Gregory Ghany; MD (NIDDK) |Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Michael  Polis; MD (NIAID) |Shyamasundaran  Kottilil; MD, PhD (NIAID)","1. Fontana RJ, Hayashi P, Bonkovsky HL, Kleiner DE, Kochhar S, Gu J, Ghabril M (2013). Presentation and outcomes with clinically apparent interferon beta hepatotoxicity. Dig Dis Sci  58, 1766-75.   https://doi.org/10.1007/s10620-012-2553-1|2. Fuss IJ, Friend J, Yang Z, He JP, Hooda L, Boyer J, Xi L, Raffeld M, Kleiner DE, Heller T, Strober W (2013). Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol  33, 748-58.   https://doi.org/10.1007/s10875-013-9873-6|3. Ghabril M, Bonkovsky HL, Kum C, Davern T, Hayashi PH, Kleiner DE, Serrano J, Rochon J, Fontana RJ, Bonacini M, US Drug-Induced Liver Injury Network (2013). Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases. Clin Gastroenterol Hepatol  11, 558-564.e3.   https://doi.org/10.1016/j.cgh.2012.12.025|4. Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM (2013). Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide. Dig Dis Sci  58, 1415-21.   https://doi.org/10.1007/s10620-012-2493-9|5. Koh C, Heller T, Haynes-Williams V, Hara K, Zhao X, Feld JJ, Kleiner DE, Rotman Y, Ghany MG, Liang TJ, Hoofnagle JH (2013). Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. Aliment Pharmacol Ther  37, 887-94.   https://doi.org/10.1111/apt.12273|6. Koh C, Turner T, Zhao X, Minniti CP, Feld JJ, Simpson J, Demino M, Conrey AK, Jackson MJ, Seamon C, Kleiner DE, Kato GJ, Heller T (2013). Liver stiffness increases acutely during sickle cell vaso-occlusive crisis. Am J Hematol  88, E250-4.   https://doi.org/10.1002/ajh.23532|7. Osinusi A, Meissner EG, Lee YJ, Bon D, Heytens L, Nelson A, Sneller M, Kohli A, Barrett L, Proschan M, Herrmann E, Shivakumar B, Gu W, Kwan R, Teferi G, Talwani R, Silk R, Kotb C, Wroblewski S, Fishbein D, Dewar R, Highbarger H, Zhang X, Kleiner D, Wood BJ, et al. [8 more authors] (2013). Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA  310, 804-11.   https://doi.org/10.1001/jama.2013.109309|8. Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, Kleiner DE, Gorden P (2013). The liver diseases of lipodystrophy: the long-term effect of leptin treatment. J Hepatol  59, 131-7.   https://doi.org/10.1016/j.jhep.2013.02.007",https://intramural.nih.gov/search/searchview.taf?ipid=83650
716,BC010858-08,"October 01, 2013 -  September 30, 2014",CCR Confocal Microscopy Core,Susan H Garfield,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Langston  Lim|Poonam  Mannan,NULL,Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Sukhbir  Kaur (Laboratory of Pathology),Chava  Kimchi-Sarfaty (OD) |Kevin G Chen; MD (NINDS) |Zuben  Sauna; PhD (OD),"1. Kedei N, Lewin NE, Géczy T, Selezneva J, Braun DC, Chen J, Herrmann MA, Heldman MR, Lim L, Mannan P, Garfield SH, Poudel YB, Cummins TJ, Rudra A, Blumberg PM, Keck GE (2013). Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1. ACS Chem Biol  8, 767-77.   https://doi.org/10.1021/cb300671s|2. Pandey GS, Yanover C, Miller-Jenkins LM, Garfield S, Cole SA, Curran JE, Moses EK, Rydz N, Simhadri V, Kimchi-Sarfaty C, Lillicrap D, Viel KR, Przytycka TM, Pierce GF, Howard TE, Sauna ZE, PATH (Personalized Alternative Therapies for Hemophilia) Study Investigators (2013). Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A. Nat Med  19, 1318-24.   https://doi.org/10.1038/nm.3270",https://intramural.nih.gov/search/searchview.taf?ipid=83730
717,BC010859-08,"October 01, 2013 -  September 30, 2014",CCR Genomics Core,Kathleen D Hartman,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",Patricia  Johnson|Steven W Shema,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83732
718,BC010903-07,"October 01, 2013 -  September 30, 2014",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,"1. Anderson MJ, Naiche LA, Wilson CP, Elder C, Swing DA, Lewandoski M (2013). TCreERT2, a transgenic mouse line for temporal control of Cre-mediated recombination in lineages emerging from the primitive streak or tail bud. PLoS One  8, e62479.   https://doi.org/10.1371/journal.pone.0062479|2. Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW (2013). ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A  110, E736-45.   https://doi.org/10.1073/pnas.1222809110|3. Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, Kim D, Tessarollo L, Dawson VL, Dawson TM (2013). Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci  16, 1392-400.   https://doi.org/10.1038/nn.3500",https://intramural.nih.gov/search/searchview.taf?ipid=83820
719,BC010905-07,"October 01, 2013 -  September 30, 2014",Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Steven A Feldman|Kenichi  Hanada|Udai S Kammula|Richard A Morgan; PhD|Maria  Parkhurst|Giao Q Phan|Show all 11,NULL,Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Marybeth S Hughes (Thoracic & Oncologic Surgery Branch)|Prakash K Pandalai; MD (Thoracic & Oncologic Surgery Branch)|Udo  Rudloff (Thoracic & Oncologic Surgery Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,"1. Beard RE, Abate-Daga D, Rosati SF, Zheng Z, Wunderlich JR, Rosenberg SA, Morgan RA (2013). Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy. Clin Cancer Res  19, 4941-50.   https://doi.org/10.1158/1078-0432.CCR-13-1253|2. Dudley ME, Gross CA, Somerville RP, Hong Y, Schaub NP, Rosati SF, White DE, Nathan D, Restifo NP, Steinberg SM, Wunderlich JR, Kammula US, Sherry RM, Yang JC, Phan GQ, Hughes MS, Laurencot CM, Rosenberg SA (2013). Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma. J Clin Oncol  31, 2152-9.   https://doi.org/10.1200/JCO.2012.46.6441|3. Pos Z, Spivey TL, Liu H, Sommariva M, Chen J, Wunderlich JR, Parisi G, Tomei S, Ayotte BD, Stroncek DF, Malek JA, Robbins PF, Rivoltini L, Maio M, Chouchane L, Wang E, Marincola FM (2014). Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology. J Invest Dermatol  134, 1389-1396.   https://doi.org/10.1038/jid.2013.495|4. Turcotte S, Gros A, Tran E, Lee CC, Wunderlich JR, Robbins PF, Rosenberg SA (2014). Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy. Clin Cancer Res  20, 331-43.   https://doi.org/10.1158/1078-0432.CCR-13-1736",https://intramural.nih.gov/search/searchview.taf?ipid=83845
720,BC010915-07,"October 01, 2013 -  September 30, 2014",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Damian  Kovalovsky; PhD|Vanja  Lazarevic|Jung-Hyun  Park,NULL,"Zhi Ming  Zheng; MD, PhD (Gene Regulation and Chromosome Biology Laboratory)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Jeffrey Burnett Kopp; MD (NIDDK) |Myung Hee  Park; PhD (NIDCR) |David Barry Sacks (CC)","1. Lamy L, Ngo VN, Emre NC, Shaffer AL, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, Staudt LM (2013). Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell  23, 435-49.   https://doi.org/10.1016/j.ccr.2013.02.017|2. Massimelli MJ, Majerciak V, Kruhlak M, Zheng ZM (2013). Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J Virol  87, 243-56.   https://doi.org/10.1128/JVI.01693-12",https://intramural.nih.gov/search/searchview.taf?ipid=83864
721,BC010923-07,"October 01, 2013 -  September 30, 2014",Tissue Array Research Program,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Elaine S Jaffe; MD|Frederic Glenn Barr,NULL,"Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Javed  Khan; MD (Pediatric Oncology Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)","Alfredo A Molinolo; MD, PhD (NIDCR)","1. Armani M, Tangrea M, Yang B, Rosenberg A, Ylaya K, Morris J, Rodriguez-Canales J, Hanson J, Shapiro B, Emmert-Buck MR, Smela E, Hewitt SM (2014). Multiplex quantitative measurement of mRNAs from fixed tissue microarray sections. Appl Immunohistochem Mol Morphol  22, 323-30.   https://doi.org/10.1097/PDM.0000000000000039|2. Barisoni L, Nast CC, Jennette JC, Hodgin JB, Herzenberg AM, Lemley KV, Conway CM, Kopp JB, Kretzler M, Lienczewski C, Avila-Casado C, Bagnasco S, Sethi S, Tomaszewski J, Gasim AH, Hewitt SM (2013). Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol  8, 1449-59.   https://doi.org/10.2215/CJN.08370812|3. Cho H, Noh KH, Chung JY, Takikita M, Chung EJ, Kim BW, Hewitt SM, Kim TW, Kim JH (2014). Synaptonemal complex protein 3 is a prognostic marker in cervical cancer. PLoS One  9, e98712.   https://doi.org/10.1371/journal.pone.0098712|4. Cho H, Shin HY, Kim S, Kim JS, Chung JY, Chung EJ, Chun KH, Hewitt SM, Kim JH (2014). The role of S100A14 in epithelial ovarian tumors. Oncotarget  5, 3482-96.   https://doi.org/10.18632/oncotarget.1947|5. Chung JY, Braunschweig T, Hong SM, Kwon DS, Eo SH, Cho H, Hewitt SM (2014). Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array. Proteome Sci  12, 27.   https://doi.org/10.1186/1477-5956-12-27|6. Du Q, Yan W, Burton VH, Hewitt SM, Wang L, Hu N, Taylor PR, Armani MD, Mukherjee S, Emmert-Buck MR, Tangrea MA (2013). Validation of esophageal squamous cell carcinoma candidate genes from high-throughput transcriptomic studies. Am J Cancer Res  3, 402-10.|7. Fang C, Avis I, Bianco C, Held N, Morris J, Ylaya K, Hewitt SM, Aplin AC, Nicosia RF, Fung LA, Lewis JD, Stetler-Stevenson WG, Salomon DS, Cuttitta F (2013). SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells. Open J Clin Diagn  3, 37-51.   https://doi.org/10.4236/ojcd.2013.32009|8. Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, et al. [15 more authors] (2013). Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int  83, 749-56.   https://doi.org/10.1038/ki.2012.428|9. Keay T, Conway CM, O'Flaherty N, Hewitt SM, Shea K, Gavrielides MA (2013). Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer. J Pathol Inform  4, 19.   https://doi.org/10.4103/2153-3539.115879|10. Kim BW, Cho H, Chung JY, Conway C, Ylaya K, Kim JH, Hewitt SM (2013). Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. J Transl Med  11, 185.   https://doi.org/10.1186/1479-5876-11-185|11. Kitano H, Chung JY, Ylaya K, Conway C, Takikita M, Fukuoka J, Doki Y, Hanaoka J, Hewitt SM (2014). Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer. J Histochem Cytochem  62, 335-46.   https://doi.org/10.1369/0022155414523022|12. Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, Lee CC, Tsokos M, Hewitt S, Rushing EJ, Tamura D, Levens DL, Digiovanna JJ, Fine HA, Patronas N, Khan SG, Kleiner DE, Oberholtzer JC, Quezado MM, Kraemer KH (2013). The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathol Commun  1, 4.   https://doi.org/10.1186/2051-5960-1-4|13. Palmieri D, Duchnowska R, Woditschka S, Hua E, Qian Y, Biernat W, Sosińska-Mielcarek K, Gril B, Stark AM, Hewitt SM, Liewehr DJ, Steinberg SM, Jassem J, Steeg PS (2014). Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner. Clin Cancer Res  20, 2727-39.   https://doi.org/10.1158/1078-0432.CCR-13-2588|14. Simpson RM, Bastian BC, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, Ward JM, Dwyer JE, Davis BJ, Anver MR, Molinolo AA, Hoover SB, Rodriguez-Canales J, Hewitt SM (2014). Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res  27, 37-47.   https://doi.org/10.1111/pcmr.12185|15. Wu Y, Antony S, Hewitt SM, Jiang G, Yang SX, Meitzler JL, Juhasz A, Lu J, Liu H, Doroshow JH, Roy K (2013). Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody. Int J Oncol  42, 1229-38.   https://doi.org/10.3892/ijo.2013.1821|16. Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene  32, 5429-38.   https://doi.org/10.1038/onc.2012.590",https://intramural.nih.gov/search/searchview.taf?ipid=83783
722,BC010930-07,"October 01, 2013 -  September 30, 2014",Molecular Cytogenetics Core,Anna V Roschke,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI","Peter D Aplan; MD|Walter M Kuehl; MD, PhD|Ester K Rozenblum|Yulia  Demchenko|Karl Thomas Ried; MD",NULL,NULL,NULL,"1. Affer M, Chesi M, Chen WG, Keats JJ, Demchenko YN, Roschke AV, Van Wier S, Fonseca R, Bergsagel PL, Kuehl WM (2014). Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia  28, 1725-1735.   https://doi.org/10.1038/leu.2014.70|2. Kim GY, Gabrea A, Demchenko YN, Bergsagel L, Roschke AV, Kuehl WM (2014). Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets. Genes Chromosomes Cancer  53, 467-74.   https://doi.org/10.1002/gcc.22158|3. Roschke AV, Rozenblum E (2013). Multi-layered cancer chromosomal instability phenotype. Front Oncol  3, 302.   https://doi.org/10.3389/fonc.2013.00302",https://intramural.nih.gov/search/searchview.taf?ipid=83793
723,BC010934-07,"October 01, 2013 -  September 30, 2014",Immune reconstitution following autologous and allogeneic stem cell transplant,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI","Monica M Cho|Jacqueline Patricia Ford|Susan  Dhamala|Jeremy J Rose|Xiao Y Yan|Steven  Pavletic; MD, MS|Show all 11",NULL,Edward W Cowen (Dermatology Branch),Ping  Jin (CC) |David F Stroncek; MD (CC),"1. Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood  121, 2864-74.   https://doi.org/10.1182/blood-2012-08-446872",https://intramural.nih.gov/search/searchview.taf?ipid=83781
724,BC010936-07,"October 01, 2013 -  September 30, 2014",CCR VB FACS CORE,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Masaki  Terabe,Cliburn  Chan (Duke University)|Marcin  Moniuszko|Kent  Weinhold (DUMC),"Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Myong-Hee  Sung (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)",Lois Jean Patterson (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83882
725,BC010937-07,"October 01, 2013 -  September 30, 2014",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Justin Michael David; PhD|Charli Lynn Dominguez|Marjorie P Duberstein|Jeffrey  Schlom; PhD|Kwong Yok Tsang|James W Hodge; PhD,"Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Mario  Roselli (Oncology, Tor Vergata)|Herbert Kim Lyerly; MD","James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. Palena C, Schlom J (2013) Brachyury, in Cancer Therapeutic Targets. Marshall J, ed., in press.|2. Hamilton DH, Litzinger MT, Jales A, Huang B, Fernando RI, Hodge JW, Ardiani A, Apelian D, Schlom J, Palena C (2013) Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine. Oncotarget 4:1777-90|3. Huang B, Cohen JR, Fernando RI, Hamilton DH, Litzinger MT, Hodge JW, Palena C (2013). The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies. Cell Death Dis  4, e682.   https://doi.org/10.1038/cddis.2013.208|4. Larocca C, Cohen JR, Fernando RI, Huang B, Hamilton DH, Palena C (2013). An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype. Mol Cancer Ther  12, 1805-15.   https://doi.org/10.1158/1535-7163.MCT-12-1007",https://intramural.nih.gov/search/searchview.taf?ipid=83893
726,BC010947-07,"October 01, 2013 -  September 30, 2014",Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,Yvona  Ward; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Zhenggang  Liu; PhD,Massimo  Santoro|Ginesa  Garcia-Rostan (University of Valladolid),"Susan  Bates; MD (Developmental Therapeutics Branch)|Ofelia  Olivero; PhD (Laboratory of Cancer Biology and Genetics)|David  Levens; PhD (Laboratory of Pathology)|Sheueyann  Cheng; PhD (Gene Regulation Section)|Olga  Aprelikova; PhD (Laboratory of Cancer Biology and Genetics)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83835
727,BC010948-07,"October 01, 2013 -  September 30, 2014",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Jessica Shari Crystal|Mona E El gamil|Shahram S Farid|Yili  Li|Yong-Chen  Lu; PhD|Arnold L Mixon|Show all 9,NULL,NULL,NULL,"1. Aung PP, Liu YC, Ballester LY, Robbins PF, Rosenberg SA, Lee CC (2014). Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol  45, 259-67.   https://doi.org/10.1016/j.humpath.2013.05.029|2. Lanitis E, Smith JB, Dangaj D, Flingai S, Poussin M, Xu S, Czerniecki BJ, Li YF, Robbins PF, Powell DJ (2014). A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther  25, 730-9.   https://doi.org/10.1089/hum.2014.006|3. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath A, Wang T, Bielekova B, Wuest SC, Akula N, et al. [6 more authors] (2013). Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother  36, 133-51.   https://doi.org/10.1097/CJI.0b013e3182829903|4. Pos Z, Spivey TL, Liu H, Sommariva M, Chen J, Wunderlich JR, Parisi G, Tomei S, Ayotte BD, Stroncek DF, Malek JA, Robbins PF, Rivoltini L, Maio M, Chouchane L, Wang E, Marincola FM (2014). Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology. J Invest Dermatol  134, 1389-1396.   https://doi.org/10.1038/jid.2013.495|5. Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E, Samuels Y, Rosenberg SA (2013). Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med  19, 747-52.   https://doi.org/10.1038/nm.3161",https://intramural.nih.gov/search/searchview.taf?ipid=83787
728,BC010953-07,"October 01, 2013 -  September 30, 2014",Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Bih-Rong  Wei|Beverly  Mock; PhD|Kent W Hunter; PhD|Show all 8,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Mark  Raffeld; MD (Laboratory of Pathology)|Harold  Varmus; MD (Office Of The Director)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Chand  Khanna; MD (Pediatric Oncology Branch),NULL,"1. Bakhsheshian J, Wei BR, Chang KE, Shukla S, Ambudkar SV, Simpson RM, Gottesman MM, Hall MD (2013). Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2. Proc Natl Acad Sci U S A  110, 20801-6.   https://doi.org/10.1073/pnas.1312159110|2. Stuelten CH, Cervoni-Curet FN, Busch JI, Sutton E, Webster JD, Kavalukas SL, Wakefield LM, Barbul A, Niederhuber JE (2013) SDF-1 mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer. PLoS One 8:e60919|3. Zhang S, Pruitt M, Tran D, Du Bois W, Zhang K, Patel R, Hoover S, Simpson RM, Simmons J, Gary J, Snapper CM, Casellas R, Mock BA (2013). B cell-specific deficiencies in mTOR limit humoral immune responses. J Immunol  191, 1692-703.   https://doi.org/10.4049/jimmunol.1201767",https://intramural.nih.gov/search/searchview.taf?ipid=83802
729,BC010965-07,"October 01, 2013 -  September 30, 2014",CCR Biophysics Resource Core,Sergey G Tarasov,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",Kylie Janice Walters,Marzena E Pazgier|Vadim  Gaponenko|Jose  Casas-Finet,Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Retroviral Replication Laboratory)|David S Waugh; PhD (Protein Engineering Section)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Joost J Oppenheim; MD (Laboratory of Molecular Immunoregulation),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83821
730,BC010978-07,"October 01, 2013 -  September 30, 2014",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Carole A Parent; PhD|Ying  Zhang|Jeffrey S Rubin; MD, PhD",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine),"Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)","Paul E Love; MD, PhD (NICHD) |Justin W Taraska (NHLBI)","1. Balagopalan L, Barr VA, Kortum RL, Park AK, Samelson LE (2013). Cutting edge: cell surface linker for activation of T cells is recruited to microclusters and is active in signaling. J Immunol  190, 3849-53.   https://doi.org/10.4049/jimmunol.1202760|2. Coussens NP, Hayashi R, Brown PH, Balagopalan L, Balbo A, Akpan I, Houtman JC, Barr VA, Schuck P, Appella E, Samelson LE (2013). Multipoint binding of the SLP-76 SH2 domain to ADAP is critical for oligomerization of SLP-76 signaling complexes in stimulated T cells. Mol Cell Biol  33, 4140-51.   https://doi.org/10.1128/MCB.00410-13|3. Sherman E, Barr V, Samelson LE (2013). Super-resolution characterization of TCR-dependent signaling clusters. Immunol Rev  251, 21-35.   https://doi.org/10.1111/imr.12010",https://intramural.nih.gov/search/searchview.taf?ipid=83745
731,BC010981-07,"October 01, 2013 -  September 30, 2014","Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations",Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,Chwee Teck  Lim (National University of Singapore)|Siyang  Zheng (Penn State University),Lee Jay Helman; MD (Pediatric Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Alice Pinting Chen (Investigational Drug Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch),NULL,"1. Harouaka R, Kang Z, Zheng SY, Cao L (2014). Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications. Pharmacol Ther  141, 209-21.   https://doi.org/10.1016/j.pharmthera.2013.10.004",https://intramural.nih.gov/search/searchview.taf?ipid=83754
732,BC010989-07,"October 01, 2013 -  September 30, 2014",Clinical production of viral vectors for cancer gene therapy,Steven A Feldman,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Yasmine  Assadipour|Hui  Xu|James Chung-Yin Yang; MD, PhD|Maria  Parkhurst|Paul  Robbins|Nicholas Phillip Restifo; MD|Show all 7",NULL,Ling  Zhang (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Crystal L. Mackall; MD (Pediatric Oncology Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Daniel W Lee (Pediatric Oncology Branch),Harry Lewis Malech; MD (NIAID),"1. Casati A, Varghaei-Nahvi A, Feldman SA, Assenmacher M, Rosenberg SA, Dudley ME, Scheffold A (2013). Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients. Cancer Immunol Immunother  62, 1563-73.   https://doi.org/10.1007/s00262-013-1459-x|2. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ, Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath A, Wang T, Bielekova B, Wuest SC, Akula N, et al. [6 more authors] (2013). Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother  36, 133-51.   https://doi.org/10.1097/CJI.0b013e3182829903",https://intramural.nih.gov/search/searchview.taf?ipid=83767
733,BC010991-07,"October 01, 2013 -  September 30, 2014",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83752
734,BC011016-07,"October 01, 2013 -  September 30, 2014",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",Jacek Tadeusz Lubkowski,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Honggao  Yan|Jozsef  Tozser",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Molecular Control and Genetics Section)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|Ding Jun Jin (Gene Regulation and Chromosome Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83823
735,BC011021-06,"October 01, 2013 -  September 30, 2014",Basic Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83444
736,BC011029-07,"October 01, 2013 -  September 30, 2014",Preclinical development and clinical monitoring of adoptive immune therapy,Frances  Hakim; PhD,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Vicki  Fellowes|Jeremy J Rose|Daniel H Fowler|Nancy M Hardy|James N Kochenderfer,NULL,NULL,NULL,"1. Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN (2013). B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res  19, 2048-60.   https://doi.org/10.1158/1078-0432.CCR-12-2422|2. Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR (2013). Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood  121, 2864-74.   https://doi.org/10.1182/blood-2012-08-446872|3. Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG, Hakim FT, Halverson DC, Fowler DH, Hardy NM, Mato AR, Hickstein DD, Gea-Banacloche JC, Pavletic SZ, Sportes C, Maric I, Feldman SA, Hansen BG, Wilder JS, Blacklock-Schuver B, Jena B, Bishop MR, Gress RE, Rosenberg SA (2013). Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood  122, 4129-39.   https://doi.org/10.1182/blood-2013-08-519413",https://intramural.nih.gov/search/searchview.taf?ipid=83782
737,BC011030-07,"October 01, 2013 -  September 30, 2014",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Richard A Morgan; PhD|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83894
738,BC011040-07,"October 01, 2013 -  September 30, 2014",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Allison  Gomez|Jonathan Keith Killian|David  Petersen|Marbin A Pineda|Holly S Stevenson|Show all 10,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Laufey Thora Amundadottir (Laboratory Translational Genomics)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch)",NULL,"1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013). Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics  12, 1621-31.   https://doi.org/10.1074/mcp.M112.026427|3. Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K (2013). Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nat Commun  4, 1449.   https://doi.org/10.1038/ncomms2438",https://intramural.nih.gov/search/searchview.taf?ipid=83764
739,BC011041-07,"October 01, 2013 -  September 30, 2014",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Sven  Bilke|Allison  Gomez|David  Petersen|Marbin A Pineda|Holly S Stevenson|Jennifer  Walling|Show all 8,NULL,"Michael R Emmert-Buck; MD, PhD (Laboratory of Pathology)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Kenneth H Kraemer; MD (Dermatology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Sharon Ann Savage (Clinical Genetics Branch)",NULL,"1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Teer JK, Johnston JJ, Anzick SL, Pineda M, Stone G, NISC Comparative Sequencing Program, Meltzer PS, Mullikin JC, Biesecker LG (2013). Massively-parallel sequencing of genes on a single chromosome: a comparison of solution hybrid selection and flow sorting. BMC Genomics  14, 253.   https://doi.org/10.1186/1471-2164-14-253",https://intramural.nih.gov/search/searchview.taf?ipid=83765
740,BC011042-07,"October 01, 2013 -  September 30, 2014",Global changes in specific histone modifications in cancer,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung|Elaine S Jaffe; MD,NULL,Gordon Lee Hager; PhD (Hormone Action and Oncogenesis Section)|Louis  Staudt; MD (Lymphoid Malignancies Branch),Keji  Zhao; PhD (NHLBI) |Katherine Rainsford Calvo (CC),"1. Baranello L, Kouzine F, Levens D (2014). CTCF and cohesin cooperate to organize the 3D structure of the mammalian genome. Proc Natl Acad Sci U S A  111, 889-90.   https://doi.org/10.1073/pnas.1321957111|2. Kouzine F, Levens D, Baranello L (2014). DNA topology and transcription. Nucleus  5, 195-202.   https://doi.org/10.4161/nucl.28909|3. Luchenko VL, Litman T, Chakraborty AR, Heffner A, Devor C, Wilkerson J, Stein W, Robey RW, Bangiolo L, Levens D, Bates SE (2014). Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin. Mol Oncol  8, 1379-92.   https://doi.org/10.1016/j.molonc.2014.05.001",https://intramural.nih.gov/search/searchview.taf?ipid=83868
741,BC011044-07,"October 01, 2013 -  September 30, 2014",Tissue ProcessingSequencing Core,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Catherine  Wells|Robert A Worrell,Catherine  Stolle (Childrenâ€™s Hospital of Philadelphia)|William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Joel  Moss; MD, PhD (NHLBI)","1. Cancer Genome Atlas Research Network (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature  499, 43-9.   https://doi.org/10.1038/nature12222|2. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J (2013). A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res  11, 1061-1071.   https://doi.org/10.1158/1541-7786.MCR-13-0111|3. Shuch B, Agochukwu N, Ricketts CJ, Vocke CD, Gautam R, Merino M, Linehan WM, Srinivasan R (2013) Vascular endothelial growth factor receptor-targeted therapy in succinate dehydrogenase C kidney cancer. J Clin Oncol, in press.|4. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|5. Sourbier C, Ricketts CJ, Matsumoto S, Crooks DR, Liao PJ, Mannes PZ, Yang Y, Wei MH, Srivastava G, Ghosh S, Chen V, Vocke CD, Merino M, Srinivasan R, Krishna MC, Mitchell JB, Pendergast AM, Rouault TA, Neckers L, Linehan WM (2014). Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell  26, 840-850.   https://doi.org/10.1016/j.ccell.2014.10.005",https://intramural.nih.gov/search/searchview.taf?ipid=83830
742,BC011047-07,"October 01, 2013 -  September 30, 2014",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",Mario A Anzano|Valery  Bliskovsky; PhD|Marta  Custer|Maudeline  Etienne|Anthony W Vieira|Susan  Walters|Show all 13,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|Konrad  Huppi; MD, PhD (Cancer Genetics Branch)|David  Levens; PhD (Laboratory of Pathology)|Philipp  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)","Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID) |Wendy  Weinberg (OD)","1. Nakahashi H, Kieffer Kwon KR, Resch W, Vian L, Dose M, Stavreva D, Hakim O, Pruett N, Nelson S, Yamane A, Qian J, Dubois W, Welsh S, Phair RD, Pugh BF, Lobanenkov V, Hager GL, Casellas R (2013). A genome-wide map of CTCF multivalency redefines the CTCF code. Cell Rep  3, 1678-1689.   https://doi.org/10.1016/j.celrep.2013.04.024|2. Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, DuBois W, Ward T, deCabo R, Gavrilova O, Mock B, Finkel T (2013). Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep  4, 913-20.   https://doi.org/10.1016/j.celrep.2013.07.030|3. Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J (2013). Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle  12, 1279-91.   https://doi.org/10.4161/cc.24364",https://intramural.nih.gov/search/searchview.taf?ipid=83760
743,BC011048-07,"October 01, 2013 -  September 30, 2014",Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu,"Shi-Yong  Sun (Emory University School of Medicine)|David  Loeb (Pediatric Hematology-Oncology, Johns Hopkins University)",Lee Jay Helman; MD (Pediatric Oncology Branch)|Chand  Khanna; MD (Pediatric Oncology Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch),Baolin  Zhang (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83755
744,BC011052-07,"October 01, 2013 -  September 30, 2014",Cytopathology Core,Armando  Filie|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Keith R Brosky|Tangi Y Howard|Dana K Erickson|Patricia A Fetsch|May Ester Owens|Mark J Roth|Show all 8,NULL,NULL,Monica C Skarulis; MD (NIDDK),"1. Murtas D, Maric D, De Giorgi V, Reinboth J, Worschech A, Fetsch P, Filie A, Ascierto ML, Bedognetti D, Liu Q, Uccellini L, Chouchane L, Wang E, Marincola FM, Tomei S (2013). IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes. Br J Cancer  109, 76-82.   https://doi.org/10.1038/bjc.2013.335",https://intramural.nih.gov/search/searchview.taf?ipid=83768
745,BC011068-07,"October 01, 2013 -  September 30, 2014",Laser Capture Microdissection Core Laboratory,"Michael R Emmert-Buck; MD, PhD",NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83766
746,BC011075-07,"October 01, 2013 -  September 30, 2014",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,"1. Chufan EE, Kapoor K, Sim HM, Singh S, Talele TT, Durell SR, Ambudkar SV (2013). Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1). PLoS One  8, e82463.   https://doi.org/10.1371/journal.pone.0082463",https://intramural.nih.gov/search/searchview.taf?ipid=83762
747,BC011077-07,"October 01, 2013 -  September 30, 2014",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83763
748,BC011079-07,"October 01, 2013 -  September 30, 2014",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Thu A Pham|Trinh  Pham|Liqiang  Xi; MD|Winnifred Theresa Navarro|Elaine S Jaffe; MD|Michael R Emmert-Buck; MD, PhD|Show all 9","rebecca  chernock (washington university)|Giuseppe  Giaccone; MD|Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Yoko  Tabe","Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Udai S Kammula (Surgery Branch)",Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID),"1. Bonzheim I, Irmler M, Klier-Richter M, Steinhilber J, Anastasov N, Schäfer S, Adam P, Beckers J, Raffeld M, Fend F, Quintanilla-Martinez L (2013). Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation. PLoS One  8, e64544.   https://doi.org/10.1371/journal.pone.0064544|2. Fuss IJ, Friend J, Yang Z, He JP, Hooda L, Boyer J, Xi L, Raffeld M, Kleiner DE, Heller T, Strober W (2013). Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol  33, 748-58.   https://doi.org/10.1007/s10875-013-9873-6|3. Herman SE, Sun X, McAuley EM, Hsieh MM, Pittaluga S, Raffeld M, Liu D, Keyvanfar K, Chapman CM, Chen J, Buggy JJ, Aue G, Tisdale JF, Pérez-Galán P, Wiestner A (2013). Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia  27, 2311-21.   https://doi.org/10.1038/leu.2013.131|4. Hudson J, Duncavage E, Tamburrino A, Salerno P, Xi L, Raffeld M, Moley J, Chernock RD (2013). Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Exp Mol Pathol  95, 62-7.   https://doi.org/10.1016/j.yexmp.2013.05.001|5. Huppmann AR, Roullet MR, Raffeld M, Jaffe ES (2013). Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol  31, e28-30.   https://doi.org/10.1200/JCO.2012.43.3797|6. Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES (2013). Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer  60, 1165-70.   https://doi.org/10.1002/pbc.24462|7. Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI (2013). Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome. Blood  121, 2364-6.   https://doi.org/10.1182/blood-2012-12-472720|8. Kreitman RJ, Wilson W, Calvo KR, Arons E, Roth L, Sapolsky J, Zhou H, Raffeld M, Stetler-Stevenson M (2013). Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clin Cancer Res  19, 6873-81.   https://doi.org/10.1158/1078-0432.CCR-13-1752|9. Lai CH, Park KS, Lee DH, Alberobello AT, Raffeld M, Pierobon M, Pin E, Petricoin Iii EF, Wang Y, Giaccone G (2014). HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. Oncogene  33, 4867-76.   https://doi.org/10.1038/onc.2013.439|10. Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES (2013). Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall. Histopathology  63, 877-80.   https://doi.org/10.1111/his.12213|11. Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES (2013). Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol  37, 816-26.   https://doi.org/10.1097/PAS.0b013e3182785610|12. Thomas A, Xi L, Carter CA, Rajan A, Khozin S, Szabo E, Dennis PA, Giaccone G, Raffeld M (2013). Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations. Clin Lung Cancer  14, 452-6.   https://doi.org/10.1016/j.cllc.2013.01.005|13. Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC (2013). Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood  121, 476-84.   https://doi.org/10.1182/blood-2012-08-450585",https://intramural.nih.gov/search/searchview.taf?ipid=83900
749,BC011086-07,"October 01, 2013 -  September 30, 2014",Brain Tumor Animal Therapeutics Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",John Keenam Park (NINDS) |Robert  Innis; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83770
750,BC011087-07,"October 01, 2013 -  September 30, 2014",Immunohistochemistry Core Laboratory,Mark  Raffeld; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Cynthia A Harris|Hong  Jin|Charisma D Roque|Elaine S Jaffe; MD|Stefania  Pittaluga|Markku Martti Miettinen,Giuseppe  Giaccone; MD|Alexander Oliver Vortmeyer; MD (NINDS),"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)","Raphaela  Goldbach-Mansky; MD, MHS (NIAMS) |Amy D Klion; MD (NIAID)","1. Carpenter RO, Evbuomwan MO, Pittaluga S, Rose JJ, Raffeld M, Yang S, Gress RE, Hakim FT, Kochenderfer JN (2013). B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin Cancer Res  19, 2048-60.   https://doi.org/10.1158/1078-0432.CCR-12-2422|2. Huppmann AR, Roullet MR, Raffeld M, Jaffe ES (2013). Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol  31, e28-30.   https://doi.org/10.1200/JCO.2012.43.3797|3. Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES (2013). Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer  60, 1165-70.   https://doi.org/10.1002/pbc.24462|4. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|5. Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI (2013). Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome. Blood  121, 2364-6.   https://doi.org/10.1182/blood-2012-12-472720|6. Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES (2013). Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall. Histopathology  63, 877-80.   https://doi.org/10.1111/his.12213|7. Nicolae A, Pittaluga S, Venkataraman G, Vijnovich-Baron A, Xi L, Raffeld M, Jaffe ES (2013). Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol  37, 816-26.   https://doi.org/10.1097/PAS.0b013e3182785610|8. Venkataraman G, Song JY, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Traverse-Glehen A, Eberle FC, Hanson JC, Raffeld MA, Pittaluga S, Jaffe ES (2013). Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood  121, 1795-804.   https://doi.org/10.1182/blood-2012-06-439455",https://intramural.nih.gov/search/searchview.taf?ipid=83897
751,BC011093-07,"October 01, 2013 -  September 30, 2014",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Linda Shonk Weaver|Constance M Yuan,NULL,"Richard  Little; MD, PhD (Clinical Investigations Branch)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83818
752,BC011104-07,"October 01, 2013 -  September 30, 2014",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Linda Shonk Weaver,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Terry J Fry (Pediatric Oncology Branch)|Daniel W Lee (Pediatric Oncology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Burotto M, Stetler-Stevenson M, Arons E, Zhou H, Wilson W, Kreitman RJ (2013). Bendamustine and rituximab in relapsed and refractory hairy cell leukemia. Clin Cancer Res  19, 6313-21.   https://doi.org/10.1158/1078-0432.CCR-13-1848|2. Degheidy HA, Gadalla SM, Farooqui MZ, Abbasi F, Arthur DC, Bauer SR, Wilson WH, Wiestner A, Stetler-Stevenson MA, Marti GE (2013). Bcl-2 level as a biomarker for 13q14 deletion in CLL. Cytometry B Clin Cytom  84, 237-47.   https://doi.org/10.1002/cyto.b.21090|3. Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ (2013). Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia. Blood  121, 1165-74.   https://doi.org/10.1182/blood-2012-06-438002|4. Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O (2014). Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. Leuk Lymphoma  55, 1402-3.   https://doi.org/10.3109/10428194.2013.831091|5. Tembhare PR, Marti G, Wiestner A, Degheidy H, Farooqui M, Kreitman RJ, Jasper GA, Yuan CM, Liewehr D, Venzon D, Stetler-Stevenson M (2013). Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemia. Am J Clin Pathol  140, 813-8.   https://doi.org/10.1309/AJCPYFQ4XMGJD6TI",https://intramural.nih.gov/search/searchview.taf?ipid=83817
753,BC011137-06,"October 01, 2013 -  September 30, 2014",Center for Applied Preclinical Research (CAPR),Terry Anne Van Dyke,NULL,"Office of the Director, NCI",Maureen Baran Gearheart|N Keith Collins|Rajaa  Elmeskini|Melanie  Gordon|Theresa Mae Guerin|Michelle Leann Gumprecht|Show all 18,"David  Gandara (University of Califormia at Davis)|Neal  Goodwin (Jackson Laboratory, West)|Marcus  Bosenberg (Yale University)|Annette  Walter (Clovis Oncology, Inc.)|Ross  Cagan (Mount Sinai School of Medicine)|Leroy E Hood",Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics),"Christopher P Austin; AB, MD (NHGRI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83447
754,BC011138-07,"October 01, 2013 -  September 30, 2014",FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83898
755,BC011139-07,"October 01, 2013 -  September 30, 2014",Application of novel laser technology for flow cytometric analysis.,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83899
756,BC011236-06,"October 01, 2013 -  September 30, 2014",CCR-Frederick Flow Cytometry Core,Kathleen  Noer,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Roberta M Matthai|Guity  Mohammadi,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83938
757,BC011237-06,"October 01, 2013 -  September 30, 2014",CIP Genomics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Hong  Lou|Ying  Qi,Robert  Lanford (Texas Biomedical Research Institute)|Effie  Petersdorf (Fred Hutchinson),"Mary  Carrington; MS, PhD (Laboratory of Experimental Immunology)|Michael  Dean; PhD (Laboratory of Experimental Immunology)|Daniel  McVicar; PhD (Laboratory of Experimental Immunology)|Scott K Durum; PhD (Laboratory of Molecular Immunoregulation)|Ruth  Nussinov; PhD (Laboratory of Experimental Immunology)",NULL,"1. Apps R, Qi Y, Carlson JM, Chen H, Gao X, Thomas R, Yuki Y, Del Prete GQ, Goulder P, Brumme ZL, Brumme CJ, John M, Mallal S, Nelson G, Bosch R, Heckerman D, Stein JL, Soderberg KA, Moody MA, Denny TN, Zeng X, Fang J, Moffett A, Lifson JD, Goedert JJ, et al. [12 more authors] (2013). Influence of HLA-C expression level on HIV control. Science  340, 87-91.   https://doi.org/10.1126/science.1232685|2. Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH, Duggal P, Hussain S, Martinson J, Weintrob A, Kirk GD, Fellay J, Buchbinder SP, Goedert JJ, Deeks SG, Pereyra F, Trowsdale J, Lichterfeld M, Telenti A, Walker BD, et al. [3 more authors] (2014). LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS Genet  10, e1004196.   https://doi.org/10.1371/journal.pgen.1004196|3. Dean M, Lou H (2013). Genetics and genomics of prostate cancer. Asian J Androl  15, 309-13.   https://doi.org/10.1038/aja.2013.29|4. Kulkarni S, Qi Y, O'hUigin C, Pereyra F, Ramsuran V, McLaren P, Fellay J, Nelson G, Chen H, Liao W, Bass S, Apps R, Gao X, Yuki Y, Lied A, Ganesan A, Hunt PW, Deeks SG, Wolinsky S, Walker BD, Carrington M (2013). Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc Natl Acad Sci U S A  110, 20705-10.   https://doi.org/10.1073/pnas.1312237110|5. McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, et al. [21 more authors] (2013). Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog  9, e1003515.   https://doi.org/10.1371/journal.ppat.1003515|6. Nickerson ML, Im KM, Misner KJ, Tan W, Lou H, Gold B, Wells DW, Bravo HC, Fredrikson KM, Harkins TT, Milos P, Zbar B, Linehan WM, Yeager M, Andresson T, Dean M, Bova GS (2013). Somatic alterations contributing to metastasis of a castration-resistant prostate cancer. Hum Mutat  34, 1231-41.   https://doi.org/10.1002/humu.22346|7. Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M, Kuhl B, Alter G, Deeks SG, Walker BD, Gao X, Sette A, Carrington M, Streeck H (2013). Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control. Nat Med  19, 930-3.   https://doi.org/10.1038/nm.3229",https://intramural.nih.gov/search/searchview.taf?ipid=83939
758,BC011257-05,"October 01, 2013 -  September 30, 2014",Applied Molecular Pathology Laboratory,"Stephen M Hewitt; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",NULL,NULL,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Jonine Danya Figueroa (Hormonal and Reproductive Epidemiology Branch)|Nicolas Albert Hermann Wentzensen (Hormonal and Reproductive Epidemiology Branch)|Xiaohong Rose Yang; PhD (Genetic Epidemiology Branch)|Lee Elizabeth Moore; PhD, MD (Occupational and Environmental Epidemiology Branch)|Philip  Taylor; MD, ScD (Genetic Epidemiology Branch)",NULL,"1. Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS (2014). Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut  63, 236-43.   https://doi.org/10.1136/gutjnl-2013-304531|2. Horne HN, Sherman ME, Garcia-Closas M, Pharoah PD, Blows FM, Yang XR, Hewitt SM, Conway CM, Lissowska J, Brinton LA, Prokunina-Olsson L, Dawson SJ, Caldas C, Easton DF, Chanock SJ, Figueroa JD (2014). Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression. Breast Cancer Res Treat  143, 181-7.   https://doi.org/10.1007/s10549-013-2771-z|3. Jia J, Bosley AD, Thompson A, Hoskins JW, Cheuk A, Collins I, Parikh H, Xiao Z, Ylaya K, Dzyadyk M, Cozen W, Hernandez BY, Lynch CF, Loncarek J, Altekruse SF, Zhang L, Westlake CJ, Factor VM, Thorgeirsson S, Bamlet WR, Hewitt SM, Petersen GM, Andresson T, Amundadottir LT (2014). CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Cancer Res  74, 2785-95.   https://doi.org/10.1158/0008-5472.CAN-13-3176|4. Li WQ, Hu N, Burton VH, Yang HH, Su H, Conway CM, Wang L, Wang C, Ding T, Xu Y, Giffen C, Abnet CC, Goldstein AM, Hewitt SM, Taylor PR (2014). PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev  23, 1579-1588.   https://doi.org/10.1158/1055-9965.EPI-13-1329|5. Yang XR, Figueroa JD, Hewitt SM, Falk RT, Pfeiffer RM, Lissowska J, Peplonska B, Brinton LA, Garcia-Closas M, Sherman ME (2013). Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat  137, 837-47.   https://doi.org/10.1007/s10549-012-2380-2",https://intramural.nih.gov/search/searchview.taf?ipid=83963
759,BC011265-05,"October 01, 2013 -  September 30, 2014",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Susan W Reid|Mary Ellen  Palko|Bradley D St Croix|Dolph Lee Hatfield; PhD,NULL,"Ola Mae Zack Howard (Laboratory of Molecular Immunoregulation)|Mark  Udey; MD (Dermatology Branch)|Teizo  Yoshimura; PhD (Laboratory of Molecular Immunoregulation)|Jairaj K Acharya; MBBS, PhD (Laboratory of Cell and Developmental Signaling)|Howard A Young; PhD (Laboratory of Experimental Immunology)",NULL,"1. Chen K, Liu M, Liu Y, Wang C, Yoshimura T, Gong W, Le Y, Tessarollo L, Wang JM (2013). Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation. J Biol Chem  288, 16262-73.   https://doi.org/10.1074/jbc.M113.450635|2. Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P (2014). Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis. Cancer Res  74, 3870-9.   https://doi.org/10.1158/0008-5472.CAN-13-3440|3. Kiviranta R, Yamana K, Saito H, Ho DK, Laine J, Tarkkonen K, Nieminen-Pihala V, Hesse E, Correa D, Määttä J, Tessarollo L, Rosen ED, Horne WC, Jenkins NA, Copeland NG, Warming S, Baron R (2013). Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages. J Exp Med  210, 969-85.   https://doi.org/10.1084/jem.20121187|4. Yang MY, Hilton MB, Seaman S, Haines DC, Nagashima K, Burks CM, Tessarollo L, Ivanova PT, Brown HA, Umstead TM, Floros J, Chroneos ZC, St Croix B (2013). Essential regulation of lung surfactant homeostasis by the orphan G protein-coupled receptor GPR116. Cell Rep  3, 1457-64.   https://doi.org/10.1016/j.celrep.2013.04.019|5. Yoshimura T, Galligan C, Takahashi M, Chen K, Liu M, Tessarollo L, Wang JM (2014). Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2. Front Immunol  4, 482.   https://doi.org/10.3389/fimmu.2013.00482",https://intramural.nih.gov/search/searchview.taf?ipid=83968
760,BC011309-05,"October 01, 2013 -  September 30, 2014",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Jung-Hyun  Park|Damian  Kovalovsky; PhD|Vanja  Lazarevic,NULL,Dinah  Singer; PhD (Molecular Regulation Section)|Richard J Hodes; MD (Immune Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83995
761,BC011310-05,"October 01, 2013 -  September 30, 2014",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Jung-Hyun  Park|Damian  Kovalovsky; PhD,NULL,Dinah  Singer; PhD (Molecular Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83996
762,BC011331-05,"October 01, 2013 -  September 30, 2014",CCR Sequencing Facility,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",Oksana  German|Sucheta Vasant Godbole|Sujatha B Gowda|Yuliya  Kriga|Natalia Eunice Theresa Noyes|Shashikala Dilhani Ratnayake|Show all 14,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84011
763,BC011380-04,"October 01, 2013 -  September 30, 2014",Multivalent Inhibition of Integrin alphaVbeta3,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84034
764,BC011392-04,"October 01, 2013 -  September 30, 2014",Center for Cancer Research Genetics Core,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84043
765,BC011428-03,"October 01, 2013 -  September 30, 2014","CCR, LGI, Flow Cytometry Core Facility",Karen Marie Wolcott,Andre A Nussenzweig; PhD,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84112
766,BC011430-03,"October 01, 2013 -  September 30, 2014",CPTR - Mass Spectrometry,Lisa Marie Jenkins,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",Yang  Zhang,NULL,"Ettore  Appella; MD (Chemical Immunology Section)|Michael Marc Gottesman; MD (Multidrug Resistence Section)|Carole A Parent; PhD (Laboratory of Cellular and Molecular Biology)|Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Curtis  Harris; MD (Molecular Genetics and Carcinogenesis Section)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)",Rafael Cristian Casellas; PhD (NIAMS) |Willy Albrecht Flegel; MD (CC),"1. Humbard MA, Surkov S, De Donatis GM, Jenkins LM, Maurizi MR (2013). The N-degradome of Escherichia coli: limited proteolysis in vivo generates a large pool of proteins bearing N-degrons. J Biol Chem  288, 28913-24.   https://doi.org/10.1074/jbc.M113.492108",https://intramural.nih.gov/search/searchview.taf?ipid=84088
767,BC011434-03,"October 01, 2013 -  September 30, 2014","Nano-scale proteomic analysis: development, implementation, and applications",Jinqiu  Chen,Vincent J. Hearing; PhD,"Laboratory of Cell Biology, NCI",Michelle Anne Herrmann,NULL,"Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Liang  Cao (Cancer Genetics Branch)|Natasha  Caplen (Cancer Genetics Branch)|Karlyne M Reilly; BS, PhD (Office of the Director)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Michael Marc Gottesman; MD (Multidrug Resistence Section)",Jeffery L Miller; MD (NIDDK),"1. Bakhsheshian J, Hall MD, Robey RW, Herrmann MA, Chen JQ, Bates SE, Gottesman MM (2013). Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos  41, 1805-12.   https://doi.org/10.1124/dmd.113.053140|2. Chen JQ, Heldman MR, Herrmann MA, Kedei N, Woo W, Blumberg PM, Goldsmith PK (2013). Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western system. Anal Biochem  442, 97-103.   https://doi.org/10.1016/j.ab.2013.07.022|3. Chen JQ, Lee JH, Herrmann MA, Park KS, Heldman MR, Goldsmith PK, Wang Y, Giaccone G (2013). Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer. Mol Cancer Ther  12, 2601-13.   https://doi.org/10.1158/1535-7163.MCT-13-0074|4. Kedei N, Lewin NE, Géczy T, Selezneva J, Braun DC, Chen J, Herrmann MA, Heldman MR, Lim L, Mannan P, Garfield SH, Poudel YB, Cummins TJ, Rudra A, Blumberg PM, Keck GE (2013). Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1. ACS Chem Biol  8, 767-77.   https://doi.org/10.1021/cb300671s",https://intramural.nih.gov/search/searchview.taf?ipid=84095
768,BC011475-02,"October 01, 2013 -  September 30, 2014",Genomics and Bioinformatics Group web site development and maintenance.,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma,NULL,NULL,NULL,"1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Reinhold WC, Varma S, Sousa F, Sunshine M, Abaan OD, Davis SR, Reinhold SW, Kohn KW, Morris J, Meltzer PS, Doroshow JH, Pommier Y (2014) NCI-60 whole exome sequencing and pharmacological CellMiner analyses. PLoS ONE, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=84126
769,BC011497-02,"October 01, 2013 -  September 30, 2014",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84124
770,BC011499-02,"October 01, 2013 -  September 30, 2014",DNA methylation data and its web-based tool for the NCI-60.,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Margot  Sunshine|Sudhir  Varma|James Halpern Doroshow,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84123
771,BC011509-02,"October 01, 2013 -  September 30, 2014",Comparison of molecular factors to drug activities.,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Vinodh  Rajapakse|Margot  Sunshine|Sudhir  Varma|Barry R Zeeberg; PhD|James Halpern Doroshow,NULL,Joel  Morris (Drug Synthesis and Chemistry Branch),NULL,"1. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, Walker RL, Pineda M, Gindin Y, Jiang Y, Reinhold WC, Holbeck SL, Simon RM, Doroshow JH, Pommier Y, Meltzer PS (2013). The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res  73, 4372-82.   https://doi.org/10.1158/0008-5472.CAN-12-3342|2. Giovinazzi S, Morozov VM, Summers MK, Reinhold WC, Ishov AM (2013). USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase. Cell Death Differ  20, 721-31.   https://doi.org/10.1038/cdd.2012.169|3. Reinhold WC, Varma S, Sousa F, Sunshine M, Abaan OD, Davis SR, Reinhold SW, Kohn KW, Morris J, Meltzer PS, Doroshow JH, Pommier Y (2014) NCI-60 whole exome sequencing and pharmacological CellMiner analyses. PLoS ONE, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=84125
772,BC011515-02,"October 01, 2013 -  September 30, 2014",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gary T Pauly,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84142
773,BC011531-02,"October 01, 2013 -  September 30, 2014",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84151
774,BC011532-02,"October 01, 2013 -  September 30, 2014",CCR Collaborative Bioinformatics Resource,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",Natalie Davidovna Abrams|Yvonne Jemimah Edwards|Fathi  Elloumi|Parthav A Jailwala|Li  Jia|Manjula Devi Kasoji|Show all 12,NULL,"Mirit I Aladjem; PhD (Developmental Therapeutics Branch)|Frederic Glenn Barr (Laboratory of Pathology)|William M Bonner; PhD (Developmental Therapeutics Branch)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Isaac Franklin Brownell; MD, PhD (Dermatology Branch)|Robert Andrew Byrd (Structural Biophysics Laboratory)",NULL,"1. Decicco-Skinner KL, Jung SA, Tabib T, Gwilliam JC, Alexander H, Goodheart SE, Merchant AS, Shan M, Garber C, Wiest JS (2013) Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis. Carcinogenesis 34:2789-98",https://intramural.nih.gov/search/searchview.taf?ipid=84161
775,BC011535-01,"October 01, 2013 -  September 30, 2014",SAXS Core,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Xianyang  Fang,Cheryl  Arrowsmith (University of Toronto)|David  Giedroc (Indiana University)|Jun  Q (Lerner Research Institute),Xinhua  Ji; PhD (Biomolecular Structure Section)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Mikhail V Kashlev (Molecular Mechanisms of Transcription Section),Adrian Riu Ferre-D'Amare (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87918
776,BC011567-01,"-  September 30, 2014",Development and Execution of High-Content Imaging Assays,Gianluca  Pegoraro,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Laurent L Ozbun|Daniel Robert Larson; PhD|Thomas A Misteli; PhD|Philipp  Oberdoerffer,NULL,"Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity)|Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)|Carol J Thiele (Pediatric Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87895
777,BC011569-01,"-  September 30, 2014",Cell Production Core Facility,Robert P Somerville,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87893
778,BC011571-01,"-  September 30, 2014",Transcription factor mobility,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Sourav  Ganguly|James G McNally; PhD|Tatsuya  Morisaki|Waltraud  Mueller,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87887
779,BC011574-01,"-  September 30, 2014",LRBGE Optical Microscopy Core,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Ronit  Salomon|Yamini Praful Dalal|Thomas A Misteli; PhD|Philipp  Oberdoerffer|Shalini  Oberdoerffer,"Alexander  Erkine (Butler University)|Keith  Wilkinson; PhD (Biochemistry, Emory University)","Munira A Basrai; PhD (Cancer Genetics Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Kyung  Lee; PhD (Chemistry Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)","Marta Liliana Catalfamo; PhD (NIAID) |Edward  Giniger; BS, MS, PHD (NINDS)","1. Poorey K, Viswanathan R, Carver MN, Karpova TS, Cirimotich SM, McNally JG, Bekiranov S, Auble DT (2013). Measuring chromatin interaction dynamics on the second time scale at single-copy genes. Science  342, 369-72.   https://doi.org/10.1126/science.1242369",https://intramural.nih.gov/search/searchview.taf?ipid=87890
780,BC011596-01,"-  September 30, 2014",CCR Dedicated Cores at the ATRF,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87876
781,CO020007-06,"October 01, 2013 -  September 30, 2014",NCI-Frederick Support and Technical Services,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Craig W Reynolds,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84167
782,CP010178-13,"October 01, 2013 -  September 30, 2014",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Tabassum  Bandey|Ian K Barrow|Michael  Beerman|Merideth  Brown|Laura Ann Burdett|Show all 25,NULL,Gilles F Thomas (Laboratory Translational Genomics)|Kashif  Haque (Office Of The Director)|Kevin  Jacobs (Laboratory Translational Genomics)|Calvin  Ott (Office Of The Director)|Liqun  Qi (Biorepositories & Biospecimen Research Branch),Jun  Lu (NIEHS),"1. Chung CC, Hsing AW, Edward Yeboah, Biritwum R, Tettey Y, Adjei A, Cook MB, De Marzo A, Netto G, Tay E, Boland JF, Yeager M, Chanock SJ (2014). A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry. Prostate  74, 579-89.   https://doi.org/10.1002/pros.22726",https://intramural.nih.gov/search/searchview.taf?ipid=84200
783,CP010203-06,"October 01, 2013 -  September 30, 2014",Applied Molecular Pathology Laboratory,Margaret Anne Tucker|IRP Faculty Profile,NULL,"Human Genetics Program, NCI",Karen E Berliner,NULL,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84223
784,CP010223-03,"October 01, 2013 -  September 30, 2014",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Louise  Brinton; PhD| | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Marianne  Henderson|Regina Gale Ziegler; PhD, MPH",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84244
785,CP010226-01,"October 01, 2013 -  September 30, 2014",Cohort and Biobank Development,"Amy  de Gonzalez|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Hannah  Yang|Amanda  Black|Catherine G Schairer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87856
786,SC006536-21,"October 01, 2013 -  September 30, 2014",Sample Processing and Analytical Methods Development for New Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Paula A Carter|Kathryn  Compton|Merrill E Goldsmith|Cody John Peer|Diana  Roame|Jeffrey Evan Roth|Show all 9,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)|Howard  Fine (NYU Langone Medical Center)",Heidi H Kong (Dermatology Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Elliot Brian Levy (CC) |Bradford J Wood; MD (CC),"1. Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL (2013). Phase I trial of a new schedule of romidepsin in patients with advanced cancers. Clin Cancer Res  19, 4499-507.   https://doi.org/10.1158/1078-0432.CCR-13-0095|2. Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR (2013). The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenet Genomics  23, 1-8.   https://doi.org/10.1097/FPC.0b013e32835aa8a2|3. Noonan AM, Eisch RA, Liewehr DJ, Sissung TM, Venzon DJ, Flagg TP, Haigney MC, Steinberg SM, Figg WD, Piekarz RL, Bates SE (2013). Electrocardiographic studies of romidepsin demonstrate its safety and identify a potential role for K(ATP) channel. Clin Cancer Res  19, 3095-104.   https://doi.org/10.1158/1078-0432.CCR-13-0109|4. Peer CJ, Brown JL, Martin TJ, Roth J, Spencer SD, Brassil P, McNeill KA, Kreisl TN, Fine HA, Figg WD (2013) A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 942-943:107-12|5. Peer CJ, Rao M, Spencer SD, Shahbazi S, Steeg PS, Schrump DS, Figg WD (2013). A rapid ultra HPLC-MS/MS method for the quantitation and pharmacokinetic analysis of 3-deazaneplanocin A in mice. J Chromatogr B Analyt Technol Biomed Life Sci  927, 142-6.   https://doi.org/10.1016/j.jchromb.2013.01.003|6. Prager AJ, Peng CR, Lita E, McNally D, Kaushal A, Sproull M, Compton K, Dahut WL, Figg WD, Citrin D, Camphausen KA (2013). Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer. Biomark Med  7, 831-41.   https://doi.org/10.2217/bmm.13.112",https://intramural.nih.gov/search/searchview.taf?ipid=84303
787,SC006537-21,"October 01, 2013 -  September 30, 2014",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office of the Director, NCI",Kathryn  Compton|Andrew Kiem Goey|Alesia J Holly|Cody John Peer|Tristan  Sissung|Jeffrey Evan Roth,"Jurgen  Venitz (School of Pharmacy, Virginia Commonwealth University)|Alex  Sparreboom|Michael  Pacanowski (FDA)|Mark  Ratain (University of Chicago)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Heidi H Kong (Dermatology Branch)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),NULL,"1. Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL (2013). Phase I trial of a new schedule of romidepsin in patients with advanced cancers. Clin Cancer Res  19, 4499-507.   https://doi.org/10.1158/1078-0432.CCR-13-0095|2. Figg WD, Newell DR (2014). Pharmacologic biomarkers in the development of stratified cancer medicine. Clin Cancer Res  20, 2525-9.   https://doi.org/10.1158/1078-0432.CCR-14-0511|3. Kelly RJ, Thomas A, Rajan A, Chun G, Lopez-Chavez A, Szabo E, Spencer S, Carter CA, Guha U, Khozin S, Poondru S, Van Sant C, Keating A, Steinberg SM, Figg W, Giaccone G (2013). A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer. Ann Oncol  24, 2601-6.   https://doi.org/10.1093/annonc/mdt249|4. Lewis JP, Horenstein RB, Ryan K, O'Connell JR, Gibson Q, Mitchell BD, Tanner K, Chai S, Bliden KP, Tantry US, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Gurbel PA, Shuldiner AR (2013). The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. Pharmacogenet Genomics  23, 1-8.   https://doi.org/10.1097/FPC.0b013e32835aa8a2|5. Moriyama B, Jarosinski PF, Figg WD, Henning SA, Danner RL, Penzak SR, Wayne AS, Walsh TJ (2013). Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype. Pharmacotherapy  33, e19-22.   https://doi.org/10.1002/phar.1192|6. Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC (2013). Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood  121, 476-84.   https://doi.org/10.1182/blood-2012-08-450585",https://intramural.nih.gov/search/searchview.taf?ipid=84304
788,SC006743-21,"October 01, 2013 -  September 30, 2014",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Elham  Fotoohabadi|Ari Benjamin Frosch|Min Jung Lee|Sunmin T Lee|Katherine Roberts Mackall|Yusuke  Tomita,"Jay  Bradner (Chemical Biology Program, Broad Institute)|Marc  Cox (University of Texas at El Paso)|Christophe  Nicot (-, University of Kansas Medical Center)|Shiv  Srivastava (Urology, CPDR, USUHS)","Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)","Karel  Pacak; MD, PhD (NICHD)","1. Beebe K, Mollapour M, Scroggins B, Prodromou C, Xu W, Tokita M, Taldone T, Pullen L, Zierer BK, Lee MJ, Trepel J, Buchner J, Bolon D, Chiosis G, Neckers L (2013). Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors. Oncotarget  4, 1065-74.   https://doi.org/10.18632/oncotarget.1099|2. Bellon M, Ko NL, Lee MJ, Yao Y, Waldmann TA, Trepel JB, Nicot C (2013). Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood  121, 5045-54.   https://doi.org/10.1182/blood-2012-07-439109|3. Giubellino A, Sourbier C, Lee MJ, Scroggins B, Bullova P, Landau M, Ying W, Neckers L, Trepel JB, Pacak K (2013). Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma. PLoS One  8, e56083.   https://doi.org/10.1371/journal.pone.0056083|4. Park SR, Speranza G, Piekarz R, Wright JJ, Kinders RJ, Wang L, Pfister T, Trepel JB, Lee MJ, Alarcon S, Steinberg SM, Collins J, Doroshow JH, Kummar S (2013). A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas. Cancer Chemother Pharmacol  71, 981-90.   https://doi.org/10.1007/s00280-013-2091-3|5. Sourbier C, Scroggins BT, Ratnayake R, Prince TL, Lee S, Lee MJ, Nagy PL, Lee YH, Trepel JB, Beutler JA, Linehan WM, Neckers L (2013). Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. Cancer Cell  23, 228-37.   https://doi.org/10.1016/j.ccr.2012.12.007|6. Yardley DA, Ismail-Khan RR, Melichar B, Lichinitser M, Munster PN, Klein PM, Cruickshank S, Miller KD, Lee MJ, Trepel JB (2013). Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor. J Clin Oncol  31, 2128-35.   https://doi.org/10.1200/JCO.2012.43.7251|7. Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S, Vartholomaiou E, Tatokoro M, Beebe K, Miyajima N, Mohney RP, Chen Y, Hasumi H, Xu W, Fukushima H, Nakamura K, Koga F, Kihara K, Trepel J, Picard D, Neckers L (2013). Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A  110, E1604-12.   https://doi.org/10.1073/pnas.1220659110",https://intramural.nih.gov/search/searchview.taf?ipid=84302
789,SC009372-23,"October 01, 2013 -  September 30, 2014",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Gregory A Jasper|Catharine S Mccoy|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Susan  Bates; MD (Developmental Therapeutics Branch)|Ira H Pastan; MD (Molecular Biology Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Richard  Little; MD, PhD (Clinical Investigations Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Flanders A, Stetler-Stevenson M, Landgren O (2013). Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity. Blood  122, 1088-9.   https://doi.org/10.1182/blood-2013-05-506170|2. Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI (2013). Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome. Blood  121, 2364-6.   https://doi.org/10.1182/blood-2012-12-472720|3. Shaffer BC, Modric M, Stetler-Stevenson M, Arthur DC, Steinberg SM, Liewehr DJ, Fowler DH, Gale RP, Bishop MR, Pavletic SZ (2013). Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia. Exp Hematol  41, 772-8.   https://doi.org/10.1016/j.exphem.2013.04.015|4. Shao H, Calvo KR, Grönborg M, Tembhare PR, Kreitman RJ, Stetler-Stevenson M, Yuan CM (2013). Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria. Leuk Res  37, 401-409.   https://doi.org/10.1016/j.leukres.2012.11.021|5. Tembhare PR, Marti G, Wiestner A, Degheidy H, Farooqui M, Kreitman RJ, Jasper GA, Yuan CM, Liewehr D, Venzon D, Stetler-Stevenson M (2013). Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemia. Am J Clin Pathol  140, 813-8.   https://doi.org/10.1309/AJCPYFQ4XMGJD6TI|6. Tembhare PR, Yuan CM, Venzon D, Braylan R, Korde N, Manasanch E, Zuchlinsky D, Calvo K, Kurlander R, Bhutani M, Tageja N, Maric I, Mulquin M, Roschewski M, Kwok M, Liewehr D, Landgren O, Stetler-Stevenson M (2014). Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases. Leuk Res  38, 371-6.   https://doi.org/10.1016/j.leukres.2013.12.007",https://intramural.nih.gov/search/searchview.taf?ipid=84255
790,BC010686-10,"October 01, 2013 -  September 30, 2014",Clinical Operations for Laboratory of Pathology,"David Erwin Kleiner; MD, PhD",John Carl Oberholtzer,"Laboratory of Pathology, NCI",Earle J Barnes|Joseph  Chinquee|Jeannette Marie McNulty|Silke  Williams|Sarah Paige Young,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83649
791,BC010694-10,"October 01, 2013 -  September 30, 2014",Clinical Cancer Cytogenetics,Diane Carol Arthur; MD,John Carl Oberholtzer,"Laboratory of Pathology, NCI","Elaine S Jaffe; MD|Stefania  Pittaluga|Maryalice  Stetler-Stevenson; MD, PhD",NULL,"Blanche P Alter (Clinical Genetics Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Neelam K Giri; MD (Clinical Genetics Branch)|Sharon Ann Savage (Clinical Genetics Branch)|Ola Anders Landgren (Lymphoid Malignancies Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Gerald Ernest Marti (NHLBI) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Mohammed Zulfiqar Farooqui; DO (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83635
792,BC010882-07,"October 01, 2013 -  September 30, 2014",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83814
793,BC010963-07,"October 01, 2013 -  September 30, 2014",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",Crystal L. Mackall; MD (Pediatric Oncology Branch)|Shivaani  Kummar; PhD (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83777
794,BC010987-07,"October 01, 2013 -  September 30, 2014",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83815
795,BC010988-07,"October 01, 2013 -  September 30, 2014",Center for Cancer Research Clinical Trials Data Management Service,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83816
796,BC010990-07,"October 01, 2013 -  September 30, 2014",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83753
797,BC011022-06,"October 01, 2013 -  September 30, 2014",Clinical Research Support for the CCR,Robert  Wiltrout; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83445
798,BC011089-07,"October 01, 2013 -  September 30, 2014",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Donald P Bottaro; PhD,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|William Laurence Dahut; MD (Office Of The Clinical Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD) |Bradford J Wood; MD (CC) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83871
799,BC011092-07,"October 01, 2013 -  September 30, 2014",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,Maria  Merino; PhD (Laboratory of Pathology)|William Laurence Dahut; MD (Office Of The Clinical Director),"Karel  Pacak; MD, PhD (NICHD) |Pamela  Stratton; MD (NICHD) |Russell R Lonser; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83872
800,BC011098-07,"October 01, 2013 -  September 30, 2014",Brain Tumor Clinical and Clinical Research Program,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),"John Keenam Park (NINDS) |John Anthony Butman; MD, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83771
801,BC011242-06,"October 01, 2013 -  September 30, 2014",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 24,Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Udai S Kammula (Surgery Branch),"Elliot Brian Levy (CC) |Nadine  Abi Jaoudeh (CC) |Aradhana M Venkatesan (CC) |Karel  Pacak; MD, PhD (NICHD) |Karen T Adams (NICHD) |David Alan Bluemke; MD, PhD (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83961
802,BC011291-05,"October 01, 2013 -  September 30, 2014",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Tiffany Ashleigh Coates|Jerzy P Lasota|Zengfeng  Wang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83982
803,BC011317-05,"October 01, 2013 -  September 30, 2014",Dermatology Consultation Service,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Raphaela  Goldbach-Mansky; MD, MHS (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84002
804,BC011349-05,"October 01, 2013 -  September 30, 2014",Development of FISH Molecular  Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,John Carl Oberholtzer,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Elaine S Jaffe; MD|Maria  Merino; PhD|Markku Martti Miettinen|Frederic Glenn Barr|Eric  Batchelor; PhD|Show all 11,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Lauren V Wood; MD (Vaccine Branch),"Alexander M Gorbach; PhD (NIBIB) |Griffin Platt Rodgers; MD (NIDDK) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Zhengping  Zhuang; MD, PhD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84022
805,BC011517-02,"October 01, 2013 -  September 30, 2014",Pediatric Oncology Branch Behavioral Science Core,Melinda S Merchant,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Stacia Martin Peron; PhD|Kari Lyn Struemph|Mary Anne Toledo Tamula|Lori  Wiener; PhD, LCSW-C|Pamela  Wolters|Sima Lehimgar Zadeh|Show all 8",Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Jimmie  Holland (MSKCC)|David  Jacobson (CNMC)|Wendy  Lichtenthal (MSKCC)|Aziza  Shad (Georgetown),NULL,Maryland  Pao; MD (NIMH),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84139
806,BC011534-01,"October 01, 2013 -  September 30, 2014",EOB Clinical Core,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Rachel Dawn Aufforth|Ann Wild Gramza|Vladimir Kostadinov Neychev|Naris  Nilubol; MD|Dhaval T Patel|Samira Mercedes Sadowski,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87919
807,BC011539-01,"October 01, 2013 -  September 30, 2014",IL-15 in the immunotherapy of cancer,Kevin Charles Conlon,"Thomas Alexander Waldmann; MD, PhD","Lymphoid Malignancies Branch, NCI",NULL,NULL,"Stephen  Creekmore; PhD (Biological Resources Branch)|George N Pavlakis; MD, PhD (Vaccine Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87916
808,BC011540-01,"October 01, 2013 -  September 30, 2014",Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core,Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Lisa Ann Bengtson|Arlene Wendy Berman|Yuanbin  Chen; MD|Corrine Marie Keen|Yvonne D Mallory|Emerson Baes Padiernos|Show all 11,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87917
809,BC011541-01,"-  September 30, 2014",TGIB Surgical Consultative Services,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Marybeth S Hughes|Tricia M Frary|Deborah Ann Nielsen|Paul J Nolen|Prakash K Pandalai; MD|Colleen Donahue Bond|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87915
810,BC011543-01,"-  September 30, 2014",Medical Oncology Service Clinical Core,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",Robert Lee Alderman; PA-C|Janet A Edds|Candis  Morrison|Jeannette Christine Nashed|Megan Marshall Putman|Kathryn G Trewhitt|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87913
811,BC011578-01,"-  September 30, 2014",Clinical management of patients on immunotherapy protocols,Christopher Austin Klebanoff,NULL,"Surgery Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87891
812,SC006329-34,"October 01, 2013 -  September 30, 2014",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Frank S Harrington|Holly  Ning|Hu-Chen  Xie|Deborah E Citrin|Show all 9,NULL,"Jennifer Clare Jones; MD, PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84251
813,SC007202-31,"October 01, 2013 -  September 30, 2014",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",David J Liewehr|William Laurence Dahut; MD|David J Venzon; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Nancy M Hardy (Experimental Transplantation and Immunology Branch)",Zenaide Maria Quezado; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84247
814,BC010843-08,"October 01, 2013 -  September 30, 2014",Medical Oncology Fellowship Program,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83689
815,BC011023-07,"October 01, 2013 -  September 30, 2014",Clinical Fellowship Training Program,Peter A Pinto; MD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Shawna Lee Boyle|Sam Joseph Brancato|Thomas P Frye|Arvin Koruthu George|An Ngoc Hoang|Daniel  Su|Show all 7,NULL,Peter L Choyke; MD (Molecular Imaging Program)|Maria  Merino; PhD (Laboratory of Pathology),Bradford J Wood; MD (CC),"1. Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G (2013). Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery. J Endourol  27, 196-201.   https://doi.org/10.1089/end.2012.0483|2. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM (2014). Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol  11, 465-75.   https://doi.org/10.1038/nrurol.2014.162|3. Linehan WM, Ricketts CJ (2014) Decade in review-kidney cancer: discoveries, therapies and opportunities. Nat Rev Urol 11:614-6|4. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|5. Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA (2014). Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int  114, 641-52.   https://doi.org/10.1111/bju.12593|6. Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA (2013). Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds. BJU Int  112, 508-16.   https://doi.org/10.1111/bju.12126|7. Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2013). Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol  190, 1721-1727.   https://doi.org/10.1016/j.juro.2013.05.052|8. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013). Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol  64, 713-719.   https://doi.org/10.1016/j.eururo.2013.05.059|9. Sourbier C, Ricketts CJ, Matsumoto S, Crooks DR, Liao PJ, Mannes PZ, Yang Y, Wei MH, Srivastava G, Ghosh S, Chen V, Vocke CD, Merino M, Srinivasan R, Krishna MC, Mitchell JB, Pendergast AM, Rouault TA, Neckers L, Linehan WM (2014). Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer. Cancer Cell  26, 840-850.   https://doi.org/10.1016/j.ccell.2014.10.005|10. Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA (2013). Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer  119, 3359-66.   https://doi.org/10.1002/cncr.28216|11. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology  268, 144-52.   https://doi.org/10.1148/radiol.13121325|12. Walter BA, Valera VA, Pinto PA, Merino MJ (2013). Comprehensive microRNA Profiling of Prostate Cancer. J Cancer  4, 350-7.   https://doi.org/10.7150/jca.6394|13. Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013). Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol  190, 2020-2025.   https://doi.org/10.1016/j.juro.2013.05.118",https://intramural.nih.gov/search/searchview.taf?ipid=83895
816,BC011241-06,"October 01, 2013 -  September 30, 2014",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Tapan Mahendra Bhavsar|Theresa M Davies Hill|Nancy Ellen Diener|Shunyou  Gong|Stephanie Lee Nara|Stefania  Pittaluga|Show all 13,NULL,NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Bajor-Dattilo EB, Pittaluga S, Jaffe ES (2013). Pathobiology of T-cell and NK-cell lymphomas. Best Pract Res Clin Haematol  26, 75-87.   https://doi.org/10.1016/j.beha.2013.04.007|2. Huppmann AR, Nicolae A, Slack GW, Pittaluga S, Davies-Hill T, Ferry JA, Harris NL, Jaffe ES, Hasserjian RP (2014). EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am J Surg Pathol  38, 316-24.   https://doi.org/10.1097/PAS.0000000000000107|3. Huppmann AR, Roullet MR, Raffeld M, Jaffe ES (2013). Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. J Clin Oncol  31, e28-30.   https://doi.org/10.1200/JCO.2012.43.3797|4. Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES (2013). Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer  60, 1165-70.   https://doi.org/10.1002/pbc.24462|5. Liu Q, Pittaluga S, Davies-Hill T, Raffeld M, Xi L, Jaffe ES (2013). Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall. Histopathology  63, 877-80.   https://doi.org/10.1111/his.12213|6. Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaïde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B (2014). Early lesions of follicular lymphoma: a genetic perspective. Haematologica  99, 481-8.   https://doi.org/10.3324/haematol.2013.094474|7. Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S (2014). A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology  64, 455-9.   https://doi.org/10.1111/his.12274|8. Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA (2013). Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma. J Clin Oncol  31, e53-6.   https://doi.org/10.1200/JCO.2012.43.2377|9. Song JY, Jaffe ES (2013). HHV-8-positive but EBV-negative primary effusion lymphoma. Blood  122, 3712.   https://doi.org/10.1182/blood-2013-07-515882|10. Venkataraman G, Song JY, Tzankov A, Dirnhofer S, Heinze G, Kohl M, Traverse-Glehen A, Eberle FC, Hanson JC, Raffeld MA, Pittaluga S, Jaffe ES (2013). Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. Blood  121, 1795-804.   https://doi.org/10.1182/blood-2012-06-439455",https://intramural.nih.gov/search/searchview.taf?ipid=83927
817,BC011384-04,"October 01, 2013 -  September 30, 2014",Anatomic Pathology Residency Program,John Carl Oberholtzer,NULL,"Laboratory of Pathology, NCI","Meghna  Alimchandani; MD|Leomar Y Ballester; MD, PhD|Gregory Thomas Brown|Jennifer Lynne Dreiling; MD|Arunima  Ghosh|Sidharth  Kerkar|Show all 9",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84038
818,BC011516-02,"October 01, 2013 -  September 30, 2014",Pediatric Oncology Branch Clinical Care and Education,Melinda S Merchant,Crystal L. Mackall; MD,"Pediatric Oncology Branch, NCI","Catherine Michelle Albert|Sherri L Depollar|Ruchika  Goel|Christine Marie Heske|Kyle William Jackson; MD, MPH|Elad  Jacoby; MD|Show all 14",Jeffry  Keefer (Johns Hopkins University School of Medicine)|Ido  PazPriel (Johns Hopkins University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84138
819,BC011542-01,"-  September 30, 2014",TGIB Surgical Oncology Fellowship Program,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Marybeth S Hughes|Janice Marie Pappas|Lance Rodgers Redding|Prakash K Pandalai; MD|Paul J Nolen|David Juan-De Chen; MD|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=87914
820,SC000853-61,"October 01, 2013 -  September 30, 2014",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Michael R Emmert-Buck; MD, PhD|Mark  Raffeld; MD|David D Roberts; PhD",NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Antonio  Fojo; MD, PhD (Genitourinary Malignancies Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Bodogai M, Lee Chang C, Wejksza K, Lai J, Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C, Biragyn A (2013). Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res  73, 2127-38.   https://doi.org/10.1158/0008-5472.CAN-12-4184|2. Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R (2013). Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol  31, 181-6.   https://doi.org/10.1200/JCO.2012.43.3383|3. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PLM, Eng C, Linehan WM, Brugarolas J (2013). A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res  11, 1061-1071.   https://doi.org/10.1158/1541-7786.MCR-13-0111|4. Fox E, Widemann BC, Chuk MK, Marcus L, Aikin A, Whitcomb PO, Merino MJ, Lodish M, Dombi E, Steinberg SM, Wells SA, Balis FM (2013). Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Cancer Res  19, 4239-48.   https://doi.org/10.1158/1078-0432.CCR-13-0071|5. Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA (2013). Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer. Cancer Immunol Immunother  62, 1521-31.   https://doi.org/10.1007/s00262-013-1448-0|6. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM (2014). Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol  11, 465-75.   https://doi.org/10.1038/nrurol.2014.162|7. Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker RL, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu Y, Wang Y, Waterfall JJ, O'Sullivan MJ, Bibikova M, Pacak K, Stratakis C, Janeway KA, et al. [4 more authors] (2013). Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov  3, 648-57.   https://doi.org/10.1158/2159-8290.CD-13-0092|8. Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G (2013). Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma. Clin Cancer Res  19, 42-9.   https://doi.org/10.1158/1078-0432.CCR-12-2606|9. Merino M (2014) Hereditary leiomyomatosis and renal cell cancer. Orphanet, in press.|10. Pacak K, Jochmanova I, Prodanov T, Yang C, Merino MJ, Fojo T, Prchal JT, Tischler AS, Lechan RM, Zhuang Z (2013). New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol  31, 1690-8.   https://doi.org/10.1200/JCO.2012.47.1912|11. Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, Le Gallo M, NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program, Zhang S, Cruz P, Cherukuri PF, Hansen NF, McManus KJ, Godwin AK, Sgroi DC, Mullikin JC, Merino MJ, Hieter P, Bell DW (2014). Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One  8, e63313.   https://doi.org/10.1371/journal.pone.0063313|12. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH (2013). An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer  132, 2640-7.   https://doi.org/10.1002/ijc.27934|13. Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA (2013). Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol  190, 1721-1727.   https://doi.org/10.1016/j.juro.2013.05.052|14. Sadowski SM, He M, Gesuwan K, Gulati N, Celi F, Merino MJ, Nilubol N, Kebebew E (2013). Prospective screening in familial nonmedullary thyroid cancer. Surgery  154, 1194-8.   https://doi.org/10.1016/j.surg.2013.06.019|15. Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH (2014). Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol  32, 23.e9-13.   https://doi.org/10.1016/j.urolonc.2012.08.011|16. Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM (2013). Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol  190, 1990-8.   https://doi.org/10.1016/j.juro.2013.06.012|17. Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA (2013). Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol  64, 713-719.   https://doi.org/10.1016/j.eururo.2013.05.059|18. Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H, ISUP Renal Tumor Panel (2013). Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol  37, 1518-31.   https://doi.org/10.1097/PAS.0b013e318299f12e|19. Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL (2013). Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology  268, 144-52.   https://doi.org/10.1148/radiol.13121325|20. Walter BA, Valera VA, Pinto PA, Merino MJ (2013). Comprehensive microRNA Profiling of Prostate Cancer. J Cancer  4, 350-7.   https://doi.org/10.7150/jca.6394|21. Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA (2013). Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol  190, 2020-2025.   https://doi.org/10.1016/j.juro.2013.05.118",https://intramural.nih.gov/search/searchview.taf?ipid=84259
821,BC010569-11,"October 01, 2013 -  September 30, 2014",Comparative Oncology Program,Chand  Khanna; MD,Robert  Wiltrout; PhD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Amy Kathleen Leblanc; DVM|Lee Jay Helman; MD,"Cheryl  London (Center for Comparative Medicine, University Of California)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Susan  Lana (Department of Clinical Sciences, Colorado State University)|Steven  Suter (Department of Clinical Sciences, North Carolina State University)|William  Kisseberth (Veterinary Medicine, Ohio State University)|Lisa  Barber (Veterinary Medicine, Tufts University)|Show all 34","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Caryn  Steakley; BA, BSN, MSW (Office Of The Clinical Director)|Joseph E Tomaszewski (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|James Halpern Doroshow (Developmental Therapeutics Branch)",NULL,"1. Paoloni M, Webb C, Mazcko C, Cherba D, Hendricks W, Lana S, Ehrhart EJ, Charles B, Fehling H, Kumar L, Vail D, Henson M, Childress M, Kitchell B, Kingsley C, Kim S, Neff M, Davis B, Khanna C, Trent J (2014). Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trials. PLoS One  9, e90028.   https://doi.org/10.1371/journal.pone.0090028",https://intramural.nih.gov/search/searchview.taf?ipid=83625
822,BC010856-08,"October 01, 2013 -  September 30, 2014",Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,Mary C Custer,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83729
823,BC010931-07,"October 01, 2013 -  September 30, 2014",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Caroline Elizabeth Salter|Jessica Ann Beck|Jennifer B Dwyer|John  Hickerson|Shelley B Hoover|Matti  Kiupel; PhD|Show all 10,"Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Boris  Bastian (UCSF)|Marcus  Bosenberg (Yale University)|Glen  Esplin (Univsity of Utah)|Michael  Goldschmidt (University of Pennsylvania)|Donald  Meuten (North Carolina State University)|Show all 11","Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Lee Jay Helman; MD (Pediatric Oncology Branch)|Giorgio  Trinchieri (Laboratory of Experimental Immunology)|Kathleen  Kelly; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)|Patricia  Steeg; PhD (Womens Malignancies Branch)","Kanta  Subbarao; MD, MPH (NIAID) |Robert S Balaban; PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83801
824,BC011161-06,"October 01, 2013 -  September 30, 2014",The automated measurement of foci in fluorescence microscopy,Stuart J Austin|IRP Faculty Profile,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83903
825,BC011235-06,"October 01, 2013 -  September 30, 2014",Support of NCI CCR Clinical Research and Bioinformatics,Jeffrey D Shilling,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83946
826,BC011445-03,"October 01, 2013 -  September 30, 2014","Coordination of DNA Replication, Transcription and Chromatin Assembly",Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Mirit I Aladjem; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84079
827,CO020005-06,"October 01, 2013 -  September 30, 2014",National Cancer Informatics Program (NCIP),Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Dwayne D Forquer|George  Komatsoulis,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84166
828,CP010205-06,"October 01, 2013 -  September 30, 2014",Scientific Computing,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,NULL,"Marianne  Henderson (Office of Division Operations and Analysis)|Karen E Berliner (Human Genetics Program)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Louise  Brinton; PhD (Hormonal and Reproductive Epidemiology Branch)|Nilanjan  Chatterjee (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84225
829,BC011234-06,"October 01, 2013 -  September 30, 2014",CCR New Space Activation,Darren W Henderson,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83922
830,CO020002-06,"October 01, 2013 -  September 30, 2014",Space and Facilities Management,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,Daryl E Paunil (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84164
831,BC011133-06,"October 01, 2013 -  September 30, 2014",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",Kathy  Augustin|Viola D Black|Terry  Moody; PhD|Mary L Velthuis,NULL,"Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83448
832,BC011285-05,"October 01, 2013 -  September 30, 2014",CCR Education and Outreach,Kimberly R Martin,Robert  Wiltrout; PhD,"Office of the Director, NCI",Chris Russell Palmer,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83979
833,BC011365-02,"October 01, 2013 -  September 30, 2014",Cancer Research Training Fellowship,Janelle  Cortner,Jeffrey N Strathern,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=73897
834,CP010204-06,"October 01, 2013 -  September 30, 2014","Communications, Education and Outreach","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine B McClave|Jennifer K Loukissas|Alyssa Marie Voss|Wendy  Schneider-Levinson|Saloni  Nayar|Victoria Anne McCallum,NULL,Jackie Ann Lavigne (Office of Education)|Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84224
835,CP010208-05,"October 01, 2013 -  September 30, 2014",Special Studies Institutional Review Board Support,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine G Schairer|Marianne  Henderson,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84229
836,BC010857-08,"October 01, 2013 -  September 30, 2014",Science and Technology Resources,David Jay Goldstein,Robert  Wiltrout; PhD,"Office of the Director, NCI",Margaret  Cam; PhD|Peter C Fitzgerald|Mariam Q Malik|Carl E Mcintosh,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83731
837,BC011193-06,"October 01, 2013 -  September 30, 2014",Office of Policy and Intellectual Property,Eric A Hale,Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=83921
838,CO020001-06,"October 01, 2013 -  September 30, 2014",Technology Transfer Center,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"National Cancer Institute, NCI",Karen M Maurey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=84163
